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Abstract 
A series of seventy achiral and chiral ionic liquids was designed, synthesized and 
characterized. Out of these seventy ILs, fifteen are achiral, twenty one lactic acid based and 
rest are mandelic acid based ILs.  All compounds were characterized by a number of 
techniques including: 1H, 13C, 19F NMR, IR, MS and specific rotation.  
Antimicrobial and antifungal toxicity studies were carried out using the representative 
examples chosen from these ILs. Lactic and mandelic acid based ILs and ester based achiral 
ILs were found to be non toxic towards eight strains of bacteria and twelve strains of fungi. 
Antifungal toxicity was performed on two monoester and two diester CILs. Twenty one ILs 
were screened for biodegradation studies out of which the ILs with diester functionality were 
found to be readily biodegradable.  
Six achiral ester and amide based ILs were chosen to employ in Tsuji-Trost reactions as 
reaction media. Reactions were performed using two methods consisting use of two different 
bases. Chiral catalysts (S,S)-iPr-phosferrox, mandyphos and R-BINAP were used for chiral 
induction. Excellent enantioselectivities with moderate yields were obtained in these 
reactions. 
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Project Aim 
 
 To synthesise and characterise a library of novel low toxicity and readily biodegradable  
achiral ionic liquids (ILs) containing ester and amide functionality in the side-chain of the 
cation moiety 
 
 To investigate the antimicrobial toxicity and biodegradation properties of the achiral IL 
library 
 
 To establish the effects of the ester moiety, oxygen-containing side-chain and anion on the 
toxicity and biodegradability 
 
 To synthesise and characterise a library of novel mandelate and lactate based chiral ILs 
(CILs) containing the ester functionality 
 
 To investigate the antimicrobial, antialgal toxicity and biodegradation properties of the CIL 
library 
 
 To establish the effects of the ester moiety, side-chain and stereochemistry on the 
biodegradability of these novel compounds 
 
 To evaluate the differences in both toxicity and biodegradability between the mandelate 
and lactate CILs 
 
 To screen the novel achiral ILs as suitable reaction solvents for asymmetric Tsuji-Trost 
reactions  
 
 To enable the identification of low toxicity and biodegradable ionic liquids through study 
of a suite of screening methods 
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List of Abbreviations 
 
A 
acac: acetylacetonate 
ACN: acetonitrile 
AP: aminopthalimide 
ATCC: American type culture collection 
 
B 
BAC: benzalkonium chloride 
BINAP: 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
[bmim]: 1-butyl-3-methylimidazolium 
BSA: bis(trimethylsilyl)acetamide 
[BuPy]: 1-butylpyridinium 
 
C 
CCM: Czech collection of micro-organisms 
CIL: chiral ionic liquid 
CFU: colony forming unit 
COD: cyclooctadiene 
COSY: correlation spectroscopy 
Cp: cyclopentyl 
CTAB: cetyltrimethylammonium bromide  
 
D 
DABCO: 1,4-diazabicyclo[2.2.2]octane 
DAP: dialkylaminopthalimide 
DAST: diethylaminosulfur trifluoride 
dba: dibenzylideneacetone   
DCM: dichloromethane 
DCU: Dublin City University 
DIPEA: N,N-di-isopropylethylamine 
DMF: dimethylformamide 
DMP: Dess-Martin periodinane 
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DMSO: dimethylsulfoxide 
[dmim]: dimethylimidazolium 
DSSC: dye-sensitized solar cell 
 
E 
EC: effective concentration 
ee: enantiomeric excess 
E factor: environmental factor 
[emim]: 1-ethyl-3-methylimidazolium 
ENT: normalised polarity parameter 
EtOAc: ethyl acetate 
ESBL: extended spectrum beta lactamase 
 
H 
HF: hydrofluoric acid 
[hmim]: 1-hexyl-3-methylimidazolium 
[hbim]: 1-hexyl-3-butylimidazolium 
HPLC: high performance liquid chromatography 
Hz: hertz 
 
I 
IBX: 2-iodoxybenzoic acid 
IC: inhibitory concentration 
IL: ionic liquid 
IPA: isopropanol 
IR: infrared 
L 
LC: lethal concentration 
LCMS: liquid chromatography-mass spectrometry 
 
M 
MBC: minimum bactericidal concentration 
MeOH: methanol 
MFC: Minimum Fungicidal Concentrations  
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MIC: minimum inhibitory concentration 
mim: methylimidazolium 
mp/MP: melting point 
MRSA: methicillin resistant Staphylococcus aureus 
MS: mass spectrometry 
 
N 
nbd: norbornadiene 
NBS: N-bromosuccinimide  
NMO: N-methylmorpholine-N-oxide 
NMR: nuclear magnetic resonance 
 
O 
[OctOSO3]: octyl sulfate 
OECD: organisation for economic cooperation and development 
[omim]: 1-octyl-3-methylimidazolium 
 
P 
Pc: critical pressure 
PEG: polyethylene glycol 
[PF6]: hexafluorophosphate 
[pmim]: 1-propyl-3-methylimidazolium 
PDA: potato dextrose agar  
psi: pounds per square inch 
PTSA: para-toluenesulfonic acid 
ppm: parts per million 
 
R 
RT/rt: room temperature 
RTIL: room temperature ionic liquid 
 
S 
scCO2: supercritical carbon dioxide 
SCF: supercritical fluid 
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SN2: bimolecular nucleophilic 
 
T 
TBA: tetrabutylammonium 
Tc: critical temperature 
TEA: triethylamine 
TGA: thermo-gravimetric analysis 
THF: tetrahydrofuran 
TLC: thin layer chromatography 
TSIL: task specific ionic liquid 
 
U 
UCD: University College Dublin 
UCC: University College Cork 
 
V 
VOC: volatile organic compound 
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A vast number of chemical reactions both in research laboratories and in industry, are 
performed in the solution phase. Solvents are also applied in the later stage of reactions (work 
up), for example, the extraction and purification of the products and so chemistry is 
dominated by the study of the species in solution. Solvents play a vital role in chemical 
processes not only by bringing reactants into contact, but also affecting the rates, chemo-, 
regio- and stereoselectivities of the reactions. Many of the organic solvents used are volatile, 
highly flammable, toxic and hazardous making them high on the list of environment 
damaging chemicals as well as due to their employment as reaction media in large quantities. 
However, solvents still are an ubiquitous feature of modern industry. Every year millions of 
tons of solvent is discharged into the atmosphere by industries worldwide and as a result, 
deleterious effects of these materials are felt on human health, safety and the environment.  
 
1.1 Need of Green Chemistry: 
Such hazardous effects of solvents on the environment and human life compelled researchers 
to design products and processes in a way that minimises the usage and generation of 
hazardous substances. This was the birth of green chemistry as a subject. The term was coined 
by Paul Anastas in 1991 who later with John Warner developed twelve principles of 'Green 
Chemistry' in 1998 (Figure 1.1).1 These principles are as follows, 
 
Figure 1.1: Green chemistry principles.1 
 8 
 
01. Prevention of waste formation 
      It is better to avoid waste formation than to treat or clean up.  
02. Atom Economy 
      Design synthetic methods which maximize the conversion of all raw materials used in the 
      process into the final product. 
03. Less Hazardous Chemical Syntheses 
      Design synthetic methods to utilise and generate substances that minimize toxic effects on 
      human health and the environment. 
04. Designing Safer Chemicals 
      Design chemical products which carry out their function while minimizing toxicity. 
05. Safer Solvents and Auxiliaries 
      Minimize the use of auxiliary substances and promote use of safer solvents wherever 
      possible.  
06. Design for Energy Efficiency 
      Minimize the energy requirements of chemical processes and conducting them at ambient 
      temperature and pressure wherever possible. 
07. Use of Renewable Feedstocks 
      Use renewable raw materials or feedstock whenever possible. 
08. Reduce Derivatives 
      Minimize or avoid unnecessary derivatization that requires additional reagents which also 
      contributes in generation of waste. 
09. Catalysis 
      Use of catalysts preferentially over stoichiometric reagents. 
10. Design for Degradation 
      Design chemical products so they break down to form innocuous products that do not 
      persist in the environment. 
11. Real-time Analysis for Pollution Prevention 
      Develop analytical methodologies needed to allow for real-time, in-process monitoring 
      and control prior to the formation of hazardous substances. 
12. Inherently Safer Chemistry for Accident Prevention  
      Choice of raw materials that have least potential for chemical accidents, including  
      explosions, and fires. 
Many researchers have directed their research to make their target molecules and processes 
greener. Ryoji Noyori an eminent Nobel laureate (2001), has established methods of 
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asymmetric synthesis by asymmetric hydrogenation, 'greener' oxidations with aqueous H2O2, 
and use of supercritical CO2 as solvent in hydrogenation reactions.2 
1.1.1 Measure of Greenness-Green Chemistry Metrics: 
The greenness of a chemical process can be measured using Green Chemistry Metrics. It is 
necessary to quantify the outcomes of chemical procedures in order to design green processes. 
Several metrics have been formulated which enable chemists to compare the difference 
between two chemical processes numerically.  
1.1.1.1. Effective mass yield: 
   This can be defined as percentage of mass of desired product relative to the mass of all non-
benign reagents used in synthesis.3 It is mathematically represented as, Effective mass yield 
(%) = mass of products × 100 / mass of nonbenign reagents 
According to Hudlicky, who formulated this equation, the benign substances are those by-
products, reagents or solvents that have no environmental risk associated with them. 
1.1.1.2. Environmental Factor (E-factor): 
E-Factor is the ratio of mass of waste per unit mass of product formed.4 
E-factor = total waste (kg) / product (kg) 
This formula helps to those who try to fulfill first two principles of green chemistry. 
Smaller the E-factor, greener is the process. 
1.1.1.3. Atom Economy: 
Atom economy is a measure of the conversion efficiency of reactant molecules to the 
product.5 
For a general reaction: A + B → C  
Atom economy = 100 × Mol. Wt. of C /(Mol. Wt. of  A + Mol. Wt. of  B) 
This is an elementary calculation made to explore the green-ness of synthetic route. 
Essentially, such calculations can be done before finalising a synthetic route helping to 
formulate a cleaner synthetic strategy. 
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1.1.1.4. Carbon Efficiency: 
Carbon efficiency is the ratio of carbon present in the product to carbon present in reactants. 
Carbon efficiency (%) = amount of carbon in product × 100 / total carbon present in reactants 
This calculation considers the stoichiometry of reactants and products and is more useful for 
pharmaceutical processes where bulky carbon skeletons are involved.  
 
1.2 Development of Green solvents: 
In past 20 years much attention has been devoted to the production of green and clean 
technologies, and to find ways of replacing conventional, volatile, hazardous and 
environmentally unfriendly organic solvents with alternative 'green solvents'. A green solvent 
must ideally have negligible vapour pressure, high boiling point, be non-toxic, and have the 
capacity to dissolve a wide range of organic/inorganic compounds. The solvent should also be 
chemically and physically stable, recyclable, inexpensive and easy to handle. In addition to 
these aspects, solvents that allow more selective and rapid chemical transformations will have 
a significant impact. Few chemical were considered as substitutes: supercritical fluids, low 
melting polymers, perfluorinated solvents, water and more particularly ionic liquids. 
 
1.2.1. Alternative solvents in organic synthesis: 
1.2.1.1. Supercritical fluids: 
A supercritical fluid (SCF) is defined as substance above its critical temperature (Tc) and 
critical pressure (Pc),6 and possesses properties of similar to its liquid and gaseous phases. 
These properties can be specifically tuned by varying the pressure and temperature in order to 
vary density. The most popular SCF is carbon dioxide (scCO2) whose critical point is at 73 
atm. and 31.1 ºC and can be readily achieved in the laboratory with the suitable apparatus (Fig 
1.2).  
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Figure 1.2: Graphical representation of the critical point of scCO2. 
 
There are numerous advantages related to the usage of scCO2 and are clearly addressed in  a 
recent article.7 Supercritical CO2 is non-flammable, less toxic than many organic solvents, has 
low viscosity and density compared to conventional solvents, is relatively inert towards 
reactive compounds and facile separation of the products can be achieved by depressurization 
of CO2. Other advantages include high gas solubility, high diffusion rates and better mass 
transfer. Furthermore, the selectivity of a reaction can be dramatically changed when 
conducted in a supercritical fluid as compared to traditional organic solvents, hence they have 
been applied into several reactions8-10 for instance hydrogenation,11 enzymatic reactions,12-18 
metal catalysed coupling17 etc. 
1.2.1.2. Poly(ethylene glycol) – PEG(400-20000): 
Poly(ethylene glycol) is the linear polymer formed from polymerization of ethylene oxide. 
PEG usually indicates the polyether of molecular weight less than 20000 and known to be 
inexpensive, thermally stable, recoverable, biologically compatible and non-toxic.19 
Furthermore, PEG and its monomethylethers have a low vapour pressure, are non-flammable, 
present easy workup procedures and can be recycled. For all these reasons PEG is considered 
to be an environmentally benign alternative for volatile solvents and a convenient media for 
organic reactions.  
 
Figure 1.3: Polyethylene glycol. 
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Several examples show that PEG with low molecular weights (< 2000) were chosen as 
reaction media due to liquid nature at room temperature.13-16,20-25 Although less popular, PEG 
is commercially available and is much cheaper than ionic liquids but unlike the latter, they 
have limited scope in tuning their properties only through the choice of end group selection. 
One of the major drawbacks is the low efficiency of product extraction by organic solvents. 
1.2.1.3. Perfluorinated (fluorous) solvents:  
Fluorous (perfluorinated) solvents (e.g. perfuoroalkenes, perfluoroalkyl ethers and 
perfluoroalkylamines, Fig. 1.4) are generally chemically benign and environmental friendly 
due to their non-flammable, thermally stable, recyclable properties. Some of these compounds 
were found to be less toxic, however, their chemical inertness results in low degradation rates 
and hence persist for a longer period in the environment.26a They also have been proved to 
possess global warming potential due to strong absorption of IR radiation.26b 
       
Figure 1.4: Commonly used fluorous solvents. 
Their ability to dissolve diatomic gases can assist mass transfer in gas-liquid reactions.27 and 
although nonpolar, the polarity of these solvents is tunable and can be utilised in a wide range 
of reactions including Michael addition28, oxidation,29,30 Tsuji-Trost31, Diels-Alder32 etc. 
Some other examples have shown that reactions can be performed in biphasic systems,33 or at 
supercritical conditions.34  
1.2.1.4. Water: 
Water is readily available, non-toxic, non-flammable and environmentally benign, providing 
opportunities for clean processing and pollution prevention. The application of water as 
solvent was limited to hydrolysis reactions due to the low solubility of many organic 
compounds and its high reactivity towards some organic compounds (e.g. organometallics). 
Breslow35 and Grieco36 in the early 1980s showed that water can be used as medium in 
several types of reactions.37-39 Since then, a vast number of studies have been published40-41 
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showing that water has unique properties as a solvent that can sometimes lead to unexpected 
results. For instance, the rates and stereoselectivities of many types of organic reactions can 
be dramatically enhanced in water due to solvophobic effects. In many examples the addition 
of phase transfer catalysts or organic co-solvents facilitates the dissolution of non-polar 
reactants.42 Besides the main drawback to water being that it can not be used in moisture 
sensitive reactions, the contaminated water after reaction requires treatment resulting in the 
need for a waste water treatment plant where the organic compounds can be converted into 
solid waste through oxidation (or in extreme cases disposal by incineration).  
1.2.1.5. Ionic Liquids (ILs): 
Ionic liquids are the next class of 'green' solvent, which can be considered as an alternative to 
conventional solvents and they have many advantages over the other green solvents discussed 
above.  
 
Figure 1.5: Number of publications on ionic liquids.43 
A large number of publications have been published on ionic liquids and their applications. 
Fig. 1.5 shows tremendously increasing graph of publications on ionic liquids.43 (data was 
determined between 1996-May 2009). 
1.3 What is an Ionic Liquid? 
An ionic liquid (IL) is a liquid containing ions i.e. cations and anions. Although in some 
papers, ionic liquids are referred as 'molten salts', there is an arbitrary distinction between 
molten salts and ionic liquids.44,45 Ionic liquids are defined as pure compounds, consisting of 
cations (mostly organic moiety) and anions, which melts at or below 100 °C 45,46 whereas, 
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salts which have high melting points, are highly viscous and  corrosive are termed as 'molten 
salts' (liquid NaCl at 803 °C).  
In some cases, ILs are liquid at room temperature, hence can be called 'room temperature 
ionic liquids' (RTILs).  
 
Figure 1.6: Comparison of cationic symmetry in NaCl (left) and ionic liquids (right). 
 
The most characteristic feature, and which may be the reason why ionic liquids have low 
melting points, is that usually they are composed of a bulky organic cation with a low degree 
of symmetry and bulky inorganic/organic anion as shown in Fig. 1.6.47 The huge interest in 
such compounds is based on the fact that they possess several attractive properties in 
particular negligible vapour pressure, high chemical and thermal stability, nonflammability, 
high ionic conductivity, wide electrochemical potential window and particularly their ability 
to act as catalysts.45,48 In addition, many of their physico-chemical properties can be changed 
substantially by variation of the cation and the anion; thus, they are ‘tunable’ to desired 
reaction. For this reason, ILs have been referred to as “designer solvents’’ in several 
publications. 
1.4 Brief History of Ionic Liquids: 
Although they have been of particular interest in the last 15 years, they have been known to 
exist for almost a century. The first ionic liquid was reported in 1914 by P. Walden,49 when 
ethylamine was reacted with concentrated nitric acid to form [EtNH3][NO3]. The first 
application based synthesis of ILs was performed by Hurley and Weir50 in 1948 where the 
final IL was synthesised from 1-ethylpyridinium chloride and aluminium chloride. This 
chloroaluminate IL was applied in the electrodeposition of aluminium, later on two other 
groups (Gale and Nardi) discovered that 1-butylpyridinium chloride-AlCl3 gave better 
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results.51 This class of ILs, with [AlCl4]- as the anion, is called 'first generation ILs'. In 1967, 
Swain et al.52, reported use of tetra-n-hexylammonium benzoate, as a solvent for their kinetic 
and electrochemical studies.  
In late 70s, Dr. L. A. King, J. Wilkes and R. Carlin were working under a US Air Force 
Academy project aimed at finding a replacement for LiCl-KCl eutectic mixtures. As the 
melting temperature for LiCl-KCl mixture is 355 °C, this causes problems with the materials 
inside the battery, as well as incompatibilities with any nearby devices.53 With extensive 
research, they found that NaCl-AlCl3 (which was remarkably close to be an IL by definition) 
has an eutectic composition possessing melting point of 107 °C, and works well in batteries. 
The physico-chemical properties and electrochemical behaviour was determined for this class 
of salts to file a patent. In extensive research, Wilkes and Hussey were working on 
alkylpyridinium chloroaluminate salts with reference to Hurley and Weir's work50a reported in 
1948, and found that the alkylpyridinium cation suffers from being easy to reduce chemically 
and electrochemically. They moved their attention on to 1-ethyl-3-methylimidazolium, (as it 
is resistant towards reduction) and prepared various compositions of [emim]Cl-AlCl3 and 
discovered exceptionally well behaved new electrolyte for batteries.54 As the anion contains 
Lewis acid, these ILs were applied as catalysts in Friedel-Craft reactions55 and as solvent in 
polymerisation.56,57   
Although ILs gave excellent results, their biggest disadvantage was their reactivity towards 
water. Hence efforts were taken to prepare water stable ILs, leading ultimately to Mike 
Zaworotko et al.58 synthesizing a new series of [emim] based ILs, with iodide, 
tetrafluoroborate, hexafluorophosphate, nitrate, sulphate and acetate anions. These air and 
water stable ILs were referred to as 'second generation ILs'. Unlike the alkyl imidazolium 
chloroaluminate ILs, second generation ILs could be synthesized out of a glove box. These 
ionic liquids are largely water tolerant, however, prolonged exposure to moisture can cause 
some changes in their physical and chemical properties. It was found that the undried ionic 
liquid [bmim]PF6 attacks gold substrate and its aggressiveness increases with the increase in 
water content. This is due to the formation of HF as a result of decomposition of the ionic 
liquid in the presence of water. Therefore, ionic liquids based on more hydrophobic anions 
such as tri-fluoromethanesulfonate (CF3SO3¯ ), bis- (trifluoromethanesulfonyl)imide 
[(CF3SO2)2N¯ ] and tris-(trifluoromethanesulfonyl)methide [(CF3SO2)3C¯ ] have been 
developed.59-61  
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The synthesis of 'second generation ILs' started a new era in ionic liquids research and since 
then numerous scientists (including J. Wilkes, Y. Chauvin, D. R. MacFarlane, K. Seddon, P. 
Wasserscheid, T. Welton, N. Gathergood, C. Chiappe to name just a few) have synthesized 
different classes of ionic liquids and utilized them in a number of applications. These details 
of the synthesis and application of ionic liquids over the past 15 years will be discussed later 
in this chapter.  
1.5 Synthesis of Ionic Liquids: 
The ionic liquid synthesis, consists of two steps, first is the formation of the cation followed 
by the second step of anion metathesis to obtain the IL containing the desired anion. In some 
cases, anion metathesis is not needed, as the first step serves the purpose of both. For 
example, quaternarization of ethyl amine with conc. HNO3 would give the final IL. Figure 1.7 
illustrates the reaction scheme for dialkylimidazolium IL synthesis. 
 
Figure 1.7: Synthetic route for imidazolium ILs.  
 
The formation of the cation can be carried out either via protonation with protic acid62 or via 
quaternization of the amine, phosphine or ternarization of the sulphide most commonly using 
alkyl halide or dialkylsulphates. The alkylation process to form the halide salt has the 
advantages of (i) a wide range of cheap alkyl halides are available, and (ii) the substitution 
reactions occur smoothly at reasonable temperatures. Several types of amines, phosphines, 
and sulphides were tried in the preparation of ILs, some of them are shown in Fig. 1.8. 
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Figure 1.8: Cation diversity in the field of ILs.   
 
Anion metathesis is needed as the halide anions obtained in the first step are often corrosive 
and the salts would be solid mostly. Hence metathesis is carried out to obtain an IL with an 
inert anion. The anion may affect the physicochemical properties of ionic liquid drastically. 
Different types of anions have been introduced and the combinations with several cations 
have been synthesized. K. Seddon predicted that there are a quintillion (1018) number of 
compounds possible with the different combination of cations and anions.63 Table 1.1 shows 
few papers which have been published over the years with different anions. 
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Table 1.1: Publications related to synthesis and applications of corresponding anions 
                   Sr. No.          Anions                      Sr. No.               Anions               
                      1.                BF4ˉ58                          16.                    ZnCl3ˉ72 
                      2.                PF6ˉ64                          17.                    CuCl2ˉ72 
                      3.                SbF6¯ 65                        18.                    SnCl3¯ 72 
                      4.                CH3CO2¯ 58                  19.                    N(EtSO)2¯ 72 
                      5.                HSO4¯ 66                       20.                    N(FSO2)¯ 72 
                      6.                NO3¯ 58                         21.                    C(CF3SO2)3¯ 73 
                      7.                NO2¯ 58                         22.                    CH3SO3¯ 72 
                      8.               CF3SO3¯ 59                    23.                    N(CN)2¯ 74 
                      9.               (CF3SO2)2N¯ 59             24.                    Halides75 
                    10.               CF3CO2¯ 59                    25.                    Al2Cl7ˉ72 
                    11.               B(Et3Hex)¯ 67                26.                    Al3Cl10¯ 72 
                    12.               OTs¯ 68                           27.                    Au2Cl7¯ 72 
                    13.               AuCl4¯ 69                       28.                    Fe2C17¯ 72 
                    14.               AlCl4¯ 70                        29.                    SbF6¯ 72 
                    15.               Carborane71 
                                        anions          
                                        (as 1-R-CB11H6Cl6¯ ) 
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1.6 Purification of ILs: 
Even small amounts of impurities can change the chemical and physical properties of ILs 
(usually originating from the starting materials being used in synthesis).76 Major impurities 
found in ILs are halide anions that arise from the first step, either by incomplete reaction or 
incomplete removal of the resultant metal halide. Effects of halide impurities in several 
reactions are extensively studied and reported.77 As ILs have negligible vapour pressure, 
purification by distillation is not so easy, in all cases. The easiest way to remove halide 
impurity is an extraction with deionised water in case of hydrophobic ILs.78 Whereas in case 
of water-miscible ILs, Seddon et al.76 used AgBF4 to remove residual halide. When studied 
further, they found that if Na+ salt is used for anion metathesis, reaction does not go to 
completion. In practical terms, it is suggested to ensure the purity of the ILs in any application 
where presence of halide may cause problems. This may be achieved by the use of an ion-
sensitive electrode or by chemical means such as the Vollhard procedure for chloride ions.76,79  
The second crucial impurity in ILs is trace amounts of water which can cause changes in the 
properties of ILs drastically.78 Hence, it is recommended to dry ILs prior to use at (at least) 70 
°C with stirring for several hours.80 Here, stirring is crucial as ILs dilates at elevated 
temperatures and water desorption takes place at the superficial layer of the ionic liquid. Even 
water-immiscible ILs such as [bmim][PF6] can absorb water when exposed to air, furthermore 
causing anion degradation to HF.81 If necessary, the amount of water may be determined 
either by Karl-Fisher titration or IR spectroscopy. 
A common problem encountered by all chemists working with ILs is synthesizing colourless 
IL. Alkylimidazolium based ILs tend to be pale yellow or brown in colour. Although the exact 
reason is yet unclear, it is believed that the colour originates from starting materials. i.e. either 
from 1-alkylimidazole or alkyl halide. Hence, it is advised to purify raw materials prior to use 
by the Amarego-Perrin method.82 A colorimetric method has been developed to determine the 
level of unreacted alkylimidazole (< 0.2 mol%) in the ionic liquid.83 A classical method of 
charcoalisation can be employed for removal of coloured impurities in ILs (Fig. 1.9).81a  
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Figure 1.9: Charcoalisation effect on colour; (right-after charcoalisation). 
 
In order to obtain a colourless ionic liquid, the following general steps should be followed, 
1. All starting materials should be purified by the Amarego-Perrin method.82 
2. The presence of traces of acetone can sometimes result in discoloration during the 
quaternization step. Thus, all glassware used in this step should be kept free of this solvent. 
3. The quaternization reaction should be carried out either in a system that has been degassed 
and sealed under nitrogen, or else under a flow of inert gas such as nitrogen. Furthermore, the 
reaction temperature should be kept as low as possible (no more than ca 80 °C for Cl¯  salts, 
and lower for Br¯  and I¯  salts). 
 
1.7 Physicochemical and Biological Properties of ILs: 
Ionic liquids are considered as green solvents and often are used as catalysts as well. Hence 
the determination of physical and chemical properties becomes extremely beneficial if ILs 
have to be incorporated in industrial applications. In order to encourage a widespread use of 
ILs, they should be cheaper to synthesize, recyclable, and robust to endure all types of 
processing conditions. Physical properties such as melting point, boiling point, solubility, 
refractive index, density, and viscosity, are related to the mechanics and engineering aspects 
associated with the process. For example, density, viscosity, and surface tension will 
determine critical parameters including rates of liquid–liquid phase separation, mass transfer 
and power requirements for stirring and mixing. Properties such as the structuredness, 
normalised polarity (EN), polarizability (π*), hydrogen bond donor acidity (α), and hydrogen 
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bond acceptor basicity (β) are more obviously related to the solubilities, partition coefficients, 
and reaction kinetics.84,85 The physical and chemical properties of ionic liquids can be 
specifically varied over a wide range by the selection of suitable cations and anions. Toxicity 
and biodegradation are the properties which give information about ILs, such as their 
biological behaviour and environmental impact.  
Knowledge of physico-chemical and biological properties enables chemists, to choose 
specific IL for a chemical process.  
 
1.7.1. Melting Point: 
By definition, the melting point is an evaluative property of ILs. The point of significance is 
the relationship between structural & chemical composition of an IL and melting point. The 
main reasons for ILs having low melting points, despite being a salt, are the low symmetry of 
the cation,86 weak inter-molecular interactions,59 and a diffuse distribution of charge in cation 
and/or anion.87 Table 1.254,88 illustrates the effect of the cation clearly; high melting points are 
characteristics for alkali metal chlorides, whereas chlorides with organic cations melts at ˂ 
100 °C.  
Table 1.2: Melting points of various chlorides.54,88  
                              Salt                                                 Melting point (°C) 
                             NaCl                                                       803 
                             KCl                                                         772 
                             [dmim][Cl]                                             125 
                             [emim][Cl]                                               87 
                             [bmim][Cl]                                               65 
 
Comparison of melting points of different salts of [emim] emphasises that, in most cases, the 
increasing size of an anion with the same charge leads to a further decrease in the melting 
point (Table 1.3).78, 89 
 22 
 
Table 1.3: Influence of anions on melting point of ILs.78,89  
                                 Imidazolium salts                           Melting points (°C) 
 [emim][Cl]                                           87 
 [emim][NO2]                                        55 
 [emim][NO3]                                        38 
 [emim][AlCl4]                                        7 
   [emim][BF4]                                           6a 
 [emim][PF6]                                         62 
 [emim][CF3SO3]                                  - 9 
  [emim][CF3SO2]                                 -14 
 [emim][NTf2]                                       - 3 
a glass transition. 
Along with an anion choice, variation in the alkyl chain length in the cation can achieve fine-
tuning of the melting point.80  
1.7.2. Vapour pressure and Thermal stability:     
Ionic liquids have no measurable vapour pressure which is a significant advantage, since 
separation of a reaction mixture becomes more effective as a method of product isolation. The 
well-known problem of azeotrope formation between the solvent and the products does not 
arise.  
Thermal stability of ionic liquids depends on the strength of carbon-heteroatom and 
heteroatom-hydrogen bond. For example, ionic liquids synthesised by the protonation of an 
amine or phosphine have low thermal stability.45 Most of the ionic liquids are shown to be 
stable up to 400 °C, except some trialkylammonium salts which decompose at 80 °C in vacuo 
depending on the boiling point of the corresponding amine.45,90  
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Recent reports have described the TGA of imidazolium salts and noted that the thermal 
decomposition is heavily dependent on the salt structure.91 These reports also indicate that 
experiments performed under N2 or air produce the same results.  
Table 1.4: Thermal decomposition temperature for ILs. 
                        Ionic Liquid                         Decomposition Temperature (°C) 
                         [emim][Cl]                                              285 
                         [pmim][Cl]                                              282 
                         [emim][Cl]                                              254 
                         [hmim][Cl]                                              253 
                         [omim][Cl]                                              243 
                         [bmim][I]                                                 265 
                         [bmim][BF4]                                            403 
                         [bmim][PF6]                                            349 
                         [bmim][NTf2]                                          439 
 
The onset of thermal decomposition is furthermore similar for the different alkyl chain lengths 
on imidazolium but appears to decrease as the anion hydrophilicity increases (Table 1.4). The 
general trend for the thermal stability has been [PF6¯ ] > [NTf2¯ ] ~ [BF4¯ ] > halides.92    
1.7.3. Viscosity: 
One of the barriers in the application of ILs arises from their high viscosity. High viscosity 
may reduce the rate of organic reactions via reduction in the diffusion rate of the reacting 
species. Current research for new and more versatile ILs is driven, in part, by the need for 
materials with low viscosity.  
The viscosity of ionic liquids is essentially determined by their tendency to form hydrogen 
bonding and the strength of their Van der Waals interactions. It is normally higher than that of 
water, ranging between 10-200 mPa.S, similar to those of vegetable and medium crude oils, 
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and decreases with increasing temperature.93 Increasing the alkyl chain length or fluorination 
of the cation leads to an increase in viscosity.91 This is due to stronger van der Waals forces 
between cations leading to an increase in the energy required for molecular motion. For 
example, an increase in viscosity was observed for the 1-butylmethylimidazolium IL when the 
[CF3SO3]¯  anion was replaced with the [n-C4F9SO3]¯  ion and from the [CF3COO]¯  ion to the 
[n-C3F7COO]¯  ions.  
Table 1.5: Influence of alkyl chain in cation and fluorinated anions on viscosity of ILs59 at 25 
°C. 
                             Ionic Liquid                                Viscosity (mPa.s) 
                              [emim][Cl]                                           43 
                              [bmim][BF4]                                       233 
                              [hmim][BF4]a                                                        314 
                              [bmim][CF3SO3]                                  90 
                              [bmim][n-C4H9SO3]                            373 
                              [bmim][CF3CO2]                                  73 
                              [bmim][n-C3F7CO2]                            182 
                              [bmim][PF6]                                        450 
                              [bmim][NTf2]                                       52 
a
 measured at 20 °C 
 
The ability of anions to form hydrogen bonds has a pronounced effect on viscosity. 
Fluorinated anions such as [BF4]¯  and [PF6]¯  form viscous ionic liquids due to hydrogen 
bonding. Table 1.559 shows the variation in viscosity with alkyl chain length and anion. The 
strength of hydrogen bonding decreases in the order [PF6]¯  > [BF4]¯  > [NTf2]¯  which results in 
a decrease of viscosity. 
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1.7.4. Density: 
The density of ILs is a property which affects the phase separation in biphasic media, 
diffusion coefficients and mass transfer of reactants when they are used as a reaction media In 
general, they are denser than water with values ranging from 1 to 1.6 g/mL. 
Table 1.6: Densities of ILs at 25 °C.91,94 
                                  Ionic Liquid                              Density (g/mL) 
                                   [bmim][Cl]                                 1.08 
                                   [hmim][Cl]                                 1.03 
                                   [omim][Cl]                                 1.00 
                                   [bmim][I]                                    1.44 
                                   [bmim][BF4]                               1.12 
                                   [bmim][PF6]                               1.36 
                                   [bmim][NTf2]                             1.43 
                                   [bmim][CF3CO2]                        1.21 
                                   [bmim][CF3SO3]                        1.29 
  
Density of an ionic liquid depends on the length and type of substituent in the cation, and also 
on the kind of anion (Table 1.6). The molar mass of the anion,91 alkyl chain length and 
bulkiness of the cation significantly affects the overall density of ILs. Density is also 
temperature dependent, as the temperature rises from 293 to 313 K, the density of 
[emim][BF4] decreases linearly.84 
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1.7.5. Solvation ability and polarity: 
 The solvation ability of an IL determines the molecular dynamics of reactants and hence 
affects the rate of reaction. It is a well known fact that IL solubilises both polar and non-polar 
solutes depending on the substituents on the cation and anion. The more lipophilic 
substituents on the cation, the more it dissolves non-polar solutes. e.g. 1-octene was found to 
be 2500 times more soluble in methyl-tri-n-octylammonium tosylate than in methyl-tri-n-
ethylammonium tosylate.95 The influence of the anion on solvation characteristics of ILs can 
be demonstrated in an impressive fashion by the examples of water solubility of different salts 
of [bmim]. While [bmim]Br, [bmim][CF3COO], and [bmim][CF3SO3] are highly water 
soluble, [bmim][PF6] and [bmim][NTf2] form biphasic mixtures. The water content of 
[bmim][NTf2] after mixing and separating with water is only 1.4 w/w% at 20 °C.59  
During solvation by ILs, translational polarisation plays a key role (whereas in molecular 
solvents orientational polarisation occurs). Anions arrange themselves close to the positive 
head of solute and vice versa (Fig. 1.10).96 
 
Figure 1.10: Solvation through translational polarization.96 
 
As a consequence, the composition of ILs varies depending on the spatial position around the 
solute or, in other words, becomes inhomogeneous. 
Now, polarisation of the solvent is dependent on solvent polarity, which is usually determined 
in a purely empirical fashion. Empirical solvent polarity parameters are derived from the 
measured absorption maxima of solvatochromic and fluorescent dyes (Fig. 1.11), which 
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reflects the solvating ability of a solvent comprehensively.97           
 
Figure 1.11: Solvatochromic and fluorescent dyes. 
 
For the evaluation of polarity parameters, partition coefficients and sometimes reaction rates 
are considered as an exact determination would not be possible using solvatochromatic dyes 
alone. Probably the most widely used empirical scale of polarity is the ET(30) scale. 
ET(30) (in kcal mol-1) = 28592/λmax 
Where λmax (in nm) is the maximum absorbance by zwitterionic Reichardt’s dye. Often a 
normalized scale of ET(30) polarity, ENT is used which is obtained by assigning water the value 
of 1.0 and tetramethylsilane zero. The solvatochromic shift of this probe is strongly affected 
by the hydrogen- bond donor ability of the IL, due to it's structure which stabilizes the ground 
state more than the excited state (Fig. 1.11). The ET(30) scale is therefore, largely but not 
exclusively, a measure of hydrogen-bonding acidity of the solvent system. The ENT values of 
several ILs are reported in Table 1.7.98 
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Table 1.7: ENT values for solvents 
                                Solvents                                        ENT 
                                 Water                                           1.00 
                                 Methanol                                     0.762 
                                 Dichloromethane                         0.309 
                                 Toluene                                        0.100 
                                 Acetone                                        0.350 
                                 [bmim][BF4]                                0.670 
                                 [bmim][PF6]                                 0.669 
                                 [bmim][OTf]                                0.656 
                                 [bmim][NTf2]                               0.644 
                                 [bmim][SbF6]                               0.673 
                                 [bm2im][BF4]                                0.576 
                                 [bm2im][NTf2]                              0.541 
 
The alkyl chain length for the 1-alkyl-3-methylimidazolium ILs hardly affects ENT values 
which are similar to that for ethanol (ENT = 0:65), but the introduction of a methyl at C-2 
reduces the solvent polarity.98b 
1.7.6. Refractive index: 
The refractive index of a medium is the ratio of the speed of light in a vacuum to its speed in 
the medium. It is also the square root of the relative permittivity of the medium at that 
frequency. This parameter is related to polarizability/dipolarity (π*) of the medium and the 
excess molar refraction. The values found for [bmim] salts are comparable to those for 
organic solvents.91 
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Table 1.8: Refractive index91  
                                Ionic liquid                                Refractive index 
                                [bmim][PF6]                                      1.409 
                                [bmim][I]                                          1.572 
                                [bmim][NTf2]                                    1.427 
                                [hmim][Cl]                                        1.515 
                                [omim][Cl]                                        1.505 
                                [omim][PF6]                                      1.423 
 
Reported data suggests that increasing length and branching of alkyl chain on the cations 
increases the refractive index (Table 1.8). Changing the anion of the IL also affects the 
refractive index with less polarizable anions giving lower values.76 
1.7.7. Surface tension: 
Surface tension may be a key property in multiphase processes. ILs are widely employed in 
transition metal catalyzed reactions carried out under multiphase conditions. Especially, the 
extraction of products occurs at the interface between the IL and the overlying organic phase. 
These reactions should therefore be dependent on the access of the catalyst to the surface and 
the transfer of the products across the interface i.e. the rates of these processes depend on 
surface tension. In general, liquid/air surface tension values for ILs are somewhat higher than 
those for conventional solvents [(3.3-5.7) ×10-4 N.cm-1], although not as high as for water.  
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Table 1.9: Surface tension for imidazolium ILs91 
                             Ionic liquids                           Surface tension (dyne/cm) 
                              Water                                              71.9             
                              [bmim][I]                                        54.7 
                              [bmim][BF4]                                   46.6 
                              [bmim][PF6]                                   48.8 
                              [bmim][NTf2]                                 37.5 
                              [hmim][Cl]                                     42.5 
                              [hbim][PF6]                                    43.4 
                              [omim][Cl]                                     33.8 
                              [omim][PF6]                                   36.5 
 
Surface tension values vary with temperature and are affected by the alkyl chain length, 
decreasing with increasing chain length (Table 1.9).91 For a fixed cation, ILs with a bulky 
anion have higher surface tension.99 
 
1.7.8. Toxicity & biodegradation: 
Volatile organic compounds (VOCs) in current industrial applications are causing concerns 
due to their toxicity, both towards process operators and the environment.100 ILs being termed 
as 'green solvents', due to their properties, are considered as alternatives to traditional 
solvents. Despite the 'green' aspects of ILs, it is irresponsible to ignore the ultimate fate of ILs 
when released into the environment. Hence the evaluation of the toxicity of ILs becomes 
inevitable.  
Biodegradation can be defined as a process “by which microbial organisms transform or alter 
(through metabolic or enzymatic action) the chemicals introduced into the environment.”101 
There are two main types of biodegradation i.e. aerobic biodegradation and anaerobic 
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biodegradation. Aerobic biodegradation takes place in the presence of oxygen, whereas 
anaerobic biodegradation occurs in the lower stratum of soil or sediments, which lack 
molecular oxygen.  Heterotrophic microorganisms utilize organic compounds as both carbon 
and energy sources for growth. The organic chemicals are transformed mainly by enzymes 
such as esterases, oxidases, etherases and sulphatases present in microorganisms.  
In the early 90’s, Boethling and co-workers102,103 studied the structure-biodegradability 
relationship and suggested a number of factors that can increase the biodegradability of an 
organic compound, which are as follows; 
(i) presence of phenyl rings, and unsubstituted linear alkyl chains (> 4 carbons in chain 
length), (ii) groups that provide possible sites for enzymatic hydrolysis (especially oxygen 
atoms in the form of hydroxyls, aldehydes, or carboxylic acids).  
Furthermore, the authors also suggested that the presence of some functional groups will 
cause greater resistance of a compound to biodegradation, for instance halogens, nitro, 
nitroso, branched alkyl chains and fused ring systems all can result in decreased 
biodegradability. These observations enabled researchers to work towards the rational design 
and synthesis of biodegradable organic compounds.  
Biodegradation studies are carried out to evaluate the environmental fate of the organic 
compounds. Due to the variety of biodegradation mechanisms in the natural environment, a 
number of methods are applied to test biodegradation of chemicals. The methods in common 
use are the Sturm test, Closed bottle test [approved by The Organisation for Economic 
Cooperation and Development (OECD 301B and D respectively)] and the BOD5 test. As 
mentioned earlier in this chapter, the determination of toxicity and biodegradation of ionic 
liquids allows researchers to evaluate the 'greenness' of ILs, which consequently enables them 
to choose greener ILs for further applications. Several scientists around the globe, for 
instance, P. Scammells, N. Gathergood, S. Stolte etc, are already working in this area. Details 
on toxicities and biodegradation are discussed in a separate chapter. (see chapter 3.0) 
Some more properties of ionic liquids are also studied in detail, in particular, conductivity,80 
electrochemical properties,104 acidity and coordination ability.105 All of these properties have 
persuaded chemists to utilise ILs in different fields of chemistry. Seddon and Plechkova put 
forward a pictorial representation for applications of ILs (Fig. 1.12).106  
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Figure 1.12: Pictorial representation for applications of ILs.106 
 
Considering the scope of this thesis, some of the main synthetic applications are briefly 
discussed in Section 1.8 below.    
 
1.8 Applications of ionic liquids in organic synthesis: 
1.8.1. Diels-Alder Reaction: 
Diels-Alder reaction is a powerful tool in synthetic chemistry when building a molecule 
scaffold. The reaction was developed in 1928 by O. T. H. Diels and K. Alder and has been 
extensively studied in nonpolar solvents and water. Dramatically, reaction rates and 
stereoselectivities were found to be enhanced in water and the results were attributed to 
hydrogen bonding between transition states and aqueous media.107 The reactions were also 
performed in other polar and environmentally friendly solvents (i.e. ionic liquids) to study 
their effects on stereoselectivities. 
The first Diels-Alder reaction in IL was reported in 1989, which was performed in  
[EtNH3][NO3] by Jaeger and Tucker.108 Promising results were obtained when C. W. Lee 
carried out cycloaddition of cyclopentadiene (23) and methyl acrylate (24) (Scheme 1.1). 
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Improved reaction rates, and selectivities were obtained in [emim][Cl] and [BuPyr][Cl] 
compared to traditional solvents .109  
 
Scheme 1.1: Diels-Alder reaction of cyclopentadiene and methyl acrylate. 
 
Furthermore, the authors studied chloroaluminate derivatives of the same ILs as reaction 
media and obtained even higher reaction rates and with endo:exo (19:1) selectivity. In some 
cases, ILs can reverse the selectivity obtained in traditional solvents.110  
Welton et al.111 investigated the effect of the anion on the selectivity of endo:exo products and 
found a clear trend for [bmim] salts. The selectivity decreased in the order [CF3CO2]¯ >[NTf2]¯  
>[OTf]¯  >[BF4]¯ >[PF6]¯  which is in agreement with the ETN values evaluated for these salts.  
Studies have already revealed that when Lewis acids are being used as catalyst, Diels-Alder 
reactions produce enhanced yields and selectivities. Hence chloroaluminate,110 
chlorozincate112 and chloroferrate salts of ILs were also studied. The most common Lewis 
acid is Sc(OTf)3, being a highly active catalyst for these reactions. In 2001, Song et al.113 
reported cycloaddition of a variety of substrates in [bmim] ILs using 0.2 mol% Sc(OTf)3 at  
20 °C (Scheme 1.2). They achieved quantitative yields (>99 %) with almost complete 
stereoselectivity for the endo product (Table 10).  
O
O
O
O
+
Sc(OTf)3 (0.2 mol%)
IL, rt, 2 h
27 28 29
 
Scheme 1.2: Cycloaddition of 1,4-naphthoquinone and 2,3-dimethylbuta-1,3-diene.  
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Table 1.10 shows the results of cycloaddition between 1,4-naphthoquinone (27) and 2,3-
dimethylbuta-1,3-diene (28).  
Table 1.10: Results for Diels-Alder reaction113 
            Entry                 Solvent                                                    Yield 29 (%)  
               1                   CD2Cl2                                                            22 
               2                  [bmim][PF6](0.1 eq.) + CD2Cl2                       46 
               3                  [bmim][PF6](0.5 eq.) + CD2Cl2                       85 
               4                  [bmim][PF6](1.0 eq.) + CD2Cl2                     >99 
               5                  [bmim][PF6]                                                   >99 
               6                  [bmim][SbF6]                                                 >99 
               7                  [bmim][OTf]                                                  >99 
Reaction conditions: 3 mmol 2,3-dimethylbuta-1,3-diene (28), 1 mmol 1,4-naphthoquinone 
(27), 0.2 mol% Sc(OTf)3, 1 mL solvent, 20 °C, 2 h  
 
Chiral induction was investigated using chiral ionic liquids (CILs) (30) and (31) as solvents 
(Fig. 1.13). 
 
  Figure 1.13: Chiral ionic liquids. 
  
When (30) was employed in the reaction, < 5 % ee was achieved114 whereas (31) gave 4.4:1 
diastereoselectivity with no significant enantioselectivity.115 Although not with CIL, notable 
chiral induction was observed, in the cycloaddition of cyclohexadiene (32) and acrolein (33) 
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using a chiral catalyst (34) immobilised in [bmim][PF6] or [bmim][SbF6] with 5 v/v% water 
(Scheme 1.3).116  
 
Scheme 1.3: Cycloaddition using chiral catalyst in IL. 
 
Moderate yields (70-80 %) and selective endo:exo ratio (17:1) with 93 % of ee was obtained. 
Authors attribute improved results to critical role of water in iminium ion hydrolysis during 
catalytic cycle.116 
1.8.2. Hydrogenation: 
Hydrogenation is often referred to as a 'green' reaction in present day chemistry. A number of 
solvents including ILs have been employed in hydrogenations with the first publication of a 
hydrogenation in ILs reported by Chauvin et al.117 in 1995. 'Osborn complex' 
[Rh(nbd)(PPh3)2][PF6] (nbd=norbornadiene) (36) was dissolved in [bmim] ILs with weakly 
coordinating anions (e.g. PF6¯ , BF4¯ , SbF6¯ ) for the hydrogenation of 1-pentene at 30 °C. 
Independent of the limited solubility of the reactants, the reaction rates in [bmim][SbF6] were 
five times faster than in acetone, with improved product selectivity.117b The Rh-catalyst was 
immobilised in the IL without any structural modification, which is generally required in the 
case of other polar solvents. Secondly, only 0.02 % leaching of catalyst was observed in the 
organic phase. Furthermore authors investigated the hydrogenation of cyclohexadiene (32) 
with the same conditions and observed 96 % conversion with 98 % product selectivity to 
cyclohexene. Product selectivity was attributed to low solubility of cyclohexene in 
[bmim][SbF6], so that further reduction is restricted. Many other researchers obtained similar 
results on several substrates including 1,3-butadiene, 1,4-cyclooctadiene and benzene.118 
Different metal catalysts have been reported to be successful for hydrogenation in ILs, for 
instance, Rh and Co-catalysts for olefins,119 Ru-catalysts for aromatic compounds.120  
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Stereoselective hydrogenation of sorbic acid was successfully carried out by Steines et al.121 
in [bmim][PF6] at 40 °C with [RuCp*(η4-sorbic acid)][OTf] (36) (Fig. 1.14) as a catalyst.  
 
Figure 1.14: [RuCp*(η4-sorbic acid)][OTf]. 
 
The product, cis-3-hexanoic acid was obtained with up to 93 % selectivity with moderate 
conversion (52 %). Increased H2 pressure lead to reduced selectivity (cis/trans) whereas the 
effect of temperature was found to be less pronounced. 
Asymmetric hydrogenation is an important reaction in organic synthesis which is used to 
synthesize chiral molecules. The application of ILs as reaction media in hydrogenation 
provides the advantage of a recyclable catalytic system. Reduction of α-acetamidocinnamic 
acid (37) was carried out in [bmim][PF6]/IPA mixture using Rh-DuPHOS (38) at 25 °C and 2 
bar of H2 (Scheme 1.4).122  
NHCOCH3
CO2CH3
NHCOCH3
CO2CH3
H2/Rh-(R,R)-MeDuPHOS
[bmim][PF6]/IPA
Rh
P P
CF3SO3
Rh-(R,R)-MeDuPHOS
ee 96 %
37 39
38
 
Scheme 1.4: Asymmetric hydrogenation in [bmim][PF6]/IPA. 
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 Moderate to good yields (83-60 %) and 96 % enantioselectivity was achieved. Although 
these results are slightly lower than obtained in 2-propanol, the immobilised catalyst is far 
more stable towards oxidation in IL.  
Table 1.11: Results for asymmetric hydrogenation of 37 to 39 
                 Entry                        Conversion (%)                ee (%) (R-isomer) 
                    1                                    83                                96 
                    2 (1st recycle)                64                                96 
                    3 (2nd recycle)               62                                95 
                    4 (3rd recycle)                60                                94 
                    5 (4th recycle)                58                                94     
Reaction conditions: 7 g IPA + 5 g [bmim][PF6], 25 °C, 2 bar of H2, 20 min. 
 
No significant drop in enantioselectivity was observed until the fourth recycle whereas 
conversion showed a considerable decrease (Table 1.11). 
The major problem encountered in hydrogenations using ionic liquids is low H2 solubilities 
compared to traditional solvents.123,124 Table 1.12 shows the H2 gas solubility in several 
solvents
.
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Table 1.12: Hydrogen concentration in common solvents and selected ILsa at 298 K and 
atmospheric pressure.123  
         Solvent                    H2 [mM]                  Solvent                    H2 [mM] 
            Water                         0.81                        [bmim][BF4]                  0.86 
            Methanol                    3.75                       [bmim][PF6]                   0.73 
            Ethanol                      2.98                        [bmim][SbF6]                 0.93 
            Benzene                     4.47                       [bmim][OTf]                  0.97 
            Toluene                     3.50                        [bmim][NTf2]                0.77 
            Cyclohexane             3.63                        [bmim][CF3CO2]            0.98 
                                                                            [hmim][BF4]                   0.79 
                                                                            [omim][BF4]                   0.62 
 
The problem can be solved by carrying out reactions at elevated temperatures as at higher 
temperature the viscosity of the IL decreases, and mass transfer effects become less 
significant.125 A similar technique was applied by Dyson et al.126 where they demonstrated a 
biphasic hydrogenation system consisting of catalyst immobilised in [omim][BF4] and 
substrate, 2-butyne-1,4-diol dissolved in water (Fig. 1.15).  
 
Figure 1.15: Hydrogenation under reversible dual-single phase solvent system.126 
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At room temperature, the phases were immiscible; however at the reaction temperature of 80 
ºC homogeneity was attained. The reaction was carried out under 60 atm. of the H2 gas with 
facile separation of the reduced products from the catalyst/IL phase being achieved simply by 
cooling the reaction (Fig. 1.15). Products dissolved in the aqueous layer were isolated and 
reuse of the IL/catalyst system demonstrated. 
 
Figure 1.16: Proposed ‘‘weak’’ catalyst-IL ionic pairs interaction.127 
 
Anions are believed to have a considerable effect on the reaction rates by defining the 
physical properties of IL, and also via stabilisation of the catalyst.127,128 T. Floris proposed 
that stabilisation occurs through structural modification of the active catalytic centre with the 
anionic pair as shown in Fig. 1.16. Similar stabilisation was observed for Wilkinson's catalyst 
by chloroaluminate anion, but these ILs are rarely used for hydrogenations due to their 
tendency to polymerise olefins.128  
1.8.3. Oxidation: 
Ionic liquids were initially developed for applications in electroplating and batteries due to 
their wide electrochemical window allowing their usage in redox reactions.129 The first metal 
catalysed oxidation in an IL was reported in 2000,130 where p-substituted benzaldehydes were 
oxidised to corresponding carboxylic acids using nickel(II)acetylacetonate [Ni(acac)2] and 
molecular oxygen in [bmim][PF6] at 60 °C. Common oxidants utilised in ILs are tabulated 
below (Table 1.13). 
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Table 1.13: Oxidants currently used in ILs123 
                 Oxidants                                    Comment 
                     O2                               Cheap and environment friendly,  
                                                        low solubility in ILs 
                aq. H2O2                          Cheap and environment friendly,  
                                                        water may be unwanted in some cases 
              aq. NaOCl                         Cheap and environment friendly,  
                                                        water may be unwanted in some cases 
                       tBuOOH                          Relatively cheap, available as both aq. and 
                                                        anhydrous solutions                     
               PhI(OAc)2                       Relatively expensive but easy to handle 
         H2NCONH2.H2O2                Water free peroxide source,  
                                                        readily soluble in many ILs 
   N-morpholine-N-oxide                Expensive, residual morpholine may be a problem                        
For a clean and green synthesis, oxidants should produce non-toxic by-products, or ideally 
water. Earle et al.131 developed an oxidation method for alkylaromatic compounds using 
nitrate based ILs. Such ILs are termed as 'task specific ionic liquids' (TSILs) where IL is 
employed as media and reagent. 70-90 % yields were obtained in these reactions. Substituted 
benzyl alcohols were oxidised to their corresponding carbonyl compounds, using NaOCl and 
guanidium IL (41) (Fig. 1.17), at pH~8-9.132  
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R2
OH
R2
O
R1 R1
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pH = 8-9
IL 41
Yields: 70-90 %
R1 = H, CH3, Cl
R2 = H, CH3
 
Figure 1.17: Guanidium IL for oxidation.132 
 
A guanidium based IL was chosen for this reaction due to its greater stability under basic 
conditions. In this case, the IL also works as a phase transfer catalyst with 65-99 % reaction 
yields obtained. Similar oxidations were attempted with IBX and DMP using [bmim][BF4] as 
a solvent to achieve > 90 % yields.133  
K. Tong et al.,134 carried out epoxidation reactions using styrenes, pinene, norbornene in 
[bmim][BF4] with tetramethylammonium bicarbonate and manganese (II) sulphate as a 
catalyst at rt. The reaction worked successfully, affording 98-99 % yields and the catalytic 
system could be recycled without loss in activity up to 5 times. Asymmetric epoxidations are 
extensively studied with ILs. As the Jacobsen epoxidation can occur even in unfunctionalised 
olefins, this is one of the popular methods of epoxidation. Song et al.135 investigated the 
biphasic epoxidation of chromenes with chiral MnIII (salen) (42) (Fig. 1.18) and NaOCl in 
mixture of [bmim][PF6] and CH2Cl2 (1:4 ratio). 
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Figure 1.18: MnIII-salen complex.135  
 
The authors found an enhancement in catalytic activity upon addition of IL to DCM. With the 
IL, 86 % conversion was observed in 2 h, whereas it took 6 h for same conversion without the 
IL. In both cases 96 % enantiomeric excess was observed which reduced by only 6 % after the 
5th cycle. Recently, asymmetric epoxidation of styrene derivatives was studied using 10 mol% 
silica supported MnIII(salen) complex and NaOCl in [bmim][X]-DCM (X=PF6, BF4) mixtures 
with NH4OAc as a co-catalyst.136 After 2 h, 45-82 % yields with 65-95 % ee were obtained. 
The outcome of the process was the catalytic system could be re-used up to 4 times without 
any leaching of the catalyst. Chiral building blocks available from Nature are often applied for 
chiral induction. Interestingly, guanidium quinate (44), was synthesized and employed as a 
solvent in the asymmetric dihydroxylation of styrene (43) (Scheme 1.5) and 1-hexene.137  
 
Scheme 1.5: Chiral induction by IL in asymmetric dihydroxylation.137 
  
 43 
 
The catalytic system utilised was K2OsO2(OH)4/NMO and reactions were performed at rt. 
Remarkably, 85 % enantiomeric excess and 95, yield was obtained when styrene was the 
substrate. A similar yield (92%) was found using 1-hexene, although the ee decreased to 72%.  
1.8.4. Carbon-carbon coupling reactions: 
Coupling reactions have had a huge impact on synthetic chemistry over the last thirty years. 
Large carbon scaffolds can be built using metal catalysed C-C coupling reactions, generally in 
excellent yields. Hence, by appreciation of the usefulness of the three main Pd-catalysed 
coupling reactions, a Nobel prize (chemistry) was awarded to their inventors in 2010. Heck, 
Suzuki, Negishi, Stille and Sonogashira couplings present easy procedures to serve the 
purpose of C-C linkage, usually with low catalyst loading (2-5 mol%). The ionic liquids 
possessing high polarity, density and viscosity interact with metal catalysts in a different way 
to conventional solvents. The hydrogenation section 1.8.2 (vide supra) shows that ionic 
liquids can be employed in metal catalysed reactions with successful recycling. C-C coupling 
reactions in ILs were studied by many researchers to investigate the effect of the IL-catalytic 
system on the yield, enantioselectivity and stability of the catalytic system. 
1.8.4.1 Heck coupling. 
Imidazolium based ILs have been studied in detail for past two decades. Their utility in Pd-
catalysed reactions, whether hydrogenation or C-C coupling reactions, was investigated 
revealing that at high temperatures under basic condition imidazolium moieties form carbene 
complexes with palladium.138 Mostly this reduces the yield of the reactions but in some cases 
better results were observed. The carbene complexes (47, 48) were formed and found to give 
better results than the original palladium catalyst during the coupling of various aryl halides 
and acrylates (Scheme 1.6).139      
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Scheme 1.6: Formation of Pd-carbene complex.139 
Reactions in [bmim]Br gave quantitative conversions (100 %) with ~ 99 % selectivity to the 
trans product. Investigation revealed that complex formation takes place only in the presence 
of halides and when [bmim][BF4] was employed in the reaction, no carbene complex was 
formed giving poor conversions. A range of Pd catalysts were tested for their catalytic activity 
in the coupling of styrene (43) and chlorobenzene.140  
     
 
Figure 1.19: Pd-carbene complexes for Heck coupling.140 
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Pd-carbene complexes that were used are shown in Fig. 1.19. The results for these reactions 
are shown in Table 1.14. Provided that the chlorobenzene possesses low reactivity towards 
Heck coupling, even in conventional solvents (especially when PdCl2 and Pd(OAc)2 used as 
catalysts) tetrabutylammonium bromide (TBAB) has yielded satisfying results.  
Table 1.14: Heck coupling of chlorobenzene and styrene in [Bu4N][Br].140 
         Catalyst                                                               Yield (%) 
                                                                        DMF                   [Bu4N][Br] 
         PdCl2                                                        0                            50  
         Pd2(dba)3                                                  2                             8 
         Pd2(dba)3 + 2 eq. P(tBu)3                        72                           92 
         Pd(OAc)2 + 3 eq. P(o-Tol)3                     29                           46 
         Pd(PPh3)4                                                17                           65 
        (51) + 5 eq. [AsPh4][Cl]                           41                           84 
        (50)                                                           3                             51 
        (52)                                                           5                             49 
Reaction conditions: Styrene (1.5 eq.), NaOAc (1.2 eq.), Pd (2 mol%), 150 °C, 18 h 
 
Recently, ligand free Heck arylation was successfully demonstrated by Petrvic et al.141 They 
synthesized triethanolammonium acetate to employ ligand-free Heck coupling. The reaction 
was carried out with iodo/bromobenzene and alkylacrylates using 2 mol% PdCl2 and 
[TEA][OAc] at 110 °C with quantitative yields (>90 %). The authors concluded that the IL in 
this case acted more than a medium and worked as a base, precatalyst, and mobile support for 
the active Pd species. Further studies revealed that cations and anions were not distinctive as 
such still molecule showing high dipole moment and also behaved like a molecular solvent 
due to strong hydrogen bonding (Fig. 1.20). 
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Figure 1.20: X-ray models of triethanolammonium acetate and its Pd-complex; (left-
intramolecular H-bonding, right-precatalyst)  
1.8.4.2 Suzuki coupling. 
Coupling of aryl/vinyl boronic acid with aryl/vinyl halide catalyzed by a palladium complex 
is known as Suzuki coupling.142 This reaction enables the linkage of aryl, vinyl, benzyl, allyl 
and alkyl groups (cf Heck coupling). Several papers have described the Suzuki reaction using 
[bmim] ILs and Pd catalysts bearing phosphanes,143 nitrogen compounds144 and carbenes.145 
The reaction of bromobenzene with phenylboronic acid in benzene, catalysed with Pd(PPh3)4 
and K2CO3, gave a 88% yield in 6 h, while the same reaction in [bmim][BF4] gave a 93% 
yield of the desired product in 10 minutes with a high turn over number.146 
Microwave/ultrasound assisted reactions are generally clean and  can be put forward under 
'green' chemistry due to their environment friendly energy efficiency. Shrinivasan et al.144a 
performed coupling of a range of halobenzenes (53a-k) with phenylboronic acid (54) in 
[bbim][BF4]/MeOH mixture under ultrasonic irradiation at 30 °C (Scheme 1.7). 
 
 
Scheme 1.7: Sono-chemical Suzuki reaction in [bbim][BF4]/MeOH.144a 
 
Palladium acetate was employed as a catalyst and 40-93 % yields were obtained as shown in 
Table 1.15. 
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Table 1.15: Ultrasonic Suzuki cross-coupling of halobenzenes with phenyl boronic acid in 
[bbim][BF4]/MeOH.144a 
       No.           Substrate                                      Time (min)             Yield (%) 
        1          Iodobenzene (53a)                               20                           92 (55a) 
        2          4-Methoxyiodobenzene (53b)             20                           93 (55b) 
        3          4-Chloroiodobenzene (53c)                 30                           85 (55c) 
        4          4-Nitroiodobenzene (53d)                   30                           82 (55d) 
        5          Bromobenzene (53e)                           45                           82 (55e) 
        6          4-Methoxybronobenzene (53f)            10                           85 (55f) 
        7          4-Nitrobromobenzene (53g)                20                           90 (55g) 
        8          Chlorobenzene (53h)                           60                           42 (55h) 
        9          4-Nitrochlorobenzene (53i)                 30                           65 (55i) 
       10         4-Chlorotoluene (53j)                          60                           52 (55j) 
       11         2,4-Dinitrochlorobenzene (53k)          90                           42 (55k) 
Reaction conditions: 0.5 g [bbim][BF4], 1 mL MeOH, 0.001 g Pd(OAc)2 
 
To achieve better immobilisation of Pd complex in ionic liquid, Dyson et al.147 synthesized 
pyridinium based ILs containing the coordinating nitrile functional group. 
 
 
Figure 1.21: Interaction between nitrile functionalised IL and PdCl2.147 
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 Coupling of iodobenzene (53a) and phenylboronic acid (54) was carried out in these ILs. The 
nitrile groups coordinate with PdCl2 forming a pre-catalyst (Fig. 1.21) and good yields (81-88 
%) were achieved with the catalyst found to be air stable. Leaching of the catalyst during 
work-up was reduced compared to [BuPy][NTf2]. 
 
1.8.4.3 Sonogashira Coupling. 
Sonogashira coupling is recognized as a powerful synthetic tool for the formation of 
asymmetrically substituted acetylenes.148The reported publications using ILs show improved 
results compared to traditional solvents.149-151 Kmentova et al.149 performed coupling of 
iodobenzene (53a) and phenylacetylene (59) in various imidazolium based ILs with 
Pd(OAc)2/PPh3 as a catalyst, CuI as a co-catalyst and NEt3 (TEA) as a base (Scheme 1.8). 
 
 
Scheme 1.8: Sonogashira coupling of iodobenzene and phenylacetylene149 
The results obtained are tabulated below (Table 1.16). 
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Table 1.16: Yields of Sonogashira coupling in different ILs.149 
               Entry                       Ionic liquid                              Yield (%) (60)  
                 1                             [bmim][PF6]                                97 
                 2                             1st recycle                                    93 
                 3                             2nd recycle                                   67 
                 4                             3rd recycle                                    58 
                 5                             4th recycle                                    52 
                 6                             [bmim][BF4]                                99 
                 7                             [hmim][PF6]                                95 
                 8                             [hmim][BF4]                                96 
                 9                             [bbim][BF4]                                 97  
Reaction conditions: 4 mol % Pd(OAc)2, 4 mol% CuI, 0.4 mL TEA, 80 °C, 2 h  
 
Excellent yields (>90 %) were obtained for imidazolium ILs and experiments with recycled 
catalyst showed a gradual decrease in yield which was due to catalyst leaching during work-
up.  
Many attempts have been made to carry out coupling without Cu catalyst because in some of 
the cases Glaser-Hay coupling can occur under Sonogashira conditions giving rise to 
unwanted homocoupling products.152 In 2002, Fukuyama et al.153 carried out coupling of 
several aryl iodides and substituted acetylenes in [bmim][PF6] with 5 mol% PdCl2(PPh3)2 and 
Hünig's base. The authors obtained 85-97 % yields despite the absence of Cu catalyst. Often 
coupling reactions are carried out at higher temp. in the presence of base which can cause 
degradation or hydrolysis of the ionic liquid. Hence in such cases, reaction conditions demand 
robust ILs that can facilitate the reaction. Recently, Harjani and co-workers154 synthesized 
nicotinate ester based ILs with the purpose to achieve stability for hydrolysis.  
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Figure 1.22: Nicotinate based ILs.154 
 
Coupling was carried out with phenyl acetylene (59) and different aryl iodides (including 53a-
b and 53d) in ionic liquids (61a-d) (Fig. 1.22) using PdCl2 and TEA under ultra-sound 
irradiation. 78-93 % yields were obtained in these reactions in accordance with expected 
reactivities of electron donating/withdrawing substituents on phenyl iodide.    
1.9 Introduction to the work in thesis: 
Apart from synthetic usage, ionic liquids have a very widespread application window in 
nuclear fuel reprocessing,155 solar thermal energy, electro-chemical devices,156 cellulose 
processing,157 etc. Along with physiochemical properties, the low toxicity and high 
biodegradability of ILs have created a keen interest in researcher's minds to test their ‘green’ 
applications in various fields.  
Considering toxicity and biodegradability of our first generation ILs and for the preparation of 
extensive library of ILs, we planned to synthesize less toxic and readily biodegradable second 
generation ionic liquids. These ionic liquids were screened for antimicrobial toxicity and 
biodegradability. Their applications in dye sensitised solar cells (DSSCs), Tsuji-Trost 
reactions and hydrogenations were investigated, depending on the results of toxicity and 
biodegradation studies. The forthcoming chapters include results and discussions of synthetic 
methods, toxicological and biodegradation studies, applications in Tsuji-Trost, hydrogenation, 
Baylis-Hillman reactions, followed by an experimental section. The outcome of the project is 
concluded with the scope for future work presented at the end. 
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2.1 Introduction: 
With respect to the results obtained previously in our group, and following the Boethling's 
'rules of thumb',1 we planned the synthesis of achiral and chiral ILs which would exhibit low 
toxicity and be readily biodegradable. This structural design was based on the guidelines that 
ester and ether functionalities facilitate biodegradation.2 (see section 1.7.8 for guidelines) 
Achiral ester and amide ILs and chiral monoester and diester ILs were synthesized. All of 
these compounds were either 1-methylimidazol-3-ium or 1-pyridinium based ILs with the 
synthetic route following a regular trend consisting of quaternarization of the nitrogen in an 
aromatic base followed by anion metathesis. 
2.2 Synthesis of Achiral ester and amide based ionic liquids: 
The synthetic route for achiral ILs involved three steps (Scheme 2.1). In the first step 
ester/amide functionality was generated by the acylation of alcohol/amine. The 
quaternarization of tertiary nitrogen from 1-methylimidazole/pyridine yields the halide IL in 
the second step. Finally, anion metathesis was carried out producing an IL with the desired 
counter anion. Scheme 2.1 depicts the synthetic route for achiral ester and imidazolium based 
ILs.2d  
 
Scheme 2.1: General synthetic route for ester based ILs.  
Once the alkylating agent is obtained, this can be reacted with a number of aromatic bases 
containing tertiary nitrogen atoms to prepare different ILs. The 1-methylimidazolium was 
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chosen as a target cation because of its robustness to many reaction conditions allowing for its 
usage in a wide range of applications. Although pyridine has been reported as susceptible to 
reduction,3 the pyridinium based ILs were reported to be readily biodegradable4 hence it was 
also chosen as a cation for study. 
2.2.1. Preparation of the Alkylating Agent: 
The first step i.e. ester/amide formation was achieved by acylation of the alcohol or amine. 
The reaction was carried out using DCM as solvent, TEA or Na2CO3 as base, and 
bromoacetyl bromide as the acylating reagent. Bromoacetyl bromide was added dropwise to 
the mixture of alcohol/amine and base in DCM at 0 to -5 °C. There were two reasons to lower 
the temperature; (i) to quench the exotherm (ii) due to the two potential electrophilic sites in 
bromoacetyl bromide, unwanted by-products may be formed, especially in the case of the 
more nucleophilic amines. Acylation reactions are believed to occur through a addition-
elimination mechanism.5 During the reaction HBr is released and hence an acid binder was 
used, either TEA or Na2CO3. When TEA was used as the base, coloured final products were 
obtained whereas use of Na2CO3 produced colourless products. This may be explained by 
triethylammonium bromide having partial solubility in the organic layer leaving behind traces 
of bromide which could impart colour to the final compound, whereas NaBr does not dissolve 
in DCM and results in colourless products. The hydrolysis of bromoacetyl bromide was 
observed when the Schotten-Baumann procedure was applied to the reaction, hence Na2CO3 
was used as a solid in these reactions. Moderate to high (67-98 %) yields were obtained for 
the acylation of both alcohols and amines giving products in liquid form at room temperature 
(Table 2.1). 
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Table 2.1: List of achiral bromoester/amides. 
                                                            
    Compound                                     R =                                              Yield (%)                 
          62                                                                      97                               
          63                                             98                                      
          64                                             67  
           65                                                                           76 
           66                                                                                 78            
           67                                                                                85 
The reaction using triethylamine as a base was performed only in the case of 65 according to 
the literature method.2d,6 All other alkylating agents were synthesized using Na2CO3 as a base. 
 
Figure 2.1: 2-(2-butoxyethoxy)ethyl-2-bromoacetate 63. 
The 1H NMR for compound 63 shows a singlet at 3.82 ppm for the H2 protons (Fig 2.1). The 
peak for -CH2 shows downfield shift due to the presence of two electron withdrawing 
neighbouring groups i.e. the bromide and carbonyl group which possess an electron 
withdrawing (-I) effect through σ bonds.7  
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2.2.2. Preparation of Bromide Ionic Liquids: 
The synthesis of bromide ionic liquids was performed according to the literature method2d,6 
and involves the addition of 1-methylimidazole/1,2-dimethylimidazole or pyridine to a 
solution of alkylating agent in diethyl ether.  
Table 2.2: Bromide ILs with different heterocycles; compound numbers in bold, and melting 
points are denoted in parentheses.  
                                                      
           Side chain                                                              
                             91% (24-26°C)               -                           - 
                                                                68a 
      90% (78-80°C)              -                           - 
                                                                69a 
     90% (94-96°C)    91% (120-122°C)    97% (168-169°C) 
                                                                70a                        71a                         72a 
                                 83% (68-70°C)                -                             - 
                                                                73a 
                                      89% (96-98°C)        87% (135-137°C)           -                    
                                                                74a                        75a 
                                    85% (170-172°C)     95% (224-226°C)   94% (95-97°C)         
                                                                76a                        77a                         78a 
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Reactions were carried out at RT under nitrogen atmosphere producing the ILs in good yields 
(83-97 %) (Table 2.2). All ionic liquids were obtained as white or off white solids. Table 2 
shows a wide range of melting points. All 1-methylimidazolium based ILs melt below 100°C 
except for 76a compared to ILs possessing other heterocycles (pyridinium and 1,2-
dimethylimidazolium) melt above 100°C except for 78a. The range of high yields achieved 
with the reactions demonstrates the efficiency of the process. In this reaction heterocycles 
containing 3° nitrogen atoms displace the bromide from the alkylating agent and hence can be 
termed as a bimolecular substitution (SN2) reaction. The reaction largely produces pure 
product, but, if required purification can be carried out simply by washing the product with 
dry diethyl ether. The reactions were also carried out using dry solvent under nitrogen 
atmosphere to minimize the contamination by moisture.  
The 1H NMR for compound 69a shows (Fig. 2.2) the -CH2 singlet for the H2 protons at 5.50 
ppm. In the alkylating agent the peak appeared at 3.82 ppm indicating the stronger electron 
withdrawing effect by the imidazolium core. This fact is supported by the 13C NMR showing 
significant shift of the C2 carbon signal from 25.85 ppm (alkylating agent 63) to 50.14 ppm. 
 
 
 
 
 
 
 
 
 
Figure 2.2: 1H NMR of compound 69a.  
The imidazolium proton H3 (Fig. 2.2) appears as a singlet at 10.13 ppm, whereas H4 and H5 
appears as triplets at 7.68 and 7.51 ppm both with J = 1.8 Hz. It was confirmed from the 
COSY spectrum that H3 couples with H4 and H5 but a singlet was observed due to a very low 
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coupling constant.8 The methylene protons H7 and H8 shows triplets at 4.33 and 3.71 ppm 
respectively. They couple with a coupling constant of 4.8 Hz. The IR spectrum shows a peak 
at 1752 cm-1 indicating an ester group.  
The amide side chain in the ILs 73a-78a is not symmetrical, the methylene groups shows 
distinctive peaks in the 1H NMR spectrum due to restricted rotation around C-N bond (Fig. 
2.3). 
 
Figure 2.3: Isomers formed due to restricted rotation. 
2.2.3. Anion Metathesis: 
Anion metathesis alters the properties of bromide ionic liquids and thus enables their utility in 
different applications.  
(1) [NTf2] ILs: 
The [NTf2] ILs were synthesized according to the literature procedure2d,6 involving addition of 
solid LiNTf2 to a solution of bromide IL in distilled water. The reactions were maintained at 
room temperature for 4 h and the [NTf2]¯  ILs were washed with distilled water 3-4 times to 
remove any unreacted starting materials. However, in the case of 69b and 73b the reaction 
time was increased (12 h) to ensure completion. The ILs 68b, 69b, 71b-73b, 75b-78b were 
synthesized in moderate to good yields (62-97 %). Compounds 71b, 72b and 76b were found 
to be white solids with melting points 53-55°C, 70-72°C and 63-65°C respectively. The 
success of the anion metathesis can be confirmed by NMR. In the 1H NMR spectrum, the H3 
proton shifts upfield due to slight shielding by [NTf2]¯  counter ion and in the 13C NMR 
spectrum, two carbon atoms from the anion couple with neighbouring -F atoms leading to a 
quartet with a coupling constant of J = 319 Hz (Fig. 2.4).  
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Figure 2.4: A quartet shown by -CF3 in 13C NMR spectrum.  
The IR spectra also confirm the metathesis by showing a strong absorption for -NSO2 group 
in 1370-1335 and 1170-1155 cm-1 region.  
(2) [OctOSO3] ILs: 
Octylsulfate ILs were prepared with little modification to literature procedure2d,6 which states 
the reaction mixture should be heated at 60°C for 2 h. However, heating was determined as 
not necessary for the completion of reaction. Hence after the addition of solid sodium 
octylsulfate to the solution of bromide IL in distilled water, the reaction was stirred at RT for 
12 h. The ILs 71c-73c, 77c and 78c were prepared by this method in moderate yields (54-79 
%). The [OctOSO3] salts are known to increase the biodegradability of ILs as demonstrated 
by N. Gathergood et al.9-12 However, a major drawback of synthesising the [OctOSO3] ILs is 
the cost of the sodium octylsulfate. Hence a cheaper method for its synthesis was adopted and 
developed.13 1-Octanol was dissolved in dichloromethane, followed by addition of 
chlorosulfonic acid at 0 to -5°C. A subsequent neutralization of the mixture with NaHCO3 and 
filtration with methanol resulted in the synthesis of sodium octylsulfate on a relatively large 
scale (65 mmol) in excellent yield (95 %).  
(3) Iodide ILs: 
Usually, the synthesis of iodide ILs involve the alkylation of 1-alkylimidazole with alkyl 
iodide.14 In our case, the iodide ILs were prepared by a step down synthesis using [NTf2] 
salts. The method was developed in our laboratory which includes the addition of 
tetrabutylammonium iodide (TBAI) to the solution of [NTf2] IL in DCM. The reaction 
mixture was stirred at RT for 3 h. The volatiles were removed by means of rotary evaporation, 
with the residue dissolved in distilled water then backwashed with DCM to remove the 
tetrabutylammonium bis(trifluoromethylsulfonyl)imide (TBANTf2) salt. Removal of water by 
S
N
S
O
O
CF3
O
O
F3C
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rotary evaporation permits the synthesis of iodide IL. The compounds 69d and 73d were 
prepared by this procedure to obtain yellow and brown solid products in 66 and 74 % yields 
possessing melting points of 52-54°C and 48-50°C respectively. The 1H NMR in both cases 
shows the H3 protons shift slightly downfield indicating deshielding by the iodide anion. The 
metathesis also can be confirmed with the absence of -CF3 quartet in the 13C NMR spectrum.  
(4) [N(CN)2] IL: 
The dicyanamide IL 69e was synthesized according to the literature procedure.2d This method 
involves the addition of solid sodium dicyanamide [NaN(CN)2] to a solution of bromide IL in 
acetonitrile at RT under nitrogen. The reaction was stirred at RT for 4 days to obtain an off 
white solid in 97 % yield with a melting point of 58-60°C. Signals corresponding to the C15 
and C16 carbons (Fig. 2.5) do not show up in the 13C NMR spectrum however the anion 
metathesis can be confirmed by the significant absorption band present at 2231 cm-1 in the IR 
spectrum. 
 
Figure 2.5: 3-{2-[2-(2-butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium 
dicyanamide (69e). 
(5) [OAc] IL: 
Acetate IL 73f was synthesized according to the literature procedure.15a A solution of AgOAc 
in water was added slowly to a solution of bromide IL 73a in water at RT with the reaction 
flask covered with aluminium foil to avoid photodegradation of the silver acetate. The 
reaction was stirred for 2 h, filtered to remove the AgBr precipitate and the resultant aq. 
solution was treated with charcoal to remove any coloured impurities. A colourless oil was 
obtained in 65 % yield. 1H NMR shows a H3 peak giving a broad singlet at 11.17 ppm but 
with integration 0.59 in comparison to H4 and H5. This observation was surprising as H3 
proton has shown extreme downfield shift. In [emim][OAc], the proton at same position 
shows a singlet at 10.36 ppm.15b The H2 protons integrate to 1.59 (should be 2) which 
indicates that these protons are partially bonded to acetate anion (Fig. 2.6). 
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Figure 2.6: Plausible partial bonding between [OAc]¯  and cation. 
2.2.4 Effect of anion on chemical shift: 
 
 
 
 
Figure 2.7: H3 proton shift in 69a-b and 69d-e. 
12345678910 ppm
Bromide
12345678910 ppm
NTf2
12345678910 ppm
Iodide
12345678910 ppm
Dicyanamide
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Fig. 2.7 illustrates the acidic proton shift in imidazolium moiety by different anions due to 
shielding or deshielding effects. From the spectra one can conclude that bromide has a 
significant deshielding effect on proton whereas [NTf2] seems to have a shielding effect. This 
is due to the localised charged on bromide showing better charge separation whilst the 
negative charge in bulky [NTf2] is delocalised which causes shielding of proton. Less 
deshielding is observed in the case of iodide due to large size of the anion. This feature may 
also be used as a rough estimation of the varying degree of charge separation in the anions.  
 
2.3 Synthesis of Chiral Lactate and Mandelate based ionic liquids: 
Lactic and mandelic acids are both bio-renewable resources with lactic acid found in sour 
milk products such as yogurt, koumiss, laban etc. while industrially produced by the 
fermentation of carbohydrates,16a and mandelic acid derivatives found naturally in almonds, 
peaches, wheat leaves, grapes etc16b and  industrially, through the hydrolysis of mandelonitrile 
by acid catalyst or enzymes.16c Although the derivatives of these feedstocks are released into 
the environment from a number of sources, no significant concentrations in the soil or water 
are found thus suggesting rapid metabolism with the metabolic pathways of mandelates 
discussed in a review by C. Fewson.16b Hence usage of such renewable feedstocks in the 
synthesis of ILs satisfy 3rd, 7th and 10th principles of green chemistry. 
2.3.1 Lactate based ILs: 
Lactate based ILs were synthesized according to the synthetic route depicted in Scheme 2.2 
comprising of four steps. 
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Scheme 2.2: Synthetic route for Lactate based ionic liquids. 
2.3.1.1 Fischer-Speier esterification: 
In this step the lactic acid was converted into an alkyl ester by Fischer-Speier esterification.17 
The substrate was dissolved into excess alcohol followed by a slow addition of thionyl 
chloride to the reaction mixture which was heated to reflux for 6 h.18 As an equilibrium 
reaction, analysis by TLC showed unreacted lactic acid. The reaction was then quenched with 
water followed by repetitive extraction with ethyl acetate however, in the case of ethyl esters, 
ethanol was removed by rotary evaporation prior to extractions. Table 2.3 shows the esters 
synthesized with this method. 
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Table 2.3: Yields for lactate esters. 
         Compound                                Structure                                Yield (%) 
               79                                                               56             
               80                                                      66    
               81                                                      71       
               82                                                 76                                                             
As butanol and pentanol have higher boiling points (117 and 137°C, respectively), removal 
required azeotropic distillation with hexane. Compound (83) (Fig. 2.8) was also recovered 
during the purification of (82).  
 
Figure 2.8: 1-oxo-1-(pentyloxy)propan-2-yl 2-hydroxypropanoate. 
The moderate range of yields (56-76 %) can be attributed to the equilibrium of the reaction.  
In the 1H NMR spectrum of 82 the H4 protons behave as non-identical and show geminal 
coupling. Each proton resulting in a pair of triplet of doublets thus appearing as 12 lines at 
4.16 ppm (Fig. 2.9).  
 
 
  
 
 
 
 
 
Figure 2.9: Coupling pattern by diastereotopic protons.
 
2.2.1.2 Preparation of Alkylating Agent:
The synthesis of the alkylating agent by the acylation of the secondary alcohol was carried out 
by two different methods. The methyl, butyl and pentyl esters (
prepared using a Na2CO3 method whereas ethyl esters were synthesized using an Al
method.19 The alumina method is quicker and easier while the Na
methods gave comparative yields (Table 2.4). The alumina 
bromoacetyl bromide (2.0 eq.) to a mixture of the secondary alcohol and Al
RT. This reaction mixture was sealed with a stopper and maintained at RT (unstirred) for 3 h. 
The RM was washed and filtered with EtO
the final product. 
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84, 85 and 
2CO3 one is cleaner but both 
method includes the addition of 
2
Ac which was then removed by distillation to yield 
88-90) were 
2O3 
O3 (1.5 eq.) at 
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Table 2.4: Yield for bromoesters. 
                                         
                         84 (32%)                                                 85 (37%) 
                                    
                          86 (82%)                                                 87 (85%) 
                           
                           88 (85%)                                                 89 (80%) 
           
                           90 (81%) 
The low yields for (84) and (85) (i.e. 32 and 37% respectively) can be attributed to the 
solubility of compounds in water (as being the methyl esters) which means they have been 
washed out during the aqueous wash cycle. Furthermore, this observation was consistent with 
the literature.6 All compounds (84-90) were obtained as liquids at room temperature. The 
acylation can be confirmed by 1H NMR with the presence of the methylene peak at H1 (Fig. 
2.10) around 3.80-3.90 ppm or with the two distinct peaks for esters (C2 and C5) in the 13C 
NMR spectrum. A general trend shows C5 is more deshielded than C2. 
 
Figure 2.10: Pentyl-2-[(2-bromoacetyl)oxy]propanoate (90). 
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2.3.1.3 Preparation of Bromide IL: 
The synthesis of the bromide salt was carried out according to the literature method2d as 
discussed in section 2.2.2. Compounds 91a-97a were synthesized in good yields (74-94 %) 
(Table 2.5). Only 92a was found to be a solid with a melting point of 110-112°C whereas 96a 
was obtained as a gel. 
Table 2.5: Bromide ionic liquids. (stereochemistry is denoted in parentheses). 
O
OR
O
O
NN
Br
 
     Compound                                    R                                        Yield (%) 
91a                                        Methyl (RS)                               87 
92a                                        Methyl (S)                                 75 
93a                                        Ethyl (RS)                                  74 
94a                                        Ethyl (S)                                    74 
95a                                        Butyl (RS)                                  89 
96a                                        Butyl (S)                                    75 
97a                                        Pentyl (RS)                                 94 
All three enantiopure compounds (i.e. 92a, 94a & 96a) were found to be laevorotatory for Na-
D line at 20°C. The 1H NMR spectrum for 92a (Fig. 2.11) exhibits two sets of doublets for H5 
protons, each one showing geminal coupling with J = 17.6 Hz which indicates that both H5 
protons are non-identical.  
        
 
 
Figure 2.11: Distereotropic protons showing roofing/tilting effect. 
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It is noteworthy that such distereotropic signals were not observed in alkylating agent 85 
despite having the same chiral centre. The ∆υ/J value is 8 in this case hence it is a first order 
spectrum.8  
2.3.1.4 Anion Metathesis: 
The lactate based ILs were synthesized for the purpose of biodegradation studies and so 
mainly [OctOSO3] salts were prepared as opposed to a wide spectrum of salts with different 
counterions. The compounds 91c-97c were synthesized (Table 2.6) according to literature 
procedure2d as discussed earlier in section 2.2.3.2.  
Table 2.6: [OctOSO3] ionic liquids. (stereochemistry is denoted in parentheses). 
 
   Compound                                     R                                        Yield (%) 
91c                                        Methyl (RS)                               76 
92c                                        Methyl (S)                                 79 
93c                                        Ethyl (RS)                                  85 
94c                                        Ethyl (S)                                    81 
95c                                        Butyl (RS)                                  81 
96c                                        Butyl (S)                                    82 
97c                                        Pentyl (RS)                                 87 
All compounds were obtained as liquids in good yields (76-87 %). The aromatic H2 protons 
showed a slight upfield shift (200 Hz) in the 1H NMR spectrum than their corresponding 
bromide ILs. The infra-red spectra exhibits the presence of -S=O with a sharp band at ~ 1050 
cm-1. 
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2.3.2 Mandelate based ILs: 
The synthesis of mandelic acid based IL was carried out in five steps (Scheme 2.3). As the 
starting materials 98 and 99 (Fig. 2.12) are expensive, it was decided to synthesize them and 
the mono-substituted mandelic acids 100, 101, 102, 103 were bought in from Sigma-Aldrich.  
 
Figure 2.12: Substituted mandelic acids. 
The second step involved the conversion of the acids into esters by Fischer-Speier method. 
Here onwards the IL synthetic route splits into two branches. In route A, the ester was 
halogenated at the α-position with thionyl halide. The SN2 reaction of this α-halo ester with 1-
methyimidazole/pyridine then allows the preparation of the bromide monoester IL which can 
be subjected to anion metathesis to tune the properties of the IL. In route B, the secondary 
alcohol in ester was acylated using bromoacetyl bromide and base. The resultant diester then 
can react with 1-methyimidazole/pyridine to give the bromide diester IL and subsequent anion 
metathesis gave the IL with the desired anion. Although the first monoester IL was obtained 
serendipitously, this class was found to possess low toxicity which will be discussed in 
chapter 3. The comparison of toxicity and biodegradation data of both monoester ILs and their 
diester counterparts will enable us to comment firmly on the role of the additional ester group. 
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Scheme 2.3: General synthetic route for imidazolium based mono- and diester ILs. 
2.3.2.1 Synthesis mandelic acids: 
Carboxylic acids 98 and 99 were prepared according to literature methods20 with slight 
modifications. The synthesis of 98 is comprised of electrophilic aromatic substitution of 
glyoxylic acid and catechol under basic conditions. This is also a modification of a Friedel-
Craft reaction where glyoxylic acid is activated by neutral alumina (Fig. 2.13). A solution of 
catechol, glyoxylic acid (1.02 eq.) and neutral alumina (0.44 eq.) in aq. NaOH (1.77 eq.) was 
heated to 60°C for 24 h. Upon cooling the reaction mixture was filtered, acidified to pH ~ 4 
and extracted with ethyl acetate to remove any unreacted catechol. The aq. layer was further 
acidified to pH 1 and extracted with ethyl acetate while the organic layer was evaporated and 
purified to obtain 98 as a brown solid in 67 % yield. In some cases, the alkaline reaction 
mixture was acidified directly to pH 1 and extracted repeatedly with toluene to remove the 
 80 
 
unreacted catechol. The alkaline conditions enhance the electron rich character of the phenyl 
ring through the formation of phenoxide which activates both the ortho and para positions, 
however, only para substituted products were formed in the reaction which was consistent 
with the reference literature.20  
 
Figure 2.13: Activation of aldehyde by Lewis acid and proton. 
Alternatively, the synthesis of 99 follows an electrophilic aromatic substitution in acidic 
conditions. Here, the catechol is protected with a methylene group hence alkaline condition 
would not affect the electronic character of phenyl ring. Activation of glyoxylic acid occures 
via protonation of the aldehyde (Fig. 2.13) and the process involves the addition of 1,2-
(methylenedioxy)benzene to an aqueous mixture of glyoxylic acid (1.03 eq.), H2SO4 (1.83 
eq.) at -10°C. The reaction mixture was then stirred at -10°C for 10 h and at RT for 14 h before 
extraction with ethyl acetate. The organic layer was concentrated and residue was purified by 
column chromatography (SiO2, EtOAc:Hexane; 20:80) to obtain 99 in 72 % yield. A double 
addition compound 99a was also isolated in 5 % yield (Fig. 2.14). 
 
Figure 2.14: 2,2-bis(2H-1,3-benzodioxol-5-yl)acetic acid (99a). 
2.3.2.2 Fischer-Speier esterification: 
A range of different esters was prepared by Fischer-Speier esterification methods.  
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Table 2.7: List of mandelate esters. 
Compound                  Structure                          Yield (%)            Melting point (°C) 
104                                        98                           N.A. 
105                               79                           42-44 
106                      54                           88-90 
107                      95                           47-49 
108                                    80                          135-137 
109                                     98                           56-58 
110                                 97                           37-38 
111                                    97                           48-50 
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The disubstituted mandelate esters were prepared by using thionyl chloride and 
monosubstituted esters were synthesized by using p-toluenesulfonic acid (PTSA). The list of 
esters with yield and melting points is tabulated below (Table 2.7). When thionyl chloride is 
added to the alcohol, HCl gas is liberated which acts as a catalyst for the reaction. Substituted 
mandelic acids were dissolved in excess of alcohol followed by slow addition of SOCl2 (0.5 
eq.) at RT, the reaction mixture was stirred at RT for 3 h and then solvent was removed by 
rotary evaporation. Residue was then dissolved in water and extracted with ethyl acetate. 
Purification of the crude product by column chromatography gave the esters (105-107) in 
moderate to good yields (54-95 %). The 1H NMR spectrum of 107 shows a doublet of 
doublets for the H8 proton (Fig. 2.15) at 6.89 ppm with J = 8.4 and 1.8 Hz. As a result the H4 
and H7 couple with H8 and exhibit two doublets at 7.00 and 6.73 ppm with corresponding 
coupling constants.   
                                                                   
Figure 2.15: Butyl 2-(2H-1,3-benzodioxol-5-yl)-2-hydroxyacetate (107); and aromatic region 
from its 1H NMR spectrum. 
The H10 protons are diastereotropic hence undergo geminal coupling showing two sets of 
triplets of doublets i.e. 12 lines however the resolution of peaks are solvent dependent (Fig. 
2.16). 
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                                  CDCl3                                                        DMSO-d6 
 
                               Acetone                                                            Benzene 
Figure 2.16: H10 protons resolution in different solvents. 
A temperature experiment was run on a sample of 107 dissolved in DMSO-d6 to study the 
effect of temperature on the coupling pattern. The spectra were obtained between a range of 
20-70°C. It was observed that with increasing temperature, two sets of  triplets of doublets 
resolved into a simple triplet with a coupling constant 6.6 Hz. This observation was consistent 
with the fact that at higher temperatures the vibrational-rotational energy increases and σ-
bonds rotate faster.21 Thus, both H10 protons experience the same environment and behave 
identically (Fig. 2.17). 
 
4.084.094.104.114.124.134.144.154.164.174.184.194.204.214.224.23 ppm 4.034.044.054.064.074.084.094.104.114.124.13 ppm
4.044.054.064.074.084.094.104.114.124.13 ppm 3.753.763.773.783.793.803.813.823.833.843.853.86 ppm
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                                20°C                                                                30°C  
 
                                  40°C                                                                  50°C 
        
                                   60°C                                                                70°C    
Figure 2.17: H10 peak at various temperatures in DMSO-d6.  
The PTSA method is quite similar to thionyl chloride method except a longer reaction time is 
required (6 h). Compounds 104 and 108-111 were synthesized using corresponding alcohol 
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and PTSA according to this method resulted in excellent yields (97-98 %). The mechanism of 
reaction includes the protonation of the carboxyl group followed by nucleophilic attack of the 
alcohol. A tetrahedral transition state breaks down into the products with subsequent removal 
of a water molecule. The reason for the low yield of 106 (54 %) could possibly be the 
solubility of the product in water due to two phenol and one alcohol group. Melting points of 
106 (88-90°C) and 108 (135-137°C) observed are higher than expected due to hydrogen 
bonding.  
2.3.2.3 Preparation of the Alkylating Agent: 
This includes two methods, a α-haloester synthesis, and O-acylation to obtain α-bromodiester. 
α-Bromo- or chloroesters were prepared as precursors for monoester ILs whereas α-
bromodiesters would yield diester ILs upon reaction with 1-methylimidazole/pyridine. In the 
case of the α-haloester, the halogenation at the benzylic position occurs via a meso 
substitution of the alcohol by the halide.  
 
        112 (76 %)                               113 (86 %)                                  114 (84 %) 
 
     115 (63 %)                          116 (80 %)                               117 (78 %) 
              
       118 (67 %)                                    119 (75 %) 
Figure 2.18: Mandelate alkylating agents; yields are shown in parentheses. 
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The process includes the addition of thionyl bromide/chloride (1.0 eq.) to the mixture of 
alcohol and TEA (1.2 eq.) in dichloromethane at 0°C and the reaction was maintained at RT 
for 3 h. The organic layer was then washed with water, the DCM removed by rotary 
evaporation and the residual product was purified by column chromatography (SiO2, 
EtOAc:Hexane; 20:80) to obtain the product in good yield (76-86 %). All three compounds 
(112-114) (Fig. 2.18) were synthesized by this method and found to be liquids. The 
mechanism includes the nucleophilic attack of the alcohol on the thionyl halide which makes 
the alcohol a good leaving group. Triethylamine promotes deprotonation of alcohol, and 
subsequently, the halide attacks the bromanesulfinate intermediate (at benzylic position) from 
the rear side followed by departure of the leaving group (Fig. 2.19). An advantage of this 
process is that the by-products formed are Et3HNBr and SO2 which are easy to remove from 
the reaction mixture.  
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Figure 2.19: Mechanism of bromination. 
Compounds 115-119 were prepared by acylation of the corresponding alcohols (105, 107 and 
109-111) according to the literature method2d as discussed in section 2.2.1. Triethylamine was 
applied as a base for 115 and 116 while 117-119 were prepared using sodium carbonate. The 
reactions resulted in moderate yields (63-80 %) giving all compounds in liquid state at RT.  
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2.3.2.4 Halide ILs: 
(A) Monoester ILs: 
Although, synthesized compounds are novel (vide infra), this class of compounds is known.22 
The monoester ILs 120a and 121a were prepared from 106 by one pot synthesis using thionyl 
bromide and thionyl chloride respectively (Fig. 2.20).23 Butyl alcohol (106) was dissolved in a 
solution of 1-methylimidazole (2.0 eq.) in DCM followed by the dropwise addition of the 
thionyl halide (1.0 eq.) at 0°C. The reaction was maintained at RT for 24 h, concentrated by 
rotary evaporation and purified by column chromatography to obtain the ILs 120a and 121a 
in moderate yield (62 and 34 %, respectively).  
    
N
OBu
O
HO
N
Cl
HO
    
    120a (62 %)                       121a (34 %)                        122a (48 %) 
        
            123a (58 %)                      124a (55 %)             125a (90 %, 123-125°C) 
 
  126a (87 %, 96-98°C) 
Figure 2.20: Monoester halide ILs; yields and melting points (if solid at RT) are given in 
parentheses. 
A low yield was obtained in the case of 121a due to the use of 1.0 eq. 1-methylimidazole 
which functions as both an acid binder and nucleophile. So by this method a step was avoided 
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that saved time, energy and solvents. The compounds 122a-126a were synthesized according 
to the literature procedure2d to obtain ILs in fair to excellent yields (48-90 %). In the case of 
125a and 126a pyridine was employed as a nucleophile instead of 1-methylimidazole. These 
were the only solid products obtained among the monoester ILs with melting points of 123-
125°C and 96-98°C, respectively (Fig. 2.20). The aromatic regions from the 1H NMR spectra 
of 123a and 125a are shown below (Fig. 2.21). 
                   
Figure 2.21: The aromatic region from 1H NMR spectra of 123a (left) and 125a (right).  
Already shown in section 2.2.2 is that bromide anions cause farthest shift in the case of the -
NCHN- proton (except for the acetate anion). A similar shift was shown for pyridinium based 
ILs although not to the same extent as 1-methyl imidazolium ILs. The protons H14 and H18 
(Fig. 2.21) appeared to be a doublet at 9.44 ppm with respect to H15 and H17 with J = 6.0 Hz. 
The apical proton H16 exhibited a triplet at 8.61 ppm with J = 7.6 Hz which must be a 
merged doublet of doublet shown for H15 and H17. The IL 123a exhibit two triplets for H15 
and H16 protons at 7.51 and 7.47 ppm respectively with J = 1.6 Hz. In this case both H15 and 
H16 couple and with H14 as well.    
(B) Diester IL: 
The diester ILs were prepared simply by SN2 reaction of the alkylating agent and 1-
methylimidazole/pyridine in diethyl ether.2d Out of seven compounds three were butyl esters, 
three methyl esters and an ethyl ester. In the case of 127a, 128a and 131a-133a 1-
methylimidazole while for 129a and 130a 1-butylimidazole and pyridine were utilised as 
nucleophiles respectively (Fig. 2.22). 
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                    127a (80 %, 74-76°C)                                               128a (60 %, 94-96°C) 
 
                                       129a (64 %)                           130a (50 %, 150-152°C) 
 
                                       131a (82 %)                                    132a (72 %) 
 
  133a (88 %, 128-130°C) 
Figure 2.22: Diester ILs; yields and melting points are shown in parentheses  
Compounds 127a, 128a, 130a and 133a were found to be solid and all seven compounds were 
obtained in moderate to good yields (50-88 %). A low yield for 130a (50 %) could not be 
improved by carrying out reaction at reflux temperature in diethyl ether and another reaction 
using THF as a solvent. This observation was in contrast with the yields of monoester ILs 
125a and 126a where pyridine displaces secondary alkyl bromide/chloride resulting 90 % and 
87 % yields respectively. The main reason to choose three different cation cores and esters 
was to compare the effects on toxicity and biodegradability of the ILs. Removal of traces of 
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water was performed under high vacuum (0.1 mbar) for 8-10 days, however, heating at ~ 40-
50°C was required in some cases (e.g. 128a and 130a). 
2.3.2.5 Anion exchange: 
(1) [NTf2] ILs: 
Six triflimide salts (i.e. 123b, 128b, 129b, 130b, 132b, 133b) (refer to Fig. 2.20 and 2.22 for 
cation structure) were prepared in 66-94 % yields according to the literature method2d using 
LiNTf2 and corresponding bromide ILs (Table 2.8). 
Table 2.8: Yields for [NTf2] ILs.  
             Compound                          Yield (%)                      Melting point (°C) 
123b                                   66                                   46-48 
128b                                   94                                    N.A. 
129b                                   90                                    N.A. 
130b                                   73                                    N.A. 
132b                                   81                                    N.A. 
133b                                   88                                   70-72 
Out of six compounds, 123b is a monoester IL while remainder are diester ILs. Compounds 
123b and 133b were isolated as solids. Anion exchange was confirmed by a quartet given by -
CF3 groups in the 13C NMR spectrum which was supported by the IR spectrum demonstrating 
-S=O stretching frequency at ~1050 cm-1. An antimicrobial toxicity was assessed for these 
compounds (See Chapter 3). 
(2) [OctOSO3] ILs: 
The octyl sulfate ILs were synthesized to evaluate the biodegradability. The process involves 
addition of solid NaOctOSO3 to the solution of bromide IL in distilled water. After overnight 
stirring at RT, the aqueous layer was extracted with DCM. The removal of DCM by rotary 
evaporation resulted in [OctOSO3] ILs (120c, 128c, 129c, 130c, 132c, 133c) (Table 2.9) in 
good to excellent yields (41-91 %). 
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Table 2.9: Yields for [OctOSO3] ILs. 
            Compound                          Yield (%)                      Melting point (°C) 
120c                                   41                                    N.A. 
128c                                   89                                   55-57 
129c                                   82                                   49-51 
130c                                   91                                    N.A. 
132c                                   88                                    N.A. 
133c                                   87                                   60-61 
Compound 120c gave low yield (41 %) due to aqueous solubility. This is also the only 
monoester [OctOSO3] salt in the list. The 1H NMR spectra for all compounds show similar 
coupling patterns for the cation core as shown for corresponding bromide salts. These 
compounds were tested for toxicity and biodegradability which will be discussed in chapter 3. 
2.4 Miscellaneous: 
2.4.1 Fluorinated ILs: 
We aim to apply our novel ILs in a range of organic syntheses as solvents and/or catalysts 
hence it is important that they should endure the (harsh) reaction conditions for instance 
acidic, basic, photochemical reactions. The 1H NMR spectrum of IL 73f shows that the α-
protons are partly abstracted by a base i.e. -OAc (pKa = 4.76).24 Hence it was decided to 
replace the α-proton from monoester ILs with fluorine atom to induce extra chemical stability 
in IL. Additionally, a new class of compounds can be tested for toxicity and biodegradability. 
The compound 134 (Fig. 2.23) was prepared according to the literature method25 using 
alcohol (104), diethylaminosulfur trifluoride (DAST) (136) (Fig. 2.23). The DAST (1.8 eq.) 
was added slowly to a mixture of 104 in DCM at 0°C and the reaction mixture was stirred at 
RT for 14 h. After work-up of the reaction, the procuct was obtained as a yellow oil in 51 % 
yield.  
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Figure 2.23: Fluorinated products, reagents and intermediates. 
A synthesis of 134 was attempted by a reaction of acylated alcohol 137 with 
tetrabutylammonium fluoride in DCM but unreacted substrate was recovered even after 
heating at reflux for 2 h. The reaction of 104 with DAST goes through nucleophilic meso 
substitution where fluorine acts as a nucleophile. The 1H NMR spectrum of 134 exhibit a 
doublet at 5.78 ppm for H2 proton with J = 48.0 Hz which represents a F-H coupling (Fig. 
2.24).      
 
Figure 2.24: The 1H NMR spectrum of compound 134.  
The compound 135 (Fig. 2.23) was synthesized by a photochemical reaction between 134 and 
N-bromosuccinimide (NBS) in CCl4 at reflux.26 A solution of 134 and NBS in CCl4 was 
irradiated with 150 W mercury lamp at reflux temperature for 5 h (Fig. 2.25). It was observed 
after 1 h that the reaction mixture turned orange and then became yellow slowly within next 4 
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h. Reaction completion was confirmed by TLC. The rotary evaporation of the solvent and 
purification of residue by column chromatography (SiO2, EtOAc:Hexane; 10:90) gave 135 in 
75 % yield.  
 
Figure 2.25: The experimental apparatus for photochemical bromination. 
The process was reported for α-fluorination of ketones by irradiation with tungsten lamp26 and 
was successfully applied for the ester 134 using mercury lamp. A limited number of 
publications available on geminal dihalogenation with two different halides indicate difficulty 
in synthesis of such compounds. Figure shows the 1H and 13C NMR spectra of compound 
135. The disappeared doublet from 134 for F-H coupling in the 1H NMR spectrum and 
downfield shift (89.4 to 96.8 ppm) of C2 carbon in the 13C NMR confirms the bromination at 
α-position (Fig. 2.26). 
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Figure 2.26: The 1H and 13C NMR spectra of compound 135. 
The 13C NMR spectrum shows that C1, C3, C4 and C8 also couples with fluorine atom with J 
= 28.3, 21.7, 8.0 and 8.0 Hz, respectively. 
2.4.2 Commercial ILs: 
Ionic liquids 138, 139 and 140 (Fig. 2.27) are known compounds. Compound 140 was 
synthesized in 45 % yield according to the literature procedure.27 The process involves neat 
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reaction of 1-methylimidazole with chloroacetic acid at 70°C for 3.5 h. The NMR data are in 
agreement with the reference literature.27  
 
Figure 2.27: Compounds 138, 139 and 140. 
Compounds 138 and 139 are commercially available ILs, commonly employed in dye 
sensitized solar cell (DSSC) research.28 These were synthesized with slight modification to 
the literature procedure.29 Therein, 1-propyl or 1-allylimidazoles were methylated with methyl 
iodide in toluene at RT for 32 h. In our case, 1-methylimidazole was alkylated with 1-propyl 
iodide and 1-allyl iodide in diethyl ether at RT for 12 h to obtain ILs 138 and 140 in 81 % & 
76 % yields, respectively. The NMR data is in agreement with reported literature.29   
2.5 Summary: 
As per our plan to synthesize low toxicity and readily biodegradable ionic liquids, twenty 
seven achiral ILs were prepared that consists of eleven bromide, nine [NTf2]¯ , five  
[OctOSO3]¯  and two iodide salts. Some representative examples, in particular, ester with ether 
side chain, open chain amide with ether, cyclic amide, cyclic amide with ether were submitted 
for antimicrobial toxicity screening at our collaborator's lab in Charles University (Czech 
Republic). Ionic Liquid samples (bromide and [OctOSO3] salts) were submitted for 
biodegradation studies to our collaborator’s lab in CSIC, Barcelona (Spain).  Compounds 69b, 
69d, 73b, 73d were synthesized in bulk quantity to apply into DSSCs (dye-sensitized solar 
cells). Only one acetate salt (73f) was prepared using the literature method15 to employ in the 
Tsuji-Trost reaction as a solvent. A new method of synthesis for iodide salts was discovered 
and applied for the preparation of 69d and 73d although, a point of concern is that this is a 
step down synthesis and increases the E-factor value. Future work should develop a direct 
synthesis of the iodide. 
Twenty one CILs comprising of different classes were prepared including seven lactate based 
and fourteen substituted mandelate based ILs. Only bromide and [OctOSO3] salts of lactate 
ILs were prepared for toxicity and biodegradation studies. Two classes of mandelate ILs were 
synthesized (i.e. monoester and diester) in five steps. Fisher-Speier esterification was 
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followed for ester synthesis. Both chloride and bromide salts were prepared in the case of 
monoester ILs. The diester ILs can be further classified as disubstituted and mono substituted. 
The monosubstituted mandelates contained both electron donor and withdrawer substituents 
at para position.  
Selected examples of each class of CILs were submitted for antimicrobial toxicity screening 
at our collaborator's lab in Charles University (Czech Republic) and (bromide and [OctOSO3] 
salts) were submitted for biodegradation studies to our collaborator’s lab in CSIC, Barcelona 
(Spain). CILs (123a, 125a, 128a and 130a) were submitted for antialgal toxicity assay at our 
collaborator’s lab in Aveiro (Portugal). Several CILs examples were submitted for additional 
antibacterial toxicity screening at high concentrations at DCU. The stability, toxicity, 
comparison of different methods to evaluate toxicity and biodegradation will be discussed in 
chapter 3.  
2.6 Conclusion: 
As discussed in section 1.1.1, atom economy is an important green chemistry metric and gives 
vital information about the greenness of a chemical procedure. The calculation of percentage 
atom economies for the procedures presented in this thesis were found to be as follows;               
(a) alkylating agents: 70-95 %; (b) bromide ILs: ~100 %; (c) [NTf2]¯  ILs: 80-92 %; (d) 
[OctOSO3]¯  ILs: 80-90 %. The new methods for synthesis of iodide ILs from [NTf2] salts 
showed low atom economies. i.e. 44 % for 69d and 42 % for 73d.  
While evaluating the chemical procedure in terms of atom economy, ease of reaction work-
up, energy requirements, use of bio-renewable sources, it can be said that these chemical 
procedures are 'green'. Although the synthesis of intermediates and ILs demands employment 
of tradiational solvents, these solvents can be recycled when reactions are carried out on bulk 
scale or alternative methods (e.g. neat reactions) can be found in future to make the process 
'greener'. In present situation the preparation of lactic acid based bromide ILs (91a-94a) are 
the greenest syntheses given that these procedures use bio-renewable raw materials, and has 
~100 % atom economy in the final stage. 
In the case of substituted mandelic acid based ILs, the raw materials (2,3-
methylenedioxymandelic acid and 2,3-dihydroxymandelic acid) were synthesized in lab due 
to their high expense. Hence it was five step synthesis of ILs, however, the yields of 
intermediates and ILs were good (>80 %) to excellent (>90 %).   
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Overall the bromide ILs were found to be in solid state whereas the [NTf2]¯ , [OctOSO3]¯  salts 
were liquid at RT. Many of the liquid ILs were found to be very thick and viscous. The actual 
viscocity was not measured due to sample quantity constraints. During the course of work-up 
the ILs were heated to 40-50°C on rota evaporator and were subjected to high vacuum drying 
but none of the compounds were found to undergo any chemical or thermal degradation under 
these conditions indicating their stability and robustness.  
This series of 56 ILs, comprising different classes, offer a choice to test representative 
examples for toxicity & biodegradation and select specific ILs for further applications.                                                              
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Chapter 3 
Toxicity and 
Biodegradation 
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3.1 Introduction: 
A number of achiral and chiral ILs were synthesized, characterized and their toxicity and 
biodegradability were subsequently evaluated. ILs has been recognised as 'greener' and safer 
solvents and as such the study of their environmental impact is of utmost importance, 
especially their fate once released into the environment. The toxicity assessment of ILs is an 
easy guide to estimate their 'greenness' and also provides information on ecological impact. 
The biodegradation study of ILs thus gives information regarding the degradation and 
transformation caused to the ILs by microorganisms. These toxicity and biodegradability 
studies are often carried out in aqueous media; hence it is necessary to assess the stability of 
the ILs in aqueous solutions. 
3.2 Aqueous stability: 
The compounds 123a, 125a, 128a and 130a (Fig. 3.1) were chosen for this study as they best 
represent the different classes.  A 0.178 M solution of 123a and 0.049 M solutions of 125a, 
128a, and 130a were prepared in D2O and maintained at 25°C for 15 days with 1H NMR 
spectra recorded every 24 h.                                                                                                                                                                              
 
Figure 3.1: ILs used for stability study 
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Compound 123a was found to be stable over the period of 15 days for given conditions (Fig. 
3.2) whereas 125a showed slight decomposition after 11 days and was calculated to be 2 % 
after 15 days (Fig. 3.3).    
 
 
Figure 3.2: 1H NMR of 123a in D2O on day 15. 
 
Figure 3.3: 1H NMR of 125a in D2O on day 15. 
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In Fig. 3.2, the NMR spectrum does not show any additional signals to those of 123a after 15 
days. The 1H NMR spectrum for 125a on day 15 (Fig. 3.3) however shows some small peaks 
at the baseline. The signals at 8.85, 8.58 and 8.05 ppm correspond to the pyridinium ring in 
125a while the peaks at 8.74, 8.49 and 7.97 ppm correspond to the degradation product. The 
singlet at 6.91 ppm appears to indicate aromatic protons from the mandelate core of the 
degraded product. The triplet at 3.54 ppm and its integration when compared to the 
degradation product peaks in the aromatic region indicate that the degradation might have 
occurred through ester hydrolysis. A number of publications have discussed the solvent 
interactions of pyridinium or substituted pyridinium compounds when dissolved in protic 
solvents.1 Kano et al.1a reported the reversible transformation of N-methyl acridinium chloride 
(141) to acridane (142) in dilute methanol (Fig. 3.4).       
 
Figure 3.4: Reversible reaction of acridinium chloride. 
An independent study on rotaxane/calixarene by Grubert et al.1c also demonstrated similar 
results. This behaviour of pyridinium compounds was utilised by Connon et al.2 for 
acetalization of aldehydes who propose an acid catalyst was generated in situ from a 
pyridinium IL and methanol (Fig. 3.5). 
With reference to the literature data, it was proposed that such a mechanism was also possible 
in the case of the ILs presented in this work in aqueous solutions. Dissolution of compound 
125a in D2O could lead to in situ generation of HBr that can then catalyse the hydrolysis of 
butyl ester, however, only 2 % degradation was observed after 15 days. This low value of 
degradation can be attributed to the fact that long chain esters hydrolyse with low reaction 
rates.3 
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Figure 3.5: Mechanism for generation of Bronsted acid.       
In contrast, the diester ILs 128a and 130a showed substantial degradation. Compound 128a 
was found to be degraded by 4 % on day 1. The 1H NMR spectrum was determined within an 
hour after dissolution of 128a in D2O. The degradation of the IL gradually continued until day 
15 demonstrating 81 % decomposition on the final day. The percentage degradation over time 
is presented in Table 3.1. 
Table 3.1: The percentage degradation of 128a. 
                              Days                                                  Degradation (%) 
                                  1                                                              4 
                                  2                                                            18 
                                  4                                                            36 
                                  7                                                            58 
                                 15                                                           81 
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Figure 3.6: 1H NMR of 128a on day 1.  
The degradation of 128a occurs most likely through the hydrolysis of the diester linkage. The 
imidazolium IL can react with a protic solvent to produce HBr, similar to the pyridinium ILs. 
This has been proved by Connon, Gathergood et al.4 who employed an imidazolium ILs in the 
acetalization reactions. In Fig. 3.6, the signals at 8.81, 7.49 and 7.48 ppm correspond to the 
imidazolium core from 128a whilst the weak signals at 8.68, 7.40 5.94 ppm are due to the 
degraded product. 
  
Figure 3.7: Degradation of 128a on day 15. 
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The 1H NMR spectrum recorded on day 15 shows 81 % degradation of 128a and butanol 
signals (formed after degradation) can be seen prominently (Fig. 3.7). The signals at 3.54, 
1.28 and 0.84 ppm could be attributed to butanol which also suggests that both esters have 
been hydrolysed. The hydrolysis of 128a was also confirmed by LC-MS analysis where a 
peak for degradation product 146 (Fig. 3.8) was observed at m/z = 141.10. 
HO
O
N
N
146
Br
 
Figure 3.8: 1-(carboxymethyl)-3-methyl-1H-imidazol-3-ium bromide. 
The 1H NMR spectrum for compound 130a showed 7 % degradation after 1 h of dissolution 
in D2O (Fig. 3.9). The signals at 8.85, 8.64 and 8.12 ppm correspond to the pyridinium core 
from 130a whereas the peaks at 8.74, 8.54, 8.04, 5.92 and 5.22 ppm represent the degraded 
product. 
 
Figure 3.9: 1H NMR of 130a on day 1. 
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Figure 3.10: 1H NMR of 130a on day 7. 
Surprisingly, 49 % degradation was observed on day 2. The new signals in the 1H NMR 
spectrum proves that the degradation has occurred through hydrolysis of both ester 
functionalities (Fig. 3.10). Further analysis of the 1-4 ppm region of the 1H NMR spectrum 
(Fig. 3.10) revealed that the peaks at 3.54, 1.26 and 0.83 ppm correspond to butanol. With 
reference to previous experiments and the literature2 it was postulated that the breakdown of 
130a was catalysed by HBr released from the reaction of 130a and water. Compound 130a 
was degraded completely by day 12, however, the rate of degradation decreased with time. 
Fig. 3.11 depicts the extent of degradation of 128a and 130a with respect to time. 
 
Figure 3.11: The rate of degradation of 128a and 130a in D2O at 25°C. 
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3.3 Toxicity: 
3.3.1 Introduction: 
The conventional solvents employed in current day chemical industry are a cause of major 
concern due to their toxicity to both process operators and the environment as well as their 
volatile and flammable nature making them a potential explosion hazard.5 The deleterious 
effects of such solvents on the environment, in particular, atmospheric emissions and 
contamination of aqueous effluents, are making the usage of these solvents prohibitive. Thus 
researchers have developed alternative ‘green’ solvents (discussed in chapter 1) which can 
overcome the limitations of these conventional solvents. Ionic liquids belong to this same 
class of alterative solvents. Hence the toxicity assessment of the ionic liquids becomes 
significant if they are to replace conventional solvents. A number of toxicity studies have 
been carried out on different classes of ILs including antibacterial, antifungal, antialgal etc.6,7 
 
3.3.2 Antibacterial Toxicity: 
Bacteria have short generation times hence they are the ideal starting points for toxicity 
studies. Ionic liquids with different cation cores have been investigated in several types of 
toxicity studies. The studies by Pernak et al.8 revealed a trend of increasing toxicity with 
increasing alkyl chain length in the cation core. Authors performed tests on a homologous 
series of 1-alkoxymethyl-3-methylimidazolium ILs with Cl, [BF4] and [PF6] counter ions 
(Fig. 3.12).  
 
Figure 3.12: Homologous 1-alkoxymethyl-3-mehtylimidazolium ILs. 
The tests were performed using a several strains of cocci (Staphylococcus epidermidis, 
Micrococcus luteus, Staphylococcus aureus, Staphylococcus aureus MRSA, Enterococcus 
hirae) and rods (Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae, Pseudomonas 
aeruginosa) to obtain the minimum inhibitory concentration (MIC/IC95) and minimum 
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bactericidal concentration (MBC/IC95) values. The benzalkonium chloride compound (BAC), 
a common biocide, was used as a reference in order to interpret the results. Authors found that 
all ILs with a side chain greater than six carbon atoms in length to be active against all 
organisms, and the activity to be dependent upon side chain length and not anion. The 
chloride salts (147a-149a) were found to be non-toxic up to 8600 µM concentration while the 
fluorine containing anions [BF4]¯  (147b-149b) and [PF6]¯  (147c-149c) did not show inhibition 
up to 7000 µM and 5850 µM respectively. The most active ILs against rods and cocci were 
those with the decyl- side chain (154), undecyl- (155), dodecyl- (156) and tetradecyl- (157) 
with dodecyl- (156) being the most active among these. Table 3.2 shows that the most toxic 
IL found among the test series (156a-c) approaches the MIC/IC95 values.  
 
Table 3.2: MIC/IC95 (µM) values of 3-dodecyloxymethyl-1-methylimidazolium (156a-c) vs. 
BAC 
       Strain                                156a                       156b                       156c                      BAC 
    M. Luteus                             25                          21                         37                           7 
    S. epidermidis                      25                          21                         18                           3 
    S. aureus                              25                          21                         18                           7 
    MRSA                                 99                          85                          73                           7 
    E. hirae                                99                          85                         37                          11 
    E. coli                                  99                         170                         73                           7 
    P. vulgaris                         197                         170                       147                         22 
    K. pneumonia                    197                         170                       147                         11 
    P. aeruginosa                    395                         340                       587                         54 
 
The antimicrobial toxicity of the ILs involves the regulation of the growth rate of bacteria 
while interfering with their productivity. The lactic acid producing bacterium Lactobacillus 
rhamnosus was tested against imidazolium ILs [bmim][PF6], [hmim][PF6] and [omim][PF6] 
to examine if they can be efficient in the extractive fermentation of lactate.9 The results of 
these experiments were based on the activity of the bacterium. The amount of glucose 
consumed was measured, along with the colony forming units (CFUs). The CFU values 
provide information on the production rate of Lactobacillus rhamnosus and these correspond 
to the glucose consumption, thus indicating that the number of viable cells which produced 
lactate. The overall results demonstrated that this bacterium survived in all ILs measured, but 
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possessed a low activity. These results were compared with toluene, for which complete 
inhibition was noted. There was a little difference found in results shown for the three varying 
side chain lengths, with [bmim] and [hmim] being approximately equal and showing slightly 
lower toxicity than [omim] IL.  
Vibrio fischeri is a gram negative, rod shaped bacterium commonly found in a symbiotic 
relationship with squids (Fig. 3.13). This is a popular choice of bacteria to measure toxicity in 
terms of an acute bioluminescence inhibition assay. Toxicity towards V. fischeri can be 
determined by measuring the difference in light output from the organism. A decrease in 
observed light output indicates an increase in toxicity. Ranke et al.10 investigated the toxicity 
of a range of imidazolium ILs against V. fischeri and found that the toxicity follows the 
expected trend, showing a gradual increase in toxicity with an increase in alkyl chain length. 
This observation was also supported by the studies of Romero & coworkers11 who performed 
these tests on several long chain imidazolium ILs bearing alkyl sulfate anions. 
 
           
Figure 3.13: Vibrio fischeri colonies12 (left); Hawaiian bobtailed squid13 (right). 
 
A slight anion effect was noted with which the [PF6]¯  anions appearing to be slightly more 
toxic compared to [BF4]¯  and Cl¯  ILs. However, one exception was observed from this trend. 
The decyl imidazolium cation combined with the [BF4]¯  anion, demonstrated higher toxicity 
than its Cl¯  and [PF6]¯  counterparts. 
 
3.3.3 Antifungal Toxicity: 
 
Antifungal toxicities of ILs 147-158 (a-c) were measured by Pernak et al.8 against two strains 
of fungi (Candida albicans and Rhodotorula rubra). The authors found that similar to their 
antibacterial results (vide supra) the fungi strains also show gradual increase in toxicity with 
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increase in alkyl chain length. The chloride ILs with propyl, butyl and pentyl chains were non 
toxic up to 8600 µM concentration whilst the [BF4] and [PF6] ILs did not show inhibition up 
to 7000 and 5850 µM concentrations. Recently, Gathergood and Connon et al.14 reported 
antifungal toxicity studies of imidazolium based ILs (Fig. 3.14).  
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Figure 3.14: Imidazolium based ester and amide ILs.  
 
These ILs were screened against a large array of fungal isolates; Candida albicans (ATCC 
44859 and ATCC 90028), Candida parapsilosis, Candida krusei (ATCC 6258 and E28), 
Candida tropicalis, Candida glabrata, Candida lusitaniae, Trichosporon beigelii, Aspergillus 
fumigatus, Absidia corymbifera and Trichophyton mentagrophytes. No fungal inhibition was 
observed against the ILs tested up to the highest test concentration of 2000 µM. Kanjilal et 
al.15 synthesized long chain ester and amide ILs and screened them against five fungal strains, 
namely Candida albicans, C. rugosa, Saccharomyces cerevisiae, Aspergillus flavus and A. 
Niger, by agar well diffusion method. The test cultures were maintained in potato dextrose 
agar (PDA) prior to testing, with Amphotericin B, Streptomycin and cetyltrimethylammonium 
bromide (CTAB) all used as test controls. The toxicity was measured in terms of zones of 
inhibition.  
Table 3.3: Antifungal toxicity of long chain imidazolium ILs.  
 
Fungi 
Zones of inhibition 150 µg [mm] 
[ROCOCH2MIm]Br [RNHCOCH2MIm]Br Control 
R = R = 
Decyl Dodecyl Hexadecyl Decyl Dodecyl Hexadecyl Amphotericin CTAB 
C. albicans 10 17 11 18 20 8 24 12 
C. rugosa 12 19 10 19 22 8 - - 
S. cerevisiae 0 21 0 12 15 0 22 0 
A. flavus 0 12 12 0 20 23 0 0 
A. niger 12 13 0 13 19 10 25 15 
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Table 3.3 (above) shows that the ILs possessing amide functionality are more toxic than the 
ester based ILs. A general trend of increasing toxicity with increase in alkyl chain length is 
consistent. The activity of the dodecyl-substituted imidazolium compounds showed better 
activity than the decyl- and hexadecyl-substituted compounds, in both the ester- and amide-
based ILs. Moreover, the dodecyl-substituted imidazolium compounds displayed better 
activity than CTAB against all the studied strains. 
In 2009, Petkovic and coworkers16 investigated the toxicity of a series of imidazolium, 
pyridinium and cholinium based ILs, towards fungi of the Penicilium genus (Penicillium 
breviocompactum, Penicillium olsonii, Penicillium janczewskii, Penicillium glandicola, 
Penicillium corylophilum, Penicillium glabrum, Penicillium restictum, Penicillium adametzii, 
Penicillium variabile, and Penicillium diversum). Fungal growth was measured in terms of 
the absorbance of the medium at 600 nm, given that an increase in absorbance means an 
increase in growth of fungi. It was found that all strains showed the least tolerance for 
imidazolium ILs. The increase in lipophilicity (through chain length) was postulated to inhibit 
the growth of the tested fungi. The environmentally benign cation cholinium exhibited the 
lowest fungal toxicity, highest MIC and Minimum Fungicidal Concentrations (MFC) values. 
Studies were carried out to evaluate the antifungal toxicity of the starting materials, namely 1-
methylimidazole and pyridine, which inhibited fungal growth by 100 and 60 % respectively.  
 
3.3.4 Antialgal Toxicity:  
 
Algae are primary producers of organic matter required by animals in the fresh water food 
chain. Thus they play a crucial role in supplying energy for higher trophic levels. The ubiquity 
and short life cycles of algae makes them interesting candidates to study the toxicological 
profile of ILs. Cho et al.17a used Pseudokirchneriella subcapitata (Fig. 3.15) to study the 
effect of different head groups, side chains and anions of ILs on algal growth.  
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Figure 3.15: Pseudokirchneriella subcapitata.18 
 
The EC50 values were estimated for short term inhibition of photosynthesis of P. Subcapitata, 
when exposed to different salts of imidazolium and pyridinium ILs. The toxicity was 
measured in terms of absorbance, provided that lesser absorbance is a consequence of more 
inhibition. The effect of IL toxicity was found to be more significant than photosynthetic 
performance. A trend of increasing toxicity with increasing alkyl chain length was observed 
when [pmim], [bmim], [hmim] and [omim] were screened. Out of the anions tested, [SbF6] 
was found to be most toxic (EC50:135 µM) with the other anions tested decreasing in toxicity 
in the order [SbF6]¯ >[PF6]¯ >[BF4]¯ >[CF3SO3]¯ >[C8H17OSO3]¯ >[Br]¯≈[Cl]¯ .19  
Table 3.4: EC50 values for IL screening with P. subcapitata after 96 h exposure. 
                              Ionic Liquids                                   EC50 (µM) 
                                [pmim]Br                                        2137 
                                [bmim]Br                                        2337 
                                [bmim]Cl                                        2384 
                                [bmim][BF4]                                   2012                     
                                [bmim][PF6]                                    1318 
                                [bmim][CF3SO3]                             2188 
                                [bmim][OctOSO3]                           2239 
                                [bmim][SbF6]                                    135 
                                [hmim]Br                                          288 
                                [omim]Br                                         38.2 
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When Kulacki and Lamberti20 performed screening of  the non-mobile Scenedesmus 
quadricauda and the mobile Chlamydomonas reinhardtii freshwater algae in nutrient-rich 
media and low nutrient groundwater using bromide salts of [bmim], [hmim], and [omim] ILs, 
the same trend was  observed with both algae, in both media tested.  
3.4 Antibacterial toxicity of synthesized compounds: 
3.4.1 Toxicity for achiral ILs: 
In vitro antibacterial activities21 of a range of achiral ILs (69, 71-73, 76-78) (Fig. 3.16) were 
evaluated on a panel of three CCM strains (SA: Staphylococcus aureus CCM 4516, EC: 
Escherichia coli CCM 4517, PA: Pseudomonas aeruginosa CCM 1961) and five clinical 
isolates (MRSA: Staphylococcus aureus MRSA H 5996/08, SE: Staphylococcus epidermidis 
H 6966/08, EF: Enterococcus sp. J 14365/08, KP-E: Klebsiella pneumoniae ESBL J 
14368/08, KP: Klebsiella pneumoniae D 11750/08) from the collection of bacterial strains 
cultured at the Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles 
University, Hradec Kralove, Czech Republic. The aforementioned CCM strains also served as 
the quality control strains. All the isolates were maintained on Mueller-Hinton dextrose agar, 
prior to being tested.   
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Figure 3.16: The achiral ILs tested for antimicrobial screening. 
 
Out of the achiral ILs tested, only 69b and 69d were ester based and the remainder (salts of 
71-73, 76-78) were amide based achiral ILs. The results from table 3.5 shows that the  
bromide ILs (73a, 76a-78a) are non toxic up to 2.0 mM/L concentration, except for 71a and 
72b which are decyl amides. The activity of salts of 71 and 72 was found to be low as 
expected, which is consistent with reference literature data.8,15 The lipophilic character of ILs 
with long alkyl chain [71(a-c) and 72(a-c)] enables them to cross the bio-membrane of cell, 
thus showing more activity compared to others.22  The iodide ILs 69d and 73d were also 
found to be non-toxic up to 2.0 mM i.e maximum test concentration. The [NTf2]¯  salt 69b was 
tested at maximum concentration 1.0 mM and found to inhibit both S. epidermis at 0.5 mM 
concentration and K. pneumoniae at 1.0 mM after 24 h. This ester containing IL (69b) was 
also tested by Deng et al.23 against a number of bacterial strains, including E. coli, and found  
the MIC value to be 6.4 mM. The authors furthermore concluded that such classes of ester 
ILs, containing ether chains, have higher inhibitory concentration in the range of 5-20 mM 
depending on length of the ester side chain. When comparing the results of 71a-71c, the effect 
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of the anion component seems to be less pronounced. However, for Gram negative bacteria IL 
71b showed lower IC95 values compared to 71a and 71b. The pyridinium IL 72a showed 
slightly higher inhibitory concentration than 71a but the trend was reversed for [OctOSO3]¯  
salts 71c and 72c.  The corresponding [NTf2] ILs 71b and 72b seem to behave in a similar 
way, with both Gram positive and Gram negative bacteria.   
 
Table 3.5: Antibacterial toxicity results for achiral ILs. 
 
 
 
No. 
 
Bacteria 
strain 
 
Time 
(h) 
MIC/IC95 (mM) 
73a-
b,d 
76a-b, 
77a-b, 
78a-b, 
69d 
 
69b 
 
71a 
 
71b 
 
71c 
 
72a 
 
72b 
 
72c 
1. 
 
SA 24h > 2.0 > 1.0 0.0625 0.0625 0.03125 0.125 0.03125 0.03125 
48h > 2.0 > 1.0 0.125 0.0625 0.03125 0.125 0.0625 0.03125 
2. MRSA 24h > 2.0 > 1.0 0.125 0.125 0.125 0.125 0.125 0.0625 
48h > 2.0 > 1.0 0.125 0.125 0.125 0.125 0.125 0.0625 
3. SE 24h > 2.0 0.5 0.03125 0.25 0.25 0.125 0.125 0.0625 
48h > 2.0 > 1.0 0.0625 0.25 0.50 0.125 0.125 0.0625 
4. EF 24h > 2.0 > 1.0 0.125 0.0625 0.125 0.125 0.0625 0.0625 
48h > 2.0 > 1.0 0.125 0.125 0.125 0.25 0.125 0.0625 
5. EC 24h > 2.0 > 1.0 0.25 0.25 0.25 0.125 0.125 0.0625 
48h > 2.0 > 1.0 0.50 0.25 0.25 0.125 0.125 0.0625 
6. KP 24h > 2.0 1.0 0.50 0.25 0.50 0.50 0.25 0.25 
48h > 2.0 > 1.0 1.0 0.25 0.50 0.50 0.25 0.25 
7. KP-E 24h > 2.0 > 1.0 1.0 0.25 1.0 0.50 0.125 0.50 
48h > 2.0 > 1.0 1.0 0.25 1.0 0.50 0.125 0.50 
8. PA 24h > 2.0 > 1.0 1.0 1.0 2.0 0.50 1.0 0.50 
48h > 2.0 > 1.0 1.0 > 1.0 2.0 0.50 1.0 1.0 
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3.4.2 Toxicity studies of Lactate and Mandelate ILs: 
Overall, thirty chiral ILs (salts of 91-97, 123, 125, 128-133) (Fig. 3.17) were screened for 
antibacterial tests which included fourteen lactate based and remaining mandelate based ILs. 
The mandelate ILs include two monoester and fourteen diester ILs. The tests were carried out 
using DMSO as the test medium. The results are presented in table 3.6.  
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Figure 3.17: Lactate and mandelate based ILs for antimicrobial screening. 
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Table 3.6: Antibacterial toxicity results for chiral ILs containing lactate and mandelate core. 
 
The results presented in table 3.6 shows that all lactate ILs, containing bromide counter-ion, 
(91a-97a) and the [OctOSO3]¯  salts (91c, 97c) were non-toxic up to 2.0 mM concentration. 
ILs 92c-96c did not show inhibition when tested at 1.0 mM concentration. The mono 
substituted mandelate ILs (131a-133a, 133b), which are methyl esters, were also non-toxic up 
to 2 mM concentration. The [NTf2]¯  IL 132b was tested at 0.5 mM concentration limit and 
found to show no inhibition to any of the bacteria. The monoester mandelate ILs 123a and 
125a did not display any inhibition up to 2mM concentration although they possess a butyl 
ester group, thus having higher lipophilicity than methyl ester ILs (131a-133a).   
 
No. 
 
Bacteria 
strain 
 
Time 
(h) 
MIC/IC95 (mM) 
91a-97a,123a, 
125a, 129a, 
131a-133a, 
133b, 91c, 
97c, 129c 
129b, 
92c-
96c 
130b, 
132b 
128a 128b 128c 130a 
1. 
 
SA 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0   2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0   2.0 > 2.0 
2. MRSA 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0   2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0   2.0 > 2.0 
3. SE 24h > 2.0 > 1.0 > 0.5   1.0   0.5 > 2.0   2.0 
48h > 2.0 > 1.0 > 0.5   2.0 > 1.0 > 2.0 > 2.0 
4. EF 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
5. EC 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
6. KP 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
7. KP-E 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
8. PA 24h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 1.0 > 2.0 > 2.0 
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The di-substituted mandelate ILs 128a and 130a showed a marginal toxicity towards S. 
epidermis after 24 h. Here, it can be seen that 128a inhibits the growth of this Gram positive 
bacteria at 1.0 mM after 24 h and 2.0 mM after 48 h. There is an explanation in that the IL 
itself shows higher toxicity towards bacteria, but the metabolites formed after 24 h do not 
show any antibacterial activity. We have seen in section 3.2 (vide supra) that 128a and 130a 
undergo chemical degradation through hydrolysis. Although this experiment was carried out 
in DMSO (100 %), the media was supplemented with buffer of pH = 7.4. Thus the possibility 
of hydrolysis can’t be ruled out as in aqueous stability studies we have seen that 128a 
hydrolysed by 18 % degradation after 24 h whereas 130a degrades by 49 %. In the case of 
130a only, growth inhibition was observed for S. epidermis after 24 h at 1.0 mM, which 
clearly suggests that even though 130a hydrolyses the metabolites are non-toxic at 2 mM 
concentration. The [OctOSO3] salt 128c gave borderline inhibition of bacteria S. aureus and 
MRSA S. aureus at 2.0 mM. The overall results show that both Mandelate and Lactate ILs are 
non-toxic towards bacteria, with some exceptions. It is noteworthy that inhibition was 
observed only in the case of Gram positive bacteria.       
3.5 Antifungal toxicity of synthesized compounds: 
3.5.1 Toxicity studies of achiral ILs: 
In vitro antifungal activities of the compounds (salts of 69, 71-73, 76-78) (Fig. 3.16) were 
evaluated on a panel of four ATCC strains (CA1: Candida albicans ATCC 44859,  CA2: 
Candida albicans ATCC 90028,  CP: Candida parapsilosis ATCC 22019, CK1: Candida 
krusei ATCC 6258) and eight clinical isolates of yeasts (CK2: Candida krusei E28,  CT: 
Candida tropicalis 156,  CG: Candida glabrata 20/I,  CL: Candida lusitaniae 2446/I,  TA: 
Trichosporon asahii 1188) and filamentous fungi (AF: Aspergillus fumigatus 231, AC: 
Absidia corymbifera 272, TM: Trichophyton mentagrophytes 445) from the collection of 
fungal strains cultured at the Department of Biological and Medical Sciences, Faculty of 
Pharmacy, Charles University, Hradec Králové, Czech Republic. Three of the above ATCC 
strains (C. albicans ATCC 90028, C. parapsilosis ATCC 22019, C. krusei ATCC 6258) also 
served as the quality control strains. All the isolates were maintained on Sabouraud dextrose 
agar prior to being tested. Minimum inhibitory concentrations (MICs) were determined by the 
micro-dilution format from the NCCLS M27-A guidelines.21 In the case of the T. 
mentagrophytes, readings were taken after 72 and 120 h and MIC/IC50 values were calculated 
for A. fumigatus, A. corymbifera and T. mentagrophytes while for all other strains MIC/IC80 
values were calculated after 24 and 48 h of exposure to ILs.  
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Table 3.7: Results for antifungal study of achiral ILs. 
 
No 
 
Fungi
strain 
 
Time 
(h) 
MIC/IC80.IC50 (mM)a 
69d, 73a-
b, 73d, 76-
78 (a, b)   
69b 71a 71b 71c 72a 72b 72c 
1. CA1 24h > 2.0 1.0 0.125 0.250 0.125 0.125 0.250 0.125 
48h > 2.0 > 1.0 0.250 0.250 0.125 0.250 0.5 0.125 
2. CA2 24h > 2.0 > 1.0 0.125 0.250 0.125 0.125 0.250 0.125 
48h > 2.0 > 1.0 0.125 0.250 0.125 0.250 0.250 0.125 
3. CP 24h > 2.0 > 1.0 0.0625 0.0625 0.125 0.0625 0.0625 0.0625 
48h > 2.0 > 1.0 0.0625 0.125 0.125 0.0625 0.125 0.0625 
4. CK1 24h > 2.0 > 1.0 0.0078 0.0313 0.0313 0.0156 0.0156 0.0078 
48h > 2.0 > 1.0 0.0078 0.0313 0.0625 0.0156 0.0156 0.0156 
5. CK2 24h > 2.0 > 1.0 0.0039 0.0156 0.0313 0.0156 0.0039 0.0039 
48h > 2.0 > 1.0 0.0039 0.0313 0.0625 0.0156 0.0156 0.0078 
6. CT 24h > 2.0 1.0 0.0039 0.0156 0.0313 0.0156 0.0156 0.0039 
48h > 2.0 > 1.0 0.0039 0.0313 0.0625 0.0156 0.0156 0.0039 
7. CG 24h > 2.0 > 1.0 0.0313 0.0625 0.125 0.125 0.0625 0.0625 
48h > 2.0 > 1.0 0.0625 0.125 0.125 0.125 0.125 0.125 
8. CL 24h > 2.0 > 1.0 0.250 0.250 0.250 0.250 0.250 0.125 
48h > 2.0 > 1.0 0.250 0.250 0.250 0.250 0.250 0.125 
9. TA 24h > 2.0 0.5 0.250 0.250 0.250 0.250 0.250 0.125 
48h > 2.0 > 1.0 0.250 0.5 0.250 0.250 0.5 0.125 
10. AF 24h > 2.0 > 1.0 0.250 0.250 0.250 0.250 0.250 0.125 
48h > 2.0 > 1.0 0.250 0.5 0.250 0.250 0.250 0.125 
11. AC 24h > 2.0 > 1.0 0.250 > 1.0 1.0 0.125 > 0.5 1.0 
48h > 2.0 > 1.0 0.250 > 1.0 1.0 0.250 > 0.5 1.0 
12. TM 72h > 2.0 > 1.0 0.250 0.250 0.125 0.250 0.250 0.125 
120h > 2.0 > 1.0 0.250 0.250 0.125 0.250 0.250 0.125 
a
 IC50 values were assessed for AF, AC and TM. For all other fungi strains IC80 values were 
evaluated. 
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Seventeen achiral ILs were screened for antifungal toxicity (Fig. 3.17). The results from table 
3.7 indicate that the imidazolium ILs, with amide side chain containing ether groups (73a-b, 
73d), were non-toxic up to 2 mM concentration. The ester IL 69d also did not exhibit any 
inhibition to the fungal growth, which is supported by the findings of Deng and coworkers.23 
The [NTf2]¯  salt 69b was tested at 1.0 mM concentration and found to be toxic for C. 
albicans, C. tropicalis and T. asahii after 24 h, but after 48 h again the IL did not exhibit 
toxicity. This behaviour was also observed in the case of antibacterial studies and can be 
explained as the IL itself may be toxic, but after 48 h the metabolites formed are not. One 
more explanation can be that on prolonged exposure the fungi adapt themselves to the 
surroundings. Pernak and co-workers reported that some fungi can change their metabolic 
pathway upon exposure to ILs, by changing their cell biochemistry.8c 
The decyl amide ILs (71a-c and 72a-c) showed high antifungal activity as expected. The 
[NTf2] salts 71b and 72b were found to be non-toxic only towards filamentous fungi (A. 
Corymbifera) up to the maximum test concentration i.e 1.0 and 0.5 mM respectively. The 
effect of both the cation and anion was less pronounced. All six ILs (71a-c and 72a-c) showed 
high antifungal toxicity especially, in the case of C. parapsilosis, C. krusei, C. krusei, C. 
tropicalis and C. glabrata. This was also observed for antibacterial studies. Other amide ILs 
(76a-b, 78a-b) were non-toxic up to a test concentration of 2.0 mM.    
 
3.5.2 Toxicity studies using Lactate and Mandelate ILs: 
Thirty chiral ILs, including lactate and mandelate salts, were screened for antifungal toxicity 
at Charles University (Czech Republic) using twelve strains of fungi. MIC/IC50 values were 
calculated the case of the T. mentagrophytes after 72 and 120 h and for A. fumigatus, A. 
corymbifera after 24 and 48 h. For all other strains MIC/IC80 values were evaluated after 24 
and 48 h of exposure to ILs. The results presented in Table 3.8 in general, show that ILs tested 
were non-toxic up to maximum test concentration, with some exceptions. All the bromide 
salts of lactate ILs (91a-97a) and the [OctOSO3]¯  salts (91c, 97c) did not show inhibition up 
to 2.0 mM concentration. The monosubstituted mandelate ILs (131a-133a) did not inhibit 
bacterial growth up to 2.0 mM. The monoester IL 123a was found to be non-toxic whilst 125a 
showed growth inhibition for C. albicans and C. lusitaniae at 2.0 mM concentration. The 
disubstituted ILs 128a and 130a behaved in a similar way towards yeast (C. krusei, C. 
tropicalis, C. glabrata, C. lusitaniae, T. asahii) and filamentous fungi (A. fumigatus, A. 
corymbifera, T. mentagrophytes) indicating structure-toxicity relationship. 
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Table 3.8: Antifungal studies using lactate and mandelate ILs. 
 
No 
 
Fungi
strain 
 
Time 
(h) 
MIC/IC80.IC50 (mM)a 
91a-97a, 
123a,129a, 
131a-133a, 
133b, 91c, 
97c, 
128b, 
129b, 
92c-96c, 
132c 
130b, 
132b 
125a 128a 128c 129c 130a 
1. CA1 24h > 2.0 > 1.0 > 0.5 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 2.0 > 2.0 2.0 > 2.0 2.0 
2. CA2 24h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 
3. CP 24h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 
4. CK1 24h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 2.0 > 2.0 > 2.0 
5. CK2 24h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 2.0 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 2.0 > 2.0 > 2.0 
6. CT 24h > 2.0 > 1.0 > 0.5 2.0 > 2.0 2.0 2.0 > 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 
7. CG 24h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 2.0 > 2.0 > 2.0 
8. CL 24h > 2.0 > 1.0 > 0.5 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 2.0 > 2.0 > 2.0 > 2.0 > 2.0 
9. TA 24h > 2.0 > 1.0 > 0.5 > 2.0 1.0 1.0 1.0 0.5 
48h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 > 2.0 2.0 
10. AF 24h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 > 2.0 > 2.0 2.0 > 2.0 
11. AC 24h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 2.0 2.0 
48h > 2.0 > 1.0 > 0.5 > 2.0 2.0 2.0 > 2.0 2.0 
12. TM 72h > 2.0 > 1.0 > 0.5 > 2.0 1.0 0.5 1.0 1.0 
120h > 2.0 > 1.0 > 0.5 > 2.0 1.0 0.5 1.0 1.0 
a
 For AF, AC and TM, IC50 values while for all other fungi strains IC80 values were evaluated. 
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The only difference between these two ILs is the cation core i.e 128a contains imidazolium 
whereas 130a possess pyridinium core. On the other hand, a similar compound, but with a 1-
butylimidzolium core (129a) has been found to be non-toxic with IC80/50 >2.0 mM. With the 
variable maximum test concentrations of different salts of the same cation, it is difficult to 
compare the overall effect of the anion. But the comparison between bromide IL (128a) and 
its [OctOSO3]¯  salt (128c) reveals that the [OctOSO3]¯  salt has higher antifungal toxicity to all 
types of fungi.  
 
3.6 Antibacterial toxicity studies at higher concentration: 
In collaboration with the Biotechnology Department at DCU, four achiral ILs (69d, 73d, 77a, 
78a) (Fig. 3.16) and five chiral ILs (123a, 125a, 128a, 130a and 133a) (Fig. 3.17) were 
screened against five bacteria strains: Gram-positive (Bacillus subtilis) and Gram-negative 
(Escherichia coli, Pseudomonas fluorescence, Pseudomonas putida CP1, Pseudomonas 
putida KT2440) (Table 3.5, entries 1-9). IL toxicity determination was based on bacterial 
growth inhibition in a 24 hour assay and was expressed as IC50 values. The maximum test 
concentration for ILs 69d, 73d, 123a, 125a and 133a was 200 mM whereas amide based 
achiral ILs (77a, 78a) were tested at 50 mM. The test concentration for 128a and 130a was 
150 mM and 6.25 mM respectively. The low test concentration was chosen due to the low 
aqueous solubility (0.013 g/mL) of 130a. The IC50 value ranges are presented in Table 3.9 
Table 3.9: Antibacterial screening of achiral and chiral ILs. 
 
Ionic 
Liquids 
IC50 (mM) 
E. coli B. subtilis P. fluorescens P. putida (CP1) P. putida (KT 2440) 
69d 50-100 50-100 50-100 50-100 50-100 
73d >200 >200 >200 >200 >200 
77a >50 >50 >50 >50 >50 
78a 25-50 >50 >50 25-50 >50 
123a 25-50 25-50 25-50 25-50 25-50 
125a 25-50 25-50 25-50 25-50 25-50 
128a 37.5-75 37.5-75 75-150 75-150 75-150 
130a 3.13-6.25 >6.25a >6.25a 3.13-6.25 3.13-6.25 
133a 3.13-6.25 3.13-6.25 3.13-6.25 3.13-6.25 3.13-6.25 
a  Solubility limit; IC50 value greater than solubility in media.  
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Among the achiral ILs, 69d and 73d are iodide salts and Table 3.9 shows that the half 
maximal inhibitory concentration values are higher for these two compounds. The ester IL 
69d has an IC50 value between 50-100 mM for all strains tested. Previously, we have seen that 
the [NTf2]¯  salt of same cation has shown MIC value of 6.4 mM for several strains of bacteria 
including E. coli.15 In our antibacterial studies, the aforementioned ILs (69d, 73d) were found 
to be non-toxic at 2.0 mM concentration. Compound 73d did not exhibit toxicity up to 200 
mM. The amide based IL, containing imidazolium core (77a), was found to be non-toxic up to 
the max. test concentration 50 mM, whereas the IL with pyridinium core (78a) shows 
inhibition of bacteria E. coli and P. putida (CP1) in the range 25-50 mM. 
 
Out of the five chiral ILs tested, the compounds 123a and 125a exhibited similar IC50 value 
range for all bacteria screened i.e. 25-50 mM. Both ILs have similar structure except for the 
cation core. The diester IL 128a showed IC50 value between 37.5-75 mM when screened 
against Gram positive bacteria B. subtilis and Gram negative bacteria E. coli, while the range 
is higher (75-150 mM) for the remaining three bacterial strains. In contrast to the similar 
results between 123a and 125a, the compounds 128a and 130a exhibit a completely different 
scenario. The IL 130a was showed to be most toxic among the disubstituted Mandelate ILs 
possessing O-CH2-O linkage on the aromatic ring. However, this does not affect the growth of 
B. subtilis and Gram negative bacteria P. fluorescence up to a max. test concentration 6.25 
mM. This compound was screened at low test concentration due to its low solubility in Milton 
broth. The only monosubstituted mandelate IL screened (133a) was found to be the most toxic 
IL in the table, inhibiting all strains of bacteria between the ranges 3.13-6.25 mM. Analysis of 
Table 3.9 across the rows reveals that Gram-negative bacterium E. coli and the Gram-positive 
bacterium B. subtilis exhibit similar IC50 values, which is in contrast with previously reported 
results for common ionic liquids.24  
 
3.7 Antialgal Toxicity Studies: 
We have seen in previous sections that the mandelate ILs (123a, 125a and 128a) show low 
antimicrobial toxicity. Hence aiming to explore in more detail the effects of these mono- and 
diester ILs (123a, 125a, 128a and 130a), their effects towards two freshwater green algae, 
namely P. subcapitata and Chlorella vulgaris (C. vulgaris), were investigated and the toxicity 
results presented in Table 3.10.   
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Table 3.10: EC50 values (mg.L-1 and µM) the ILs tested towards two freshwater microalgae 
(P. subcapitata and C. vulgaris). 
 
Ionic Liquids 
EC50 (mg/L) 
(lower limit; upper limit) 
EC50 (µM) 
(lower limit; upper limit) 
P. subcapitata C. vulgaris P. subcapitata C. vulgaris 
123a 
(Mw: 397.3) 
24.1 
(17.5; 30.7) 
251 
(225; 277) 
61 
(44; 77) 
632 
(566; 698) 
125a 
(Mw: 394.3) 
196 
(155; 237) 
344 
(266; 422) 
497 
(393; 601) 
873 
(675; 1070) 
128a 
(Mw: 455.3) 
7.1 
(6.0; 8.1) 
19.9 
(16.2; 23.6) 
16 
(13; 18) 
44 
(36; 52) 
130a 
(Mw: 452.3) 
16.6 
(14.1; 19.7) 
109 
(85; 140) 
37 
(31; 44) 
241 
(188; 310) 
 
These two distinct species of algae were used to determine (i) the effect of the mandelate ILs 
synthesized on a more complex trophic level and (ii) the effect of these ionic structures with 
respect to different species of the same trophic level. The results reported in Table 3.10 show 
the trend of low toxicity in descending order for both P. subcapitata and C. Vulgaris as, 125a 
< 123a < 130a < 128a  
According to Passino’s classification,24 these ILs are included in different categories and 
dependent on the algae species investigated. Thus, for the P. subcapitata, the IL 128a can be 
classified as slightly toxic (1-10 mg/L), a moderately toxic label can be attributed to the ILs 
123a and 130a (10-100 mg/L) while 125a can be considered as low toxicity (100-1000 mg/L). 
The C. vulgaris is less sensitive to these ionic liquids, with 128a categorized as moderately 
toxic whereas 123a, 125a and 130a exhibiting low toxicity. These ILs appear to have an 
impact on algae different from the ordinary ionic liquids previously described in the 
literature25 that we propose is related to the high complexity (c.f. [bmim]Br) of their chemical 
structures. 
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Table 3.11: Toxicity of dialkylimidazolium halides towards fresh water green algae.26,27 
IL Mol. wt. 
(g/mol) 
Algae 
tested 
EC50 
(mg/L) 
EC50 
(µM) 
N,N-dimethyl-N-octadecyl-1-octadecanaminium 
chloride [N1,1,18,18]Cl 
586.502 P. subcapitata 0.46 0.784  
3-decyl-1-methyl-1H-imidazolium chloride [dmim]Cl 258.831 S. vacuolatus  7.05 × 10-5 2.72 × 10-4 
1-methyl-3-tetradecyl-1H-imidazolium chloride 
[tdmim]Cl 314.937 S. vacuolatus  9.25 × 10
-4
 2.94 × 10-3 
 
When these results were compared with those of other ILs (Table 3.11) on the basis of Mw 
and/or carbon content, it was found that mandelate based ILs were 105-106 times less toxic. 
However, there are two differing variables in this study (i) chloride anion instead of bromide 
and (ii) a different alga was screened i. e. S. vacuolatus. However, the results of this study can 
be used as a rough guide.   
3.8 Biodegradation: 
3.8.1 Introduction: 
Gathergood and Scammells were first to design and synthesize biodegradable ILs. 
Considering Boethling's suggestions28-31 and observations from biodegradation studies of 
surfactants, which indicated that the unbranched long alkyl chains and hydrolysable sites in a 
molecule increase biodegradation,32 they prepared several ester and amide based imidazolium 
ILs (including 161a-b).33 These functional groups were chosen in order to retain important 
properties of ILs (i.e. melting point <100°C) while having a hydrolysable site in the molecule. 
Both Sturm test (OECD 301B) and closed Bottle Test (OECD 301D) were performed on new 
ILs 161a-b (Fig. 3.18) along with commercial [bmim] ILs, for comparison.    
 
Figure 3.18: Ester based imidazolium ILs 
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In the Sturm test, the biodegradability was calculated in terms of the amount of CO2 evolved 
from wastewater microorganisms in an aerobic aqueous medium containing the IL to be 
tested. A CO2 evolution of 60 % was the threshold value to pass this test and ILs are required 
to pass this value (60%) to be termed as “readily biodegradable”. Compounds 161a, 161b and 
[bmim][PF6] displayed 48, 59 and 60 % degradation. After these preliminary tests, more 
comprehensive tests were performed using the 'closed bottle test' which involves inoculation 
of waste water microorganisms in an aerobic aqueous medium. Sodium n-dodecyl sulfate 
(SDS) was used as reference standard and depletion of dissolved molecular oxygen was 
measured up to 28 days. The ester based IL (161a) exhibited 19 % biodegradation compared 
to 0 % in the case of [bmim][BF4] and [bmim][PF6], however, a significant difference was 
observed between the results of two different test methods. The authors continued this 
research and synthesized propyl ester based ILs with a wide range of anions, in particular Br¯ , 
[BF4]¯ , [PF6]¯ , [NTf2]¯ , [N(CN)2]¯ , and [OctOSO3]¯ .34 The 'closed bottle' biodegradation tests 
were performed on these ILs and compared with the results of [bmim] based ILs possessing 
similar anions. The results clearly revealed that incorporation of ester functionality increased 
the biodegradability of ILs, with all ILs showing 10-50 % biodegradation. In the case of 
[bmim] based ILs <10 % biodegradation was observed, except for a [OctOSO3]¯  salt (~25 %).  
In 2009, Morrissey et al.35 (from the same group) reported the biodegradation studies of a 
number of ester and amide based ILs containing Br¯  and [OctOSO3]¯  anions. ILs which 
possess an ester and amide side chain with ether functionalities are shown in Fig. 3.19. The 
biodegradation was evaluated using the 'CO2 headspace test' (ISO 14593), which measures 
biodegradability in terms of CO2 evolution during metabolism of IL by microbes.  
 
Figure 3.19: Long chain ester and amide based ILs including ether examples.  
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The results showed that all [OctOSO3]¯  salts 68b, 69b, 162-164b exhibit ~ 60 % 
biodegradation, whereas the amide based ILs35 (73b, 165b-167b) displayed 30-40 % 
biodegradation. The low values in the case of amide ILs were attributed to low reaction 
kinetics of enzymatic hydrolysis of amide functionalities. 
Stolte et al.36 investigated the primary biodegradation of imidazolium and pyridinium ILs 
using activated sludge microbes, according to a modified version of OECD guideline 301 D.  
 
Figure 3.20: Imidazolium and Pyridinium based ILs. 
 
A wide range of imidazolium and pyridinium based ILs (including 168-172) were studied and 
it was found that ILs 168-172 undergo 100 % degradation after 31 days. This observation was 
consistent with the study of Doherty and co-workers.37 The short chain ILs containing ether, 
nitrile and alcohol functional groups displayed 0 % biodegradation. The metabolites from the 
breakdown of 172 were studied, which revealed the pathway of biodegradation. Authors 
stated that the transformation of the alkyl chain starts with the oxidation of the terminal 
methyl group (ω-oxidation) catalysed probably by mono-oxygenases, e.g. by   bacterial 
cytochrome P450 systems. The alcohol formed is subsequently oxidised by dehydrogenases, 
via aldehydes, to carboxylic acids. The resulting carboxylic acids then can undergo β-
oxidation and the two released carbon fragments can enter the tricarboxylic acid cycle as 
acetylCo-A.  
This postulate can be linked to the low biodegradation observed by Harjani et al.38 where 
authors studied a number of imidazolium ILs bearing alcohol, olefin, benzyl and sulphonate 
functionalities at the terminal carbon. These ILs exhibited <5 % biodegradation despite 
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possessing [OctOSO3]¯  anion, which is known to increase biodegradation. This group further 
investigated the biodegradability of a number of nicotinate ester and nicotinamide based ILs 
(Fig. 3.21).  
 
Figure 3.21: Nicotinate ester and nicotinamide based ILs. 
 
The biodegradability was evaluated using the CO2 headspace test. All salts of 173, 174 and 
175b were found to be readily biodegradable, whereas 176b displayed 30 % biodegradation 
after 28 days, as expected. Further studies resulted in a 10-20% decrease in biodegradability 
of ILs, when an ester functionality on the pyridinium ring was replaced with an ether side 
chain.39  
Limited data are available on the biodegradation of ammonium ILs. When mono, bis and tris 
(2-hydroxyethyl)ammonium lactate ionic liquids were tested for biodegradability using the 
BOD method40, all ILs were found to be readily biodegradable (60-95%).41 Interesting results 
were obtained when NAILs (naphthenic acid ILs) were screened for biodegradation.42 In this 
case, carboxylates of various cores were chosen as anions for ILs for instance; alicyclic 
carboxylate, salicylate and lithocholate. Eight out of ten ILs (177a-f and 177i-j) (Fig. 3.22) 
were found to be ‘readily biodegradable’ (60-83%), when tested using closed bottle test.42  
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Figure 3.22: NAILs based ionic liquids; biodegradation values are given in parentheses. 
The ILs possessing 2-naphthoxyacetate (177g) and anthracene-9-carboxylate (177h) anions 
demonstrated 42 and 49 % biodegradation after 28 days, which was attributed to the plausible 
toxicity of these anions towards micro-organisms. 
3.8.2 Biodegradation study of synthesized ILs: 
Twenty one ILs were screened for biodegradation studies (Fig. 3.23).  
 130 
 
 
Figure 3.23: ILs screened for biodegradation study. 
This panel of ILs was chosen in order to study the effect of monoester and diester 
functionalities on biodegradation, along with mono and di-substitution on the phenyl ring. 
The tests were carried out by the CO2 headspace method (ISO 14593), using 20 mg C /L 
concentration of the ILs above. Sodium n-dodecyl sulfate was used as a reference standard. 
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The obtained results are classified according to the percentage biodegradation and presented 
below.  
3.8.2.1: Readily Biodegradable ILs. 
Table 3.12 lists the six compounds that were found to be readily biodegradable (>60 %; 
according to ISO requirements). The R,S-lactate based IL, 95c possessing [OctOSO3]¯  anion 
showed 62 % biodegradation. The [OctOSO3]¯  salts are generally known to be readily 
biodegradable,34,35 in part due to the high propensity for the [OctOSO3]¯  ion to biodegrade. 
Control experiments (SDS/95c mixture) were performed to determine whether the 95c was 
toxic to the inoculum. No inhibition of SDS biodegradation was observed. 
Table 3.12: Results for readily biodegradable ILs (by CO2 headspace method; ISO 14593).a 
IL Biodegradation (%) 
6 days 13 days 21 days 28 days 
SDS 73 91 92 93±2.5 
95c 52 57 61 62±1.0 
128a 17 21 61 60±2.2 
128b 11 46 52 60±0.9 
130a 35 59 63 75±3.7 
130b 26 51 73 80±1.5 
132b 33 64 63 64±0.9 
 
a IL initial concentration= 20 mg C/L; 95% confidence limits calculated from 4 replicate 
experiments 
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Figure 3.24: Graph of readily biodegradable ILs (by CO2 headspace method; ISO 14593). 
 
The pyridinium ILs both 130a (Br¯  salt) and 130b ([NTf2]¯  salt) demonstrated 75 % and 80 % 
biodegradation respectively, indicating that both are readily biodegradable. Neither was toxic 
to inoculum in control biodegradation test. We postulate that the 130a-b are hydrolysed to 
179 and 180a-b (Fig. 3.25), and both these metabolites are readily biodegradable. This 
postulation is supported by the aqueous stability studies (section 3.2) where 100 % hydrolysis 
of 130a was observed in 15 days when tested at 25°C. Further evidence to support the higher 
biodegradation of the pyridinium metabolite 180a (c.f. imidazolium metabolite 178a) is found 
from results published by Harjani et. al.38 for the pyridinium IL 173a (87 % by CO2 
headspace test; ISO 14593). The authors attributed the higher value of biodegradation to 
presence of ester functionality and tendency of pyridine ring to mineralize. To enable a clearer 
understanding of the biodegradation of the ILs, results of Br¯  (130a) and [NTf2]¯  (130b) salts 
were compared. While the [NTf2]¯  contains two carbon atoms (c.f. Br), we would expect 
similar biodegradation values, as long as the toxicity of the ILs is independent of the anion. 
Imidazolium derivatives 128a and 128b also are readily biodegradable, (60 %) and (60 %) 
respectively, however, the values obtained in the CO2 headspace test (ISO 14593) are lower 
than recorded for the pyridinium ILs (130a-b). Previously, we have determined the 
biodegradation of the Cl¯  salt of 178a, and recorded low to negligible CO2 evolution in the 
CO2 headspace test (ISO 14593). As the 128a-b is postulated to breakdown via hydrolysis to 
metabolites 178a and 179 (Fig. 3.25), this supports our hypothesis that 179 is readily 
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biodegradable and 128a-b also, albeit with a recalcitrant metabolite 178a. The postulation of 
hydrolytic breakdown of 128a-b can be further supported by aqueous stability study of 128a 
(section 3.2) which demonstrated 81 % breakdown after 15 days at 25°C.  
 
Figure 3.25: Hydrolysed products of 128a and 130a. 
 
After breakdown of ILs the resultant mandelate core may follow standard metabolic pathway 
as shown in Fig. 3.26. The mandelate core containing protected catechol functionality may 
undergo deprotection through oxidation leaving behind the catechol moiety which breaks 
down to pyruvic acid, ultimately.  
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Figure 3.26: Metabolic pathway of biodegradation through enzymatic oxidation of substituted 
phenyl ring43 and proposed entry point from metabolite 179. 
Compound 132b possessing methyl protected phenol showed 64 % biodegradation. Fig. 3.27 
represents proposed breakdown pathway for 132b. The hydrolysis of secondary ester yields 
178b and mandelate derivative 181. The Cl¯  salt of 178b was shown to be resistant towards 
biodegradation (2 %, CO2 headspace test; ISO 14593), during our studies. The metabolite 181 
may undergo enzymatic oxidation by enzyme 'catechol dioxygenase'44 according to the 
general metabolic pathway shown in Fig. 3.26. Although one of the metabolites (178b) from 
primary biodegradation shows poor biodegradation, we propose further breakdown of 181 
enables compound 132b to be classed readily biodegradable (ISO 14593).      
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Figure 3.27: Proposed breakdown pathway for 132b. 
 
3.8.2.2: Moderately Biodegradable ILs. 
Table 3.13 presents moderate biodegradability results (21-59 %) obtained for ten ILs. The 
[NTf2]¯  IL, 68b displayed 32 % biodegradation. The [OctOSO3]¯  salt of 68 was screened for 
biodegradation previously in our group, which showed 55 % biodegradation.35 A significant 
drop from 55 to 32 % can be attributed to the low biodegradability and low carbon content of 
anion [NTf2]¯ , as compared to [OctOSO3]¯ . The S-Lactate salts, 96b and 96c exhibited 40 and 
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58 % biodegradation, respectively. The comparison of results for 95c (R,S-lactate, Table 3.12) 
and 96c indicates that there is no significant difference between enantiopure and racemic IL.  
 
Table 3.13: Results for moderately biodegradable ILs (by CO2 headspace method; ISO 
14593).a 
IL Biodegradation (%) 
6 days 13 days 21 days 28 days 
SDS 73 91 92 93±2.5 
68b 28 28 35 32±0.6 
96b 27 25 39 40±0.5 
96c 48 57 58 58±3.0 
121a 18 29 43 36±5.1 
123b 20 26 27 25±2.8 
125a 15 22 29 28±2.3 
126a 13 20 27 32±5.0 
127a 13 36 42 37±4.3 
129a 30 35 37 46±5.2 
129b 7 43 51 49±1.7 
 
a IL initial concentration = 20 mg C/L; 95% confidence limits calculated from 4 replicate 
experiments 
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Figure 3.28: Graph of moderately biodegradable (21-59 %) ILs (by CO2 headspace method; 
ISO 14593). 
 
The catechol based IL 121a showed 36 % biodegradation which was unexpectedly low  
because a molecule possessing a catechol functionality, should facilitate biodegradation, 
according to the pathway shown in Fig. 3.26 and our own results for ILs 128a-b and 130a-b. 
Here, we postulate that the breakdown of compound 121a occurred via hydrolysis of the butyl 
ester and further biodegradation of the resulting carboxylate was inhibited (Fig. 3.29). Our 
hypothesis is that the catechol moiety 182 is too sterically hindered and lacks the co-
ordination sphere for Fe (III) from the 'catechol dioxygenase' enzyme to bind.44b,45 The 25-36 
% biodegradation value (CO2 headspace test-ISO 14593) can be attributed to the conversion 
of butanol formed due to enzymatic hydrolysis. 
 
0
10
20
30
40
50
60
70
80
90
100
0 6 Days 13 Days 21 Days 28 days
B
io
d
e
g
ra
d
a
ti
o
n
 (
%
)
Biodegradation (%) vs Time (Days)
SDS
68b
96b
96c
121a
123b
125a
126a
127a
129a
129b
 138 
 
 
 
Figure 3.29: Plausible pathway to support slow biodegradation of 121a.  
 
The monoester compounds 123b and 125a, both possessing methylene di-oxy (-OCH2O-) 
linkage displayed 25 and 28 % biodegradation respectively. Compound 125a containing 
pyridinium core showed moderate biodegradability probably due to the same reason as in the 
case of 121a. If the CO2 evolved was due to breakdown of the aromatic ring having the butyl 
ester intact, then we would observe significantly lower biodegradation for these 
methylenedioxy series. This was not observed, thus further supporting our claims that the 
butyl ester is cleaved. The Cl¯  salt 126a (same cation from 125a) showed 32 % 
biodegradation after 28 days which suggests that the effect of two different halides is less 
significant.     
In the case of ethyl ester IL 127a, 42 % biodegradation was observed after 21 days, which 
reduced to 37 %. This suggests that the metabolites formed after 21 days did not show further 
breakdown. Compounds 129a and 129b possessing 1-butylimidazolium core demonstrated 46 
and 49 % biodegradation respectively. The studies by Stolte et al.36 already have revealed that 
1-methylimidazolium core showed 0 % biodegradation after 31 days. Hence 1-butylimidazole 
may not break down easily, thus reducing the overall biodegradability of the compound. Here, 
both Br¯  (129a) and [NTf2]¯  (129b) salts displayed analogous biodegradability as similar in 
the cases of 128a-b and 130a-b (Table 3.12). 
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3.8.2.3: Low Biodegradability ILs. 
Table 3.14 shows the low biodegradation (0-20 %) results obtained for five ILs. The achiral 
IL 73b exhibited low (3 %) biodegradation as expected due to the amide functionality, which 
generally presents low kinetics for hydrolysis.  
 
Table 3.14: Results for low biodegradation ILs (by CO2 headspace method; ISO 14593).a 
 
IL 
 Biodegradation (%) 
6 days 13 days 20 days 28 days 
SDS 71 91 87 89±2.5 
73b 0 0 1 3±1.6 
123a 14 18 21 16±0.6 
124a 14 19 22 18±5.5 
131a 3 5 7 4±0.4 
133a 3 5 6 3±0.7 
 
a IL initial concentration = 20 mg C/L; 95% confidence limits calculated from 4 replicate 
experiments. 
 
 140 
 
 
Figure 3.30: Graph of low biodegradable (0-20 %) ILs (by CO2 headspace method; ISO 
14593). 
 
The monoester compounds 123a (Br¯  salt) and 124a (Cl¯  salt) showed 16 and 18 % 
biodegradation respectively. The aqueous stability study of 123a (section 3.2) revealed that 
this compound did not hydrolyse after 15 days at 25°C. This resistance towards hydrolysis 
accounts for the low biodegradation values obtained for 123a and 124a. Again the effect of 
two different halides on biodegradation was found to be less pronounced. The 
monosubstituted ILs 131a and 133a displayed 4 and 3 % biodegradation respectively. 
Although these are methyl ester ILs and contains two ester functionalities, the breakdown of 
the phenyl ring would be necessary to obtain higher values as in these cases, more carbon 
content resides within the phenyl ring. Fig. 3.31 shows the proposed pathway for breakdown 
of 131a and 133a. The primary biodegradation gives the metabolites 178a and mandelate 
derivative. We already have seen that 178a shows poor biodegradation (Fig. 3.25), hence the 
percentage biodegradation now depends on breakdown of mandelate core. In the case of 133a, 
the -CF3 group withdraws electron density from the phenyl ring in the mandelate core through 
a negative inductive effect (-I effect) causing lower reactivity of the aromatic system towards 
enzymatic oxidation (Fig. 3.31), thus resisting biodegradation by this pathway. While for 
compound 131a, the scenario is different as phenyl ring experiences both resonance (+R) and 
inductive (-I) effects due to the bromo- substituent. But the often limiting factor in the 
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biodegradation of aryl halide possessing compounds is the enzymatic conversion of the halide 
into a phenolic functionality. The process is usually slow and hence adversely affects the rate 
of biodegradation.30,31 This general observation by Boethling accounts for low biodegradation 
obtained in the case of 131a (Fig. 3.31). Thus poor biodegradability of metabolites formed by 
primary biodegradation of 131a and 133a gives overall low biodegradation values. 
 
Figure 3.31: Proposed breakdown pathway for 131a and 133a (ISO 14593 data shown).     
 
3.9 Summary: 
Seventeen achiral ILs (salts of 69, 71-73 and 76-78) (Fig. 3.16) and thirty chiral ILs (salts of 
91-97, 123, 125, 128-130) (Fig. 3.17) were screened for antimicrobial toxicity. The achiral 
ILs consisted of ester side chain with ether, long chain alkyl amides, amide with ether side 
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chain and cyclic amides with ether chain. All ILs with decyl side chains (71a-c, 72a-c) were 
found to exhibit high antibacterial and antifungal activity. On the other hand, amide ILs 
containing a morpholine ring (76a,b-78a,b) did not exhibit any antimicrobial toxicity. The 
iodide ILs (69d, 73d) were non-toxic at a maximum test concentration of 2.0 mM. The 
antibacterial tests at higher concentrations revealed that the IC50 value for 73d is higher than 
200 mM whereas in case of 69d it is between 50-100 mM.  
Out of the thirty chiral ILs, fourteen were lactate based ILs containing both racemic and S 
isomer components. The bromide and [OctOSO3]¯  salts (91a,c-97a,c) were found to be non 
toxic in antimicrobial screening up to corresponding maximum test concentrations. As the 
actual IC80/IC95 values were above the limit,  comments on effect of anion type and 
enantioselectivity effects of the  compounds could not be made.  
Four Mandelate based ILs (123a, 125a, 128a and 130a) were investigated for stability in D2O. 
Monoester IL 123a was found to be most stable amongst screened ILs, showing no 
degradation till day 15 at 25°C, while another monoester IL was degrading by 2 % by day 15. 
The diester ILs (128a and 130a) showed significant degradation in 15 days i.e. 81 % and 100 
% respectively. Pyridinium IL was  surprisingly found to degrade by 49 % on day 2. The 
antimicrobial screening shows that 130a possess toxicity only towards yeasts (C. glabrata, C. 
lusitaniae, T. asahii) and filamentous fungi (A. fumigatus, A. corymbifera, T. mentagrophytes) 
suggesting that eventhough the IL has a rapid degradation rate in water, the metabolites are 
non-toxic except against a few strains of fungi. The IL 128a generally was non-toxic for 
bacteria, but marginally toxic towards yeasts (C. glabrata, C. lusitaniae, T. asahii) and 
filamentous fungi (A. fumigatus, A. corymbifera, T. mentagrophytes). The bromide salts of 
monosubstituted Mandelate ILs (131a-133a) were non-toxic throughout the antimicrobial 
tests. The antibacterial screening at higher concentrations revealed that only 130a was toxic 
towards five strains of bacteria between 3.13-6.25 mM concentration, whereas all others 
(123a, 125a and 128a) have higher IC50 values. The antifungal screening of 123a, 125a, 128a 
and 130a against fresh water algae P. subcapitata and C. vulgaris showed that monoester ILs 
125a exhibited low toxicity, 123a and 130a were moderately toxic whilst diester ILs 128a 
was slightly toxic, according to Passino's classification. Further investigation revealed that  
generalisation is not possible in this study and the toxicities observed are specific to the strain 
employed in the tests. 
Overall twenty one ILs were screened in this biodegradation study, out of which eleven were 
halides, eight [NTf2]¯  examples based and two [OctOSO3]¯  salts. The studies were carried out 
using the 'CO2 headspace test' (ISO-14593) with sodium n-dodecyl sulfate as the reference 
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standard. All compounds were non-toxic to inoculum in control biodegradation tests. Overall 
six compounds were found to be readily biodegradable. The [OctOSO3]¯  salt 95c 
demonstrated 62 % biodegradability as expected due high propensity of [OctOSO3]¯  ion to 
biodegrade. Pyridinium base ILs 130a-b exhibited 75 and 80 % biodegradation respectively 
and we proposed that metabolites 179 and 180a obtained from primary biodegradation are 
readily biodegradable. The imidazolium ILs 128a-b, both displayed 60 % biodegradability, 
the lower value was attributed to poor biodegradability of one of the metabolites (178a).  
Monoester ILs 121a, 123b, 125a and 126a displayed moderate biodegradability which was 
proposed to be due to biodegradation of butanol. The other metabolite, containing mandelate 
core (182) seems to be sterically hindered inhibiting enzymatic oxidation. In general, the 
diester ILs displayed higher biodegradation values than monoester ILs. The effect of two 
different halides (i.e. Br¯  and Cl¯ ) on biodegradation was found to be negligible. The 
monosubstituted mandelic ILs (131a, 133a) were found to be resistant towards biodegradation 
due to poor biodegradability of metabolite 178a and resistance of mandelate core towards 
enzymatic oxidation. When [NTf2]¯  salts were studied, overall it was found that they exhibited 
slightly higher biodegradation than their bromide salts. All three [NTf2]¯  ILs (128b, 130b and 
132b) were found to be readily biodegradable.  
In the case of lactate [OctOSO3]¯  ILs, the enantiopure salt (96c) displayed a similar value (58 
%) to the racemic salt 95c (62 %) indicating the parity of enzymes for these compounds. The 
amide based achiral IL 73b showed negligible biodegradation (3 %) as expected due to 
resistance of amides towards enzyme catalysed hydrolysis. The overall results were 
satisfactory and indicated that not only the substitution on phenyl ring but also the number of 
ester moieties in the molecule, cation core and the anion type greatly affects the 
biodegradation of ILs. 
Finally, we conclude that the aim of synthesizing novel low toxicity and readily 
biodegradable lactate and mandelate based ILs was achieved and further applications of these 
ILs were investigated. 
 
3.10 Conclusion: 
Out of fourty seven ILs tested in toxicity studies, the amide ILs possessing decyl chain (71a-c 
and 72a-c) were found to be most toxic (low MIC values) against both bacteria (8 strains) and 
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fungi (12 strains). Whilst the lactate based ILs (91a-97a) were found to be least toxic (high 
MIC values) to the eight strains of bacteria and twelve strains of fungi. Although it is well 
known that toxicity is strain specific, we can make an arbitrary comment that increase in the 
lipophilic character of the IL may increase antimicrobial and antialgae toxicity. The comment 
can be supported by an observation that with increasing lipophilicity the penetration ability of 
organic compound through the cell membrane increases. While designing the low toxicity ILs 
one shall remember that the ILs possessing oxygen functionalities (i.e. ether and/or ester) 
were found to be less toxic to bacteria, fungi and algae. We have seen in the presented work 
that the butyl esters of lactate and mandalate core were non-toxic upto 2 mM whereas the 
decyl amides demonstrated high antimicrobial activity. Hence long side chains should be 
avoided as they increase the lipophilic character of the IL.     
Out of twenty one ILs tested in biodegradation studies, the pyridinium IL 130b exhibited 
maximum biodegradation (80 %) while amide IL 73b showed lowest biodegradation (3 %). 
The aqueous stability studies had already shown the degradation behaviour of the mono- and 
diester ILs. The biodegradation data was found to be consistent with the outcomes of aqueous 
stability study. It was observed that ether, ester functionality, [OctOSO3]¯  anion, catechol 
ring, pyridinium core facilitate the biodegradation process. While presence of amide 
functional group, aromatic ring with bromo/trifluoromethyl substituents resist the 
biodegradation process. Some factors such as steric bulk, lack of co-ordination sphere, 
presence of 1-alkylimidazole also contribute to lower  the biodegradation of ILs. 
Biodegradation of ILs is not strain specific hence the design of biodegradable ILs presents its 
own challanges. One can design readily biodegradable ILs by following Boethling's 
guidelines, however every compound is unique and experimental data is essential, before 
classifying biodegradable.30,31 The IL shall possess phenyl/aryl rings, unbranched alkyl 
chains, enzymatically hydrolysable sites (for instance ester, alcohols, phenols, aldehydes) and 
anions like [OctOSO3]¯  which helps the biodegradability. At the same time the branched alkyl 
chains, fused ring systems, substituents such as bromo-, nitro- must be avoided which resist 
the biodegradability. Alongwith the aforementioned rules, one must consider the probable 
toxicity, stability and synthetic viability of the chemical structure while designing the ILs. 
Considering the Boethling's guidelines and results from current work, several biodegradable 
ILs are suggested for the future work (Fig. 3.32).   
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Figure 3.32: Design of ionic liquids for the future work. 
Incorporation of ether and ester groups in pyridinium core would facilitate the 
biodegradability and break down will occur at a faster rate. In our recent studies,46 
tetrabutylammonium 4-hydroxyprolinate was found to be readily biodegradable. In this case 
4-hydroxy proline ester has been included as part of the cation. The substitution of acidic 
proton at α-position with fluorine we postulate would increase the chemical stablity of the IL, 
but biodegradation data of these ILs is required to determine if these are readily biodegradable 
(or not).  
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Reactions 
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4.1 Introduction: 
The Tsuji-Trost reaction is one of the classical coupling methods to form C-C bonds using 
transition metal catalysts. A special feature of this reaction is the replacement of the leaving 
group on the allylic carbon with a range of suitable nucleophiles, thus it holds importance in 
synthesizing allyl substituted organic molecules.1 Asymmetric Tsuji-Trost reactions are 
significant for synthesis of enantiopure drug molecules.2 Ionic liquids have been investigated 
heavily as reaction media in transition metal catalysis for over a decade mainly because of 
their properties such as low vapour pressure,3 non-flammability, high boiling point, high 
dielectric constant etc. There are many examples displaying the use of ILs in hydrogenation,4 
Heck,5 Suzuki,6 carbonyl-ene7 and Diels-Alder reactions.8  
A number of attempts have been made to apply ionic liquids in Tsuji-Trost reactions9-15 as 
well as reactions using chitosan supported catalysts,16 microwave assisted reactions,17 and 
reactions in ionic liquids-organic solvent biphasic media.18 Toma et al.19,20 reported 
enantioselective Tsuji-Trost reactions in [bmim][PF6] using a range of homochiral ferrocenyl 
phoshphine ligands.  
Ionic liquids are considered as alternatives for conventional solvents hence evaluation of the 
toxicity and biodegradability of ionic liquids is a necessary step and gives added advantage in 
their applications. Reported data on the toxicity of [bmim] based ionic liquids shows that they 
are less toxic than conventional solvents (e.g. DCM, DMF).21 The amide based ionic liquids 
synthesized in our group were found to have lower antimicrobial toxicity than [bmim] ILs.22 
Luczak et al.22 tested the antimicrobial toxocity of [bmim][NTf2] and found that the growth of 
E. coli was inhibited at MIC/IC95 = 2 mM concentration. The MIC/IC95 value for 
Staphylococcus aureus was observed to be > 2 mM whereas in our case the [NTf2] salts 69b, 
73b, 75b and 77b were non-toxic up to 2 mM concentraton for eight strains of bacteria (see 
chapter 3). We reported the application of such ILs in hydrogenation reactions in our previous 
publication.23 
 
4.2 Results and Discussion: 
We have seen in the toxicity section (chapter 3) that the achiral ILs 69b, 73b and 77b were 
non-toxic up to 2.0 mM concentration. Also these ILs are liquids at RT, facilitating their 
application as solvent in the reactions (Fig. 4.1).  
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Figure 4.1: Ionic liquids used in the Tsuji-Trost reactions. 
 
 
Figure 4.2: Catalysts used for the Tsuji-Trost reaction. 
 
The Tsuji-Trost reactions were performed at RT, under argon atmosphere, using (E)-1,3-
diphenylallyl acetate as a substrate, dimethyl malonate as nucleophile (2.0 eq.), homochiral 
ferrocenyl phosphine based ligands (8 mol%) (Fig. 4.2), Pd2(dba)3 (2 mol%) as Pd0 source 
and potassium carbonate (2.0 eq.) as base (Scheme 4.1). The results are shown in Table 4.1. 
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Scheme 4.1: Tsuji-Trost reaction of (E)-1,3-diphenylallyl acetate. 
The starting point of this work was to repeat the best result obtained by Toma et al.20 This was 
successfully repeated giving 31 % yield with 86 % enantioselectivity towards the S-isomer. 
The [bmim] salt was then replaced with our low antimicrobial toxicity ILs. An ester IL 69b 
gave good enantioselectivity but with poor yield (entry 2), whereas amide IL containing ether 
linkage gave the best ee (96 %) in the reported work howver with 21 % yield (entry 3). To 
study the reaction kinetics, we carried out reactions for 5 h. A reaction in 73b retained the 
enantioselectivity (94 %) with a very poor yield (11 %) (entry 4).  
Table 4.1: Results of Tsuji-Trost reactions by K2CO3 method. 
      Entry            IL             Temp. (°C)         Time (h)            Yield (%)        ee (%) (S)           
          1       [bmim][PF6]        RT                      15                        31                   86   
          2             69b                RT                      15                        27                   80 
          3             73b                RT                      15                        21                   96 
          4             73b                RT                      05                        11                   94  
          5             73ba               RT                      15                        29                   88 
          6             73bb               RT                      15                        26                   85  
          7             69b                40                       05                        20                   74 
          8             69b                40                       15                        12                   77 
          9             69b                60                       05                        24                   66 
         10            73b                40                       05                        37                   92 
         11            73b                40                       15                        37                   92 
         12            73b                60                       05                        32                   88 
         13            73b                60                       15                        39                   80               
Reaction conditions: The reaction was performed under Ar atmosphere at RT using dimethyl 
malonate (2.0 eq.), Pd2(dba)3 (2 mol%), (S,S)-iPr-phospherrox (8 mol%), K2CO3 (2.0 eq.), IL 
(1.0 eq.); a DIPEA (2.0 eq.), b mandyphos ligand (8 mol%).     
 
The dissolution of potassium carbonate in 73b was observed to be low as this is an inorganic 
salt and excess (2.0 eq.) was used in the reaction. Hence it was replaced with N,N-di-
isopropylethylamine, but a similar yield with a lower ee  was observed (entry 5). In another 
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experiment, the phospherrox ligand was replaced with a ligand from the mandyphos family 
(Fig. 4.2) which gave 26 % yield with 85 % enantioselectivity. The temperature effect on the 
yield and ee was investigated which revealed that the IL 69b gave poor performance in terms 
of both yield and enantioselectivity (entries 7-9) whilst 73b proved to be the better solvent, 
particularly at 40°C giving 37 % yield and 92 % ee (entries 10, 11).The reactions gave poor 
yields however, with excellent ee (88-96 %).  
Poor yields were initially attributed to the stability of the enolate intermediate and hence we 
decided to shift the keto-enolate equilibrium towards the enolate by trapping it in situ as a 
silyl ether (similar to Mukaiyama condensation24). Thus using KOAc (2.0 eq.) and 
bis(trimethylsilyl)acetamide (2.0 eq.) the reactions were carried out under similar conditions. 
Along with being utilised as a base, the other reason in using  KOAc in the reaction was to 
suppress the minor decomposition of starting material (161) to the corresponding alcohol, 
caused by trace amounts of water in the reaction. The reactions were carried out using amide 
based ILs (Fig. 4.1) with results presented in Table 4.2. 
 
Table 4.2: Results of Tsuji-Trost reactions by KOAc/BSA method. 
      Entry            IL              Temp. (°C)         Time (h)             Yield (%)         ee (%) (S)           
          1              73b                 RT                      15                        38                   87   
          2              73ba                RT                      15                        61                   83 
          3              73ba                RT                      15                        59                   86 
          4              73bb                RT                      15                        75                   48  
          5              77b                 RT                      15                        47                   64 
          6              75b                 RT                      15                        43                   94  
          7              75ba                RT                      15                        53                   55 
          8              73c                 RT                      15                        58                   44 
          9              73f                  RT                      15                        54                   49 
         10             THF                RT                      15                        61                   79 
         11             THFa              RT                      15                        65                   63 
         12             DMSO           RT                       15                        62                   97 
         13             DMSOa          RT                      15                        71                   91               
Reaction conditions: The reactions were performed under Ar atmosphere using IL (1.0 eq.), 
dimethyl malonate (2.0 eq.), Pd2(dba)3 (2 mol%), (S,S)-iPr-phospherrox (8 mol%), KOAc (2.0 
eq.), bis(trimethylsilyl)acetamide (2.0 eq.); a Pd2(dba)3 (4 mol%), b R-BINAP (8 mol%).    
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A reaction in 73b with 2 mol% (Pd0) catalyst loading (entry 1) gave 38 % yield and 87 % ee, 
and when 4 mol% catalyst was used, the yield was boosted by 23 % with a minor drop in ee 
(83 % obtained) (entry 2). The repeated reaction in 73b under same conditions gave similar 
results (entry 3). When the (S,S)-iPr-phospherrox ligand was replaced with R-BINAP (8 
mol%), the reaction gave moderate yield (75 %) but with a substantial drop in the 
enantioselectivity (48 %) (entry 4). The IL (73b) was replaced with other amide based ILs 
(75b and 77b, Fig. 4.1) to investigate the effects of structural modifications in the IL solvent, 
as our main observations lead us to postulate that due to the presence of an ether group in the 
IL, the catalyst may be more stable resulting in higher enantioselectivity. The IL 77b is 
comprised of a cyclic ether moiety whereas 75b has lack of ether functional group. The 
results were inconsistent with this theory however as improved result was obtained for 75b 
(entry 6, 94 % ee) than for 77b (entry 5, 64 % ee). Both reactions gave fair yields (43% and 
47% respectively, entry 5, vs entry 6). On doubling catalyst loading (entry 7), 75b gave only 
53 % yield with a substantial drop in the enantioselectivity (55 %). The IL 73c (Fig. 4.1) was 
shown to possess low antimicrobial toxicity,25 hence 73c was employed in a reaction which 
yielded 58 % product (162) with 44 % ee. On the other hand, the acetate IL (73f) gave 162 in 
54 % yield with 49 % ee (entry 9). Several reactions were performed in conventional solvents 
for the comparision of the results. A common solvent used for Tsuji-Trost reactions (THF) 
lead to 162 isolated in 61 % yield with 79 % ee (entry 10) while with double catalyst loading 
(4 mol% Pd0), gave 65 % yield and 63 % enantioselectivity was achieved (entry 11). A 
reaction in DMSO gave 62 % yield with excellent ee (97 %) (entry 12) and with 4 mol% 
catalyst loading reaction yield increased to 71 %, giving 91 % enantioselectivity (entry 13). 
The mechanism of this reaction involves coordination of the chiral Pd-phospherrox catalyst 
with the target olefin (161) followed by oxidative addition of Pd complex to form a π-allyl 
complex (Fig. 4.3). SN2 attack of the formed enolate species of dimethyl malonate on the π-
allyl complex causes reduction of PdII to Pd0. Subsequent decomplexation of the Pd-
phospherrox catalyst yields product (162).26 In this case the π-allyl complex possesses C2 
symmetry, hence SN2 attack of enolate at either of the allyl termini would give the same 
product. 
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Figure 4.3: Mechanism of Tsuji-Trost reaction.  
 
4.3 Summary:  
A range of low antimicrobial toxicity ILs (69b, 73b-c, 73f, 75b and 77b) were employed in 
Tsuji-Trost reactions of (E)-1,3-diphenylallyl acetate (161). The reactions were performed 
using two methods i.e K2CO3 method and KOAc/BSA method. The ester based IL 69b gave 
poor yields of 162 (12-27 %) with moderate to good ee (66-80 %). The amide based IL 73b 
exhibited excellent enantioselectivities (88-96 %) by K2CO3 method but with poor yields (21-
29 %) whereas by KOAc/BSA method, reactions gave fair to moderate yields (38-61 %) with 
good enantioselectivities (83-87 %). When piperidine based IL (75b) was used as a solvent, 
fair yield (43 %) with excellent enantioselectivity (94 %) was obtained. The temperature 
studies revealed that at higher temperature reactions with IL 69b showed a decrease in both 
yield and ee, whilst the reactions with 73b showed 16 % increase in the yield with a minimal 
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decrease in enantioselectivity. The experiments with lower reaction time displayed decreased 
yields suggesting slow reaction kinetics within the reactions.  
4.4 Conclusion:   
Reactions were carried out using two methods consisting two different bases. In the K2CO3 
method, 96 % ee was obtained with 21 % yield using amide IL 73b. The second best result by 
this method was at 40°C which gave 92 % ee with 37 % yield. Whilst in 
KOAc/bis(trimethylsilyl)acetamide method, IL 75b gave 94 % ee with 43 % yield and IL 73b 
showed 87 % ee with 38 % yield. While preparing the catalyst, the Pd-source and (S,S)-iPr-
phosferrox were heated in IL at 80°C. It is well known that at higher temperature and under 
basic conditions imidazole ILs form carbene complex with Pd. In some cases these carbene 
complexes have been found to be more reactive than the original catalyst (see section 1.8.4).  
Pd L*L*
NN
N N
N
O O
O
N
OO
O
L* = (S,S)-iPr-phosferrox
 
Figure 4.4: Carbene-Pd complex. 
Hence in this case it can be said that IL forms a carbene complex with Pd while providing the 
added stability to the catalyst (Fig. 4.4). The low yields obtained in these reactions can be 
attributed to the mass transfer effects resulting from high viscosities of applied ILs.   
The KOAc/BSA method is advantageous in terms of yields, especially, with 4 mol% (Pd0) 
catalyst loading. The conventional solvents, THF and DMSO showed moderate yields and 
excellent enantioselectivities. However, from a toxicity point of view our ILs proved to be 
‘greener’ and safer. Also these ILs have the potential to be further optimised for this reaction 
to give improved yields and enantioselectivities.   
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Atom economy is an important green chemistry metric and gives vital information about the 
greenness of a chemical procedure. The calculation of percentage atom economies for the 
procedures presented in this thesis were found to be as follows; (a) alkylating agents: 70-95 
%; (b) bromide ILs: ~100 %; (c) [NTf2]¯  ILs: 80-92 %; (d) [OctOSO3]¯  ILs: 80-90 %. The 
new methods for synthesis of iodide ILs from [NTf2] salts showed low atom economies. i.e. 
44 % for 69d and 42 % for 73d.  
While evaluating the chemical procedure in terms of atom economy, ease of reaction work-
up, energy requirements, use of bio-renewable sources, it can be said that these chemical 
procedures are 'green'. Although the synthesis of intermediates and ILs demands employment 
of traditional solvents, these solvents can be recycled when reactions are carried out on bulk 
scale or alternative methods (e.g. neat reactions) can be found in future to make the process 
'greener'. In present situation the preparation of lactic acid based bromide ILs (91a-94a) are 
the greenest syntheses given that these procedures use bio-renewable raw materials, and has 
~100 % atom economy in the final stage. 
In the case of substituted mandelic acid based ILs, the raw materials (2,3-
methylenedioxymandelic acid and 2,3-dihydroxymandelic acid) were synthesized in lab due 
to their high expense. Hence it was five step synthesis of ILs, however, the yields of 
intermediates and ILs were good (>80 %) to excellent (>90 %).   
Overall the bromide ILs were found to be in solid state whereas the [NTf2]¯ , [OctOSO3]¯  salts 
were liquid at RT. Many of the liquid ILs were found to be very thick and viscous. The actual 
viscosity was not measured due to sample quantity constraints. During the course of work-up 
the ILs were heated to 40-50°C on rota evaporator and were subjected to high vacuum drying 
but none of the compounds were found to undergo any chemical or thermal degradation under 
these conditions indicating their stability and robustness.  
This series of 56 ILs, comprising different classes, offer a choice to test representative 
examples for toxicity & biodegradation and select specific ILs for further applications.   
Out of fourty seven ILs tested in toxicity studies, the amide ILs possessing decyl chain (71a-c 
and 72a-c) were found to be most toxic (low MIC values) against both bacteria (8 strains) and 
fungi (12 strains). Whilst the lactate based ILs (91a-97a) were found to be least toxic (high 
MIC values) to the eight strains of bacteria and twelve strains of fungi. Although it is well 
known that toxicity is strain specific, we can make an arbitrary comment that increase in the 
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lipophilic character of the IL may increase antimicrobial and antialgal toxicity. The comment 
can be supported by an observation that with increasing lipophilicity the penetration ability of 
organic compound through the cell membrane increases. While designing the low toxicity ILs 
one shall remember that the ILs possessing oxygen functionalities (i.e. ether and/or ester) 
were found to be less toxic to bacteria, fungi and algae. We have seen in the presented work 
that the butyl esters of lactate and mandelate core were non-toxic up to 2 mM whereas the 
decyl amides demonstrated high antimicrobial activity. Hence long side chains should be 
avoided as they increase the lipophilic character of the IL.     
Out of twenty one ILs tested in biodegradation studies, the pyridinium IL 130b exhibited 
maximum biodegradation (80 %) while amide IL 73b showed lowest biodegradation (3 %). 
The aqueous stability studies had already shown the degradation behaviour of the mono- and 
diester ILs. The biodegradation data was found to be consistent with the outcomes of aqueous 
stability study. It was observed that ether, ester functionality, [OctOSO3]¯  anion, catechol 
ring, pyridinium core facilitate the biodegradation process. While presence of amide 
functional group, aromatic ring with bromo/trifluoromethyl substituents resist the 
biodegradation process. Some factors such as steric bulk, lack of co-ordination sphere, 
presence of 1-alkylimidazole also contribute to lower  the biodegradation of ILs. 
Biodegradation of ILs is not strain specific hence the design of biodegradable ILs presents its 
own challenges. One can design readily biodegradable ILs by following Boethling's 
guidelines, however every compound is unique and experimental data is essential, before 
classifying biodegradable.30,31 The IL shall possess phenyl/aryl rings, unbranched alkyl 
chains, enzymatically hydrolysable sites (for instance ester, alcohols, phenols, aldehydes) and 
anions like [OctOSO3]¯  which helps the biodegradability. At the same time the branched alkyl 
chains, fused ring systems, substituents such as bromo-, nitro- must be avoided which resist 
the biodegradability. Alonwith the aforementioned rules, one must consider the probable 
toxicity, stability and synthetic viability of the chemical structure while designing the ILs. 
Considering the Boethling's guidelines and results from current work, several biodegradable 
ILs are suggested for the future work (Fig. 5.1).   
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Figure 5.1: Design of ionic liquids for the future work. 
Incorporation of ether and ester groups in pyridinium core would facilitate the 
biodegradability and break down will occur at a faster rate. In our recent studies,46 
tetrabutylammonium 4-hydroxyprolinate was found to be readily biodegradable. In this case 
4-hydroxy proline ester has been included as part of the cation. The substitution of acidic 
proton at α-position with fluorine we postulate would increase the chemical stability of the IL, 
but biodegradation data of these ILs is required to determine if these are readily biodegradable 
(or not). 
The Tsuji-Trost reactions were carried out using two methods consisting two different bases. 
In the K2CO3 method, 96 % ee was obtained with 21 % yield using amide IL 73b. The second 
best result by this method was at 40°C which gave 92 % ee with 37 % yield. Whilst in 
KOAc/bis(trimethylsilyl)acetamide method, IL 75b gave 94 % ee with 43 % yield and IL 73b 
showed 87 % ee with 38 % yield. While preparing the catalyst, the Pd-source and (S,S)-iPr-
phosferrox were heated in IL at 80°C. It is well known that at higher temperature and under 
basic conditions imidazole ILs form carbene complex with Pd. In some cases these carbene 
complexes have been found to be more reactive than the original catalyst (see section 1.8.4).  
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Figure 5.2: Carbene-Pd complex. 
Hence in this case it can be said that IL forms a carbene complex with Pd while providing the 
added stability to the catalyst (Fig. 5.2). The low yields obtained in these reactions can be 
attributed to the mass transfer effects resulting from high viscosities of applied ILs.   
The KOAc/BSA method is advantageous in terms of yields, especially, with 4 mol% (Pd0) 
catalyst loading. The conventional solvents, THF and DMSO showed moderate yields and 
excellent enantioselectivities. However, from a toxicity point of view our ILs proved to be 
‘greener’ and safer. Also these ILs have the potential to be further optimised for this reaction 
to give improved yields and enantioselectivities. 
Finally, we conclude that our aim of synthesizing low toxicity and readily biodegradable ionic 
liquids was achieved successfully. Fifty six novel chiral and achiral ILs were prepared and 
representative examples were tested for toxicity and biodegradability studies. Six achiral ILs 
were chosen to employ as reaction media in Tsuji-Trost reactions while nine achiral ILs are 
being tested for applications in dye-sensitized solar cells as electrolyte media.  
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6.1 Introduction: 
6.1.1 Chemicals: 
All chemicals were used from Sigma Aldrich, with the exceptions of lithium 
bis(trifluromethanesulfonyl) imide (LiNTf2) which was purchased from Solvionic. Sodium 
octyl sulphate (NaOctSO4) was synthesized according to the litereature method.1 Methanol, 
hexane and triethylamine were dried over molecular sieves and distilled before use. 1-butanol, 
1-pentanol and 1-octanol were dried over molecular sieves and used without further 
purification. Diethyl ether was dried over sodium metal wire (checked with benzophenone) 
and distilled before use. DCM was dried over calcium hydride, and distilled before use. 
Riedel de Haën silica gel was used for flash and thin layer chromatography. Sodium carbonate 
(Na2CO3), ammonium chloride (NH4Cl), calcium chloride anhydrous (CaCl2·2H2O) and 
Magnesium sulphate heptahydrate (MgSO4.7H2O) were obtained from Riedel de Haën. and 
Fluka respectively. 
6.1.2 NMR Analysis 
The NMR analysis was carried out on a Bruker 400 MHz and 600 MHz spectrometers, 
operating at 400, 600 MHz for 1H NMR and 100, 150 MHz for 13C NMR, in deuterated 
chloroform, DMSO, acetone, benzene or water. Chemical shifts are measured in parts per 
million (ppm) and coupling constants (J) are measured in Hertz (Hz). Numbering of specific 
protons and carbons of the compounds is assigned for all intermediates and ionic liquids. 
Splitting patterns are noted as follows:  
s: singlet; d: doublet; t: triplet; q: quartet; dd: doublet of doublets; dt: doublet of triplets;  
tt: triplet of triplets; tq: triplet of quartets; bs: broad singlet. 
6.1.3 IR analysis 
All IR analysis was carried out on a Perkin Elmer FT-IR spectrum GX spectrometer with neat 
samples.  
6.1.4 Optical Rotation 
All optical rotation measurements were carried out on a Perkin Elmer 343 Polarimeter in 
chloroform or ethanol at 20 ºC and the values are expressed in degrees. 
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6.1.5 Melting point 
All melting point (uncorrected) measurements were carried out on a Griffin melting point 
apparatus and values are expressed in degrees celcius (ºC). 
6.1.6 Mass Spectrometry 
The HRMS analysis was carried out in our collaborator's laboratory at Cork using Waters 
Micromass LCT Premier mass spectrometer (Instrument number KD 160) at capillary voltage 
3.52 kV. HMRS was obtained for all halide ionic liquids and after anion metathesis only 
LRMS was obtained for analogues composed of the same cation. The analysis of both chiral 
and achiral α-bromo ester and α-bromo amide alkylating agents was unsuccessful hence not 
reported.  
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6.2 Achiral Ionic Liquids: 
6.2.1 Alkylating agents: 
General Proceedure A: Preparation of achiral α-bromoesters2  
2-Ethoxyethyl-2-bromoacetate (62)2 
 
 
To a stirred solution of ethoxyethanol (20.04 g, 222.4 mmol) in CH2Cl2 (100 mL) at -5 oC was 
added sodium carbonate (28.22 g, 266.2 mmol) followed by bromoacetyl bromide (21.4 mL, 
244.1 mmol). The reaction mixture was allowed to warm to room temperature and stirred for 
12 h. Then reaction mixture was filtered and washed with saturated sodium bicarbonate (50 
mL) and brine solution (3 × 50 mL). The organic phase was then concentrated by rotary 
evaporation and crude product was purified by column chromatography (SiO2, 
EtOAc:Hexane, 20:80) to obtain the title compound (62) as a colourless liquid in 97 % yield 
(45.67 g, 216.4 mmol). 
Molecular formula: C6H11BrO3 
Molecular weight: 211.05 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 4.30 (t, J = 4.6 Hz, 2H, H3), 3.86 (s, 2H, H2), 3.64 (t, J = 
4.6 Hz, 2H, H4), 3.52 (q, J = 7.0 Hz, 2H, H5), 1.20 (t, J = 7.0 Hz, 3H, H6). 
13C NMR (100 MHz, CDCl3) ppm: 167.21 (COO, C1), 67.87 (OCH2, C3), 66.61 (CH2O, C4), 
65.37 (OCH2, C5), 25.90 (CH2, C2), 15.04 (CH3, C6). 
1H and 13C-NMR spectra are in agreement with the literature data.2 
2-(2-Butoxyethoxy)ethyl-2-bromoacetate (63)2 
 
The title compound (63) was prepared from di(ethyleneglycol)-n-butylether (23.83 g, 146.9 
mmol), sodium carbonate (23.35 g, 220.3 mmol) and bromoacetyl bromide (15.4 mL, 176 
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mmol) according to general procedure A to afford as a colourless liquid in 98 % yield (40.82 
g, 144.2 mmol). 
Molecular formula: C10H19BrO4 
Molecular weight: 283.16 g/mol 
1H NMR (400 MHz, CDCl3, δ): 4.26 (t, J = 4.8 Hz, 2H, H3), 3.82 (s, 2H, H2), 3.67 (t, J = 4.8 
Hz, 2H, H4), 3.60-3.57(m, 2H, H5), 3.53-3.50 (m, 2H, H6), 3.39 (t, J = 6.8 Hz, 2H, H7), 1.50 
(tt, J = 7.4, 6.8 Hz, 2H, H8), 1.30 (qt, J = 7.4, 7.2 Hz, 2H, H9), 0.85 (t, J = 7.2 Hz, 3H, H10).   
13C NMR (100 MHz, CDCl3, δ): 167.19 (COO, C1), 71.18 (OCH2, C7), 70.63 (OCH2, C5), 
70.01 (OCH2, C6), 68.70 (OCH2, C4), 65.31 (OCH2, C3), 31.65 (NCH2, C8), 25.85 (CH2, 
C2), 19.23 (CH2, C9), 13.89 (CH3, C10). 
IR (neat, cm-1): 2958, 2933, 2867, 1738, 1279, 1107, 1035, 962, 864, 666. 
1H and 13C-NMR spectra are in agreement with the literature data.2 
2-Bromo-N-decylacetamide (64)3 
 
 
The title compound (64) was prepared from n-decylamine (12.65 g, 80.4 mmol), sodium 
carbonate (10.23 g, 96.5 mmol) and bromoacetyl bromide (8.40 mL, 96.5 mmol) according to 
general procedure A as a pale yellow solid in 67 % yield (14.90 g, 53.6 mmol). 
Molecular formula: C12H24BrNO 
Molecular weight: 278.23 g/mol 
Melting point: 42-44 °C 
1H NMR (400 MHz, CDCl3) ppm: 6.43 (bs, 1H, NH), 3.85 (s, 2H, H2), 3.25 (dt, J = 7.2, 6.0 
Hz, 2H, H3), 1.51 (tt, J = 7.2, 6.8 Hz, 2H, H4), 1.32-1.19 (m, 14 H, H5-H11), 0.85 (t, J = 6.8 
Hz, 3H, H12). 
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13C NMR (100 MHz, CDCl3) ppm: 165.42 (CO,C2), 40.36 (HNCH2,C4), 31.95 (CH2,C5), 
29.60 (CH2), 29.58 (CH2), 29.44 (CH2), 29.37 (CH2), 29.32 (CH2), 29.26 (CH2,C2), 26.89 
(CH2), 22.75 (CH2), 14.20 (CH3,C12). 
IR (neat, cm-1): 3276, 2919, 2851, 1675, 1636, 1555, 1470, 1434, 1322, 1212, 941, 717. 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.3 
2-Bromo-N,N-bis(2-methoxyethyl)acetamide (65)4 
 
To a stirred solution of bis(2-methoxyethyl)amine (40.10 g, 301.1 mmol) in CH2Cl2 (500 mL) 
at −78 °C was added triethylamine (48.51 g, 479.4 mmol) followed by bromoacetyl bromide 
(34.8 mL, 400 mmol). The reaction mixture was stirred at −78 oC for 5 h. Then reaction 
mixture was washed with 10 % NH4Cl solution (200 mL), 10 % sodium bicarbonate (200 
mL), water (200 mL) and brine solution (200 mL). The organic phase was then dried over 
anhydrous MgSO4, filtered and concentrated under high vacuum to obtain the title compound 
(65) as a brown liquid in 76 % yield (58.15 g, 228.8 mmol). 
Molecular formula: C8H16BrNO3 
Molecular weight: 254.12 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 3.96 (s, 2H, H2), 3.59 (t, J = 5.2 Hz, 2H, H3/H6), 3.52-
3.48 (m, 4H, H3/H6, H4/C7), 3.48 (t, J = 5.2 Hz, 2H, H4/H7), 3.28 (s, 6H, H5, H8). 
13C NMR (100 MHz, CDCl3) ppm: 167.66 (COO, C1), 70.70 (OCH2, C4/C7), 70.28 (OCH2, 
C4/C7), 59.09 (OCH3, C5/C8), 58.89 (OCH3, C5/C8), 50.05 (NCH2, C3/C6), 46.83 (NCH2, 
C3/C6), 27.25 (CH2, C2). 
1H and 13C-NMR spectra are in agreement with the literature data.4 
IR (neat, cm-1): 2984, 2929, 2890, 1643, 1456, 1419, 1365, 1189, 1112, 1012, 964, 825, 708. 
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2-Bromo-1-(piperidin-1-yl)ethan-1-one (66) 
 
The title compound (66) was prepared from piperidine (30.12 g, 345.7 mmol), sodium 
carbonate (35.68 g, 336.6 mmol) and bromoacetyl bromide (23.4 mL, 269 mmol) according to 
the general procedure A as a colourless liquid in 78 % yield (36.25 g, 175.9 mmol). 
Molecular formula: C7H12BrNO 
Molecular weight: 206.08 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 3.82 (s, 2H, H2), 3.51 (t, J = 5.6 Hz, 2H, H3/H7), 3.40 (t, J 
= 5.6 Hz, 2H, H3/H7), 1.63-1.60 (m, 4H, H4/ H6, H5), 1.55-1.49 (m, 2H, H4/H6).  
13C NMR (100 MHz, CDCl3) ppm: 164.98 (CON, C1), 47.91 (NCH2, C3/C7), 43.23 (NCH2, 
C3/C7), 26.25 (CH2, C4/C6), 26.19 (CH2, C2), 25.37 (CH2, C5), 24.26 (CH2, C4/C6). 
IR (neat, cm-1): 2936, 2856, 1634, 1443, 1367, 1272, 1258, 1211, 1129, 1101, 1020, 953, 852, 
714. 
2-Bromo-1-(morpholin-4-yl)ethan-1-one (67) 
       
The title compound (67) was prepared from morpholine (30.12 g, 345.7 mmol), sodium 
carbonate (54.97 g, 518.59 mmol) and bromoacetyl bromide (36.2 mL, 415 mmol) according 
to the general procedure A as a colourless liquid in 85 % yield (61.06 g, 293.5 mmol). 
Molecular formula: C6H10BrNO2 
Molecular weight: 208.05 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 3.78 (s, 2H, H2), 3.63 (t, J = 4.8 Hz, 2H, H4/H5), 3.58 (t, J 
= 4.8 Hz, 2H, H4/H5), 3.51 (t, J = 4.8 Hz, 2H, H3/H6), 3.42 (t, J = 4.8 Hz, 2H, H3/H6). 
13C NMR (100 MHz, CDCl3) ppm: 165.27 (COO, C1), 66.35 (OCH2, C4/C5), 66.14 (OCH2, 
C4/C5), 46.92 (NCH2, C3/C6), 42.19 (NCH2, C3/C6), 25.48 (CH2, C2). 
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IR (neat, cm-1): 2966, 2857, 1636, 1459, 1436, 1361, 1274, 1217, 1109, 1068, 1036, 964, 846, 
719. 
6.2.2 Bromide Ionic Liquids: 
General Procedure B: Preparation of achiral bromide ILs2  
3-[2-(2-Ethoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium bromide (68a)2    
  
To a stirred solution of 2-ethoxyethyl-2-bromoacetate (62) (45.67 g, 216.4 mmol) in diethyl 
ether (200 mL), 1-methylimidazole (17.77 g, 216.4 mmol) was added dropwise at RT under a 
N2 atmosphere. After stirring overnight the white solid of product was separated from the 
solvent by decantation. The solid was washed with diethyl ether (5 x 100 mL) and dried under 
high vacuum to obtain the title compound (68a) as white solid in 91 % yield (57.96 g, 197.7 
mmol). 
Molecular formula: C10H17BrN2O3  
Molecular weight: 293.16 g/mol 
Melting Point: 24-26 °C 
1H NMR (400 MHz, CDCl3) ppm: 10.28 (s, 1H, H3), 7.55 (t, J = 1.8 Hz, 1H, H4/H5), 7.40 (t, 
J = 1.8 Hz, 1H, H4/H5), 5.52 (s, 2H, H2), 4.35 (t, J = 4.8 Hz, 2H, H7), 4.01 (s, 3H, H6), 3.67 
(t, J = 4.8 Hz, 2H, H8), 3.53 (q, J = 7.0 Hz, 2H, H9), 1.20 (t, J = 7.0 Hz, 3H, H10). 
13C NMR (100 MHz, CDCl3) ppm: 166.09 (COO, C1), 137.82 (ArCH, C3), 123.74 (ArCH, 
C4/C5), 123.16 (ArCH, C4/C5), 67.49 (OCH2, C8), 66.40 (OCH2, C9), 65.50 (OCH2, C7), 
50.03 (NCH2, C2), 36.71 (NCH3, C6), 14.88 (CH3, C10). 
IR (neat, cm-1): 3411, 3152, 3085, 2975, 1747, 1632, 1576, 1437, 1378, 1217, 1174, 1115, 
1025, 875. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C10H17N2O3+, requires = 213.1231,                                               
found = 213.1239. 
MS (m/z): 213.10 [M-Br¯ ]+ 
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1H, 13C-NMR spectra and melting point are in agreement with the literature data.2 
3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium bromide 
(69a)2 
  
The title compound (69a) was prepared from 1-methylimidazole (5.85 g, 71.3 mmol) and 2-
(2-butoxyethoxy)ethyl-2-bromoacetate (63) (20.18 g, 71.3 mmol) according to the general 
procedure B to afford a white solid in 90 % yield (23.5 g, 63.3 mmol). 
Molecular formula: C14H25BrN2O4 
Molecular weight: 365.26 g/mol 
Melting Point: 78-80°C 
1H NMR (400 MHz, CDCl3) ppm: 10.13 (s, 1H, H3), 7.68 (t, J = 1.8, Hz, 1H, H4/H5), 7.51 
(t, J = 1.8, Hz, 1H, H4/H5),  5.50 (s, 2H, H2), 4.33 (t, J = 4.8 Hz, 2H, H7), 4.06 (s, 3H, H6), 
3.71 (t, J = 4.8 Hz, 2H, H8), 3.61 (t, J = 5.2 Hz, 2H, H9), 3.55 (t, J = 5.2 Hz, 2H, H10), 3.42 
(t, J = 6.8 Hz, 2H, H11), 1.51 (tt, J = 7.6, 6.8 Hz, 2H, H12), 1.31 (tq, J = 7.6, 7.4 Hz, 2H, 
H13), 0.87 (t, J = 7.4 Hz, 3H, H14).  
13C NMR (100 MHz, CDCl3) ppm: 166.19 (COO, C1), 138.05 (ArCH, C3), 123.91 (ArCH, 
C4/C5), 123.15 (ArCH, C4/C5), 71.09 (OCH2, C11), 70.49 (OCH2, C9), 69.84 (OCH2, C10), 
68.45 (OCH2, C8), 65.53 (OCH2, C7), 50.14 (NCH2, C2), 36.84 (NCH3, C6), 31.53 (CH2, 
C12), 19.14 (CH2, C13), 13.86 (CH3, C14). 
IR (neat, cm-1): 3134, 3094, 2954, 2871, 1752, 1577, 1567, 1448, 1370, 1341, 1281, 1236, 
1219, 1193, 1169, 1128, 1096, 1044, 967, 881, 850, 770, 713.  
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C14H25N2O4+, requires = 285.1814,                                               
found = 285.1803. 
MS (m/z): 285.20 [M-Br¯ ]+ 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.2  
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3-[(Decylcarbamoyl)methyl]-1-methyl-1H-imidazol-3-ium bromide (70a)3 
 
The title compound (70a) was prepared from 1-methylimidazole (0.68 g, 8.28 mmol) and 
alkylating agnt (64) (2.30 g, 8.3 mmol) according to the general procedure B to obtain a white 
solid in 90 % yield (2.69 g, 7.5 mmol). 
Molecular formula: C16H30BrN3O 
Molecular weight: 360.33 g/mol 
Melting Point: 94-96 °C 
1H NMR (400 MHz, CDCl3) ppm: 9.76 (s, 1H, H3), 8.56 (t, J = 6.0 Hz, 1H, NH), 7.62 (t, J = 
1.6 Hz, 1H, H4/H5), 7.25 (t, J = 1.6 Hz, 1H, H4/H5), 5.35 (s, 2H, H2), 4.02 (s, 3H, H6), 3.19 
(td, J = 7.2, 6.0 Hz, 2H, H7), 1.54 (tt, J = 7.2, 6.8 Hz, 2H, H8), 1.30-1.18 (m, 14H, H9-15), 
0.85 (t, J = 6.8 Hz, 3H, H16). 
13C NMR (100 MHz, CDCl3) ppm: 164.34 (CO, C1), 137.58 (NCHN, C3), 123.90 (NCH, 
C4/C5), 122.52 (NCH, C4/C5), 51.90 (NCH2, C2), 40.21 (HNCH2, C7), 36.89 (NCH3, C6), 
31.98 (CH2, C8), 29.67 (CH2), 29.66 (CH2), 29.40 (CH2), 29.36 (CH2), 29.21 (CH2), 27.15 
(CH2), 22.77 (CH2), 14.22 (CH3, C16). 
IR (neat, cm-1): 3450, 2981, 1693, 1608, 1512, 1435, 1292, 1173, 1030, 827. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C16H30N3O+, requires = 280.2383,                                               
found = 280.2389. 
MS (m/z): 280.20 [M-Br¯ ]+ 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.3 
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3-[(Decylcarbamoyl)methyl]-1,2-dimethyl-1H-imidazol-3-ium bromide (71a) 
 
The title compound (71a) was prepared from 1,2-dimethylimidazole (1.82 g, 18.9 mmol) and 
alkylating agnt (64) (5.27 g, 18.9 mmol) according to the general procedure B to afford a 
white solid in 91 % yield (6.48 g, 17.3 mmol). 
Molecular formula: C17H32BrN3O 
Molecular weight: 374.36 g/mol 
Melting point: 120-122 °C 
1H NMR (400 MHz, CDCl3) ppm: 8.72 (t, J = 5.8 Hz, 1H, NH), 7.65 (d, J = 2.0 Hz, 1H, 
H5/H6), 7.33 (d, J = 2.0 Hz, 1H, H5/H6), 5.26 (s, 2H, H2), 3.88 (s, 3H, H7), 3.18 (td, J = 7.6, 
5.8 Hz, 2H, H8), 2.78 (s, 3H, H4), 1.55 (tt, J = 7.6, 7.2 Hz, 2H, H9), 1.27-1.21 (m, 14H, H10-
16), 0.84 (t, J = 7.2 Hz, 3H, H17). 
13C NMR (100 MHz, CDCl3) ppm: 164.37 (CO, C1), 145.46 (NCN, C3), 122.80 (NCH, 
C5/C6), 122.04 (NCH, C5/C6), 51.13 (NCH2, C2), 40.12 (HNCH2, C8), 35.97 (NCH3, C7), 
31.96 (CH2, C9), 29.65 (CH2), 29.64 (CH2), 29.38 (CH2), 29.33 (CH2), 29.22 (CH2), 27.14 
(CH2), 22.75 (CH2), 14.20 (CH3, C17), 11.14 (CH3, C4). 
IR (neat, cm-1): 3419, 3218, 2920, 1691, 1671, 1638, 1565, 1487, 1252, 1090, 782. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C17H32N3O+, requires = 294.2539,                                               
found = 294.2542. 
MS (m/z): 294.20 [M-Br¯ ]+ 
 1-[(Decylcarbamoyl)methyl]pyridin-1-ium bromide (72a) 
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The title compound (72a) was prepared from pyridine (1.58 g, 20.02 mmol) and alkylating 
agnt (64) (5.56 g, 20.0 mmol) according to the general procedure B to obtain a white solid in 
97 % yield (6.90 g, 19.3 mmol). 
Molecular formula: C17H29BrN2O 
Molecular weight: 357.33 g/mol 
Melting point: 168-169 °C 
1H NMR (400 MHz, CDCl3) ppm: 9.28 (dd, J = 5.5, 1.6 Hz, 2H, H3, H7), 8.80 (t, J = 5.6 Hz, 
1H, NH), 8.47 (tt, J = 7.6, 1.6 Hz, 1H, H5), 8.05 (dd, J = 7.6, 5.5 Hz, 2H, H4, H6), 5.95 (s, 
2H, H2), 3.21 (td, J = 7.2, 5.6 Hz, 2H, H8), 1.55 (tt, J = 7.6, 7.2 Hz, 2H, H9), 1.28-1.21 (m, 
14H, H10-16), 0.85 (t, J = 7.2 Hz, 3H, H17). 
13C NMR (100 MHz, CDCl3) ppm: 163.37 (CO, C1), 146.03 (2ArCH, C3, C7), 145.41 
(ArCH, C5), 127.82 (2ArCH, C4/C6), 62.52 (NCH2, C2), 40.46 (HNCH2, C8), 31.97 (CH2), 
29.66 (CH2), 29.63 (CH2), 29.39 (CH2), 29.32 (CH2), 29.14 (CH2), 27.13 (CH2), 22.76 (CH2), 
14.21 (CH3, C17). 
IR (neat, cm-1): 3418, 3218, 2921, 2851, 1671, 1637, 1566, 1486, 1342, 1251, 1090, 782. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C17H29N2O+, requires = 277.2274,                                               
found = 277.2280. 
MS (m/z): 277.20 [M-Br¯ ]+ 
3-{[bis(2-Methoxyethyl)carbamoyl]methyl}-1-methyl-1H-imidazol-3-ium bromide (73a)2 
  
The title compound (73a) was prepared from 1-methylimidazole (23.06 g, 280.8 mmol) and 
2-bromo-N,N-bis-(2-methoxyethyl) acetamide (65) (71.37 g, 280.9 mmol) according to the 
general procedure B to obtain a yellow solid in 83 % yield (78.04 g, 232.1 mmol). 
Molecular formula: C12H22BrN3O3 
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Molecular weight: 336.23 g/mol 
Melting Point: 68-70 °C 
1H NMR (400 MHz, CDCl3) ppm: 9.76 (s, 1H, H3), 7.47 (t, J = 1.6 Hz, 1H, H4/H5), 7.41 (t, J 
= 1.6 Hz, 1H, H4/H5), 5.57 (s, 2H, H2), 3.98 (s, 3H, H6), 3.62 (t, J = 4.8 Hz, 2H, H7/H10), 
3.49 (t, J = 4.8 Hz, 2H, H8/H11), 3.47 (t, J = 4.8 Hz, 2H, H8/H11), 3.41(t, J = 4.8 Hz, 2H, 
H7/H10), 3.28 (s, 3H, H9/H12), 3.23 (s, 3H, H9/H12). 
13C NMR (100 MHz, CDCl3) ppm: 165.62 (COO, C1), 138.01 (ArCH, C3), 123.99 (ArCH, 
C4/C5), 122.61 (ArCH, C4/C5), 70.30 (OCH2, C8/C11), 70.04 (OCH2, C8/C11), 59.19 
(OCH3, C9/C12), 58.80 (OCH3, C9/C12), 50.61 (NCH2, C2), 48.59 (NCH2, C7/C10), 46.68 
(NCH2, C7/C10), 36.73 (NCH3, C6). 
IR (neat, cm-1): 3420, 3078, 2930, 1651, 1570, 1470, 1424, 1350, 1175, 1111, 1014, 922, 827, 
727. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C12H22N3O3+, requires = 256.1661,                                               
found = 256.1653. 
MS (m/z): 256.20 [M-Br¯ ]+ 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.2 
 
1-Methyl-3-[2-(piperidin-1-yl)-2-oxoethyl]-1H-imidazol-3-ium bromide (74a) 
  
The title compound (74a) was prepared from 1-methylimidazole (1.65 mL, 20.77 mmol) and 
2-bromo-1-(piperidin-1-yl)ethan-1-one (66) (4.28 g, 20.8 mmol) according to the general 
procedure B to obtain a white solid in 89 % yield (5.33 g, 18.5 mmol). 
Molecular formula: C11H18BrN3O 
Molecular weight: 288.18 g/mol 
Melting Point: 96-98°C 
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1H NMR (400 MHz, CDCl3)  ppm: 9.89 (s, 1H, H3), 7.56 (t, J = 1.8 Hz, 1H, H4/5), 7.35 (d, J 
= 1.8 Hz, 1H, H4/H5), 5.68 (s, 2H, H2), 4.01 (s, 3H, H6), 3.52-3.49 (m, 4H, H7, H11), 1.73-
1.62 (m, 4H, H8/H10, H9), 1.58-1.53 (m, 2H, H8/H10). 
13C NMR (100 MHz, CDCl3) ppm: 162.52 (COO, C1), 138.36 (ArCH, C3), 124.59 (ArNCH, 
C4/C5), 122.15 (ArCH, C4/C5), 50.86 (NCH2, C2), 46.37 (NCH2, C7/C11), 43.70 (NCH2, 
C7/C11), 36.83 (NCH3, C6), 26.32 (CH2, C8/C10), 25.38 (CH2, C9), 24.25 (CH2, C8/C10).   
IR (neat, cm-1): 3420, 3100, 3065, 2951, 2924, 2860, 1648, 1565, 1454, 1410, 1320, 1252, 
1229, 1167, 1127, 1019, 959, 854, 787. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C11H18N3O+, requires = 208.1444,                                               
found = 208.1442. 
MS (m/z): 208.10 [M-Br¯ ]+  
1,2-Dimethyl-3-[2-(piperidin-1-yl)-2-oxoethyl]-1H-imidazol-3-ium bromide (75a) 
The title compound (75a) was prepared from 1,2-
dimethylimidazole (2.99 g, 31.1 mmol) and 2-bromo-1-(piperidin-1-yl)ethan-1-one (66) (6.41 
g, 31.1 mmol) according to the general procedure B to obtain a white solid in 87 % yield (8.17 
g, 27.0 mmol). 
Molecular formula: C12H20BrN3O 
Molecular weight: 302.21 g/mol 
Melting Point: 135-137 °C 
1H NMR (400 MHz, DMSO-d6) ppm: 7.64 (d, J = 2.0 Hz, 1H, H5/H6), 7.55 (d, J = 2.0 Hz, 
1H, H5/H6), 5.35 (s, 2H, H2), 3.81 (s, 3H, H7), 3.45-3.42 (m, 4H, H8, H12), 2.49 (s, 3H, H4), 
1.64-1.69 (m, 4H, H9/ H11, H10), 1.49-1.47 (m, 2H, H9/H11). 
13C NMR (100 MHz, DMSO-d6) ppm: 162.80 (COO, C1), 145.83 (ArC, C3), 122.36 
(ArNCH, C5/C6), 121.92 (ArCH, C5/C6), 49.14 (NCH2, C2), 45.22 (NCH2, C8/C12), 42.71 
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(NCH2, C8/C12), 34.84 (NCH3, C7), 25.71 (CH2, C9/C11), 25.14 (CH2, C10), 23.74 (CH2, 
C9/C11), 9.39 (CH3, C4).  
IR (neat, cm-1): 3131, 3077, 2940, 2860, 1640, 1589, 1542, 1475, 1439, 1418, 1325, 1278, 
1253, 1232, 1166, 1144, 1112, 1019, 962, 817, 764, 752. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C12H20N3O+, requires = 222.1601,                                               
found = 222.1600. 
MS (m/z): 222.10 [M-Br¯ ]+  
1-Methyl-3-[2-(morpholin-4-yl)-2-oxoethyl]-1H-imidazol-3-ium bromide (76a) 
  
The title compound (76a) was prepared from 1-methylimidazole (23.37 mL, 293 mmol) and 
2-bromo-1-(morpholin-4-yl)ethan-1-one (67) (61.06 g, 293.5 mmol) according to the general 
procedure B to obtain a white solid in 85 % yield (72.29 g, 249.1 mmol). 
Molecular formula: C10H16BrN3O2 
Molecular weight: 290.16 g/mol 
Melting Point: 170-172°C 
1H NMR (400 MHz, CDCl3) ppm: 9.65 (s, 1H, H3), 7.64 (t, J = 1.6 Hz, 1H, H4/H5), 7.38 (t, J 
= 1.6 Hz, 1H, H4/H5), 5.75 (s, 2H, H2), 3.98 (s, 3H, H6), 3.76 (t, J = 4.8 Hz, 2H, H8/H9), 
3.64 (t, J = 4.8 Hz, 2H, H8/H9), 3.59 (t, J = 4.8, Hz, 2H, H7/H10), 3.52 (t, J = 4.8, Hz, 2H, 
H7/H10). 
13C NMR (100 MHz, CDCl3) ppm: 163.34 (CON, C1), 137.94 (NCHN, C3), 124.56 (NCH, 
C4/C5), 122.33 (NCH, C4/C5), 66.50 (OCH2, C8/C9), 66.40 (OCH2, C8/C9), 50.75 
(NCH2CO, C2), 45.51 (NCH2, C7/C10), 42.67 (NCH2, C7/C10), 36.83 (NCH3, C6).  
IR (neat, cm-1): 3364, 3076, 2864, 1640, 1574, 1425, 1242, 1165, 1113, 1042, 959, 857. 
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HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C10H16N3O2+, requires = 210.1237,                                               
found = 210.1232. 
MS (m/z): 210.10 [M-Br¯ ]+ 
1,2-Dimethyl-3-[2-(morpholin-4-yl)-2-oxoethyl]-1H-imidazol-3-ium bromide (77a) 
 
The title compound (77a) was prepared from 1,2-dimethylimidazole (3.42 g, 35.6 mmol) and 
2-bromo-1-(morpholin-4-yl)ethan-1-one (67) (7.40 g, 35.6 mmol) according to the general 
procedure B to afford a white solid in 95 % yield (10.24 g, 33.7 mmol). 
Molecular formula: C11H18BrN3O2 
Molecular weight: 304.18 g/mol 
Melting Point: 224-226°C 
1H NMR (400 MHz, DMSO-d6) ppm: 7.65 (d, J = 2.0 Hz, 1H, H5/H6), 7.55 (d, J = 2.0 Hz, 
1H, H5/H6), 5.39 (s, 2H, H2), 3.81 (s, 3H, H7), 3.68 (t, J = 5.0 Hz, 2H, H9/H10), 3.59 (t, J = 
5.0 Hz, 2H, H9/H10), 3.48 (t, J = 5.0 Hz, 2H, H8/H11), 3.45 (t, J = 5.0, Hz, 2H, H8/H11), 
2.51 (s, 3H, H4). 
13C NMR (100 MHz, DMSO-d6) ppm: 163.56 (CON, C1), 145.90 (NCN, C3), 122.27 (NCH, 
C5/C6), 121.99 (NCH, C5/C6), 65.88 (OCH2, C9/C10), 65.79 (OCH2, C9/C10), 49.07 
(NCH2CO, C2), 44.72 (NCH2, C8/C11), 42.08 (NCH2, C8/C11), 34.86 (NCH3, C7), 9.44 
(CCH3, C4).  
IR (neat, cm-1): 2961, 2858, 1667, 1652, 1540, 1417, 1354, 1244, 1113, 1039, 818. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C11H18N3O2+, requires = 224.1394,                                               
found = 224.1395. 
MS (m/z): 224.10 [M-Br¯ ]+ 
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1-[2-(Morpholin-4-yl)-2-oxoethyl]pyridin-1-ium bromide (78a) 
 
The title compound (78a) was prepared from pyridine (2.39 g, 30.2 mmol) and 2-bromo-1-
(morpholin-4-yl)ethan-1-one (67) (6.28 g, 30.2 mmol) according to the general procedure B to 
obtain a white solid in 94 % yield (8.11 g, 28.2 mmol). 
Molecular formula: C11H15BrN2O2 
Molecular weight: 287.15 g/mol 
Melting Point: 95-97°C 
1H NMR (400 MHz, DMSO-d6) ppm: 8.99 (d, J = 6.8 Hz, 2H, H3, H7), 8.69 (t, J = 7.6 Hz, 
1H, H5), 8.22 (dd, J = 7.6, 6.8 Hz, 2H, H4, H6), 5.88 (s, 2H, H2), 3.72 (t, J = 4.8 Hz, 2H, 
H9/H10), 3.61 (t, J = 4.8 Hz, 2H, H9/H10), 3.50 (t, J = 4.8 Hz, 2H, H8/H11), 3.47 (t, J = 4.8, 
Hz, 2H, H8/H11). 
13C NMR (100 MHz, DMSO-d6) ppm: 163.46 (CON, C1), 146.34 (2ArCH, C3/ H7), 146.28 
(ArCH, C5), 127.58 (2ArCH, C4/C6), 65.83 (OCH2, C9/C10), 65.72 (OCH2, C9/C10), 61.13 
(NCH2CO, C2), 44.78 (NCH2, C8/C11), 42.28 (NCH2, C8/C11).  
IR (neat, cm-1): 2961, 2864, 1646, 1633, 1484, 1425, 1243, 1207, 1112, 1045, 855, 763. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C11H15N2O2+, requires = 207.1128,                                               
found = 207.1125. 
MS (m/z): 207.10 [M-Br¯ ]+ 
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6.2.3 [NTf2] Ionic Liquids: 
General Procedure C: Preparation of the achiral [NTf2] ILs2 
3-[2-(2-Ethoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (68b)2 
 
To a stirred solution of bromide salt (68a) (11.25 g, 38.4 mmol) in distilled water (50 mL), 
LiNTf2 was added (11.02 g, 38.4 mmol) at RT. After stirring for 4 h at RT the liquid product 
was separated from the water by decantation. The liquid was washed with distilled water (3 × 
50 mL) and dried under high vacuum to obtain the title compound (68b) as a colourless oil in 
91 % yield (17.13 g, 34.7 mmol). 
Molecular formula: C12H17F6N3O7S2 
Molecular weight: 493.4 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.72 (s, 1H, H3), 7.38 (t, J = 1.8 Hz, 1H, H4/H5), 7.34 (t, J 
= 1.8 Hz, 1H, H4/H5), 5.00 (s, 2H, H2), 4.33 (t, J = 4.6 Hz, 2H, H7), 3.91 (s, 3H, H6), 3.68 (t, 
J = 4.6 Hz, 2H, H8), 3.50 (q, J = 7.0 Hz, 2H, H9), 1.17 (t, J = 7.0 Hz, 3H, H10). 
13C NMR (100 MHz, CDCl3) ppm: 165.89 (COO, C1), 137.60 (ArCH, C3), 123.97 (ArCH, 
C4/C5), 123.46 (ArCH, C4/C5), 119.82 (q, J =319 Hz, 2CF3’s, C11, C12), 67.71 (OCH2, C8), 
66.73 (OCH2, C9), 66.00 (OCH2, C7), 49.99 (NCH2, C2), 36.58 (NCH3, C6), 15.06 (CH3, 
C10).  
19F NMR (376 MHz, CDCl3) ppm: - 79.35 (6F) 
IR (neat, cm-1): 3163, 3126, 2979, 1754, 1569, 1439, 1347, 1174, 1131, 1051, 789, 740. 
MS (m/z): 213.10 [M-NTf2¯ ]+ 
1H and 13C-NMR spectra are in agreement with the literature data.2 
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3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (69b)2 
 
The title compound (69b) was prepared from bromide IL (69a) (126.03 g, 345.0 mmol) and 
LiNTf2 (108.97 g, 379.6 mmol) according to the general procedure C to obtain a colourless oil 
in 80 % yield (155.39 g, 274.8 mmol). 
Molecular formula: C16H25F6N3O8S2 
Molecular weight: 565.51 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.74 (s, 1H, H3), 7.39 (t, J = 1.6 Hz, 1H, H4/H5), 7.34 (t, J 
= 1.6 Hz, 1H, H4/H5), 5.00 (s, 2H, H2), 4.33 (t, J = 4.8 Hz, 2H, H7), 3.92 (s, 3H, H6), 3.70 (t, 
J = 4.8 Hz, 2H, H8), 3.61 (t, J = 4.8 Hz, 2H, H9), 3.56 (t, J = 4.8 Hz, 2H, H10), 3.43 (t, J = 
6.8 Hz, 2H, H11),  1.52 (tt, J = 7.6, 6.8 Hz, 2H, H12), 1.32 (tq, J = 7.6, 7.2 Hz, 2H, H13), 
0.88 (t, J = 7.2 Hz, 3H, H14). 
13C NMR (100 MHz, CDCl3) ppm: 165.84 (COO, C1), 137.49 (ArCH, C3), 123.97 (ArCH, 
C4/C5), 123.44 (ArCH, C4/C5), 119.76 (q, J = 320 Hz, 2CF3, C15, C16), 71.18 (OCH2, C11), 
70.56 (OCH2, C9), 69.92 (OCH2, C10), 68.43 (OCH2, C8), 65.74 (OCH2, C7), 49.86 (CH2, 
C2), 36.47 (NCH3, C6), 31.66 (CH2, C12), 19.25 (CH2, C13), 13.90 (CH3, C14). 
19F NMR (376 MHz, CDCl3) ppm: -79.20 (6F). 
IR (neat, cm-1): 3162, 2964, 2873, 1765, 1569, 1348, 1331, 1177, 1133, 1053, 976, 789, 740. 
MS (m/z): 285.15 (M-NTf2¯ )+ 
1H and 13C-NMR spectra are in agreement with the literature data.2 
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3-[(Decylcarbamoyl)methyl]-1,2-dimethyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (71b) 
 
The title compound (71b) was prepared from bromide salt (71a) (2.22 g, 5.9 mmol) and 
LiNTf2 (1.70 g, 5.9 mmol) according to the general procedure C to obtain a white solid in 97 
% yield (3.30 g, 5.7 mmol). 
Molecular formula: C19H32F6N4O5S2 
Molecular weight: 574.60 g/mol 
Melting Point: 53-55°C 
1H NMR (400 MHz, CDCl3) ppm: 7.26 (d, J = 2.0 Hz, 1H, H5/H6), 7.13 (d, J = 2.0 Hz, 1H, 
H5/H6), 6.89 (t, J = 6.0 Hz, 1H, NH), 4.86 (s, 2H, H2), 3.81 (s, 3H, H7), 3.18 (dt, J = 7.2, 6.0 
Hz, 2H, H8), 2.60 (s, 3H, H4), 1.51 (tt, J = 7.6, 7.2 Hz, 2H, H9), 1.31-1.25 (m, 14H, H10-16), 
0.87 (t, J = 7.2 Hz, 3H, H17). 
13C NMR (100 MHz, CDCl3) ppm: 163.82 (CO, C1), 145.68 (NCN, C3), 122.80 (NCH, 
C5/C6), 121.96 (NCH, C5/C6), 119.41 (q, J = 319 Hz, 2CF3’s,  C18, C19), 50.64 (NCH2, 
C2), 40.36 (HNCH2, C8), 35.58 (NCH3, C7), 32.01 (CH2, C9), 29.67 (CH2), 29.61 (CH2), 
29.43 (CH2), 29.33 (CH2), 29.14 (CH2), 26.94 (CH2), 22.81 (CH2), 14.25 (CH3, C17), 10.13 
(CH3, C4). 
19F NMR (376 MHz, CDCl3) ppm: -78.94 (6F) 
IR (neat, cm-1): 2981, 2972, 1734, 1668, 1608, 1512, 1434, 1247, 1172, 1111, 1030, 981. 
MS (m/z): 294.25 (M-NTf2¯ )+ 
 
 
 
 184 
 
1-[(Decylcarbamoyl)methyl]pyridin-1-ium bis(trifluoromethylsulfonyl)imide (72b) 
 
The title compound (72b) was prepared from bromide salt (72a) (2.33 g, 6.5 mmol) and 
LiNTf2 (1.87 g, 6.5 mmol) according to the general procedure C to obtain a white solid in 94 
% yield (3.41 g, 6.1 mmol). 
Molecular formula: C19H29F6N3O5S2 
Molecular weight: 557.57 g/mol 
Melting Point: 70-72°C 
1H NMR (400 MHz, CDCl3) ppm: 8.77 (d, J = 6.8 Hz, 2H, H3, H7), 8.50 (t, J = 7.8 Hz, 1H, 
H5), 8.02 (dd, J = 7.8, 6.8 Hz, 2H, H4, H6), 7.08 (t, J = 6.0 Hz, 1H, NH), 5.35 (s, 2H, H2), 
3.25 (dt, J = 7.2, 6.0 Hz, 2H, H8), 1.52 (tt, J = 7.6, 7.2 Hz, 2H, H9), 1.31-1.24 (m, 14H, H10-
16), 0.87 (t, J = 7.2 Hz, 3H, H17). 
13C NMR (100 MHz, CDCl3) ppm: 162.72 (CO,C1), 145.09 (ArCH,C5), 145.88 (2ArCH, C3, 
C7), 127.97 (2ArCH,C4/C6), 119.79 (q, J = 319.0 Hz, 2CF3’s, C18, C19), 62.42 (NCH2, C2), 
40.68 (HNCH2, C8), 32.01 (CH2), 29.67 (CH2), 29.58 (CH2), 29.42 (CH2), 29.31 (CH2), 29.02 
(CH2), 26.91 (CH2), 22.81 (CH2), 14.24 (CH3, C17). 
19F NMR (376 MHz, CDCl3) ppm: -78.91 (6F) 
IR (neat, cm-1): 3429, 2969, 1727, 1665, 1609, 1509, 1449, 1250, 1169, 1078, 1027, 977. 
MS (m/z): 277.70 (M-NTf2¯ )+ 
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3-{[bis(2-Methoxyethyl)carbamoyl]methyl}-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (73b) 
 
The title compound (73b) was prepared from bromide salt (73a) (74.99 g, 223 mmol) and 
LiNTf2 (66.82 g, 232.7 mmol) according to the general procedure C to obtain a yellow oil in 
74 % yield (88.64 g, 165.2 mmol). 
Molecular formula: C14H22F6N4O7S2 
Molecular weight: 536.47 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.63 (s, 1H, H3), 7.27 (t, J = 1.8 Hz, 1H, H4/H5), 7.26 (t, J 
= 1.8 Hz, 1H, H4/H5), 5.24 (s, 2H, H2), 3.91 (s, 3H, H6), 3.58 (t, J = 4.8 Hz, 2H, H7/H10), 
3.57-3.52 (m, 4H, H7/H10, H8/H11), 3.49 (t, J = 4.8 Hz, 2H, H6/H11), 3.34 (s, 3H, H9/H12), 
3.30 (s, 3H, H9/H12). 
13C NMR (100 MHz, CDCl3) ppm: 165.17 (COO, C1), 137.68 (ArCH, C3), 124.26 (ArCH, 
C4/C5), 122.72 (ArCH, C4/C5), 119.86 (q, J = 319 Hz, 2CF3’s, C13, C14), 70.52 (OCH2, 
C8/C11), 69.99 (OCH2, C8/C11), 59.16 (OCH3, C9/C12), 58.89 (OCH3, C9/C12), 50.52 
(NCH2, C2), 48.63 (NCH2, C7/C10), 46.89 (NCH2, C7/C10), 36.45 (NCH3, C6). 
19F NMR (376 MHz, CDCl3) ppm: -78.97 (6F) 
IR (neat, cm-1): 3161, 2938, 2898, 1659, 1575, 1473, 1427, 1348, 1330, 1175, 1133, 1116, 
1052, 830, 789, 739. 
MS (m/z): 256.15 (M-NTf2¯ )+ 
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1,2-Dimethyl-3-[2-oxo-2-(piperidin-1-yl)ethyl]-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (75b) 
 
 
The title compound (75b) was prepared from bromide salt (75a) (1.84 g, 6.09 mmol) and 
LiNTf2 (1.75 g, 6.09 mmol) according to the general procedure C to obtain a colourless liquid 
in 89 % yield (2.72 g, 5.42 mmol). 
Molecular formula: C14H20F6N4O5S2 
Molecular weight: 502.45 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.16 (bs, 2H, H5, H6), 5.01 (s, 2H, H2), 3.76 (s, 3H, H7), 
3.50 (t, J = 5.6 Hz, 2H, H8/H12), 3.40 (t, J = 5.6 Hz, 2H, H8/H12), 2.46 (s, 3H, H4), 1.66-
1.63 (m, 4H, H9/ H11, H10), 1.55 (tt, J = 5.6, 4.8 Hz, 2H, H9/H11). 
13C NMR (100 MHz, CDCl3) ppm: 161.82 (CO, C1), 145.89 (ArCH, C3), 122.71 (ArNCH, 
C5/C6), 121.81 (ArCH, C5/C6), 119.81 (q, J = 319.0 Hz, 2CF3’s, C13, C14), 49.87 (NCH2, 
C2), 45.91 (NCH2, C8/C12), 43.65 (NCH2, C8/C12), 35.36 (NCH3, C7), 26.03 (CH2, 
C9/C11), 25.37 (CH2, C10), 24.12 (CH2, C9/C11), 9.86 (CH3, C4). 
19F NMR (376 MHz, CDCl3) ppm: -78.84 (6F)  
IR (neat, cm-1): 2982, 1735, 1688, 1667, 1608, 1512, 1435, 1292, 1248, 1173, 1111, 1030, 
827. 
MS (m/z): 222.10 [M-NTf2¯ ]+ 
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1-Methyl-3-[2-(morpholin-4-yl)-2-oxoethyl]-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (76b) 
 
 
The title compound (76b) was prepared from bromide salt (76a) (88.12 g, 303.7 mmol) and 
LiNTf2 (95.93 g, 334.1 mmol) according to the general procedure C to afford a crystalline 
white solid 62 % yield (92.30 g, 188.2 mmol). 
Molecular formula: C12H16F6N4O6S2 
Molecular weight: 490.4 g/mol 
Melting Point: 63-65°C 
1H NMR (400 MHz, DMSO-d6): 9.41 (s, 1H, H3), 8.16 (t, J = 1.6 Hz, 1H, H4/H5), 8.10 (t, J 
= 1.6 Hz, 1H, H4/H5), 5.95 (s, 2H, H2), 4.57 (s, 3H, H6), 4.14 (t, J = 4.8 Hz, 2H, H8/H9), 
4.08 (t, J = 4.8 Hz, 2H, H8/H9), 4.03-3.99 (m, 4H, H7, H10). 
13C NMR (100 MHz, DMSO-d6): 163.93 (CON, C1), 137.91 (NCHN, C3), 124.04 (NCH, 
C4/C5), 123.00 (NCH, C4/C5), 119.56 (q, J =320 Hz, 2CF3’s, C11, C12), 65.95 (OCH2, 
C8/C9), 65.83 (OCH2, C8/C9), 49.99 (NCH2CO, C2), 44.70 (NCH2, C7/C10), 42.14 (NCH2, 
C7/C10), 35.87 (NCH3, C6).  
19F NMR (376 MHz, CDCl3) ppm: -78.99 (6F) 
IR (neat, cm-1): 3164, 3109, 3000, 2872, 1656, 1579, 1564, 1475, 1440, 1348, 1328, 1275, 
1184, 1136, 1108, 1050, 1033, 975, 845, 807, 771, 740. 
MS (m/z): 210.10 [M-NTf2¯ ]+ 
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1,2-Dimethyl-3-[2-(morpholin-4-yl)-2-oxoethyl]-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (77b) 
 
 
The title compound (77b) was prepared from bromide salt (77a) (2.46 g, 8.09 mmol) and 
LiNTf2 (2.32 g, 8.09 mmol) according to the general procedure C to obtain a colourless liquid 
in 76 % yield (3.08 g, 6.11 mmol). 
Molecular formula: C13H18F6N4O6S2 
Molecular weight: 504.43 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.21 (d, J = 2.4 Hz, 1H, H5/H6), 7.16 (d, J = 2.4 Hz, 1H, 
H5/H6), 5.09 (s, 2H, H2), 3.79 (s, 3H, H7), 3.74 (t, J = 4.8 Hz, 2H, H9/H10), 3.70 (t, J = 4.8 
Hz, 2H, H9/H10), 3.58 (t, J = 4.8 Hz, 2H, H8/H11), 3.52 (t, J = 4.8, Hz, 2H, H8/H11), 2.51 (s, 
3H, H4). 
13C NMR (100 MHz, CDCl3) ppm: 162.61 (CON, C1), 146.07 (NCN, C3), 122.87 (NCH, 
C5/C6), 121.86 (NCH, C5/C6), 119.84 (q, J =320 Hz, 2CF3’s, C12, C13), 66.53 (OCH2, 
C9/C10), 66.36 (OCH2, C9/C10), 49.85 (NCH2CO, C2), 45.20 (NCH2, C8/C11), 42.76 
(NCH2, C8/C11), 35.52 (NCH3, C7), 10.01 (CCH3, C4).  
19F NMR (376 MHz, CDCl3) ppm: -78.99 (6F) 
IR (neat, cm-1): 2976, 1661, 1595, 1543, 1470, 1347, 1328, 1177, 1133, 1112, 1051, 739. 
MS (m/z): 224.10 [M-NTf2¯ ]+ 
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1-[2-(Morpholin-4-yl)-2-oxoethyl]pyridin-1-ium bis(trifluoromethylsulfonyl)imide (78b) 
 
The title compound (78b) was prepared from bromide salt (78a) (2.72 g, 9.5 mmol) and 
LiNTf2 (2.72 g, 9.5 mmol) according to the general procedure C to obtain a colourless liquid 
in 71 % yield (3.28 g, 6.7 mmol). 
Molecular formula: C13H15F6N3O6S2 
Molecular weight: 487.40 g/mol 
1H NMR (400 MHz, DMSO-d6) ppm: 8.91 (d, J = 6.8 Hz, 2H, H3, H7), 8.68 (t, J = 7.8 Hz, 
1H, H5), 8.20 (dd, J = 7.8, 6.8 Hz, 2H, H4, H6), 5.75 (s, 2H, H2), 3.71 (t, J = 5.2 Hz, 2H, 
H9/H10), 3.62 (t, J = 5.2 Hz, 2H, H9/H10), 3.50-3.47 (m, 4H, H8, H11). 
13C NMR (100 MHz, DMSO-d6) ppm: 163.44 (CON, C1), 146.38 (2ArCH, C3, H7), 146.27 
(ArCH, C5), 127.59 (2ArCH, C4, C6), 119.49 (q, J =320 Hz, 2CF3’s, C12, C13), 65.85 
(OCH2, C9/C10), 65.70 (OCH2, C9/C10), 61.15 (NCH2CO, C2), 44.75 (NCH2, C8/C11), 
42.28 (NCH2, C8/C11).  
19F NMR (376 MHz, CDCl3) ppm: -79.16 (6F) 
IR (neat, cm-1): 2978, 1662, 1493, 1466, 1347, 1328, 1178, 1132, 1112, 1049, 850, 755. 
MS (m/z): 207.10 [M-NTf2¯ ]+ 
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6.2.4 [OctOSO3] Ionic Liquids: 
General Procedure D: Preparation of the achiral [OctOSO3] ILs2 
3-[(Decylcarbamoyl)methyl]-1,2-dimethyl-1H-imidazol-3-ium octyl sulfate (71c) 
 
To a stirred solution of bromide salt (71a) (2.02 g, 5.4 mmol), in distilled water (10 mL) was 
added in one portion sodium octyl sulphate (1.25 g, 5.4 mmol). The mixture was stirred 
overnight, then the water was evaporated by rotary evaporation. The crude product was 
dissolved in DCM (25 mL) and washed with water (3 x 5 mL). The product was then dried by 
rotary evaporation and under high vacuum to afford a white gel in 71 % yield (1.94 g, 3.9 
mmol). 
Molecular formula: C25H49N3O5S 
Molecular weight: 503.74 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.01 (t, J = 6.2 Hz, 1H, NH), 7.28 (d, J = 2.0 Hz, 1H, 
H5/H6), 7.27 (d, J = 2.0 Hz, 1H, H5/H6), 4.79 (s, 2H, H2), 3.74 (t, J = 7.0 Hz, 2H, H18), 3.65 
(s, 3H, H7), 2.95 (td, J = 7.2, 6.2 Hz, 2H, H8), 2.44 (s, 3H, H4), 1.42 (tt, J = 7.6, 7.2 Hz, 2H, 
H9), 1.31 (tt, J = 7.6, 7.0 Hz, 2H, H19), 1.15-1.03 (m, 24H, H10-16, H20-24), 0.65 (t, J = 7.2 
Hz, 6H, H17, H25). 
13C NMR (100 MHz, CDCl3) ppm: 164.21 (CO, C1), 144.97 (NCN, C3), 121.97 (2NCH, C5, 
C6), 67.27 (NCH2, C2), 49.90 (HNCH2, C8), 39.58 (CH2), 34.96 (CH3, C7), 31.46 (CH2), 
31.39 (CH2), 29.19 (2CH2), 29.10 (CH2), 28.93 (2CH2), 28.89 (CH2), 28.85 (CH2), 28.79 
(CH2), 26.61 (CH2), 25.49 (CH2), 22.22 (CH2), 22.20 (CH2), 13.66 (2CH3, C17, C25 ), 9.59 
(CH3, C4). 
IR (neat, cm-1): 3453, 2960, 1736, 1649, 1630, 1480, 1238, 1210, 1153, 1027, 922, 757. 
MS (m/z): 294.20 [M-OctOSO3¯ ]+ 
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1-[(Decylcarbamoyl)methyl]pyridin-1-ium octyl sulfate (72c) 
 
 
The title compound (72c) was prepared using bromide salt (72a) (1.91 g, 5.4 mmol), sodium 
octyl sulphate (1.24 g, 5.4 mmol) and distilled water (10 mL) according to general procedure 
D to obtain a white gel in 75 % yield (1.95 g, 4.0 mmol). 
Molecular formula: C25H46N2O5S 
Molecular weight: 486.71 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.83 (dd, J = 6.8, 1.2 Hz, 2H, H3, H7), 8.35 (tt, J = 8.0, 1.2 
Hz, 1H, H5), 8.15 (t, J = 6.0 Hz, 1H, NH), 7.88 (dd, J = 8.0, 6.8 Hz, 2H, H4, H6), 5.41 (s, 2H, 
H2), 3.79 (t, J = 6.6 Hz, 2H, H18), 2.98 (td, J = 7.2, 6.0 Hz, 2H, H8), 1.43 (tt, J = 7.6, 7.2 Hz, 
2H, H9), 1.33 (tt, J = 7.2, 6.6 Hz, 2H, H19), 1.13-1.03 (m, 24H, H10-16, H20-24), 0.65 (t, J = 
7.2 Hz, 6H, H17). 
13C NMR (100 MHz, CDCl3) ppm: 163.25 (CO, C1), 145.66 (2ArCH, C3, C7), 145.49 
(ArCH, C5), 127.47 (2ArCH, C4, C6), 67.50 (OCH2, C18), 61.65 (NCH2, C2), 39.89 (CH2), 
31.45 (CH2), 31.39 (CH2), 29.19 (CH2), 29.10 (CH2), 28.94 (2CH2), 28.90 (CH2), 28.85 
(2CH2), 28.71 (CH2), 26.61 (CH2), 25.49 (CH2), 22.22 (CH2), 22.20 (CH2), 13.65 (2CH3, 
C17, C25). 
IR (neat, cm-1): 2981, 1737, 1644, 1608, 1512, 1435, 1292, 1247, 1173, 1111, 1030, 827. 
MS (m/z): 277.70 [M-OctOSO3¯ ]+ 
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3-{[bis(2-Methoxyethyl)carbamoyl]methyl}-1-methyl-1H-imidazol-3-ium octyl sulfate 
(73c)4 
 
The title compound (73c) was prepared using bromide salt (73a) (2.16 g, 6.4 mmol), sodium 
octyl sulphate (1.49 g, 6.4 mmol) and distilled water (15 mL) according to general procedure 
D to obtain a brown oil in 54 % yield (1.61 g, 3.5 mmol). 
Molecular formula: C20H39N3O7S 
Molecular weight: 465.61 g/mol 
1H NMR (600 MHz, CDCl3) ppm: 9.19 (s, 1H), 7.39 (t, J = 1.8 Hz, 1H), 7.30 (t, J = 1.8 Hz, 
1H), 5.36 (s, 2H), 3.94 (t, J = 6.8 Hz, 2H), 3.91 (s, 3H), 3.59 (t, J = 4.8 Hz, 2H), 3.51-3.44 (m, 
6H), 3.31 (s, 3H), 3.26 (s, 3H), 1.59 (tt, J = 7.2, 6.8 Hz, 2H), 1.32-1.15 (m, 10H), 0.80 (t, J = 
6.8 Hz, 3H). 
13C NMR (150 MHz, CDCl3) ppm: 165.63, 138.64, 124.00, 122.69, 70.48, 70.13, 67.64, 
59.11, 58.82, 50.29, 48.53, 46.84, 36.35, 31.79, 29.53, 29.34, 29.23, 25.88, 22.62, 14.09. 
IR (neat, cm-1): 3480, 3112, 2926, 1653, 1575, 1472, 1428, 1220, 1119, 1016. 
MS (m/z): 256.10 (M-OctOSO3¯ )+ 
1H and 13C-NMR spectra are in agreement with the literature data.4 
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1,2-Dimethyl-3-[2-(morpholin-4-yl)-2-oxoethyl]-1H-imidazol-3-ium octyl sulfate (77c) 
 
The title compound (77c) was prepared using bromide salt (77a) (2.23 g, 7.3 mmol), sodium 
octyl sulphate (1.70 g, 7.3 mmol) and distilled water (10 mL) according to general procedure 
D to obtain a colourless liquid in 79 % yield (2.52 g, 5.8 mmol). 
Molecular formula: C19H35N3O6S 
Molecular weight: 433.56 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.49 (d, J = 2.0 Hz, 1H, H5/H6), 7.30 (d, J = 2.0 Hz, 1H, 
H5/H6), 5.44 (s, 2H, H2), 3.94 (t, J = 7.0 Hz, 2H, H12), 3.81 (s, 3H, H7), 3.77 (t, J = 5.2 Hz, 
2H, H9/H10), 3.68 (t, J = 5.2 Hz, 2H, H9/H10), 3.63 (t, J = 5.2 Hz, 2H, H8/H11), 3.52 (t, J = 
5.2, Hz, 2H, H8/H11), 2.56 (s, 3H, H4), 1.61 (tt, J = 8.0, 7.0 Hz, 2H, H13), 1.34-1.23 (m, 
10H, H14-18), 0.85 (t, J = 7.2 Hz, 3H, H19).   
13C NMR (100 MHz, CDCl3) ppm: 163.60 (CON, C1), 146.06 (NCN, C3), 122.57 (NCH, 
C5/C6), 122.34 (NCH, C5/C6), 65.48 (OCH2, C9/C10), 65.78 (OCH2, C9/C10), 65.50 
(OCH2, C12), 49.07 (NCH2CO, C2), 44.72 (NCH2, C8/C11), 42.08 (NCH2, C8/C11), 34.86 
(NCH3, C7), 31.78 (CH2), 29.51 (CH2), 29.22 (CH2), 28.30 (CH2), 25.81 (CH2), 22.60 (CH2), 
14.09 (CH3), 9.44 (CCH3, C4).  
IR (neat, cm-1): 2927, 1709, 1658, 1594, 1543, 1429, 1362, 1219, 1114, 1038, 956, 790. 
MS (m/z): 224.10 [M-OctOSO3¯ ]+ 
1-[2-(Morpholin-4-yl)-2-oxoethyl]pyridin-1-ium octyl sulfate (78c) 
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The title compound (78c) was prepared using bromide salt (78a) (2.29 g, 7.98 mmol), sodium 
octyl sulphate (1.85 g, 7.98 mmol) and distilled water (10 mL) according to general procedure 
D to obtain a colourless liquid in 73 % yield (2.43 g, 5.84 mmol). 
Molecular formula: C19H32N2O6S 
Molecular weight: 416.53 g/mol 
1H NMR (400 MHz, DMSO-d6) ppm: 8.93 (d, J = 6.8 Hz, 2H, H3, H7), 8.37 (t, J = 7.4 Hz, 
1H, H5), 7.89 (dd, J = 7.4, 6.8 Hz, 2H, H4, H6), 5.94 (s, 2H, H2), 3.87 (t, J = 7.0 Hz, 2H, 
H12), 3.69 (t, J = 4.8 Hz, 2H, H9/H10), 3.58 (t, J = 4.8 Hz, 2H, H9/H10), 3.50 (t, J = 4.8, 2H, 
H8/H11), 3.46 (t, J = 4.8 Hz, 2H, H8/H11), 1.52 (tt, J = 7.6, 7.0 Hz, 2H, H13), 1.22 (m, 10 H, 
H14-18), 0.77 (t, J = 7.2 Hz, 3H, H19). 
13C NMR (100 MHz, DMSO-d6) ppm: 163.65 (CON, C1), 146.31 (2ArCH, C3, H7), 146.12 
(ArCH, C5), 127.29 (2ArCH, C4, C6), 65.83 (OCH2, C9/C10), 65.71 (OCH2, C9/C10), 65.55 
(OCH2, C12), 61.15 (NCH2CO, C2), 44.75 (NCH2, C8/C11), 42.28 (NCH2, C8/C11), 31.56 
(CH2), 29.46 (CH2), 29.29 (CH2), 28.21 (CH2), 25.76 (CH2), 22.34 (CH2), 14.26 (CH3). 
IR (neat, cm-1): 2926, 1709, 1661, 1639, 1467, 1362, 1244, 1219, 1113, 1040, 957, 758. 
MS (m/z): 207.10 [M-OctOSO3¯ ]+ 
 
6.2.5 Iodide Ionic Liquids: 
General Procedure E: Preparation of the achiral iodide ILs 
3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium iodide (69d) 
 
To a stirred solution of [NTf2] salt (69b) (88.64 g, 156.7 mmol) in DCM (100 mL) was added 
a solution of tetrabutylammonium iodide (63.69 g, 172.4 mmol) in DCM (100 mL) slowly at 
RT. After stirring for 3 h at RT the solvent was evaporated completely, the residue was 
dissolved in distilled water (100 mL). The aq. solution was washed with DCM (50 mL) and 
then evaporated on rota evaporator, dried under high vacuum to afford the title compound 
(69d) as yellow solid in 66 % yield (42.81 g, 103.8 mmol).  
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Molecular formula: C14H25IN2O4 
Molecular weight: 412.26 g/mol 
Melting Point: 52-54°C 
1H NMR (400 MHz, CDCl3) ppm: 9.63 (s, 1H, H3), 7.68 (t, J = 1.8 Hz, 1H, H4/H5), 7.58 (t, J 
= 1.8 Hz, 1H, H4/H5), 5.37 (s, 2H, H2), 4.29 (t, J = 4.8 Hz, 2H, H7), 4.02 (s, 3H, H6), 3.67 
(t, J = 4.8 Hz, 2H, H8), 3.56 (t, J = 4.4 Hz, 2H, H9), 3.50 (t, J = 4.4 Hz, 2H, H10), 3.36 (t, J 
= 6.8 Hz, 2H, H11), 1.45 (tt, J = 7.6, 6.8 Hz, 2H, H12), 1.25 (tq, J = 7.6, 7.2 Hz, 2H, H13), 
0.82 (t, J = 7.2 Hz, 3H, H14). 
13C NMR (100 MHz, CDCl3) ppm: 165.86 (COO, C1), 137.53 (ArCH, C3), 123.93 (ArCH, 
C4/C5), 123.24 (ArCH, C4/C5), 71.03 (OCH2, C11), 70.45 (OCH2, C9), 69.80 (OCH2, C10), 
68.42 (OCH2, C8), 65.63 (OCH2, C7), 50.46 (CH2, C2), 37.21 (NCH3, C6), 31.48 (CH2, C12), 
19.09 (CH2, C13), 13.83 (CH3, C14). 
IR (neat, cm-1): 3131, 3100, 2955, 2934, 2869, 1751, 1633, 1577, 1565, 1450, 1430, 1340, 
1220, 1196, 1172, 1127, 1094, 1044, 969, 869, 841, 765. 
MS (m/z): 285.20 (M-I¯ )+ 
 
3-{[bis(2-Methoxyethyl)carbamoyl]methyl}-1-methyl-1H-imidazol-3-ium iodide (73d) 
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The title compound (73d) was prepared from [NTf2] salt (73b) (99.8 g, 186.0 mmol), 
tetrabutylammonium iodide (77.6 g, 210.1 mmol) and DCM (300 mL) according to the 
general procedure E as a brown solid in 74 % yield (52.97 g, 138.3 mmol).  
Molecular formula: C12H22IN3O3 
Molecular weight: 383.23 g/mol 
Melting Point: 48-50°C 
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1H NMR (400 MHz, CDCl3) ppm: 9.54 (s, 1H, H3), 7.45 (d, J = 2.4 Hz, 1H, H4/H5), 7.44 (d, 
J = 2.4 Hz, 1H, H4/H5), 5.59 (s, 2H, H2), 4.03 (s, 3H, H6), 3.67 (t, J = 4.8 Hz, 2H, H7/H10), 
3.55-3.52 (m, 4H, H7/H10, H8/H11), 3.48 (t, J = 4.8 Hz, 2H, H8/H11), 3.35 (s, 3H, H9/H12), 
3.29 (s, 3H, H9/H12). 
13C NMR (100 MHz, CDCl3) ppm: 165.12 (COO, C1), 137.66 (ArCH, C3), 124.10 (ArCH, 
C4/C5), 122.60 (ArCH, C4/C5), 70.44 (OCH2, C8/C11), 70.05 (OCH2, C8/C11), 59.32 
(OCH3, C9/C12), 58.88 (OCH3, C9/C12), 50.85 (NCH2, C2), 48.84 (NCH2, C7/C10), 46.87 
(NCH2, C7/C10), 37.07 (NCH3, C6). 
IR (neat, cm-1): 3149, 3101, 2921, 2889, 1662, 1651, 1562, 1472, 1423, 1341, 1195, 1169, 
1118, 1095, 1069, 1031, 1003, 831, 804, 751. 
MS (m/z): 256.10 [M-I¯ ]+ 
 
6.2.6 [N(CN)2] Ionic Liquids: 
3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium dicyanamide 
(69e)2 
 
A dry flask was charged with bromide salt (69a) (10.52 g, 28.8 mmol) and acetonitrile (100 
mL) under a nitrogen atmosphere NaN(CN)2 (2.82 g, 32.7 mmol) was added in one portion 
and the suspension was stirred vigorously for 4 days at RT. The fine white precipitate was 
filtered quickly in air and washed with dry acetonitrile (3 x 10 mL). The filtrate and washings 
were combined, solvent removed by rotary evaporation and then under high vacuum to obtain 
a off white solid in 97 % yield (9.86 g, 28.1 mmol) 
Molecular formula: C16H25N5O4 
Molecular weight: 351.4 g/mol 
Melting Point: 58-60°C 
1H NMR (400 MHz, CDCl3) ppm: 9.59 (s, 1H, H3), 7.60 (t, J = 1.6 Hz, 1H, H4/H5), 7.49 (t, J 
= 1.6 Hz, 1H, H4/H5), 5.31 (s, 2H, H2), 4.31 (t, J = 4.8 Hz, 2H, H7), 4.01 (s, 3H, H6), 3.69 (t, 
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J = 4.8 Hz, 2H, H8), 3.58 (t, J = 4.4 Hz, 2H, H9), 3.53 (t, J = 4.4 Hz, 2H, H10), 3.38 (t, J = 
6.8 Hz, 2H, H11),1.48 (tt, J = 7.2, 6.8 Hz, 2H, H12), 1.29 (qt, J = 7.6, 7.2 Hz, 2H, H13), 0.84 
(t, J = 7.6 Hz, 3H, H14). 
13C NMR (100 MHz, CDCl3) ppm: 166.13 (COO, C1), 137.96 (ArCH, C3), 123.98 (ArCH, 
C4/C5), 123.27 (ArCH, C4/C5), 71.14 (OCH2, C11), 70.53 (OCH2, C9), 69.89 (OCH2, C10), 
68.49 (OCH2, C8), 65.69 (OCH2, C7), 50.14 (CH2, C2), 36.83 (NCH3, C6), 31.60 (CH2, C12), 
19.21 (CH2, C13), 13.92 (CH3, C14). 
 Note: C’s from anion are not visible in 13C NMR. 
IR (neat, cm-1): 2957, 2933, 2869, 2231, 2194, 2130, 1750, 1628, 1567, 1456, 1375, 1304, 
1216, 1175, 1095, 1042, 967, 878, 769. 
MS (m/z): 285.20 [M- N(CN)2¯ ]+ 
1H and 13C-NMR spectra and melting point are in agreement with the literature data.2 
 
6.2.7 [OAc] Ionic Liquids: 
3-{[bis(2-Methoxyethyl)carbamoyl]methyl}-1-methyl-1H-imidazol-3-ium acetate (73f) 
 
The title compound (73f) was synthesized by a slow addition of an aq. bromide solution (73a) 
[(4.22 g, 12.6 mmol) in 10 mL water] into an equimolar Ag(CH3COO) solution [(2.09 g, 12.6 
mmol) in 200 mL water]. The reaction was covered with aluminum foil to prevent the 
photodegradation of silver acetate. The reaction mixture was stirred at room temperature for 2 
h, followed by a removal of AgBr precipitate through filtration. Charcoal was added to the 
filtrate to remove color and impurities overnight. After filtering off the charcoal, water was 
removed from the filtrate through rotary evaporation under vacuum at 60 °C to obtain a 
colourless oil in 65 % yield (2.56 g, 8.1 mmol).5 
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Molecular formula: C14H25N3O5 
Molecular weight: 315.37 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 11.17 (bs, 1H, H3), 7.19 (s, 1H, H3/H4), 7.12 (s, 1H, 
H3/H4), 5.58 (s, 2H, H2), 3.88 (s, 3H, H6), 3.60 (t, J = 4.8 Hz, 2H, H8/H11), 3.47-3.39 (m, 
6H, H7, H10, H8/H11), 3.25 (s, 3H, H9/H12), 3.22 (s, 3H, H9/H12), 1.89 (s, 3H, H14). 
13C NMR (100 MHz, CDCl3) ppm: 175.39 (COO, C13), 165.99 (COO, C1), 141.38 (ArCH, 
C3), 123.70 (ArCH, C4/C5), 121.58 (ArCH, C4/C5), 70.53 (OCH2, C8/C11), 70.05 (OCH2, 
C8/C11), 59.02 (OCH3, C9/C12), 58.80 (OCH3, C9/C12), 49.97 (NCH2, C2), 48.53 (NCH2, 
C7/C10), 46.58 (NCH2, C7/C10), 36.03 (NCH3, C6), 25.25 (COCH3, C14). 
IR (neat, cm-1): 2995, 1648, 1560, 1474, 1400, 1341, 1178, 1109, 1013, 919. 
MS (m/z): 256.20 [M-OAc¯ ]+ 
 
6.3 Lactate Ionic Liquids: 
6.3.1 Esters: 
General procedure F: Preparation of the Lactate esters4 
Ethyl-2-hydroxypropanoate (79)4 
 
To a stirred mixture of lactic acid (21.53 g, 239 mmol) in ethanol (200 mL), thionyl chloride 
(3.0 mL, 41.1 mmol) was added at RT and reaction was heated to reflux for 8 h. The reaction 
mixture was cooled to RT and volatiles were removed by rotary evaporation. With the 
purification by column chromatography (SiO2, EtOAc:Hexane; 20:80) a pale yellow oil was 
obtained in 56 % yield (15.80 g, 133.8 mmol). 
Molecular formula: C5H10O3 
Molecular weight: 118.13 g/mol 
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1H NMR (400 MHz, CDCl3) ppm: 4.27-4.22 (m, 3H, H1, H4), 2.77(d, J = 5.2 Hz, 1H, OH), 
1.41 (d, J = 7.6 Hz, 3H, H2), 1.30 (t, J = 7.2 Hz, 3H, H5). 
13C NMR (100 MHz, CDCl3) ppm: 175.78 (COO, C3), 66.93 (CHOH, C1), 61.53 (OCH2, 
C4), 20.38 (CH2, C2), 14.21 (CH3, C5). 
IR (neat, cm-1): 3466, 2987, 1739, 1452, 1373, 1191, 1124, 1091, 1045, 1018, 861. 
1H and 13C-NMR spectra are in agreement with the literature data.4 
Butyl-2-hydroxypropanoate (80)6 
 
The title compound (80) was prepared using lactic acid (11.38 g, 126.3 mmol), butanol (80 
mL) and thionyl chloride (4.0 mL, 54.8 mmol) according to the general procedure F as a 
colourless liquid in 66 % yield (12.25 g, 83.8 mmol). 
Molecular formula: C7H14O3 
Molecular weight: 146.18 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 4.22 (q, J = 6.8 Hz, 1H, H1), 4.13 (dt, J = 10.8, 6.8 Hz, 
2H, H4), 3.05 (s, 1H, OH), 1.59 (tt, J = 7.0, 6.8 Hz, 2H, H5), 1.36 (d, J = 6.8 Hz, 3H, H2), 
1.34 (qt, J = 7.4, 7.0 Hz, 2H, H6), 0.89 (t, J = 7.4 Hz, 3H, H7). 
13C NMR (100 MHz, CDCl3) ppm: 175.79 (COO, C3), 66.70 (CHOH, C1), 65.35 (OCH2, 
C4), 30.50 (CH2, C5), 20.32 (CH2, C6), 18.96 (CH3, C2), 13.57 (CH3, C7). 
IR (neat, cm-1): 3458, 2961, 1732, 1460, 1376, 1263, 1205, 1125, 1043, 964, 943, 843. 
1H and 13C-NMR spectra are in agreement with the literature data.6 
(S) Butyl 2-hydroxypropanoate (81)6 
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The title compound (81) was preapred using (S)-lactic acid (40 % in water) (27.19 g, 120.7 
mmol), butanol (200 mL) and thionyl chloride (5.0 mL, 68.5 mmol) according to the general 
procedure F as a colourless liquid in 71 % yield (12.57 g, 85.99 mmol). 
Molecular formula: C7H14O3 
Molecular weight: 146.18 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 4.23 (q, J = 6.8 Hz, 1H, H1), 4.13 (dt, J = 10.8, 6.4 Hz, 
2H, H4), 3.03 (s, 1H, OH), 1.60 (tt, J = 7.0, 6.4 Hz, 2H, H5), 1.37 (d, J = 6.8 Hz, 3H, H2), 
1.34 (qt, J = 7.4, 7.0 Hz, 2H, H6), 0.89 (t, J =7.4 Hz, 3H, H7). 
13C NMR (100 MHz, CDCl3) ppm: 175.83 (COO, C3), 66.71 (CHOH, C1), 65.42 (OCH2, 
C4), 30.52 (CH2, C5), 20.37 (CH2, C6), 18.98 (CH3, C2), 13.61 (CH3, C7). 
IR (neat, cm-1): 3456, 2961, 1732, 1460, 1376, 1284, 1205, 1125, 1043, 943, 843. 
[α]20D = -7.1º (2.1 c, CHCl3)  
1H and 13C-NMR spectra are in agreement with the literature data.6 
Pentyl-2-hydroxypropanoate (82)6 
 
The title compound (82) was preapred using lactic acid (7.61 g, 84.5 mmol), pentanol (50 mL) 
and thionyl chloride (3.0 mL, 41.1 mmol) according to the general procedure F as a colourless 
liquid in 76 % yield (10.3 g, 64.3 mmol).  
Molecular formula: C8H16O3 
Molecular weight: 160.21 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 4.25 (q, J = 7.0 Hz, 1H, H1), 4.16 (dt, J = 8.8, 6.8 Hz, 2H, 
H4), 2.85 (s, 1H, OH), 1.64 (tt, J = 7.2, 6.8 Hz, 2H, H5), 1.39 (d, J = 7.0 Hz, 3H, H2), 1.33-
1.30 (m, 4H, H’s 6 and 7), 0.89 (t, J =7.2 Hz, 3H, H8). 
13C NMR (100 MHz, CDCl3) ppm: 175.86 (COO, C3), 66.73 (CHOH, C1), 65.79 (OCH2, 
C4), 28.22 (CH2, C5), 27.91 (CH2, C6), 22.25 (CH2, C7), 20.43 (CH3, C2), 13.92 (CH3, C8). 
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IR (neat, cm-1): 3391, 2958, 2932, 1735, 1461, 1379, 1205, 1129, 1077, 1051, 970, 886.  
1H and 13C-NMR spectra are in agreement with the literature data.6 
6.3.2 Alkylating agents: 
General Procedure G: Preparation of the Lactate based alkylating agents2 
Methyl 2-[(2-bromoacetyl)oxy]propanoate (84)4 
 
To a stirred solution of methyl lactate (2.76 g, 26.5 mmol) in CH2Cl2 (25 mL) sodium 
carbonate (4.22 g, 39.8 mmol) was added, followed by bromoacetyl bromide (2.8 mL, 31.9 
mmol) at 0°C. Reaction mixture was allowed to warm to room temperature then stirred for 8 
h. The reaction mixture was filtered, washed with 25 mL 10 % NaHCO3 solution, dried over 
anhydrous MgSO4 and concentrated under high vacuum. The crude product was purified by 
column chromatography (SiO2, hexane:EtOAc, 80:20) to obtain the title compound (84) as a 
colourless liquid in 32 % yield (1.92 g, 8.5 mmol). 
Molecular formula: C6H9BrO4 
Molecular weight: 225.04 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 5.13 (q, J = 7.2 Hz, 1H, H3), 3.89 (s, 2H, H1), 3.73 (s, 3H, 
H6), 1.50 (d, J = 7.2 Hz, 3H, H4). 
13C NMR (100 MHz, CDCl3) ppm: 170.47 (COO, C5), 166.64 (COO, C2), 70.03 (OCH, C3), 
52.54 (OCH3, C6), 25.35 (CH2, C1), 16.77 (CH3, C4). 
IR (neat, cm-1): 2958, 1745, 1453, 1405, 1315, 1280, 1225, 1167, 1098, 1047, 981. 
1H and 13C-NMR spectra are in agreement with the literature data.4 
Methyl-(2S)-2-[(2-bromoacetyl)oxy]propanoate (85) 
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The title compound (85) was synthesized using (S)-methyl lactate (7.06 g, 67.8 mmol), dry 
DCM (70 mL), sodium carbonate (10.78 g, 101.7 mmol), and bromoacetyl bromide (7.1 mL, 
81.3 mmol) according to general procedure G to afford a colourless liquid in 37 % yield (5.63 
g, 25.0 mmol). 
Molecular formula: C6H9BrO4 
Molecular weight: 225.04 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 5.13 (q, J = 7.2 Hz, 1H, H3), 3.89 (s, 2H, H1), 3.74 (s, 3H, 
H6), 1.50 (d, J = 7.2 Hz, 3H, H4). 
13C NMR (100 MHz, CDCl3) ppm: 170.47 (COO, C5), 166.64 (COO, C2), 70.03 (OCH, C3), 
52.54 (OCH3, C6), 25.29 (CH2, C1), 16.78 (CH3, C4). 
IR (neat, cm-1): 2958, 1741, 1452, 1407, 1314, 1275, 1214, 1132, 1093, 1045, 981, 836. 
[α]20D = -104.5º (0.6 c, CHCl3) 
General procedure H: Preparation of Lactate based alkylating agents7 
Ethyl 2-[(2-bromoacetyl)oxy]propanoate (86)4 
 
Bromoacetyl bromide (14.6 mL, 168 mmol) was added, in one portion, to the mixture of 
alcohol (79) (9.91 g, 83.9 mmol) and neutral Al2O3 (12.84 g, 125.9 mmol). The resultant 
dispersion was stoppered tightly and kept aside unstirred at 25 °C, and the progress of the 
reaction was monitored by TLC. When the reaction was complete, EtOAc (50 mL) was added 
to the reaction mixture and filtered. The solvent was removed by rotary evaporation to furnish 
the product in 82 % yield (16.36 g, 68.8 mmol). 
Molecular formula: C7H11BrO4 
Molecular weight: 239.06 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 5.06 (q, J = 7.2 Hz, 1H, H3), 4.15 (q, J = 7.2 Hz, 2H, H6), 
3.86 (s, 2H, H1), 1.46 (d, J = 7.2 Hz, 3H, H4), 1.22 (t, J = 7.2 Hz, 3H, H7), 
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13C NMR (100 MHz, CDCl3) ppm: 169.95 (COO, C5), 166.61 (COO, C2), 70.11 (OCH, C3), 
61.59 (CH2, C6), 25.37 (CH2, C1), 16.71 (CH3, C4), 14.05 (CH3, C7). 
IR (neat, cm-1): 2985, 1739, 1449, 1380, 1370, 1273, 1206, 1132, 1092, 1045, 1017, 960, 860. 
1H and 13C-NMR spectra are in agreement with the literature data.4 
Ethyl-(2S)-2-[(2-bromoacetyl)oxy]propanoate (87) 
 
The title compound (87) was synthesized from bromoacetyl bromide (16.1 mL, 185 mmol), 
alcohol (10.93 g, 92.6 mmol) and neutral Al2O3 (14.16 g, 138.9 mmol) according to general 
procedure H as a yellow oil in 85 % yield (18.66 g, 78.4 mmol). 
Molecular formula: C7H11BrO4 
Molecular weight: 239.06 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 5.07 (q, J = 7.2 Hz, 1H, H3), 4.16 (q, J = 7.2 Hz, 2H, H6), 
3.87 (s, 2H, H1), 1.47 (d, J = 7.2 Hz, 3H, H4), 1.23 (t, J = 7.2 Hz, 3H, H7). 
13C NMR (100 MHz, CDCl3) ppm: 169.99 (COO, C5), 166.65 (COO, C2), 70.15 (OCH, C3), 
61.63 (CH2, C6), 25.39 (CH2, C1), 16.75 (CH3, C4), 14.08 (CH3, C7). 
IR (neat, cm-1): 2986, 1739, 1450, 1380, 1312, 1273, 1206, 1132, 1092, 1045, 1017, 960. 
[α]20D = -38.1º (2.383 c, CHCl3) 
Butyl-2-[(2-bromoacetyl)oxy]propanoate (88)4 
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The title compound (88) was prepared using butyl lactate (80) (7.63 g, 52.2 mmol), DCM (75 
mL), sodium carbonate (8.29 g, 78.2 mmol), and bromoacetyl bromide (5.5 mL, 62.62 mmol) 
according to general procedure G to obtain a pale yellow liquid in 85 % yield (11.78 g, 44.1 
mmol). 
 204 
 
Molecular formula: C9H15BrO4 
Molecular weight: 267.12 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 5.11 (q, J = 7.2 Hz, 1H, H3), 4.13 (dt, J = 6.8, 6.4 Hz, 2H, 
H6), 3.89 (s, 2H, H1), 1.61 (tt, J = 7.0, 6.4 Hz, 2H, H7), 1.50 (d, J = 7.2 Hz, 3H, H4), 1.35 (qt, 
J = 7.6, 7.0 Hz, 2H, H8), 0.90 (t, J = 7.6 Hz, 3H, H9). 
13C NMR (100 MHz, CDCl3) ppm: 175.07 (COO, C5), 166.63 (COO, C2), 70.15 (CHOH, 
C3), 65.45 (OCH2, C6), 30.46 (CH2, C1), 25.35 (CH2, C7), 18.99 (CH2, C8), 16.78 (CH3, C4), 
13.64 (CH3, C9). 
IR (neat, cm-1): 2962, 1741, 1457, 1351, 1274, 1203, 1132, 1094, 1044, 963, 937, 842. 
HRMS (ESI+,m/z): Calculated for [M]+1, C9H16O4Br+, requires = 267.0232,                                               
found = 267.0234. 
1H and 13C-NMR spectra are in agreement with the literature data.4 
Butyl-(2S)-2-[(2-bromoacetyl)oxy]propanoate (89) 
 
The title compound (89) was prepared using (S)-butyl lactate (81) (16.55 g, 113.2 mmol), 
DCM (200 mL), sodium carbonate (18.0 g, 169.8 mmol), and bromoacetyl bromide (11.8 mL, 
136 mmol) according to general procedure G to obtain a pale yellow liquid in 80 % yield 
(24.25 g, 90.8 mmol). 
Molecular formula: C9H15BrO4 
Molecular weight: 267.12 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 5.09 (q, J = 7.2 Hz, 1H, H3), 4.10 (dt, J = 10.8, 6.6 Hz, 
2H, H6), 3.87 (s, 2H, H1), 1.59 (tt, J = 7.2, 6.6 Hz, 2H, H7), 1.48 (d, J = 7.2 Hz, 3H, H4), 
1.33 (tq, J = 7.6, 7.2 Hz, 2H, H8), 0.89 (t, J = 7.6 Hz, 3H, H9). 
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13C NMR (100 MHz, CDCl3) ppm: 170.08 (COO, C5), 166.64 (COO, C2), 70.15 (CH, C3), 
65.45 (OCH2, C6), 30.45 (CH2, C1), 25.37 (CH2, C7), 18.81 (CH2, C8), 16.79 (CH3, C4), 
13.65 (CH3, C9). 
IR (neat, cm-1): 2962, 1747, 1458, 1312, 1278, 1207, 1134, 1098, 1046, 964. 
[α]20D = -34.9º (1.09 c, CHCl3) 
Pentyl-2-[(2-bromoacetyl)oxy]propanoate (90) 
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The title compound (90) was prepared using pentyl lactate (82) (2.48 g, 15.5 mmol), DCM 
(25 mL), sodium carbonate (2.46 g, 23.2 mmol), and bromoacetyl bromide (1.60 mL, 18.58 
mmol) according to general procedure G as a colourless liquid in 81 % yield (3.53 g, 12.6 
mmol). 
Molecular formula: C10H17BrO4 
Molecular weight: 281.14 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 5.12 (q, J = 7.2 Hz, 1H, H3), 4.13 (dt, J = 10.8, 6.6 Hz, 
2H, H6), 3.90 (s, 2H, H1), 1.63 (tt, J = 7.2, 6.6 Hz, 2H, H7), 1.51 (d, J = 7.2 Hz, 3H, H4), 
1.32-1.29 (m, 4H, H8-9), 0.88 (t, J = 7.2 Hz, 3H, H10). 
13C NMR (100 MHz, CDCl3) ppm: 175.86 (COO, C5), 166.59 (COO, C2), 70.13 (CH, C3), 
65.69 (OCH2, C6), 28.11 (CH2, C1), 27.86 (CH2, C7), 25.34 (CH2, C8), 22.21 (CH2, C9), 
16.76 (CH3, C4), 13.91 (CH3, C10). 
IR (neat, cm-1): 2959, 1743, 1455, 1380, 1274, 1194, 1131, 1093, 1045, 968, 891. 
HRMS (ESI+,m/z): Calculated for [M]+1, C10H18O4Br+, requires = 281.0388,                                               
found = 281.0399. 
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6.3.3 Bromide Ionic Liquids: 
General Procedure I: Preparation of Lactate based bromide ILs2 
3-{2-[(1-Methoxy-1-oxopropan-2-yl)oxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium 
bromide (91a)4 
 
To a stirred solution of 84 (1.92 g, 8.53 mmol) in diethyl ether (25mL) 1-methylimidazole 
(700 mg, 8.53 mmol) was added dropwise at RT and the reaction mixture was stirred for 12 h. 
The viscous liquid which had settled to the bottom of the flask was washed with diethyl ether 
(5 x 20 mL) and dried under high vacuum to obtain the title compound (91a) as a colourless 
liquid in 87 % yield (2.29 g, 7.46 mmol). 
Molecular formula: C10H15BrN2O4 
Molecular weight: 307.14 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 10.04 (s, 1H, H2), 7.68 (t, J = 1.6 Hz, 1H, H4), 7.61 (t, J = 
1.6 Hz, 1H, H3), 5.67 (d, J = 17.6 Hz, 1H, H5), 5.42 (d, J = 17.6 Hz, 1H, H5), 5.12 (q, J = 7.2 
Hz, 1H, H7), 4.05 (s, 3H, H1), 3.69 (s, 3H, H10), 1.48 (d, J = 7.2 Hz, 3H, H8). 
13C NMR (100 MHz, CDCl3) ppm: 170.05 (COO, C9), 166.49 (COO, C6), 137.68 (NCHN, 
C2), 123.61 (NCH, C3/C4), 123.49 (NCH, C3/C4), 69.90 (CH, C7), 52.43 (NCH2, C5), 49.16 
(OCH3, C10), 35.98 (NCH3, C1), 16.64 (CH3, C8). 
IR (neat, cm-1): 3101, 2957, 1747, 1622, 1578, 1430, 1382, 1230, 1171, 1086, 976, 834, 754. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C10H15N2O4+, requires = 227.1026,                                               
found = 227.1022. 
MS (m/z): 227.10 [M-Br¯ ]+  
1H and 13C-NMR spectra are in agreement with the literature data.4 
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3-(2-{[(2S)-1-Methoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
bromide (92a) 
 
The title compound (92a) was prepared from 85 (2.86 g, 12.7 mmol) and 1-methylimidazole 
(1.05 g, 12.78 mmol) according to the general procedure I to obtain an off white solid in75 % 
yield (2.92 g, 9.5 mmol). 
Molecular formula: C10H15BrN2O4 
Molecular weight: 307.14 g/mol  
Melting Point: 110-112°C 
1H NMR (400 MHz, CDCl3) ppm: 10.22 (s, 1H, H2), 7.62 (t, J = 1.8 Hz, 1H, H4), 7.50 (t, J = 
1.8 Hz, 1H, H3), 5.76 (d, J = 17.8 Hz, 1H, H5), 5.41 (d, J = 17.8 Hz, 1H, H5), 5.17 (q, J = 7.2 
Hz, 1H, H7), 4.07 (s, 3H, H1), 3.74 (s, 3H, H10), 1.53 (d, J = 7.2 Hz, 3H, H8). 
13C NMR (100 MHz, CDCl3) ppm: 170.35 (COO, C9), 165.81 (COO, C6), 138.33 (NCHN, 
C2), 123.81 (NCH, C3/C4), 123.21 (NCH, C3/C4), 70.66 (CH, C7), 52.82 (NCH2, C5), 50.17 
(OCH3, C10), 37.00 (NCH3, C1), 16.87 (CH3, C8). 
IR (neat, cm-1): 3071, 2952, 1742, 1569, 1454, 1343, 1207, 1165, 1108, 975, 784.  
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C10H15N2O4+, requires = 227.1026,                                               
found = 227.1022. 
MS (m/z): 227.10 [M-Br¯ ]+ 
 [α]20D = - 43.92º (1.06 c, EtOH) 
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3-{2-[(1-Ethoxy-1-oxopropan-2-yl)oxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium 
bromide (93a)4 
 
The title compound (93a) was prepared from 86 (10.48 g, 43.8 mmol) and 1-methylimidazole 
(3.5 mL, 43.8 mmol) according to the general procedure I to obtain a colourless liquid in 74 % 
yield (10.47 g, 32.60 mmol). 
Molecular formula: C11H17BrN2O4 
Molecular weight: 321.17 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.86 (s, 1H, H2), 7.62 (m, 2H, H3, H4), 5.57 (d, J = 17.6 
Hz, 1H, H5), 5.35 (d, J = 17.6 Hz, 1H, H5), 5.02 (q, J = 7.2 Hz, 1H, H7), 4.06 (q, J = 7.2 Hz, 
2H, H10), 3.98 (s, 3H, H1), 1.40 (d, J = 7.2 Hz, 3H, H8), 1.14 (t, J = 7.2 Hz, 3H, H11). 
13C NMR (100 MHz, CDCl3) ppm: 169.65 (COO, C9), 165.60 (COO, C6), 137.84 (NCHN, 
C2), 123.66 (NCH, C3/C4), 123.32 (NCH, C3/C4), 70.53 (CH, C7), 61.69 (OCH2, C10), 
49.92 (NCH2, C5), 36.79 (NCH3, C1), 16.67 (CH3, C8), 13.93 (CH3, C11). 
IR (neat, cm-1): 3156, 2983, 1730, 1578, 1375, 1206, 1174, 1125, 1093, 1040, 751. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C11H17N2O4+, requires = 241.1188,                                               
found = 241.1179. 
MS (m/z): 241.10 [M-Br¯ ]+ 
1H and 13C-NMR spectra are in agreement with the literature data.4 
3-(2-{[(2S)-1-Ethoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
bromide (94a) 
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The title compound (94a) was prepared from 87 (13.35 g, 55.8 mmol) and 1-methylimidazole 
(4.5 mL, 55.8 mmol) according to the general procedure I to obtain a colourless liquid in 74 
% yield (13.35 g, 41.6 mmol). 
Molecular formula: C11H17BrN2O4 
Molecular weight: 321.17 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.78 (s, 1H, H2), 7.63 (t, J = 1.6 Hz, 1H, H3/4), 7.61 (t, J = 
1.6 Hz, 1H, H3/4), 5.57 (d, J = 17.6 Hz, 1H, H5), 5.37 (d, J = 17.6 Hz, 1H, H5), 5.04 (q, J = 
7.2 Hz, 1H, H7), 4.08 (q, J = 7.2 Hz, 2H, H10), 3.99 (s, 3H, H1), 1.43 (d, J = 7.2 Hz, 3H, H8), 
1.16 (t, J = 7.2 Hz, 3H, H11). 
13C NMR (100 MHz, CDCl3) ppm: 169.80 (COO, C9), 165.75 (COO, C6), 137.88 (NCHN, 
C2), 123.70 (NCH, C3/C4), 123.35 (NCH, C3/C4), 70.55 (CH, C7), 61.76 (OCH2, C10), 
49.99 (NCH2, C5), 36.86 (NCH3, C1), 16.72 (CH3, C8), 13.98 (CH3, C11). 
IR (neat, cm-1): 3094, 2982, 1735, 1578, 1450, 1373, 1201, 1174, 1130, 1092, 1045, 1018, 
855. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C11H17N2O4+, requires = 241.1188,                                   
found = 241.1182. 
MS (m/z): 241.10 [M-Br¯ ]+ 
 [α]20D = - 37.6º (2.159 c, CHCl3) 
 
3-{2-[(1-Butoxy-1-oxopropan-2-yl)oxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium 
bromide (95a)4 
 
The title compound (95a) was prepared from 88 (10.93 g, 40.9 mmol) and 1-methylimidazole 
(3.36 g, 40.9 mmol) according to the general procedure I as a pale yellow liquid in 89 % yield 
(12.69 g, 36.3 mmol). 
 210 
 
Molecular formula: C13H21BrN2O4 
Molecular weight: 349.22 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 10.11 (s, 1H, H2), 7.61 (t, J = 1.8 Hz, 1H, H4), 7.59 (t, J = 
1.8 Hz, 1H, H3), 5.72 (d, J = 17.6 Hz, 1H, H5), 5.36 (d, J = 17.6 Hz, 1H, H5), 5.12 (q, J = 7.0 
Hz, 1H, H7), 4.09 (dt, J = 10.8, 6.4 Hz, 2H, H10), 4.06 (s, 3H, H1), 1.57 (tt, J = 7.0, 6.4, Hz, 
2H, H11), 1.49 (d, J = 7.0 Hz, 3H, H8), 1.31 (qt, J = 7.6, 7.0 Hz, 2H, H12), 0.88 (t, J = 7.6 
Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 169.87 (COO, C9), 165.65 (COO, C6), 138.31 (NCHN, 
C2), 123.74 (NCH, C3/C4), 123.26 (NCH, C3/C4), 70.74 (CH, C7), 65.68 (NCH2, C5), 50.12 
(OCH2, C10), 36.97 (NCH3, C1), 30.41 (CH2, C11), 18.96 (CH2, C12), 16.87 (CH3, C8), 
13.66 (CH3, C13).  
IR (neat, cm-1): 2960, 1742, 1565, 1456, 1373, 1195, 1175, 1132, 1093, 964, 776, 753. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C13H21N2O4+, requires = 269.1501,                                               
found = 269.1507. 
MS (m/z): 269.10 [M-Br¯ ]+ 
1H and 13C-NMR spectra are in agreement with the literature data.4 
3-(2-{[(2S)-1-Butoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
bromide (96a) 
 
The title compound (96a) was prepared from 89 (19.12 g, 71.6 mmol) and 1-methylimidazole 
(5.87 g, 71.6 mmol) according to the general procedure I to obtain a white gel in 75 % yield 
(22.08 g, 9.5 mmol). 
Molecular formula: C13H21BrN2O4 
Molecular weight: 349.22 g/mol 
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1H NMR (400 MHz, CDCl3) ppm: 9.83 (s, 1H, H2), 7.61 (t, J = 1.8 Hz, 1H, H4), 7.57 (t, J = 
1.8 Hz, 1H, H3), 5.65 (d, J = 18 Hz, 1H, H5), 5.37 (d, J = 18 Hz, 1H, H5), 5.11 (q, J = 7.2 Hz, 
1H, H7), 4.09 (dt, J = 9.2, 6.6 Hz, 2H, H10), 4.04 (s, 3H, H1), 1.57 (tt, J = 7.0, 6.6 Hz, 2H, 
H11), 1.49 (d, J = 7.2 Hz, 3H, H8), 1.31 (tq, J = 7.6, 7.0 Hz, 2H, H12), 0.88 (t, J = 7.6 Hz, 
3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 175.84 (COO, C9), 165.87 (COO, C6), 138.16 (NCHN, 
C2), 123.75 (NCH, C3/C4), 123.34 (NCH, C3/C4), 70.64 (CH, C7), 65.69 (NCH2, C5), 50.15 
(OCH2, C10), 37.00 (NCH3, C1), 30.39 (CH2, C11), 18.95 (CH2, C12), 16.88 (CH3, C8), 
13.65 (CH3, C13). 
IR (neat, cm-1): 2960, 1741, 1578, 1456, 1374, 1196, 1175, 1132, 1094, 1046, 964, 841, 753, 
718. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C13H21N2O4+, requires = 269.1501,                                               
found = 269.1498. 
MS (m/z): 269.10 [M-Br¯ ]+ 
[α]20D = -34.4º (0.5 c, CHCl3) 
1-Methyl-3-(2-oxo-2-{[1-oxo-1-(pentyloxy)propan-2-yl]oxy}ethyl)-1H-imidazol-3-ium 
bromide (97a) 
 
The title compound (97a) was prepared from 90 (3.53 g, 12.6 mmol) and 1-methylimidazole 
(1.03 g,12.6 mmol) according to the general procedure I to obtain a pale yellow liquid in 94 % 
yield (4.30 g, 11.8 mmol). 
Molecular formula: C14H23BrN2O4 
Molecular weight: 363.25 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 10.23 (s, 1H, H2), 7.56 (t, J = 1.6 Hz, 1H, H4), 7.46 (t, J = 
1.6 Hz, 1H, H3), 5.79 (d, J = 17.6 Hz, 1H, H5), 5.34 (d, J = 17.6 Hz, 1H, H5), 5.16 (q, J = 7.0 
Hz, 1H, H7), 4.12 (dt, J = 10.8, 6.8 Hz, 2H, H10), 4.07 (s, 3H, H1), 1.63 (tt, J = 6.8, 6.8 Hz, 
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2H, H11), 1.53 (d, J = 7.0 Hz, 3H, H8), 1.31-1.27 (m, 4H, H12, H13), 0.88 (t, J = 6.8 Hz, 3H, 
H14). 
13C NMR (100 MHz, CDCl3) ppm: 169.87 (COO, C9), 165.59 (COO, C6), 138.66 (ArCH, 
C2), 123.67 (ArCH, C3/C4), 122.97 (ArCH, C3/C4), 70.78 (CH, C7), 65.99 (OCH2, C10), 
50.19 (NCH2, C5), 36.95 (NCH3, C1), 28.12 (CH2, C11), 27.85 (CH2, C12), 22.21 (CH2, 
C13), 16.85 (CH3, C8), 13.93 (CH3, C14).  
IR (neat, cm-1): 2957, 1743, 1565, 1455, 1373, 1193, 1175, 1093, 1046, 968, 872, 754.   
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C14H23N2O4+, requires = 283.1658,                                               
found = 283.1658. 
MS (m/z): 283.10 [M-Br¯ ]+ 
 
6.3.4 [NTf2] Ionic Liquid: 
3-(2-{[(2S)-1-Butoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (96b) 
 
 
To a stirred solution of (96a) (760 mg, 2.16 mmol) in distilled water (10 mL) LiNTf2 (590 
mg, 2.06 mmol) was added and reaction mixture was stirred at RT for 4 h. The viscous liquid 
was washed with distilled water (3 x 10 mL) and dried under high vacuum to afford a 
colourless liquid in 63 % yield (720 mg, 1.31 mmol). 
Molecular formula: C15H21F6N3O8S2 
Molecular weight: 549.46 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.72 (s, 1H, H2), 7.39 (t, J = 1.8 Hz, 1H, H3/H4), 7.35 (t, J 
= 1.8 Hz, 1H, H3/H4), 5.14 (q, J = 7.2 Hz, 1H, H7), 5.23 (d, J = 18 Hz, 1H, H5), 5.02 (d, J = 
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18 Hz, 1H, H5), 4.14 (dt, J = 10.8, 6.6 Hz, 2H, H10), 3.94 (s, 3H, H1), 1.60 (tt, J = 7.0, 6.6, 
Hz, 2H, H11), 1.50 (d, J = 7.2 Hz, 3H, H8), 1.33 (qt, J = 7.6, 7.0 Hz, 2H, H12), 0.90 (t, J = 
7.6 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 169.93 (COO, C9), 165.38 (COO, C6), 137.46 (NCHN, 
C2), 123.87 (NCH, C3/C4), 123.56 (NCH, C3/C4), 119.76 (q, 2CF3, J = 319 Hz, C14, C15), 
70.95 (CH, C7), 65.73 (NCH2, C5), 49.75 (OCH2, C10), 36.51 (NCH3, C1), 30.43 (CH2, 
C11), 18.98 (CH2, C12), 16.63 (CH3, C8), 13.61 (CH3, C13).  
19F NMR (376 MHz, CDCl3) ppm: -79.20 (6F) 
[α]20D = -47.6º (0.75 c, CHCl3) 
IR (neat, cm-1): 3163, 2966, 1746, 1580, 1459, 1347, 1177, 1133, 1094, 1052, 788. 
MS (m/z): [M-NTf2¯ ]+ 
 
6.3.5 [OctOSO3] Ionic Liquids: 
General Procedure J: Preparation of the Lactate based [OctOSO3] ILs. 
3-{2-[(1-Methoxy-1-oxopropan-2-yl)oxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium octyl 
sulfate (91c)4 
 
To a stirred solution of bromide salt (91a) (1.14 g, 3.71 mmol) in distilled water (10 mL) was 
added sodium octyl sulphate (860 mg, 3.71 mmol) in one portion. The mixture was stirred 
overnight then the water was removed by the rotary evaporation. The crude product was 
dissolved in DCM (25 mL) and washed with water (3 x 5 mL). The organic layer was 
removed by the rotary evaporation and compound (91c) dried under high vacuum to obtain a 
colourless liquid in 76 % yield (1.24 g, 2.84 mmol). 
Molecular formula: C18H32N2O8S 
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Molecular weight: 436.52 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.35 (s, 1H, H2), 7.53 (t, J = 1.6 Hz, 1H, H4), 7.49 (t, J = 
1.6 Hz, 1H, H3), 5.35 (d, J = 16.0 Hz, 1H, H5), 5.18 (d, J = 16.0 Hz, 1H, H5), 5.14 (q, J = 7.2 
Hz, 1H, H7), 3.96-3.93 (m, 5H, H1, H11), 3.71 (s, 3H, H10), 1.60 (tt, J = 7.2, 6.8 Hz, 2H, 
H12), 1.49 (d, J = 7.2 Hz, 3H, H8), 1.29-1.24 (m, 10H, H’s 13-17), 0.86 (t, J = 6.8 Hz, 3H, 
H18). 
13C NMR (100 MHz, CDCl3) ppm: 170.04 (COO, C9), 166.49 (COO, C6), 137.72 (NCHN, 
C2), 123.64 (NCH, C3/C4), 123.51 (NCH, C3/C4), 69.89 (OCH3, C10), 65.41 (CH, C7), 
52.41 (OCH2, C11), 49.13 (NCH2, C5), 35.95 (NCH3, C1), 31.23 (CH2, C12), 29.03 (CH2), 
28.71 (CH2), 28.67 (CH2), 25.50 (CH2), 22.07 (CH2), 16.63 (CH3, C8/C18), 13.95 (CH3, 
C8/C18). 
IR (neat, cm-1): 3118, 2926, 1749, 1628, 1578, 1456, 1378, 1207,1176, 1057, 977, 905, 837, 
789, 755. 
MS (m/z): 227.10 [M-OctOSO3¯ ]+ 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.4   
3-(2-{[(2S)-1-Methoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
octyl sulfate (92c) 
 
The title compound (92c) was prepared from bromide salt (92a) (1.27 g, 4.13 mmol) and 
sodium octyl sulphate (960 mg, 4.13 mmol) according to the general procedure J to afford a 
colourless liquid in 79 % yield (1.43 g, 3.28 mmol). 
Molecular formula: C18H32N2O8S 
Molecular weight: 436.52 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.41 (s, 1H, H2), 7.50 (t, J = 1.6 Hz, 1H, H4), 7.42 (t, J = 
1.6 Hz, 1H, H3), 5.39 (d, J = 17.6 Hz, 1H, H5), 5.19 (d, J = 17.6 Hz, 1H, H5), 5.17 (q, J = 7.2 
 215 
 
Hz, 1H, H7), 3.99 (t, J = 7.2 Hz, 2H, H11), 3.98 (s, 3H, H1), 3.74 (s, 3H, H10), 1.63 (tt, J = 
7.2, 6.8 Hz, 2H, H12), 1.53 (d, J = 7.2 Hz, 3H, H8), 1.28-1.24 (m, 10H, H’s 13-17), 0.85 (t, J 
= 6.8 Hz, 3H, H18). 
13C NMR (100 MHz, CDCl3) ppm: 170.42 (COO, C9), 166.04 (COO C6), 138.72 (NCHN, 
C2), 123.72 (NCH, C3/C4), 123.25 (NCH, C3/C4), 70.58 (OCH3, C10), 68.06 (CH, C7), 
52.70 (OCH2, C11), 49.75 (NCH2, C5), 36.56 (NCH3, C1), 31.82 (CH2, C12), 29.45 (CH2), 
29.34 (CH2), 29.25 (CH2), 25.84 (CH2), 22.65 (CH2), 16.79 (CH3, C8/C18), 14.12 (CH3, 
C8/C18).  
IR (neat, cm-1): 3099, 2926, 1744, 1569, 1456, 1374, 1206, 1169, 1099, 1035, 976, 757. 
MS (m/z): 227.10 [M- OctOSO3¯ ]+ 
[α] 20D = -19.99º (1.055 c, EtOH) 
3-{2-[(1-Ethoxy-1-oxopropan-2-yl)oxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium octyl 
sulfate (93c) 
 
The title compound (93c) was prepared from bromide salt (93a) (4.59 g, 14.3 mmol) and 
sodium octyl sulphate (3.32 g, 14.3 mmol) according to the general procedure J to obtain a 
colourless liquid in 85 % yield (5.46 g, 12.1 mmol). 
Molecular formula: C19H34N2O8S 
Molecular weight: 450.55 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.35 (s, 1H, H2), 7.50 (t, J = 1.8 Hz, 1H, H3/H4), 7.47 (t, J 
= 1.8 Hz, 1H, H3/H4), 5.37 (d, J = 17.6 Hz, 1H, H5), 5.17 (d, J = 17.6 Hz, 1H, H5), 5.12 (q, J 
= 7.0 Hz, 1H, H7), 4.16 (q, J = 7.2 Hz, 2H, H10), 3.97-3.94 (m, 5H, H1, H12), 1.61 (tt, J = 
7.2, 6.8 Hz, 2H, H13), 1.50 (d, J = 7.0 Hz, 3H, H8), 1.33-1.22 (m, 13H, H’s 11, 14-18), 0.83 
(t, J = 7.2 Hz, 3H, H19). 
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13C NMR (100 MHz, CDCl3) ppm: 169.96 (COO, C9), 166.05 (COO, C6), 138.79 (NCHN, 
C2), 123.83 (NCH, C3/C4), 123.42 (NCH, C3/C4), 70.73 (OCH, C7), 67.71 (OCH2, C12), 
61.86 (OCH2, C10), 49.79 (NCH2, C5), 36.59 (NCH3, C1), 31.87 (CH2), 29.57 (CH2), 29.41 
(CH2), 29.31 (CH2), 25.93 (CH2), 22.70 (CH2), 16.83 (CH3, C8), 14.17 (CH3, C11/C19), 
14.15 (CH3, C11/C19).  
IR (neat, cm-1): 3115, 2927, 1742, 1579, 1568, 1457, 1377, 1182, 1095, 1047, 976, 753. 
MS (m/z):  241.10 [M-OctOSO3¯ ]+ 
3-(2-{[(2S)-1-Ethoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
octyl sulfate (94c) 
 
The title compound (94c) was prepared from bromide salt (94a) (4.63 g, 14.4 mmol) and 
sodium octyl sulphate (3.35 g, 14.4 mmol) according to the general procedure J to afford a 
colourless liquid with in 81 % yield (5.28 g, 11.7 mmol). 
Molecular formula: C19H34N2O8S 
Molecular weight: 450.55 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.33 (s, 1H, H2), 7.51 (t, J = 1.8 Hz, 1H, H3/H4), 7.48 (t, J 
= 1.8 Hz, 1H, H3/H4), 5.35 (d, J = 18 Hz, 1H, H5), 5.17 (d, J = 18 Hz, 1H, H5), 5.12 (q, J = 
7.0 Hz, 1H, H7), 4.15 (q, J = 7.2 Hz, 2H, H10), 3.97-3.93 (m, 5H, H1, H12), 1.60 (tt, J = 7.2, 
6.8 Hz, 2H, H13), 1.49 (d, J = 7.0 Hz, 3H, H8), 1.32-1.21 (m, 13H, H11, H14-18), 0.82 (t, J = 
7.2 Hz, 3H, H19). 
13C NMR (100 MHz, CDCl3) ppm: 169.93 (COO, C9), 166.04 (COO, C6), 138.71 (NCHN, 
C2), 123.83 (NCH, C3/C4), 123.44 (NCH, C3/C4), 70.70 (OCH, C7), 67.79 (OCH2, C12), 
61.83 (OCH2, C10), 49.75 (NCH2, C5), 36.55 (NCH3, C1), 31.84 (CH2), 29.54 (CH2), 29.38 
(CH2), 29.28 (CH2), 25.90 (CH2), 22.67 (CH2), 16.80 (CH3, C8), 14.14 (CH3, C11/C19), 
14.12 (CH3, C11/C19).  
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IR (neat, cm-1): 3115, 2956, 1742, 1578, 1457, 1377, 1345, 1182, 1132, 1047, 1017, 956, 907. 
MS (m/z): 241.10 [M-OctOSO3¯ ]+ 
 [α] 20D = -30.0º (2.446 c, CHCl3) 
3-{2-[(1-Butoxy-1-oxopropan-2-yl)oxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium octyl 
sulfate (95c)4 
 
The title compound (95c) was prepared from bromide salt (95a) (2.35 g, 6.7 mmol) and 
sodium octyl sulphate (1.56 g, 6.7 mmol) according to the general procedure J to obtain a 
colourless liquid in 81 % yield (2.61 g, 5.5 mmol). 
Molecular formula: C21H38N2O8S 
Molecular weight: 478.6 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.23 (s, 1H, H2), 7.49 (t, J = 1.8 Hz, 1H, H4), 7.48 (t, J = 
1.8 Hz, 1H, H3), 5.29 (d, J = 18 Hz, 1H, H5), 5.14 (d, J = 18 Hz, 1H, H5), 5.07 (q, J = 7.0 Hz, 
1H, H7), 4.05 (dt, J = 7.2, 6.8 Hz, 2H, H10), 3.90 (s, 3H, H1), 3.89 (t, J = 7.2 Hz, 2H, H14), 
1.54 (tt, J = 7.2, 6.8 Hz, 2H, H11), 1.45 (d, J = 7.0 Hz, 3H, H8), 1.33-1.17 (m, 14H, H’s 12, 
15-20), 0.84 (t, J = 7.2 Hz, 3H, H21), 0.78 (t, J = 6.8 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 169.94 (COO, C9), 166.0 (COO, C6), 138.45 (NCHN, 
C2), 123.77 (NCH, C3/C4), 123.50 (NCH, C3/C4), 70.53 (OCH2, C14), 67.71 (CH, C7), 
65.50 (OCH2, C10), 49.63 (NCH2, C5), 36.43 (NCH3, C1), 31.75 (CH2, C11/C15), 30.37 
(CH2, C11/C15), 29.43 (CH2), 29.29 (CH2), 29.19 (CH2), 25.81 (CH2), 22.58 (CH2), 18.91 
(CH2), 16.76 (CH3, C8), 14.04 (CH3, C13/C21), 13.58 (CH3, C13/C21).  
IR (neat, cm-1): 2928, 1749, 1579, 1458, 1377, 1197, 1133, 1096, 1058, 978, 906, 785, 753. 
MS (m/z): 269.10 [M-OctOSO3¯ ]+ 
1H and 13C-NMR spectra are in agreement with the literature data.4 
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3-(2-{[(2S)-1-Butoxy-1-oxopropan-2-yl]oxy}-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
octyl sulfate (96c) 
 
The title compound (96c) was prepared from bromide salt (96a) (3.67 g, 10.5 mmol) and 
sodium octyl sulphate (2.44 g, 10.5 mmol) according to the general procedure J to obtain a 
colourless liquid in 82 % yield (4.13 g, 8.6 mmol). 
Molecular formula: C21H38N2O8S 
Molecular weight: 478.6 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.44 (s, 1H, H2), 7.45 (t, J = 1.8 Hz, 1H, H4), 7.40 (t, J = 
1.8 Hz, 1H, H3), 5.43 (d, J = 18 Hz, 1H, H5), 5.16 (d, J = 18 Hz, 1H, H5), 5.15 (q, J = 7.0 Hz, 
1H, H7), 4.13 (dt, J = 10.2, 7.0 Hz, 2H, H10), 4.0 (t, J = 6.8 Hz, 2H, H14), 3.99 (s, 3H, H1), 
1.62 (tt, J = 7.6, 7.0 Hz, 2H, H11), 1.53 (d, J = 7.0 Hz, 3H, H8), 1.41-1.24 (m, 14H, H 12, 
H15-20), 0.92 (t, J = 7.2 Hz, 3H, H21), 0.85 (t, J = 6.8 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 169.87 (COO, C9), 165.93 (COO, C6), 138.50 (NCHN, 
C2), 123.73 (NCH, C3/C4), 123.49 (NCH, C3/C4), 70.54 (OCH2, C14), 67.78 (CH, C7), 
65.46 (OCH2, C10), 49.63 (NCH2, C5), 36.45 (NCH3, C1), 31.74 (CH2, C11/C15), 30.36 
(CH2, C11/C15), 29.41 (CH2), 29.27 (CH2), 29.18 (CH2), 25.79 (CH2), 22.57 (CH2), 18.90 
(CH2), 16.75 (CH3, C8), 14.04 (CH3, C13/C21), 13.58 (CH3, C13/C21). 
IR (neat, cm-1): 2957, 2928, 1745, 1579, 1458, 1378, 1201, 1179, 1133, 1096, 1057, 977, 906, 
789, 753. 
MS (m/z): 269.10 [M-OctOSO3¯ ]+ 
[α] 20D = -12.3º (1.067 c, EtOH) 
 
1-Methyl-3-(2-oxo-2-{[1-oxo-1-(pentyloxy)propan-2-yl]oxy}ethyl)-1H-imidazol-3-ium 
octyl sulfate (97c) 
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The title compound (97c) was prepared from bromide salt (97a) (1.42 g, 3.91 mmol) and 
sodium octyl sulphate (910 mg, 3.91 mmol) according to the general procedure J to afford a 
colourless liquid in 87 % yield (1.68 g, 3.41 mmol). 
Molecular formula: C22H40N2O8S 
Molecular weight: 492.63 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.43 (s, 1H, H2), 7.48 (t, J = 1.8 Hz, 1H, H4), 7.44 (t, J = 
1.8 Hz, 1H, H3), 5.40 (d, J = 17.6 Hz, 1H, H5), 5.151 (d, J = 17.6 Hz, 1H, H5),5.147 (q, J = 
7.2 Hz, 1H, H7), 4.10 (dt, J = 10.8, 6.8 Hz, 2H, H10), 3.98 (t, J = 7.2 Hz, 2H, H15), 3.97 (s, 
3H, H1), 1.66-1.58 (m, 4H, H11, H16), 1.52 (d, J = 7.2 Hz, 3H, H8), 1.35-1.23 (m, 14H, H 
17-H21, H12, H13 ), 0.89-0.83 (m, 6H, H14,H22). 
13C NMR (100 MHz, CDCl3) ppm: 169.60 (COO, C9), 166.47 (COO, C6), 137.71 (NCHN, 
C2), 123.61 (NCH, C3/C4), 123.52 (NCH, C3/C4), 69.97 (OCH2, C15), 65.42 (CH, C7), 
65.05 (OCH2, C10), 49.12 (NCH2, C5), 35.95 (NCH3, C1), 31.23 (CH2, C11/C16), 29.03 
(CH2, C11/C16), 28.71 (CH2), 28.66 (CH2), 27.58 (CH2), 27.29 (CH2), 25.50 (CH2), 22.07 
(CH2), 21.64 (CH2), 16.65 (CH3, C8), 13.94 (CH3, C14/C22), 13.79 (CH3, C14/C22). 
IR (neat, cm-1): 2956, 2927, 1745, 1579, 1458, 1377, 1201, 1133, 1097, 1049, 975, 906, 789, 
754. 
MS (m/z): 283.10 [M-OctOSO3¯ ]+ 
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6.4 Mandelate Ionic Liquids: 
6.4.1 Carboxylic Acids:8 
2-(3,4-Dihydroxyphenyl)-2-hydroxyacetic acid (98)8 
 
Catechol (5.10 g, 46.3 mmol) was dissolved in aqueous NaOH (3.21 g, 80.3 mmol in 55 mL 
of water) and Al2O3 (2.04 g, 20.0 mmol) was added. After 5 min glyoxylic acid (50 % aq. 
solution, 7.12 g, 48.1 mmol) was added and the reaction mixture heated to 60 °C with 
vigorous stirring and maintained for 24 h at 60°C. After 24 h the reaction mixture was allowed 
to cool for 10 min, filtered and the filter cake washed with aqueous NaOH solution (1M, 20 
mL). The basic washings were combined with the filtrate, acidified to pH ~ 4 with 37 % HCl 
and extracted with ethyl acetate (2 x 50 mL) to remove unreacted catechol. The aqueous 
solution was then further acidified to pH 1 and extracted with ethyl acetate (5 x 100 mL). The 
organic phase was concentrated under high vacuum and residue was purified by column 
chromatography (SiO2, MeOH:DCM; 20:80) to obtain a brown solid in 67 % yield (5.70 g, 
30.9 mmol).  
Molecular formula: C8H8O5 
Molecular weight: 184.15 g/mol 
Melting point: 134-136°C 
1H NMR (400 MHz, DMSO-d6) ppm: 12.43 (bs, 1H, OH at C1), 8.93 (s, 1H, OH at C5/C6), 
8.85 (s, 1H, OH at C5/C6),  6.79 (d, J = 1.6, 1H, H4), 6.66 (d, J = 8.0 Hz, 1H, H7), 6.64 (dd, J 
= 8.0, 1.6 Hz, 1H, H8), 5.71 (bs, 1H, OH at C2), 4.80 (s, 1H, H2). 
13C NMR (100 MHz, DMSO-d6) ppm: 174.44 (COO, C1), 144.85 (2ArC, C5, C6), 131.06 
(ArC, C3), 117.80 (ArCH, C8), 115.02 (ArCH, C4/C7), 114.10 (ArCH, C4/C7), 72.08 
(CHOH, C2) 
IR (neat, cm-1): 3405, 3333, 3208, 3035, 2909, 1693, 1604, 1534, 1430, 1348, 1280, 1256, 
1208, 1189, 1149, 1116, 1084, 980, 879, 867, 803, 709. 
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1H, 13C-NMR spectra and melting point are in agreement with the literature data.8 
2-(2H-1,3-Benzodioxol-5-yl)-2-hydroxyacetic acid (99)8 
 
A flask was charged with glyoxylic acid solution (50 % in water) (6.25 g, 42.2 mmol), water 
(1 mL, 55.6 mmol) and at −10 °C conc. sulphuric acid (4.0 mL, 75.1 mmol) was added 
dropwise to the stirred mixture. 1,2-(methylenedioxy)benzene (5.00 g, 40.9 mmol) was then 
added dropwise over 1 h at −10 °C. The reaction mixture was stirred at −10 °C for 10 h and 
then allowed to warm to room temperature and stirring continued for an additional 14 h. 
Water (50 mL) was added to reaction mixture and product was extracted with ethyl acetate (5 
× 75 mL). The organic phase was dried over anhydrous MgSO4, concentrated under high 
vacuum and purified by column chromatography (SiO2, EtOAc:Hexane; 20:80) to obtain the 
title compound (99) as an off white solid in 72 % yield (5.74 g, 29.3 mmol).  
Molecular formula: C9H8O5 
Molecular weight: 196.16 g/mol 
Melting point: 146-148°C 
1H NMR (400 MHz, DMSO-d6) ppm: 12.60 (bs, 1H, COOH), 6.94 (s, 1H, H4), 6.90 (d, J = 
8.2, Hz, 1H, H8), 6.87 (d, J = 8.2 Hz, 1 H, H7), 5.99 (s 2H, H9), 5.81 (bs, 1H, OH, C2), 4.94 
(s, 1H, H2). 
13C NMR (100 MHz, DMSO-d6) ppm: 174.26 (COO, C1), 147.17 (ArC, C5/C6), 146.79 
(ArC, C5/C6), 134.24 (ArC, C3), 120.23 (ArCH, C7), 107.98 (ArCH, C8), 107.08 (ArCH, 
C4), 101.02 (OCH2O, C9), 72.15 (HCOH, C2). 
IR (neat, cm-1): 3409, 2907, 1715, 1609, 1501, 1485, 1445, 1357, 1246, 1198, 1121, 1097, 
1068, 1046, 937, 811, 747. 
1H, 13C-NMR spectra and melting point are in agreement with literature.8 
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6.4.2 Preparation of ester: 
General Procedure K:  Preparation of Mandelate ester:9 
Ethyl 2-hydroxy-2-phenylacetate (104)4 
 
To a stirred solution of mandelic acid (5.17 g, 33.9 mmol) in ethanol (50 mL) was added p-
toluenesulfonic acid monohydrate (PTSA) (650 mg, 3.39 mmol) at RT. After stirring for 6 h 
the reaction mixture was concentrated, added water (50 mL) and the product was extracted 
with ethyl acetate (5 × 50 mL). The combined extracts were dried over anhydrous MgSO4, 
filtered and concentrated under high vacuum. The crude product was purified by column 
chromatography (SiO2, Hexane:EtOAc, 80:20) to obtain a colourless liquid in 98 % yield 
(6.02 g, 33.4 mmol). 
Molecular formula: C10H12O3 
Molecular weight: 180.20 g/mol  
1H NMR (400 MHz, CDCl3, δ): 7.38-7.30 (m, 5H, H4-H8), 5.17 (s, 1H, H2), 4.29-4.11 (m, 
2H, H9), 3.81 (bs, 1H, OH at C2), 1.21 (t, J = 7.2 Hz, 3H, H10).   
13C NMR (100 MHz, CDCl3, δ): 173.69 (COO, C1), 138.46 (ArC, C3), 128.57 (2ArCH, 
C5,C7), 128.40 (ArCH, C6), 126.57 (2ArCH, C4,C8), 72.92 (CHOH, C2), 62.21(OCH2, C9), 
14.03 (CCH3, C10). 
IR (neat, cm-1): 3453, 2984, 1728, 1689, 1597, 1452, 1200, 1177, 1093, 1066, 1015, 861. 
1H and 13C-NMR spectra are in agreement with the literature data.4 
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General Procedure L: Preparation of Mandelate ester2 
Ethyl 2-(2H-1,3-benzodioxol-5-yl)-2-hydroxyacetate (105)10 
 
To a stirred solution of 3,4-methylenedioxymandelic acid (99) (7.87 g, 40.1 mmol) in ethanol 
(100 mL) was added thionyl chloride (1.0 mL, 13.7 mmol) dropwise at RT. After stirring for 
3 h the reaction was quenched with water and the product was extracted with ethyl acetate (5 
× 50 mL). The combined extracts were washed with saturated aqueous sodium bicarbonate 
(50 mL), dried over anhydrous MgSO4, filtered and concentrated under high vacuum to obtain 
the title compound (105) as a white solid in 79 % yield (7.12 g, 31.8 mmol).   
Molecular formula: C11H12O5 
Molecular weight: 224.21 g/mol 
Melting point: 42-44°C 
1H NMR (400 MHz, CDCl3) ppm: 6.90 (dd, J = 6.8, 1.6 Hz, 1H, H8), 6.88 (d, J = 1.6 Hz, 1H, 
H4), 6.78 (d, J = 6.8 Hz, 1H, H7), 5.96 (s, 2H, H9), 5.05 (d, J = 5.6 Hz, 1H, H2), 4.27 (dt, J = 
10.8, 7.0 Hz, 1H, H10), 4.16 (dt, J = 10.8, 7.0 Hz, 1H, H10), 3.44 (d, J = 5.6 Hz, 1H, OH, 
C2), 1.24 (t, J = 7.0 Hz, 3H, H11). 
13C NMR (100 MHz, CDCl3) ppm: 173.82 (COO, C1), 147.99 (ArC, C5/C6), 147.84 (ArC, 
C5/C6), 132.42 (ArC, C3), 120.47 (ArCH, C4/C8), 108.40 (ArCH, C7), 107.07 (ArCH, 
C4/C8), 101.33 (OCH2O, C9), 72.74 (CHOH, C2), 62.43 (OCH2, C10), 14.20 (CH3, C11). 
IR (neat, cm-1): 3657, 2981, 1748, 1733, 1608, 1512, 1434, 1292, 1247, 1172, 1111, 1030,  
981, 827. 
1H, 13C-NMR spectra and melting point are in agreement with literature.10 
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Butyl 2-(3,4-dihydroxyphenyl)-2-hydroxyacetate (106) 
 
The title compound (106) was prepared from 3,4-dihydroxymandelic acid (98) (4.04 g, 21.9 
mmol), butanol (25 mL) and thionyl chloride (0.40 mL, 5.43 mmol) according to general 
procedure L to obtain a yellow solid in 54 % yield (2.86 g, 11.9 mmol). 
Molecular formula: C12H16O5 
Molecular weight: 240.25 g/mol 
Melting point: 88-90°C 
1H NMR (400 MHz, DMSO-d6) ppm: 8.93 (s, 1H, OH, C5/C6), 8.88 (s, 1H, OH, C5/C6), 
6.78 (d, J = 1.6 Hz, 1H, H4), 6.66 (d, J = 8.0 Hz, 1H, H7), 6.62 (dd, J = 8.0, 1.6 Hz, 1H, H8), 
5.75 (s, 1H, OH, C2), 4.89 (s, 1H, H2), 4.05-3.97 (m, 2H, H9), 1.51-1.44 (m, 2H, H10), 1.21 
(qt, J = 7.6, 7.2 Hz, 2H, H11), 0.82 (t, J = 7.6 Hz, 3H, H12)  
13C NMR (100 MHz, DMSO-d6) ppm: 173.00 (COO, C1), 145.04 (ArC, C5/C6), 144.99 
(ArC, C5/C6), 130.64 (ArC, C3), 117.81 (ArCH, C8), 115.14 (ArCH, C7), 114.08 (ArCH, 
C4), 72.24 (CHOH, C2), 63.76 (OCH2, C10), 30.14 (CH2, C11), 18.45 (CH2, C12), 13.50 
(CH3, C13). 
IR (neat, cm-1): 3465, 2960, 1731, 1514, 1235, 1260, 1139, 1024, 803, 764. 
Butyl 2-(2H-1,3-benzodioxol-5-yl)-2-hydroxyacetate (107) 
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The title compound (107) was prepared using 3,4-methylenedioxymandelic acid (99) (11.06 
g, 56.4 mmol), butanol (70 mL) and thionyl chloride (2.1 mL, 28.19 mmol) according to 
general procedure L as an off white solid in 95 % yield (13.45 g, 53.3 mmol).   
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Molecular formula: C13H16O5 
Molecular weight: 252.26 g/mol 
Melting point: 47-49°C 
1H NMR (400 MHz, CDCl3) ppm: 7.00 (d, J = 1.8 Hz, 1H, H4), 6.89 (dd, J = 8.4, 1.8 Hz, 1H, 
H8), 6.73 (d, J = 8.4 Hz, 1H, H7), 5.96 (s, 2H, H9), 5.06 (s, 1H, H2), 4.17 (dt, J = 10.8, 6.8 
Hz, 1H, H10), 4.14 (dt, J = 10.8, 6.8 Hz, 1H, H10), 3.42 (bs, 1H, OH at C2), 1.57 (tt, J = 6.8, 
6.8 Hz, 2H, H11), 1.27 (tq, J = 7.4, 6.8 Hz, 2H, H12), 0.87 (t, J = 7.4 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 172.68 (COO, C1), 147.16 (ArC, C5/C6), 146.86 (ArC, 
C5/C6), 133.70 (ArC, C3), 120.22 (ArCH, C8), 107.99 (ArCH, C7), 106.96 (ArCH, C4), 
101.03 (OCH2O, C9), 72.14 (CHOH, C2), 64.00 (OCH2, C10), 30.11 (CH2, C11), 18.44 
(CH2, C12), 13.49 (CH3, C13). 
IR (neat, cm-1): 3456, 2961, 2946, 2890, 1730, 1498, 1487, 1443, 1397, 1295, 1260, 1233, 
1194, 1173, 1100, 1082, 1033, 929, 818, 763. 
Methyl-2-hydroxy-2-(4-hydroxyphenyl)acetate (108)11 
 
The title compound (108)  was prepared using 4-hydroxymandelic acid (100) (4.99 g, 26.8 
mmol), methanol (50 mL) and p-toluenesulfonic acid monohydrate (PTSA) (510 mg, 2.68 
mmol) according to general procedure K to obtain an off white solid in 80 % yield (3.91 g, 
21.5 mmol). 
Molecular formula: C9H10O4 
Molecular weight : 182.17 g/mol 
Melting point: 135-137°C  
1H NMR (400 MHz, DMSO-d6) ppm: 9.46 (s, 1H, OH, C6), 7.17 (d, J = 6.0 Hz, 2H, H5, H7),  
6.72 (d, J = 6.0 Hz, 2H, H4, H8), 5.87 (d, J = 3.4 Hz, 1H, OH at C2), 5.00 (d, J = 3.4 Hz, 1H, 
H2), 3.58 (s, 3H, H9). 
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13C NMR (100 MHz, DMSO-d6) ppm: 173.47 (COO, C1), 157.17 (ArC, C6), 130.03 (ArC, 
C3), 128.04 (2ArCH, C5, C7), 115.01 (2ArCH, C4, C8), 72.08 (CHOH, C2), 51.66 (OCH3, 
C9). 
IR (neat, cm-1): 3529, 3231, 3048, 2949, 1732, 1615, 1596, 1517, 1450, 1432, 1326, 1262, 
1215, 1190, 1172, 1109, 1076, 980, 827, 814, 758. 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.11 
Methyl-2-(4-bromophenyl)-2-hydroxyacetate (109)12 
 
The title compound (109) was prepared from 4-bromomandelic acid (101) (9.20 g, 39.8 
mmol), methanol (100 mL) and p-toluenesulfonic acid monohydrate (760 mg, 3.99 mmol) 
according to general procedure K to obtain an off white solid in 98 % yield (9.56 g, 39.0 
mmol). 
Molecular formula: C9H9BrO3 
Molecular weight: 245.07 g/mol  
Melting point: 56-58°C 
1H NMR (400 MHz, CDCl3) ppm: 7.50 (d, J = 8.4 Hz, 2H, H5, H7), 7.31 (d, J = 8.4 Hz, 2H, 
H4, H8), 5.14 (s, 1H, H2), 3.76 (s, 3H, H9). 
13C NMR (100 MHz, CDCl3) ppm: 173.81 (COO, C1), 137.28 (ArC, C6), 131.86 (2ArCH, 
C5, C7), 128.40 (2ArCH, C4, C8), 122.68 (ArC, C3), 72.34 (CHOH, C2), 53.39 (OCH3, C9). 
IR (neat, cm-1): 3325, 3000, 2951, 1732, 1592, 1485, 1435, 1407, 1248, 1213, 1197, 1109, 
1086, 1003, 980, 828, 761. 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.12 
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Methyl-2-hydroxy-2-(4-methoxyphenyl)acetate (110)12 
 
The title compound (110) was prepared from 4-methoxy mandelic acid (102) (1.00 g, 5.49 
mmol), methanol (20 mL) and p-toluenesulfonic acid monohydrate (110 mg, 0.57 mmol) 
according to general procedure K to obtain an off white solid in 97 % yield (1.05 g, 5.35 
mmol). 
Molecular formula: C10H12O4 
Molecular weight: 196.20 g/mol  
Melting point: 37-38°C 
1H NMR (400 MHz, CDCl3) ppm: 7.32 (d, J = 8.8 Hz, 2H, H5, H7), 6.88 (d, J = 8.8 Hz, 2H, 
H4, H8), 5.12 (s, 1H, H2), 3.80 (s, 3H, H9), 3.74 (s, 3H, H10), 3.49 (s, 1H, OH, C2).   
13C NMR (100 MHz, CDCl3) ppm: 174.45 (COO, C1), 159.82 (ArC, C6), 130.53 (ArC, C3), 
128.02 (2ArCH, C4, C8), 114.11 (2ArCH, C5, C7), 72.56 (CHOH, C2), 55.38 (OCH3, C9), 
53.08 (OCH3, C10). 
IR (neat, cm-1): 3427, 2969, 1727, 1609, 1509, 1441, 1249, 1168, 1078, 1027, 976, 796. 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.12 
Methyl 2-hydroxy-2-[4-(trifluoromethyl)phenyl]acetate (111)13 
 
The title compound (111) was synthesized from 4-(trifluoromethyl)mandelic acid (103) (9.20 
g, 41.79 mmol), methanol (50 mL) and p-toluenesulfonic acid monohydrate (790 mg, 4.18 
mmol) according to general procedure K to afford an off white solid in 97 % yield (9.48 g, 
40.48 mmol). 
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Molecular formula: C10H9F3O3 
Molecular weight: 234.17 g/mol  
Melting point: 48-50°C 
1H NMR (400 MHz, CDCl3) ppm: 7.62 (d, J = 8.0 Hz, 2H, H5, H7), 7.56 (d, J = 8.0 Hz, 2H, 
H4, H8), 5.25 (s, 1H, H2), 3.77 (s, 3H, H10), 3.73 (s, 1H, OH, C2). 
13C NMR (100 MHz, CDCl3) ppm: 173.57 (COO, C1), 142.07 (ArC, C3), 130.75 (q, J = 31.7 
Hz, CF3C, C6), 127.04 (2ArCH, C4, C8), 125.64 (q, J = 8.7 Hz, 2ArCH, C5, C7), 124.10 (q, 
CF3, C9, J = 270.3 Hz), 72.73 (CHOH, C2), 53.46 (OCH3, C10). 
19F NMR (376 MHz, CDCl3) ppm: -62.63 (CF3) 
IR (neat, cm-1): 3445, 2964, 1738, 1704, 1618, 1439, 1327, 1158, 1114, 1090, 1065, 1017, 
989, 833. 
1H, 13C-NMR spectra and melting point are in agreement with the literature data.13 
 
6.4.3 Alkylating Agents: 
General Procedure M: Preparation of Mandelate based alkylating agents14 
Butyl-2-(2H-1,3-benzodioxol-5-yl)-2-bromoacetate (112) 
 
To a stirred solution of butyl (3,4-methylenedioxy)mandelate (107) (9.04 g, 35.8 mmol) and  
TEA (6.0 mL, 43 mmol) in CH2Cl2 (100 mL) at 0 oC was added thionyl bromide (3.1 mL, 39 
mmol) dropwise, and the reaction mixture was allowed to warm to room temperature. After 
stirring for 3 h the reaction mixture was washed with distilled water (3 × 50 mL). The organic 
phase was dried over anhydrous MgSO4, filtered and concentrated under high vacuum. The 
resulting oil was purified by column chromatography (SiO2, EA:hexane, 20:80) to obtain the 
title compound (112) as a yellow oil in 76 % yield (8.62 g, 27.3 mmol).  
Molecular formula: C13H15BrO4 
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Molecular weight: 315.16 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.13 (d, J = 2.0 Hz, 1H, H4), 6.95 (dd, J = 8.0, 2.0 Hz, 1H, 
H8), 6.73 (d, J = 8.0 Hz, 1H, H7), 5.96 (d, part A of an AB system, J = 2.0 Hz, 1H, H9), 5.95 
(d, part B of an AB system, J = 2.0 Hz, 1H, H9), 5.29 (s, 1H, H2), 4.19 (dt, J = 10.8, 6.8 Hz, 
1H, H10), 4.14 (dt, J = 10.8, 6.8 Hz, 1H, H10), 1.63 (tt, J = 7.4, 6.8 Hz, 2H, H11), 1.35 (tq, J 
= 7.4, 7.2 Hz, 2H, H12), 0.91 (t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 168.34 (COO, C1), 148.56 (ArC, C5/C6), 148.14 (ArC, 
C5/C6), 129.46 (ArC, C3), 122.66 (ArCH, C8), 109.20 (ArCH, C7), 108.12 (ArCH, C4), 
101.58 (OCH2O, C9), 66.35 (OCH2, C10), 47.11 (CH, C2), 30.41 (CH2, C11), 19.03 (CH2, 
C12), 13.71 (CH3, C13).   
IR (neat, cm-1): 2960, 2875, 1737, 1503, 1489, 1445, 1370, 1315, 1245, 1177, 1139, 1102, 
1036, 928, 815, 736. 
Butyl-2-(2H-1,3-benzodioxol-5-yl)-2-chloroacetate (113) 
 
The title compound (113) was synthesized according to general procedure M using alcohol 
(107) (2.68 g, 10.62 mmol), thionyl chloride (0.77 mL, 10.62 mmol) and TEA (1.48 mL, 
10.62 mmol) to obtain a yellow liquid in 86 % yield (2.48 g, 9.16 mmol). 
 Molecular formula: C13H15ClO4 
Molecular weight: 270.71 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.03 (d, J = 1.6 Hz, 1H, H4), 6.92 (dd, J = 8.0, 1.6 Hz, 1H, 
H8), 6.73 (d, J = 8.0 Hz, 1H, H7), 5.98 (d, part A of an AB system, J = 2.0 Hz, 1H, H9), 5.97 
(d, part B of an AB system, J = 2.0 Hz, 1H, H9), 5.26 (s, 1H, H2), 4.19 (dt, J = 10.8, 6.8Hz, 
1H, H10), 4.14 (dt, J = 10.8, 6.8 Hz, 1H, H10), 1.61 (tt, J = 7.4, 6.8 Hz, 2H, H11), 1.32 (tq, J 
= 7.4, 7.2 Hz, 2H, H12), 0.90 (t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 168.51 (COO, C1), 148.58 (ArC, C5/C6), 148.20 (ArC, 
C5/C6), 129.59 (ArC, C3), 122.16 (ArCH, C8), 108.36 (ArCH, C7), 108.28 (ArCH, C4), 
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101.60 (OCH2O, C9), 66.41 (OCH2, C10), 59.24 (CH, C2), 30.46 (CH2, C11), 19.03 (CH2, 
C12), 13.72 (CH3, C13). 
IR (neat, cm-1): 2961, 1743, 1629, 1504, 1489, 1445, 1368, 1246, 1161, 1036, 928, 803. 
Methyl 2-chloro-2-(4-hydroxyphenyl)acetate (114) 
 
To a stirred solution of alcohol (108) (690 mg, 3.79 mmol), and DMF (0.1 mL, 1.29 mmol) in 
DCM (10 mL) was added thionyl chloride (0.28 mL, 3.79 mmol) and reaction mixture was 
stirred at RT for 3 h. The organic layer was washed with water (5 mL) and volatiles were 
removed by rotary evaporation. The crude product was purified by column chromatography 
(SiO2, MeOH:DCM, 10:90) to obtain a yellow liquid in 84 % yield (0.64 g, 3.17 mmol). 
 Molecular formula: C9H9ClO3 
Molecular weight: 200.62 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.05 (s, 1H, OH), 7.35 (d, J = 8.2 Hz, 2H, H4, H8), 6.87 
(d, J = 8.2 Hz, 2H, H5, H7), 5.35 (s, 1H, H2), 3.78 (s, 3H, H9). 
13C NMR (100 MHz, CDCl3) ppm: 172.86 (COO, C1), 158.05 (ArC, C6), 131.43 (ArC, C3), 
127.64 (2ArCH, C5, C7), 115.37 (2ArCH, C4, C8), 59.88 (CHOH, C2), 51.46 (OCH3, C9). 
IR (neat, cm-1): 3569, 3233, 3058, 2949, 1739, 1625, 1589, 1537, 1451, 1316, 1272, 1191, 
1182, 1075, 981, 847, 815, 768. 
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General Procedure N: Preparation Mandelate based alkylating agents2 
Ethyl-2-(2H-1,3-benzodioxol-5-yl)-2-[(2-bromoacetyl)oxy]acetate (115) 
7
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To a stirred solution of ethyl-3,4-methylenedioxymandelate (105) (6.85 g, 30.6 mmol) in 
CH2Cl2 (75 mL) at 0 °C was added triethylamine (6.38 mL, 45.8 mmol) followed by 
bromoacetyl bromide (3.19 mL, 36.7 mmol). The reaction mixture was allowed to attain room 
temperature and stirred overnight. Water
 
(50 mL) was added to the reaction mixture; organic 
layer was separated and washed with saturated NH4Cl solution (25 mL), 10 % NaHCO3 
solution (25 mL) and saturated brine solution (25 mL), dried over anhydrous MgSO4 and 
evaporated by rotary evaporation. The crude product was purified by column chromatography 
(SiO2, hexane:EtOAc ,90:10) and dried under high vacuum to obtain the title compound (115) 
as a yellow oil in 63 % yield (6.68 g, 19.4 mmol). 
Molecular formula: C13H13BrO6 
Molecular weight: 345.14 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 6.9255 (dd, J = 8.4, 1.6 Hz, 1H, H8), 6.9250 (d, J = 1.6 
Hz, 1H, H4), 6.79 (d, J = 8.4 Hz, 1H, H7), 5.97 (bs, 2H, H9), 5.84 (s, 1H, H2), 4.23 (dt, J = 
10.8, 7.2 Hz, 1H, H10), 4.15 (dt, J = 10.8, 7.2 Hz, 1H, H10), 3.96 (d, part A of an AB system, 
J = 14.4 Hz, 1H, H13), 3.93 (d, part B of an AB system, J = 14.4 Hz, 1H, H13),  1.22 (t, J = 
7.2 Hz, 3H, H11).  
13C NMR (100 MHz, CDCl3) ppm: 168.20 (COO, C1), 166.66 (COO, C12), 148.71 (ArC, 
C5/C6), 148.12 (ArC, C5/C6), 126.71 (ArC, C3), 122.06 (ArCH, C8), 108.55 (ArCH, C7), 
107.97 (ArCH, C4), 101.56 (OCH2O, C9), 75.72 (CH, C2), 62.09 (CH2, C10), 25.41 (CH2, 
C13), 14.07 (CH2, C11). 
IR (neat, cm-1): 2960, 2828, 1736, 1630, 1499, 1480, 1446, 1238, 1210, 1153, 1027, 922. 
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Butyl-2-(2H-1,3-benzodioxol-5-yl)-2-[(2-bromoacetyl)oxy]acetate (116) 
 
The title compound (116) was prepared using butyl-3,4-methylenedioxymandelate (107) (6.53 
g, 25.9 mmol), CH2Cl2 (65 mL), triethylamine (5.4 mL, 38.8 mmol) and bromoacetyl bromide 
(2.71 mL, 31.06 mmol) according to general procedure N to afford a colourless liquid in 80 % 
yield (7.72 g, 20.7 mmol). 
Molecular formula: C15H17BrO6 
Molecular weight: 373.20 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 6.932 (dd, J = 8.4, 1.6 Hz, 1H, H8), 6.931 (d, J = 1.6 Hz, 
1H, H4), 6.81 (d, J = 8.4 Hz, 1H, H7), 5.98 (bs, 2H, H9), 5.85 (s, 1H, H2), 4.16 (dt, J = 10.8, 
6.8 Hz, 1H, H10), 4.11 (dt, J = 10.8, 6.8 Hz, 1H, H10), 3.97 (d, part A of an AB system, J = 
14.4 Hz, 1H, H15), 3.94 (d, part B of an AB system, J = 14.4 Hz, 1H, H15 ), 1.58 (tt, J = 6.8, 
6.8 Hz, 2H, H11), 1.29 (qt, J = 7.4, 6.8 Hz, 2H, H12), 0.88 (t, J = 7.4 Hz, 3H, H13).  
13C NMR (100 MHz, CDCl3) ppm: 168.32 (COO, C1), , 166.69 (COO, C14), 148.73 (ArC, 
C5/C6), 148.15 (ArC, C5/C6), 126.83 (ArC, C3), 122.06 (ArCH, C8), 108.59 (ArCH, C7), 
108.00 (ArCH, C4), 101.59 (OCH2O, C9), 75.77 (CH, C2), 65.82 (CH2, C10), 30.48 (CH2, 
C11), 25.44 (CH2, C15), 19.00 (CH2, C12), 13.71 (CH2, C13). 
IR (neat, cm-1): 2961, 2875, 1740, 1504, 1490, 1446, 1337, 1240, 1178, 1101, 1034, 976, 925, 
865, 806, 762. 
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General Procedure O: Preparation of Mandelate based alkylating agent15 
Methyl-2-[(2-bromoacetyl)oxy]-2-(4-bromophenyl)acetate (117) 
 
To a stirred solution of methyl-2-(4-bromophenyl)-2-hydroxyacetate (109) (4.81 g, 19.63 
mmol) in CH2Cl2 (50 mL) sodium carbonate (3.12 g, 29.43 mmol) was added, followed by 
bromoacetyl bromide (2.1 mL, 23.6 mmol) at 0°C. Reaction mixture was allowed to warm to 
room temperature then stirred for 8 h. The reaction mixture was filtered, washed with 25 mL 
10 % NaHCO3 solution, dried over anhydrous MgSO4 and concentrated under high vacuum. 
The crude product was purified by column chromatography (SiO2, hexane:EtOAc, 80:20) to 
obtain the title compound (117) as a colourless liquid in 78 % yield (5.61 g, 15.33 mmol). 
Molecular formula: C11H10Br2O4 
Molecular weight: 366.0 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 7.54 (d, J = 8.4 Hz, 2H, H5, H7), 7.35 (d, J = 8.4 Hz, 2H, 
H4, H8), 5.94 (s, 1H, H2), 3.97 (s, 2H, H11), 3.73 (s, 3H, H9).  
13C NMR (100 MHz, CDCl3) ppm: 168.24 (COO, C1), 166.55 (COO, C10), 132.22 (2ArCH, 
C5, C7), 132.06 (ArC, C3), 129.33 (2ArCH, C4, C8), 123.95 (ArC, C6), 75.00 (CH, C2), 
53.11 (OCH3, C9), 25.23 (CH2, C11). 
IR (neat, cm-1): 2956, 1743, 1593, 1489, 1436, 1405, 1345, 1275, 1257, 1215, 1138, 1105, 
1070, 1011, 978, 820, 768. 
Methyl-2-[(2-bromoacetyl)oxy]-2-(4-methoxyphenyl)acetate (118) 
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The title compound (118) was synthesized using methyl-2-(4-methoxyphenyl)-2-
hydroxyacetate (110) (1.26 g, 6.42 mmol), CH2Cl2 (15 mL), sodium carbonate (1.02 g, 9.63 
mmol) and bromoacetyl bromide (0.70 mL, 7.7 mmol) according to general procedure O to 
afford a colourless liquid in 67 % yield (1.36 g, 4.30 mmol). 
Molecular formula: C12H13BrO5 
Molecular weight: 317.13 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 7.37 (d, J = 8.8 Hz, 2H, H5, H7), 7.56 (d, J = 8.8 Hz, 2H, 
H4, H8), 5.92 (s, 1H, H2), 3.97 (d, J = 15.2 Hz, 1H, H12), 3.93 (d, J = 15.2 Hz, 1H, H12), 
3.80 (s, 3H, H9), 3.71 (s, 3H, H10).  
13C NMR (100 MHz, CDCl3) ppm: 168.85 (COO, C1), 166.68 (COO, C11), 160.53 (ArCH, 
C6), 129.24 (2ArCH, C4, C8), 125.00 (ArC, C3), 114.31 (2ArCH, C5, C7), 75.39 (CH, C2), 
53.35 (OCH3, C9), 52.78 (OCH3, C10), 25.46 (CH2, C12). 
IR (neat, cm-1): 2981, 2889, 1748, 1733, 1608, 1512, 1434, 1292, 1247, 1215, 1172, 1029, 
827. 
Methyl-2-[(2-bromoacetyl)oxy]-2-[4-(trifluoromethyl)phenyl]acetate (119) 
 
The title compound (119) was synthesized using methyl-2-[4-(trifluoromethyl)phenyl]-2-
hydroxyacetate (111) (9.26 g, 39.5 mmol), CH2Cl2 (100 mL), sodium carbonate (6.29 g, 59.3 
mmol) and bromoacetyl bromide (4.10 mL, 47.6 mmol) according to general procedure O to 
afford a colourless liquid in 75 % yield (10.54 g, 29.7 mmol). 
Molecular formula: C12H10BrF3O4 
Molecular weight: 355.1 g/mol  
1H NMR (400 MHz, CDCl3) ppm: 7.62 (d, J = 8.0 Hz, 2H, H5, H7), 7.56 (d, J = 8.0 Hz, 2H, 
H4, H8), 5.26 (s, 1H, H2), 3.88 (s, 2H, H12), 3.77 (s, 3H, H10).  
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13C NMR (100 MHz, CDCl3) ppm: 173.62 (COO, C1), 171.61 (COO, C11), 141.98 (ArCH, 
C3), 130.70 (q, J = 32 Hz, ArC, C6), 127.05 (2ArCH, C4, C8), 125.65 (q, J = 4.0 Hz, 2ArCH, 
C5, C7), 124.08 (q, J = 270.5, CF3, C9), 72.39 (CH, C2), 53.50 (OCH3, C9), 25.46 (CH2, 
C10). 
19F NMR (376 MHz, CDCl3) ppm: -62.09 (3F) 
IR (neat, cm-1): 2965, 1731, 1621, 1419, 1323, 1288, 1164, 1116, 1066, 1017, 831. 
6.4.4 Bromide Ionic Liquids: 
6.4.4.1 Mandelate based Monoester Ionic Liquids: 
General Procedure P: Preparation of monoester chloride/bromide ILs15 
3-[2-Butoxy-1-(3,4-dihydroxyphenyl)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium bromide 
(120a) 
 
A solution of butyl 3,4-dihydroxy mandelate (106) (10.04 g, 41.78 mmol), 1-methylimidazole 
(6.6 mL, 83.3 mmol) in DCM (200 mL) was stirred at 0oC. Thionyl bromide (3.20 mL, 41.6 
mmol) was added drop wise and the reaction mixture was allowed to warm to RT and stirred 
for 24 h. Completion of reaction was confirmed by TLC. The volatiles were removed via 
rotary evaporation and the crude product was purified by column chromatography. (SiO2, 20 
% Methanol: 80 % DCM) to obtain a brown oil in 62 % yield (9.97 g, 25.9 mmol).  
Molecular formula: C16H21BrN2O4. 
Molecular weight: 385.25 g/mol 
1H NMR (400 Hz, DMSO-d6) ppm: 9.49 (s, 1H, OH at C5/C6), 9.31 (s, 1H, OH at C5/C6), 
9.11 (s, 1H, H13), 7.77 (t, J = 2.0 Hz, 1H, H14/H15), 7.74 (t, J = 2.0 Hz, 1H, H14/H15), 6.85 
(d, J = 2.4 Hz, 1H, H4), 6.83 (d, J = 8.4 Hz, 1H, H7), 6.75 (dd, J = 8.4, 2.4 Hz, 1H, H8), 6.60 
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(s, 1H, H2), 4.26-4.14 (m, 2H, H9), 3.86 (s, 3H, H16), 1.59-1.51 (m, 2H, H10), 1.23 (qt, J = 
7.6, 7.2 Hz, 2H, H11), 0.83 (t, J = 7.6 Hz, 3H, H12). 
13C NMR (100 Hz, DMSO-d6) ppm: 167.89 (COO, C1), 147.01 (ArC, C5/C6), 145.95 (ArC, 
C5/C6), 136.61 (ArCH, C13), 123.42 (ArC, C3), 122.86 (ArCH, C14/C15), 122.31 (ArCH, 
C8), 119.64 (ArCH, C14/C15), 116.31 (ArCH, C7), 116.03 (ArCH, C4), 65.89 (NCH, C2), 
63.52 (OCH2, C9), 35.95 (NCH3, C16), 29.77 (CH2, C10), 18.33 (CH2, C11), 13.30 (CH3, 
C12). 
IR (neat, cm-1): 3370, 3138.82, 2959.43, 1740.05, 1602.05, 1580.49, 1549.42, 1527.26, 
1447.51, 1278.17, 1197.90, 1162.98, 1118.79, 1085.62, 943.24, 752.19  cm-1 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C16H21N2O4+, requires = 305.1496,                                   
found = 305.1493. 
MS (m/z): 305.15 [M-Br¯ ]+ 
3-[2-Butoxy-1-(3,4-dihydroxyphenyl)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium chloride 
(121a) 
 
The title compound (121a) was synthesized from butyl 3,4-dihydroxy mandelate (106) (1.04 
g, 4.16 mmol), 1-methylimidazole (0.30 mL, 4.16 mmol), thionyl chloride (0.10 mL, 1.04 
mmol) and DCM (20 mL) according to general procedure P to obtain a brown oil in 34 % 
yield (480 mg, 1.40 mmol).  
Molecular formula: C16H21ClN2O4. 
Molecular weight: 340.80 g/mol 
1H NMR (400 Hz, DMSO-d6) ppm: 9.55 (s, 1H, OH at C5/C6), 9.37 (s, 1H, OH at C5/C6), 
9.10 (s, 1H, H13), 7.75 (t, J = 2.0 Hz, 1H, H14/H15), 7.72 (t, J = 2.0 Hz, 1H, H14/H15), 6.86 
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(d, J = 2.0 Hz, 1H, H4), 6.83 (d, J = 8.0 Hz, 1H, H7), 6.74 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.57 
(s, 1H, H2), 4.25-4.15 (m, 2H, H9), 3.78 (s, 3H, H16), 1.57-1.52 (m, 2H, H10), 1.23 (qt, J = 
7.6, 7.2 Hz, 2H, H11), 0.84 (t, J = 7.6 Hz, 3H, H12). 
13C NMR (100 Hz, DMSO-d6) ppm: 167.85 (COO, C1), 147.01 (ArC, C5/C6), 145.95 (ArC, 
C5/C6), 136.58 (ArCH, C13), 123.46 (ArC, C3), 122.78 (ArCH, C14/C15), 122.39 (ArCH, 
C8), 119.71 (ArCH, C14/C15), 116.20 (ArCH, C7), 115.89 (ArCH, C4), 65.91 (NCH, C2), 
63.60 (OCH2, C9), 35.13 (NCH3, C16), 29.78 (CH2, C10), 18.34 (CH2, C11), 13.37 (CH3, 12). 
IR (neat, cm-1): 3373, 3141, 2960, 1740, 1601, 1527, 1449, 1280, 1198, 1163, 1120  cm-1 
HRMS (ESI+,m/z): Calculated for [M-Cl¯ ]+, C16H21N2O4+, requires = 305.1496,                                               
found = 305.1494. 
MS (m/z): 305.15 [M-Cl¯ ]+ 
General Procedure Q: Preparation of monoester bromide/chloride IL4 
3-[1-(4-Hydroxyphenyl)-2-methoxy-2-oxoethyl]-1-methyl-1H-imidazol-3-ium chloride 
(122a) 
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To a stirred solution of 114 (970 mg, 4.82 mmol) in diethyl ether (20 mL) at RT was added 1-
methylimidazole (0.40 mL, 4.29 mmol) dropwise and the reaction mixture was stirred for 12 
h. The viscous liquid which had settled to the bottom of the flask, was washed with diethyl 
ether (5 x 20 mL) and dried under high vacuum to give the title compound (122a) as a 
colourless oil in 66 % yield (900 mg, 3.19 mmol). 
Molecular formula: C13H15ClN2O3 
Molecular weight: 282.72 g/mol 
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1H NMR (400 MHz, DMSO-d6) ppm: 9.45 (s, 1H, OH), 9.16 (s, 1H, H9), 7.80 (t, J = 1.6 Hz, 
1H, H10/H11), 7.74 (t, J = 1.6 Hz, 1H, H10/H11), 7.30 (d, J = 8.4 Hz, 2H, H4, H8), 6.87 (d, J 
= 8.4 Hz, 2H, H5, H7), 6.70 (s, 1H, H2), 3.85 (s, 3H, H13), 3.77 (s, 3H, H12).  
13C NMR (100 MHz, DMSO-d6) ppm: 172.87 (COO, C1), 156.80 (ArC, C6), 138.49 (ArCH, 
C9), 131.14 (2ArCH, C5, C7), 129.35 (ArC, C3), 123.88 (ArCH, C10/C11), 122.71 (ArCH, 
C10/C11), 116.31 (2ArCH, C4, C8), 75.28 (CHOH, C2), 51.86 (OCH3, C13), 37.11 (NCH3, 
C12). 
IR (neat, cm-1): 3512, 3229, 2941, 1739, 1635, 1576, 1470, 1422, 1321, 1271, 1189, 1142,  
1056, 960, 817, 834. 
HRMS (ESI+,m/z): Calculated for [M-Br¯ ]+, C13H15N2O3+, requires = 247.1077,                        
found = 247.1073. 
MS (m/z): 247.10 [M-Br¯ ]+ 
3-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]-1-methyl-1H-imidazol-3-ium 
bromide (123a) 
 
The title compound (123a) was prepared using butyl-2-bromo-2-(3,4-methylenedioxyphenyl) 
acetate (112) (2.24 g, 7.11 mmol), diethyl ether (25mL) and 1-methylimidazole (0.60 mL, 
7.11 mmol) according to general procedure Q to obtain a brown gel in 58 % yield (1.65 g, 
4.15 mmol).  
Molecular formula: C17H21BrN2O4 
Molecular weight: 397.26 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 10.38 (s, 1H, H14), 7.51 (t, J = 1.6 Hz, 1H, H15/H16), 
7.47 (t, J = 1.6 Hz, 1H, H15/H16), 7.13 (s, 1H, H2), 7.06 (dd, J = 8.0, 1.8 Hz, 1H, H8), 7.03 
(d, J = 1.8 Hz, 1H, H4), 6.79 (d, J = 8.0 Hz, 1H, H7), 5.97 (d, part A of an AB system, J = 1.2 
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Hz, 1H, H9), 5.96 (d, part B of an AB system, J = 1.2 Hz, 1H, H9), 4.03 (s, 3H, H17), 4.21 
(dt, J = 10.8, 6.8 Hz, 1H, H10), 4.15 (dt, J = 10.8, 6.8 Hz, 1H, H10), 1.56 (tt, J = 7.4, 6.8 Hz, 
2H, H11), 1.24 (qt, J = 7.4, 7.2 Hz, 2H, H12), 0.83 (t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.72 (COO, C1), 149.31 (ArC, C5/C6), 148.67 (ArC, 
C5/C6), 137.49 (ArC, C14), 125.61 (ArC, C3), 123.04 (ArC, C15/C16), 122.99 (ArCH, C8), 
121.77 (ArC, C15/C16 ), 109.20 (ArCH, C7), 108.77 (ArCH, C4), 101.91 (OCH2O, C9), 
67.11 (OCH2, C10), 63.75 (CHN, C2), 36.93 (NCH3, C17), 30.21 (CH2, C11), 18.88 (CH2, 
C12), 13.59 (CH3, C13). 
IR (neat, cm-1): 3074, 2960, 1741, 1628, 1577, 1552, 1504, 1491, 1447, 1367, 1250, 1234, 
1210, 1161, 1105, 1033, 925, 795, 759, 717. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C17H21N2O4+, requires = 317.1501,                                               
found = 317.1510. 
MS (m/z): 317.10 [M-Br¯ ]+ 
3-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]-1-methyl-1H-imidazol-3-ium 
chloride (124a) 
 
The title compound (124a) was prepared from butyl-2-chloro-2-(3,4-methylenedioxyphenyl) 
acetate (113) (1.16 g, 4.29 mmol), 1-methylimidazole (0.35 mL, 4.29 mmol) and diethyl ether 
(10 mL) according to representative procedure Q to get a brown gel in 55 % yield (830 mg, 
2.36 mmol). 
Molecular formula: C17H21ClN2O4 
Molecular weight: 352.81 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 10.47 (s, 1H, H14), 7.66 (s, 1H, H15/H16), 7.44 (s, 1H, 
H15/H16), 7.13 (s, 1H, H2), 6.95-6.93 (m, 2H, H4, H8), 6.66 (d, J = 8.0 Hz, 1H, H7), 5.85 (d, 
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part A of an AB system, J = 3.2 Hz, 1H, H9), 5.84 (d, part B of an AB system, J = 3.2 Hz, 
1H, H9), 4.05 (m, 2H, H10), 3.94 (s, 3H, H17), 1.44 (tt, J = 7.4, 6.8 Hz, 2H, H11), 1.12 (tq, J 
= 7.4, 7.2 Hz, 2H, H12), 0.71 (t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.54 (COO, C1), 148.94 (ArC, C5/C6), 148.36 (ArC, 
C5/C6), 137.48 (ArCH, C14), 125.91 (ArC, C3), 123.23 (ArC, C15/C16), 122.62 (ArCH, 
C8), 121.47 (ArC, C15/C16 ), 108.88 (ArCH, C7), 108.58 (ArCH, C4), 101.65 (OCH2O, C9), 
66.72 (OCH2, C10), 63.41 (CHN, C2), 36.54 (NCH3, C17), 29.99 (CH2, C11), 18.65 (CH2, 
C12), 13.37 (CH3, C13). 
IR (neat, cm-1): 3081, 2960, 1740, 1630, 1577, 1504, 1491, 1448, 1250, 1162, 1032, 924. 
HRMS (ESI+,m/z): Calculated for [M-Cl¯ ]+, C17H21N2O4+, requires = 317.1501,                                               
found = 317.1502. 
MS (m/z): 317.10 [M-Cl¯ ]+ 
1-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]pyridin-1-ium bromide (125a) 
 
The title compound (125a) was prepared using butyl-2-bromo-2-(3,4-methylenedioxyphenyl) 
acetate (112) (2.06 g, 6.54 mmol), pyridine (0.55  mL, 6.54 mmol) and diethyl ether (20mL) 
according to representative general procedure Q to obtain a white solid in 90 % yield (1.33 g, 
3.37 mmol). 
Molecular formula: C18H20BrNO4 
Molecular weight: 394.26 g/mol 
Melting Point: 123-125 oC 
1H NMR (400 MHz, CDCl3) ppm: 9.44 (d, J = 6.6 Hz, 2H, H14, H18), 8.61 (t, J = 7.4 Hz, 1H, 
H16), 8.11 (s, 1H, H2), 8.10 (dd, J = 7.4, 6.6 Hz, 2H, H15, H17), 7.18 (d,  J = 1.6 Hz, 1H, 
H4), 7.15 (dd,  J = 8.0, 1.6 Hz, 1H, H8), 6.80 (d, J = 8.0 Hz, 1H, H7), 5.96 (d, part A of an 
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AB system, J = 4.0 Hz, 1H, H9), 5.95 (d, part B of an AB system, J = 4.0 Hz, 1H, H9), 4.26 
(dt, J = 10.8, 7.0 Hz, 1H, H10), 4.16 (dt, J = 10.8, 7.0 Hz, 1H, H10), 1.57 (tt, J = 7.2, 6.8, 2H, 
H11), 1.23 (qt, J = 7.6, 7.0 Hz, 2H, H12), 0.81 (t, J = 7.6 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.32 (COO, C1), 149.86 (ArC C5/C6), 148.90 (ArC 
C5/C6), 146.74 (ArCH, C16), 144.82 (2ArCH, C14, C18), 127.94 (2ArCH, C15, C17), 
124.26 (ArCH, C8), 124.24 (ArCH, C3), 109.86 (ArCH, C4), 109.31 (ArCH, C7), 102.06 
(OCH2O, C9), 73.17 (CHN, C2), 67.62 (OCH2, C10), 30.13 (CH2, C11), 18.83 (CH2, C12), 
13.53 (CH3, C13). 
IR (neat, cm-1): 3023, 2960, 1736, 1630, 1498, 1479, 1447, 1369, 1304, 1261, 1239, 1210, 
1151, 1108, 1028, 922, 809, 757. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C18H20NO4+, requires = 314.1392,                                               
found = 314.1404. 
MS (m/z): 314.10 (M-Br¯ )+ 
1-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]pyridin-1-ium chloride (126a) 
 
The title compound (126a) was prepared using butyl-2-chloro-2-(3,4-methylenedioxyphenyl) 
acetate (113) (1.21 g, 4.5 mmol), pyridine (0.35 mL, 4.47 mmol) and diethyl ether (10mL) 
according to representative general procedure Q to get a white solid in 87 % yield (1.36 g, 3.9 
mmol). 
Molecular formula: C18H20ClNO4 
Molecular weight: 349.81 g/mol 
Melting Point: 96-98°C 
1H NMR (400 MHz, CDCl3) ppm: 9.56 (d, J = 6.4 Hz, 2H, H14, H18), 8.56 (t, J = 7.4 Hz, 1H, 
H16), 8.29 (s, 1H, H2), 8.08 (dd, J = 7.4, 6.4 Hz, 2H, H15, H17), 7.19 (d,  J = 1.6 Hz, 1H, 
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H4), 7.16 (dd,  J = 8.0, 1.6 Hz, 1H, H8), 6.80 (d, J = 8.0 Hz, 1H, H7), 5.96 (d, part A of an 
AB system, J = 4.0 Hz, 1H, H9), 5.95 (d, part B of an AB system, J = 4.0 Hz, 1H, H9), 4.27 
(dt, J = 10.8, 7.0 Hz, 1H, H10), 4.14 (dt, J = 10.8, 7.0 Hz, 1H, H10), 1.57 (tt, J = 7.2, 6.8, 2H, 
H11), 1.23 (qt, J = 7.6, 7.0 Hz, 2H, H12), 0.81 (t, J = 7.6 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.57 (COO, C1), 149.80 (ArC C5/C6), 148.89 (ArC 
C5/C6), 146.46 (ArCH, C16), 145.14 (2ArCH, C14, C18), 127.87 (2ArCH, C15, C17), 
124.75 (ArCH, C8), 124.19 (ArCH, C3), 109.87 (ArCH, C4), 109.29 (ArCH, C7), 102.04 
(OCH2O, C9), 73.18 (CHN, C2), 67.57 (OCH2, C10), 30.15 (CH2, C11), 18.86 (CH2, C12), 
13.57 (CH3, C13). 
IR (neat, cm-1): 3022, 2959, 1735, 1630, 1499, 1480, 1238, 1210, 1153,1027, 922, 758. 
HRMS (ESI+, m/z): Calculated for [M-Cl¯ ]+, C18H20NO4+, requires = 314.1392,                                               
found = 314.1383. 
MS (m/z): 314.10 [M-Cl¯ ]+ 
6.4.4.2 Diester Ionic Liquids: 
General Procedure R: Preparation of diester bromide IL4 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-ethoxy-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-
imidazol-3-ium bromide (127a) 
 
To a stirred mixture of ethyl-2-(2-bromoacetoxy)-2-(3,4-methylenedioxyphenyl)acetate (115) 
(1.17 g, 3.4 mmol) in  diethyl ether (15 mL) was added 1-methylimidazole (0.25 mL, 3.22 
mmol) at RT and stirred for 12 h. The separated product was washed with diethyl ether (5 x 
15 mL) and dried under high vacuum to obtain an off white solid in 80 % yield (1.10 g, 4.6 
mmol). 
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Molecular formula: C17H19BrN2O6 
Molecular weight: 427.25 g/mol 
Melting point: 74-76°C 
1H NMR (400 MHz, CDCl3) ppm: 10.21 (s, 1H, H14), 7.59 (t, J = 1.8 Hz, 1H, H15/H16), 
7.48 (t, J = 1.8 Hz, 1H, H15/H16), 6.89 (dd, J = 8.0, 1.6 Hz, 1H, H8), 6.85 (d, J = 1.6 Hz, 
1H, H4), 6.78 (d, J = 8.0 Hz, 1H, H7), 5.98 (dd, J = 3.2, 3.2 Hz, 2H, H9), 5.86 (s, 1H, H2), 
5.73 (d part A of an AB system, J = 18 Hz, 1H, H13), 5.47 (d part B of an AB system, J = 18 
Hz, 1H, H13), 4.20 (dt, J = 10.8, 7.0 Hz, 1H, H10), 4.11 (dt, J = 10.8, 7.0 Hz, 1H, H10), 4.05 
(s, 3H, H17), 1.20 (t, J = 7.0 Hz, 3H, H11). 
13C NMR (100 MHz, CDCl3) ppm: 168.06 (COO, C1), 165.73 (COO, C12), 148.94 (ArC, 
C5/C6), 148.18 (ArC, C5/C6), 138.66 (ArCH, C14), 125.99 (ArC, C3), 123.78 (ArCH, 
C15/C16), 123.15 (ArCH, C8), 122.41 (ArCH, C15/C16 ), 108.70 (ArCH, C7), 108.09 
(ArCH, C4), 101.67 (OCH2O, C9), 76.29 (OCH, C2), 62.36 (OCH2, C10), 50.27 (OCH2, 
C13), 37.03 (NCH3, C17), 14.11 (CH3, C11). 
IR (neat, cm-1): 3023, 2960, 1736, 1630, 1489, 1480, 1238, 1210, 1153, 1027, 922, 758. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C17H19N2O6+, requires = 347.1238 ,                                              
found = 347.1237. 
MS (m/z): 347.10 [M-Br¯ ]+ 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-
imidazol-3-ium bromide (128a) 
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The title compound (128a) was prepared using butyl-2-(2-bromoacetoxy)-2-(3,4-
methylenedioxyphenyl)acetate (116) (2.86 g, 7.7 mmol), 1-methylimidazole (0.60 mL, 7.7 
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mmol) in diethyl ether (50 mL) according to general procedure R to obtain a white solid in 60 
% yield (2.11 g, 4.6 mmol). 
Molecular formula: C19H23BrN2O6 
Molecular weight: 455.30 g/mol 
Melting point: 94-96°C 
1H NMR (400 MHz, CDCl3) ppm: 10.34 (s, 1H, H16), 7.51 (t, J = 1.8 Hz, 1H, H17/H18), 
7.36 (t, J = 1.8 Hz, 1H, H17/H18), 6.89 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.86 (d, J = 2.0 Hz, 
1H, H4), 6.80 (d, J = 8.0 Hz, 1H, H7), 5.99 (dd, J = 3.2, 3.2 Hz, 2H, H9), 5.87 (s, 1H, H2), 
5.77 (d part A of an AB system, J = 17.6 Hz, 1H, H15), 5.43 (d part B of an AB system, J = 
17.6 Hz, 1H, H15), 4.14 (dt, J = 10.8, 6.8 Hz, 1H, H10), 4.10 (dt, J = 10.8, 6.8 Hz, 1H, H10), 
4.06 (s, 3H, H19), 1.55 (tt, J = 7.6, 6.8 Hz, 2H, H11), 1.25 (tq, J = 7.6, 7.2 Hz, 2H, H12), 0.86 
(t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.84 (COO, C1), 166.39 (COO, C14), 148.23 (ArC, 
C5/C6), 148.57 (ArC, C5/C6), 137.76 (ArCH, C16), 126.52 (ArC, C3), 123.63 (ArCH, 
C17/C18), 123.58 (ArCH, C8), 121.90 (ArCH, C17/C18 ), 108.49 (ArCH, C7), 107.77 
(ArCH, C4), 101.53 (OCH2O, C9), 74.92 (OCH, C2), 65.09 (OCH2, C10), 49.24 (OCH2, 
C15), 36.01 (NCH3, C19), 29.87 (CH2, C11), 18.26 (CH2, C12), 13.33 (CH3, C13). 
IR (neat, cm-1): 2961, 1750, 1608, 1580, 1502, 1491, 1449, 1347, 1240, 1190, 1024, 918. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C19H23N2O6+, requires = 375.1556 ,                                              
found = 375.1559. 
MS (m/z): 375.10 [M-Br¯ ]+ 
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1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}-3-butyl-1H-
imidazol-3-ium bromide (129a) 
 
The title compound (129a) was prepared using butyl-2-(2-bromoacetoxy)-2-(3,4-
methylenedioxyphenyl)acetate (116) (7.82 g, 20.9 mmol), 1-butylimidazole (2.8 mL, 20.9 
mmol) and diethyl ether (100 mL) according to general procedure R to obtain a brown liquid 
in 64 % yield (6.62 g, 13.3 mmol). 
Molecular formula: C22H29BrN2O6 
Molecular weight: 497.38 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 10.01(s, 1H, H16), 7.4 (t, J = 1.8 Hz, 1H, H17/H18), 7.51 
(t, J = 1.8 Hz, 1H, H17/H18), 6.77 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.73 (d, J = 2.0 Hz, 1H, 
H4), 6.66 (d, J = 8.0 Hz, 1H, H7), 5.86 (dd, J = 2.8, 2.8 Hz, 2H, H9), 5.74 (s, 1H, H2), 5.59 
(d part A of an AB system, J = 17.6 Hz, 1H, H15), 5.41 (d part B of an AB system, J = 17.6 
Hz, 1H, H15), 4.20 (t, 2H, H19), 4.03-3.93 (m, 2H, H10), 1.80-1.73 (m, 2H, H20), 1.46-1.38 
(m , 2H, H11), 1.27-1.20 (m, 2H, H21), 1.17-1.07 (m, 2H, H12), 0.81 (t, J = 7.6 Hz, 3H, 
H22), 0.73 (t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 173.42 (COO, C1), 167.88 (COO, C14), 148.52 (ArC, 
C5/C6), 147.82 (ArC, C5/C6), 137.46 (ArCH, C16), 125.87 (ArC, C3), 123.99 (ArCH, 
C17/C18), 123.63 (ArCH, C8), 122.03 (ArCH, C17/C18 ), 108.30 (ArCH, C7), 107.70 
(ArCH, C4), 101.36 (OCH2O, C9), 75.81 (OCH, C2), 66.71 (OCH2, C10), 53.10 (NCH2, 
C19), 49.88 (OCH2, C10), 31.78 (CH2, C11/C20), 30.17 (CH2, C11/C20), 19.15 (CH2, 
C12/C21), 18.65 (CH2, C12/C21), 13.33 (CH3, C13/C22), 13.22 (CH3, C13/C2). 
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IR (neat, cm-1): 3143, 3085, 2961, 2935, 1737, 1627, 1566, 1489, 1443, 1237, 1166, 1101, 
1034, 750.  
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C22H29N2O6+, requires = 417.2020,                                               
found = 417.2018. 
MS (m/z): 417.20 [M-Br¯ ]+ 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}pyridin-1-ium 
bromide (130a) 
7
6
5
4
3
8 2
O
1
O
O
10
14
15
O
N Br
O
O
9
11
12
13
16
17
18
19
20
 
The title compound (130a) was prepared using butyl-2-(2-bromoacetoxy)-2-(3,4-
methylenedioxyphenyl)acetate (116) (11.56 g, 30.9 mmol), pyridine (2.5 mL, 30.9 mmol) and 
diethyl ether (150 mL) according to general procedure R to obtain an off white solid in 50 % 
yield (7.0 g, 15.5 mmol). 
Molecular formula: C20H22BrNO6 
Molecular weight: 452.23 g/mol 
Melting point: 150-152°C 
1H NMR (400 MHz, CDCl3) ppm: 9.39 (d, J = 6.4 Hz, 2H, H16, H20), 8.53 (t, J = 8.0 Hz, 1H, 
H18), 8.07 (dd, J = 8.0, 6.4 Hz, 2H, H17, H19), 6.89 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.86 (d, J 
= 2.0 Hz, 1H, H4), 6.76 (d, J = 8.0 Hz, 1H, H7), 6.50 (d part A of an AB system, J = 17.2 
Hz, 1H, H15), 6.21 (d part B of an AB system, J = 17.2 Hz, 1H, H15), 5.97 (dd, J = 4.8, 4.8 
Hz, 2H, H9), 5.88 (s, 1H, H2), 4.10 (dt, J = 10.8, 6.8 Hz, 1H, H10), 4.07 (dt, J = 10.8, 6.8 Hz, 
1H, H10), 1.52 (tt, J = 7.2, 6.8 Hz, 2H, H11), 1.22 (qt, J = 7.6, 7.2 Hz, 2H, H12), 0.83 (t, J = 
7.6 Hz, 3H, H13). 
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13C NMR (100 MHz, CDCl3) ppm: 168.02 (COO, C1), 165.46 (COO, C14), 148.87 (ArC, 
C5/C6), 148.12 (ArC, C5/C6), 146.70 (2ArCH, C16, C20), 146.54 (ArCH, C18), 127.92 
(2ArCH, C17, C19), 126.05 (ArC, C3), 122.36 (ArCH, C8), 108.68 (ArCH, C7), 108.12 
(ArCH, C4), 101.64 (OCH2O, C9), 76.52 (OCH, C2), 66.09 (OCH2, C10), 61.04 (OCH2, 
C15), 30.36 (CH2, C11), 18.90 (CH2, C12), 13.65 (CH3, C13). 
IR (neat, cm-1): 3135, 3037, 2960, 1746, 1720, 1634, 1576, 1491, 1448, 1367, 1251, 1197, 
1177, 1112, 1029, 922, 824, 760. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C20H22NO6+, requires = 372.1447,                                               
found = 372.1450. 
MS (m/z): 372.10 [M-Br¯ ]+ 
1-{2-[1-(4-Bromophenyl)-2-methoxy-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-imidazol-3-
ium bromide (131a) 
 
The title compound (131a) was prepared using methyl-2-(2-bromoacetoxy)-2-(4-
bromophenyl)acetate (117) (5.21 g, 14.3 mmol), 1-methylimidazole (1.15 mL, 14.2 mmol) 
and diethyl ether (25 mL) according to general procedure R to obtain a brown gel in 82 % 
yield (5.24 g, 11.7 mmol). 
Molecular formula: C15H16Br2N2O4 
Molecular weight: 448.11 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.89 (s, 1H, H12), 7.64 (t, J = 1.6 Hz, 1H, H13/H14), 7.51 
(t, J = 1.6 Hz, 1H, H13/H14), 7.49 (d, J = 8.4 Hz, 2H, H5, H7), 7.31 (d, J = 8.4 Hz, 2H, H4, 
H8), 5.97 (s, 1H, H2), 5.75 (d, J = 17.2 Hz, 1H, H11), 5.55 (d, J = 17.2 Hz, 1H, H11), 4.01 (s, 
3H, H15), 3.68 (s, 3H, H9). 
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13C NMR (100 MHz, CDCl3) ppm: 168.18 (COO, C1), 165.92 (COO, C10), 138.21 (ArCH, 
C12), 132.26 (2ArCH, C5/C7), 131.75 (ArC, C3), 129.56 (2ArCH, C4, C8), 124.06 (ArC, 
C6), 123.87 (ArCH, C13/C14), 123.39 (ArCH, C13/C14), 75.49 (OCH, C2), 53.32 (OCH3, 
C9), 50.40 (CH2, C11), 37.23 (CH3, C15). 
IR (neat, cm-1): 2961, 1752, 1655, 1224, 1176, 1052, 1024, 820, 757. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C15H16BrN2O4+, requires = 367.0288,                                               
found = 367.0276. 
MS (m/z): 367.05 [M-Br¯ ]+ 
1-{2-[2-Methoxy-1-(4-methoxyphenyl)-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-imidazol-
3-ium bromide (132a) 
 
The title compound (132a) was prepared using methyl-2-(2-bromoacetoxy)-2-(4-
methoxyphenyl)acetate (118) (5.31 g, 16.7 mmol), 1-methylimidazole (1.35 mL, 16.7 mmol) 
and diethyl ether (25 mL) according to the general procedure R to obtain a brown liquid in 72 
% yield (4.83 g, 12.1 mmol). 
Molecular formula: C16H19BrN2O5 
Molecular weight: 399.24 g/mol 
1H NMR (400 MHz, DMSO-d6) ppm: 9.17 (s, 1H, H13), 7.77 (d, J = 1.6 Hz, 1H, H14/H15), 
7.76 (t, J = 1.6 Hz, 1H, H14/H15), 7.41 (d, J = 8.4 Hz, 2H, H4, H8), 7.01 (d, J = 8.4 Hz, 2H, 
H5/H7), 6.08 (s, 1H, H2), 5.53 (d, J = 17.6 Hz, 1H, H12), 5.42 (d, J = 17.6 Hz, 1H, H12), 
3.93 (s, 3H, H9), 3.78 (s, 3H, H16), 3.67 (s, 3H, H10). 
13C NMR (100 MHz, DMSO-d6) ppm: 168.54 (COO, C1), 166.55 (COO, C11), 160.15 (ArC, 
C6), 137.72 (ArCH, C13), 129.35 (2ArCH, C4, C8), 124.75 (ArC, C3), 123.63 (ArCH, 
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C14/C15), 123.55 (ArCH, C14/C15), 114.30 (2ArCH, C5, C7), 74.76 (OCH, C2), 55.26 
(OCH3, C9), 52.66 (OCH3, C10), 49.19 (CH2, C12), 35.99 (CH3, C16). 
IR (neat, cm-1): 3099, 2955, 1735, 1610, 1579, 1511, 1438, 1239, 1171, 1077, 1025, 833. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C16H19N2O5+, requires = 319.1289,                                               
found = 319.1279. 
MS (m/z): 319.10 [M-Br¯ ]+ 
1-(2-{2-Methoxy-2-oxo-1-[4-(trifluoromethyl)phenyl]ethoxy}-2-oxoethyl)-3-methyl-1H-
imidazol-3-ium bromide (133a) 
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The title compound (133a) was prepared using methyl-2-(2-bromoacetoxy)-2-[4-
(trifluoromethyl)phenyl]acetate (119) (6.98 g, 19.7 mmol), 1-methylimidazole (1.6 mL, 19.7 
mmol) and diethyl ether (70 mL) according to general procedure R to obtain a white solid in 
88 % yield (7.57 g, 17.3 mmol). 
Molecular formula: C16H16BrF3N2O4 
Molecular weight: 437.21 g/mol 
Melting point: 128-130°C 
1H NMR (400 MHz, CDCl3) ppm: 10.24 (s, 1H, H13), 7.65 (d, J = 8.4 Hz, 2H, H5, H7), 7.62 
(t, J = 1.6 Hz, 1H, H14/H15), 7.59 (d, J = 8.4 Hz, 2H, H4, H8), 7.40 (t, J = 1.6 Hz, 1H, 
H14/H15), 6.08 (s, 1H, H2), 5.90 (d, J = 18.0 Hz, 1H, H12), 5.57 (d, J = 18.0 Hz, 1H, H12), 
4.04 (s, 3H, H16), 3.73 (s, 3H, H10). 
13C NMR (100 MHz, CDCl3) ppm: 173.22 (COO, C1), 170.61 (COO, C11), 142.00 (ArCH, 
C3), 137.11 (ArCH, C13), 131.17 (q, J = 32.0 Hz, ArC, C6), 128.15 (2ArCH, C4, C8), 126.50 
(q, J = 4.0 Hz, 2ArCH, C5, C7), 124.76 (ArCH, C14/C15), 124.68 (q, J = 270.5, CF3, C9), 
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120.44 (ArCH, C14/C15), 72.49 (CH, C2), 53.70 (OCH3, C9), 35.35 (NCH3, C16), 24.86 
(CH2, C10). 
19F NMR (376 MHz, CDCl3) ppm: -62.46 (3F) 
IR (neat, cm-1): 3093, 2961, 2925, 1762, 1751, 1621, 1577, 1440, 1419, 1323, 1254, 1226, 
1165, 1122, 1063, 1018, 979, 833, 782. 
HRMS (ESI+, m/z): Calculated for [M-Br¯ ]+, C16H16F3N2O4+, requires = 357.1057,                                               
found = 357.1053. 
MS (m/z): 357.10 [M-Br¯ ]+ 
 
6.4.5 [NTf2] Ionic Liquids: 
General Procedure S: Preparation of Mandelate based [NTf2] ILs4 
3-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (123b) 
 
To a stirred solution of bromide salt (123a) (450 mg, 1.13 mmol) in distilled water (5 mL) 
was added LiNTf2 (330 mg, 1.33 mmol) and stirred for 4 h. The solid was washed with 
distilled water (3 x 5 mL) and dried under high vacuum to obtain a pale yellow solid in 66 % 
yield (450 mg, 0.75 mmol). 
Molecular formula: C19H21F6N3O8S2 
Molecular weight: 597.51 g/mol  
Melting Point: 46-48°C 
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1H NMR (400 MHz, CDCl3) ppm: 8.76 (s, 1H, H14), 7.33 (t, J = 1.6 Hz, 1H, H15/H16), 7.30 
(t, J = 1.6 Hz, 1H, H15/H16), 6.90 (dd, J = 8.0, 1.6 Hz, 1H, H8), 6.84 (d, J = 8.0 Hz, 1H, H7), 
6.83 (d, J = 1.6 Hz, 1H, H4), 6.20 (s, 1H, H2), 6.005 (d, part A of an AB system, J = 1.2 Hz, 
1H, H9), 6.000 (d, part B of an AB system, J = 1.2 Hz, 1H, H9), 4.22 (dt, J = 10.8, 6.8 Hz, 
2H, H10), 3.92 (s, 3H, H17), 1.59 (tt, J = 7.4, 6.8 Hz, 2H, H11), 1.26 (tq, J = 7.4, 7.2 Hz, 2H, 
H12), 0.85 (t, J = 7.2 Hz, 3H, H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.36 (COO, C1), 149.71 (ArC, C5/C6), 149.04 (ArC, 
C5/C6), 136.38 (ArC, C14), 124.43 (ArC, C15/C16), 123.39 (ArCH, C8), 123.08 (ArC, 
C15/C16 ), 122.19 (ArCH, C3), 119.83 (q, 2CF3, J = 319 Hz, C18, C19), 109.41 (ArCH, C7), 
108.56 (ArCH, C4), 102.10 (OCH2O, C9), 67.28 (OCH2, C10), 64.71 (CHN, C2), 36.61 
(NCH3, C17), 30.17 (CH2, C11), 18.84 (CH2, C12), 13.52 (CH3, C13). 
19F NMR (376 MHz, CDCl3) ppm: -79.22 (6F) 
IR (neat, cm-1): 3056, 2981, 1736, 1608, 1512, 1435, 1292, 1247, 1215, 1172, 1110, 1030, 
982, 827. 
MS (m/z): 317.10 [M-NTf2¯ ]+ 
 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-
imidazol-3-ium bis(trifluoromethylsulfonyl)imide (128b) 
 
The title compound (128b) was prepared using bromide salt (128a) (1.0 g, 2.2 mmol), 
distilled water (5 mL) and LiNTf2 (760 mg, 2.6 mmol) according to the general procedure S 
to afford a colourless oil in 94 % yield (1.35 g, 2.1 mmol).  
Molecular formula: C21H23F6N3O10S2 
Molecular weight: 655.54 g/mol 
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1H NMR (400 MHz, CDCl3) ppm: 8.86 (s, 1H, H16), 7.38 (t, J = 1.6 Hz, 1H, H17/H18), 7.31 
(t, J = 1.6 Hz, 1H, H17/H18), 6.90 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.86 (d, J = 2.0 Hz, 1H, 
H4), 6.81 (d, J = 8.0 Hz, 1H, H7), 5.99 (s, 2H, H9), 5.87 (s, 1H, H2), 5.18 (d part A of an AB 
system, J = 18.0 Hz, 1H, H15), 5.12 (d part B of an AB system, J = 18.0 Hz, 1H, H15), 4.14 
(dt, J = 10.8, 6.8 Hz, 1H, H10), 4.10 (dt, J = 10.8, 6.8 Hz, 1H, H10), 3.95 (s, 3H, H19), 1.55 
(tt , J = 7.2, 6.8 Hz, 2H, H11), 1.25 (qt, J = 7.6, 7.2 Hz, 2H, H12), 0.85 (t, J = 7.6 Hz, 3H, 
H13). 
13C NMR (100 MHz, CDCl3) ppm: 168.01 (COO, C1), 165.16 (COO, C14), 148.92 (ArC, 
C5/C6), 148.16 (ArC, C5/C6), 137.83 (ArCH, C16), 125.93 (ArC, C3), 123.73 (ArCH, 
C17/C18), 123.32 (ArCH, C8), 122.26 (ArCH, C17/C18 ), 119.71 (q, 2CF3, C20, C21, J = 
319.2 Hz), 108.59 (ArCH, C7), 107.92 (ArCH, C4), 101.56 (OCH2O, C9), 76.36 (OCH, C2), 
66.06 (OCH2, C10), 49.91 (OCH2, C15), 36.64 (NCH3, C19), 30.31 (CH2, C11), 18.81 (CH2, 
C12), 13.48 (CH3, C13). 
19F NMR (376 MHz, CDCl3) ppm: -79.13 (6F) 
IR (neat, cm-1): 3163, 2965, 1746, 1519, 1348, 1173, 1133, 1053, 1037, 927.  
MS (m/z): 375.10 [M-NTf2¯ ]+ 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}-3-butyl-1H-
imidazol-3-ium bis(trifluoromethylsulfonyl)imide (129b) 
 
The title compound (129b) was prepared using bromide salt (129a) (2.03 g, 4.0 mmol), 
LiNTf2 (1.27 g, 4.4 mmol) and distilled water (10 mL) according to the general procedure S to 
afford a yellow oil in 90 % yield (2.53 g, 3.6 mmol). 
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Molecular formula: C24H29F6N3O10S2 
Molecular weight: 697.62 g/mol 
1H NMR (400 MHz, DMSO-d6) ppm: 9.21 (s, 1H, H16), 7.85 (t, J = 1.8 Hz, 1H, H17/H18), 
7.76 (t, J = 1.8 Hz, 1H, H17/H18), 6.97-6.94 (m, 3H, H4, H7, H8), 6.06 (s, 2H, H9), 6.03 (s, 
1H, H2), 5.48 (d part A of an AB system, J = 17.8 Hz, 1H, H15), 5.39 (d part B of an AB 
system, J = 17.8 Hz, 1H, H15), 4.25 (t, J = 7.0 Hz, 2H, H19), 4.10 (dt, J = 10.8, 6.8 Hz, 2H, 
H10), 1.76 (tt, J = 7.6, 7.0 Hz, 2H, H20), 1.49 (tt, J = 7.6, 6.8 Hz, 2H, H11), 1.27-1.15 (m , 
4H, H12, H21), 0.89 (t, J = 7.6 Hz, 3H, H13/H22), 0.80 (t, J = 7.6 Hz, 3H, H13/H22). 
13C NMR (100 MHz, DMSO-d6) ppm: 168.09 (COO, C1), 165.18 (COO, C14), 148.92 (ArC, 
C5/C6), 148.16 (ArC, C5/C6), 137.32 (ArCH, C16), 125.91 (ArC, C3), 123.80 (ArCH, 
C17/C18), 122.26 (ArCH, C8), 121.88 (ArCH, C17/C18 ), 119.74 (q, 2CF3, C20, C21, J = 
319 Hz), 108.59 (ArCH, C7), 107.90 (ArCH, C4), 101.55 (OCH2O, C9), 76.33 (OCH, C2), 
66.08 (OCH2, C10), 50.36 (NCH2, C19), 50.05 (CH2, C15), 31.80 (CH2, C20), 30.31 (CH2, 
C11), 19.32 (CH2, C21), 18.81 (CH2, C12), 13.48 (CH3, C13/C22), 13.20 (CH3, C13/C22). 
19F NMR (376 MHz, CDCl3) ppm: -79.16 (6F). 
IR (neat, cm-1): 3153, 2965, 1741, 1611, 1567, 1506, 1491, 1447, 1347, 1180, 1133, 1054, 
1037, 929.  
MS (m/z): 417.20 [M-NTf2¯ ]+ 
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1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}pyridin-1-ium 
bis(trifluoromethylsulfonyl)imide (130b) 
 
The title compound (130b) was prepared using bromide salt (130a) (1.0 g, 2.2 mmol), LiNTf2 
(640 mg, 2.2 mmol) and distilled water (10 mL) according to the general procedure S to 
afford a brown oil in 73 % yield (1.05 g, 1.6 mmol). 
Molecular formula: C22H22F6N2O10S2 
Molecular weight: 652.54 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 8.78 (d, J = 6.4 Hz, 2H, H16, H20), 8.54 (t, J = 8.0 Hz, 
1H, H18), 8.06 (dd, J = 8.0, 6.4 Hz, 2H, H17, H19), 6.89 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.84 
(d, J = 2.0 Hz, 1H, H4), 6.80 (d, J = 8.0 Hz, 1H, H7), 5.98 (s, 2H, H9), 5.89 (s, 1H, H2), 5.58 
(s, 2H, H15), 4.12 (dt, J = 10.8, 6.8 Hz, 1H, H10), 4.09 (dt, J = 10.8, 6.8 Hz, 1H, H10), 1.53 
(tt, J = 7.2, 6.8 Hz, 2H, H11), 1.23 (qt, J = 7.6, 7.2 Hz, 2H, H12), 0.84 (t, J = 7.6 Hz, 3H, 
H13). 
13C NMR (100 MHz, CDCl3) ppm: 167.90 (COO, C1), 164.73 (COO, C14), 148.98 (ArC, 
C5/C6), 148.17 (ArC, C5/C6), 146.73 (ArCH, C18), 146.09 (2ArCH, C16, C20), 128.32 
(2ArCH, C17, C19), 125.74 (ArC, C3), 122.32 (ArCH, C8), 119.67 (q, 2CF3, C21, C22, J = 
319 Hz), 108.61 (ArCH, C7), 107.94 (ArCH, C4), 101.57 (OCH2O, C9), 76.79 (OCH, C2), 
66.15 (OCH2, C10), 61.03 (OCH2, C15), 30.27 (CH2, C11), 18.79 (CH2, C12), 13.46 (CH3, 
C13). 
19F NMR (376 MHz, CDCl3) ppm: -78.91 (6F) 
IR (neat, cm-1): 3095, 2965, 1740, 1639, 1491, 1447, 1347, 1179, 1132, 1054, 1035, 928, 789.  
MS (m/z): 372.10 [M-NTf2¯ ]+ 
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1-{2-[2-Methoxy-1-(4-methoxyphenyl)-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-imidazol-
3-ium bis(trifluoromethylsulfonyl)imide (132b) 
 
The title compound (132b) was prepared using bromide salt (132a) (1.50 g, 3.8 mmol), 
LiNTf2 (1.08 g, 3.8 mmol) and distilled water (10 mL) according to the general procedure S to 
afford a brown oil in 81 % yield (1.83 g, 3.1 mmol). 
Molecular formula: C18H19F6N3O9S2 
Molecular weight: 599.48 g/mol 
1H NMR (400 MHz,CDCl3) ppm: 8.84 (s, 1H, H13), 7.38 (d, J = 1.8 Hz, 1H, H14/H15), 7.33 
(d, J = 8.8 Hz, 2H, H4, H8),7.29 (t, J = 1.6 Hz, 1H, H14/H15), 6.91 (d, J = 8.8 Hz, 2H, H5, 
H7), 5.95 (s, 1H, H2), 5.13 (s, 2H, H12), 3.94 (s, 3H, H9), 3.81 (s, 3H, H16), 3.72 (s, 3H, 
H10). 
13C NMR (100 MHz, CDCl3) ppm: 168.63 (COO, C1), 165.30 (COO, C11), 160.81 (ArC, 
C6), 137.65 (ArCH, C13), 129.39 (2ArCH, C4, C8), 127.93 (ArC, C3), 124.32 (ArCH, 
C14/C15), 123.79 (ArCH, C14/C15), 119.71 (q, J = 319 Hz, 2CF3, C17, C18), 114.10 
(2ArCH, C5, C7), 76.15 (OCH, C2), 55.36 (OCH3, C9), 52.87 (OCH3, C10), 49.85 (CH2, 
C12), 35.55 (CH3, C16). 
19F NMR (376 MHz, CDCl3) ppm: -79.06 (6F) 
IR (neat, cm-1): 2962, 1749, 1611, 1583, 1515, 1440, 1347, 1170, 1132, 1052, 1028. 
MS (m/z): 319.10 [M-NTf2¯ ]+ 
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1-(2-{2-Methoxy-2-oxo-1-[4-(trifluoromethyl)phenyl]ethoxy}-2-oxoethyl)-3-methyl-1H-
imidazol-3-ium bis(trifluoromethylsulfonyl)imide (133b) 
 
The title compound (133b) was prepared using bromide salt (133a) (440 mg, 1.01 mmol), 
LiNTf2 (320 mg, 1.11 mmol) and distilled water (5 mL) according to the general procedure S 
to afford a white solid in 88 % yield (570 mg, 0.89 mmol). 
Molecular formula: C18H16F9N3O8S2 
Molecular weight: 637.45 g/mol 
Melting point: 70-72°C 
1H NMR (400 MHz, DMSO-d6) ppm: 9.13 (s, 1H, H13), 7.86 (d, J = 8.0 Hz, 2H, H5,H7), 
7.75 (s, 2H, H14, H15), 7.74 (d, J = 8.0 Hz, 2H, H4,H8), 6.36 (s, 1H, H2), 5.56 (d part A of 
an AB system, J = 17.6 Hz, 1H, H12), 5.45 (d part B of an AB system, J = 17.6 Hz, 1H, 
H12), 3.92 (s, 3H, H10), 3.70 (s, 3H, H16). 
13C NMR (100 MHz, DMSO-d6) ppm: 167.72 (COO, C1), 166.22 (COO, C11), 137.80 (ArC, 
C13), 137.50 (ArC, C3), 129.83 (q, J = 31.5 Hz, ArCH, C6), 128.44 (2ArCH, C4, C8), 125.85 
(q, J = 271.5 Hz, CF3, C9), 123.60 (q, J = 4.0 Hz, 2ArCH, C5, C7), 120.54 (ArCH, C14/C15), 
118.40 (q, J = 319 Hz, 2CF3, C17, C18), 116.27 (ArCH, C14/C15), 74.15 (OCH, C2), 52.99 
(OCH3, C10), 49.22 (CH2, C12), 36.00 (CH3, C16). 
19F NMR (376 MHz, CDCl3) ppm: -62.64 (3F, C9), -79.23 (6F, C17, C18).  
IR (neat, cm-1): 3164, 1748, 1624, 1570, 1441, 1349, 1325, 1175, 1139, 1127, 1052, 1020. 
MS (m/z): 357.10 [M-NTf2¯ ]+ 
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6.4.6 [OctOSO3] Ionic Liquids: 
General Procedure T: Preparation of Mandelate based [OctOSO3] ILs4 
3-[2-Butoxy-1-(3,4-dihydroxyphenyl)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium octyl 
sulfate (120c) 
 
To a stirred solution of bromide salt (120a) (2.0 g, 5.2 mmol), in distilled water (10 mL) was 
added sodium octyl sulphate (1.21 g, 5.19 mmol) in one portion. The mixture was stirred 
overnight, then the water was evaporated on the rotary evaporator. The crude product was 
dissolved in DCM (25 mL) and washed with water (3 x 5 mL). The product was then dried  
by rotary evaporation and under high vacuum to obtain a brown oil in 41 % yield (1.10 g, 2.1 
mmol). 
Molecular formula: C24H38N2O7S 
Molecular weight : 514.63 g/mol 
1H NMR (400 Hz, DMSO-d6) ppm: 9.49 (s, 1H, OH, C5/C6), 9.31 (s, 1 H, OH, C5/C6), 9.07 
(s, 1H, H13), 7.74 (t, J = 1.6 Hz, 1H, H14/H15), 7.72 (t, J = 1.6 Hz, 1H, H14/H15), 6.83 (d, J 
= 2.0 Hz, 1H, H4), 6.82 (d, J = 8.0 Hz, 1H, H7), 6.74 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.53 (s, 
1H, H2), 4.26-4.14 (m, 2H, H9), 3.86 (s, 3H, H16), 3.68 (t, J = 6.8 Hz, 2H, H17), 1.58-1.45 
(m, 4H, H10, H18), 1.28-1.19 (m, 12H, H11, H19, H20, H21, H22, H23), 0.86 (t, J = 7.2 Hz, 
3H, H12/H24), 0.84 (t, J = 7.6 Hz, 3H, H12/H24). 
13C NMR (100 Hz, DMSO-d6) ppm: 167.84 (COO, C1), 146.98 (ArC, C5/C6), 145.93 (ArC, 
C5/C6), 136.58 (ArCH, C13), 123.47 (ArC, C3), 122.77 (ArCH, C14/C15), 122.37 (ArCH, 
C8), 119.77 (ArCH, C14/C15), 116.11 (ArCH, C7), 115.77 (ArCH, C4), 65.91 (NCH, C2), 
65.45 (OCH2, C17), 63.61 (OCH2, C9), 35.95 (NCH3, C16), 31.22 (CH2, C18), 29.78 (CH2, 
C10), 29.03 (CH2, C19), 28.70 (CH2, C11), 28.65 (CH2, C20), 25.50 (CH2, C21), 22.06 (CH2, 
C22), 18.34 (CH2, C23), 13.93 (CH3, C12/C24), 13.37 (CH3, C12/C24). 
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IR (neat, cm-1):  3356, 3151, 2928, 1743, 1605, 1524, 1452, 1378, 1191, 1164, 1120, 1057, 
955, 908, 798, 753.  
MS (m/z): 305.15 [M-OctOSO3¯ ]+ 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-
imidazol-3-ium octyl sulfate (128c) 
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The title compound (128c) was prepared using bromide salt (128a) (520 mg, 1.09 mmol), 
sodium octyl sulphate (260 mg, 1.09 mmol) and distilled water (5 mL) according to general 
procedure T to obtain pale yellow solid in 89 % yield (570 mg, 0.98 mmol). 
Molecular formula: C27H40N2O10S 
Molecular weight : 584.68 g/mol 
Melting point: 55-57°C 
1H NMR (400 Hz, CDCl3) ppm: 9.12 (s, 1H, H16), 7.75 (t, J = 1.6 Hz, 1H, H17/H18), 7.73 (t, 
J = 1.6 Hz, 1H, H17/H18), 7.00-6.98 (m, 3H, H4, H7, H8), 6.07 (s, 2H, H9), 6.03 (s, 1H, H2), 
5.50 (d part A of an AB system, J = 17.6 Hz, 1H, H15), 5.39 (d part B of an AB system, J = 
17.6 Hz, 1H, H15), 4.10 (dt, J = 10.8, 6.8 Hz, 1H, H10), 4.09 (dt, J = 10.8, 6.8 Hz, 1H, H10), 
3.91 (s, 3H, H19), 3.66 (t, J = 6.8 Hz, 2H, H20), 1.48 (tt , J =  7.6, 6.8 Hz, 2H, H11), 1.30-
1.15 (m, 14H, H12, H21-H26), 0.86 (t, J = 6.8 Hz, 3H, H13), 0.81 (t, J = 7.6 Hz, 3H, H27).  
13C NMR (100 Hz, CDCl3) ppm: 168.21 (COO, C1), 165.99 (COO, C14), 148.87 (ArC, 
C5/C6), 148.16 (ArC, C5/C6), 139.08 (ArCH, C16), 126.21 (ArC, C3), 123.68 (ArCH, 
C14/C15), 123.25 (ArCH, C8), 122.31 (ArCH, C14/C15), 108.64 (ArCH, C7), 108.11 (ArCH, 
C4), 101.63 (CH2, C9), 76.19 (OCH, C2), 68.15 (CH2, C20), 66.13 (OCH2, C10), 49.92 
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(OCH2, C15), 36.70 (NCH3, C19), 31.93 (CH2), 30.50 (CH2), 29.54 (CH2), 29.44 (CH2), 25.93 
(CH2), 22.77 (CH2), 18.99 (CH2), 18.95 (CH2), 14.23 (CH3, C13/C27), 13.68 (CH3, C13/C27). 
IR (neat, cm-1): 3402, 2959, 1745, 1636, 1503, 1491, 1447, 1368, 1249, 1196, 1170, 1027, 
979, 921.  
MS (m/z): 375.00 [M-OctOSO3¯ ]+ 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}-3-butyl-1H-
imidazol-3-ium octyl sulfate (129c) 
 
The title compound (129c) was prepared using bromide salt (129a) (2.05 g, 4.12 mmol), 
sodium octyl sulphate (930 mg, 4.12 mmol) and distilled water (10 mL) according to general 
procedure T to obtain a pale yellow solid in 82 % yield (2.13 g, 3.39 mmol). 
Molecular formula: C30H46N2O10S 
Molecular weight: 626.76 g/mol 
Melting point: 49-51°C 
1H NMR (400 Hz, DMSO-d6) ppm: 9.22 (s, 1H, H16), 7.86 (t, J = 1.6 Hz, 1H, H17/H18), 
7.77 (t, J = 1.6 Hz, 1H, H17/H18), 7.00-6.98 (m, 3H, H4, H7, H8), 6.07 (s, 2H, H9), 6.03 (s, 
1H, H2), 5.49 (d part A of an AB system, J = 17.6 Hz, 1H, H15), 5.40 (d part B of an AB 
system, J = 17.6 Hz, 1H, H15), 4.25 (t, J = 7.2 Hz, 2H, H23), 4.12-4.09 (m, 2H, H10), 3.67 (t, 
J = 6.8 Hz, 2H, H19), 1.77-1.75 (m, 2H), 1.50-1.46 (m , 4H), 1.28-1.19 (m, 14H), 0.90 (t, J = 
7.2 Hz, 3H), 0.86 (t, J = 7.2 Hz, 3H), 0.81 (t, J = 7.6 Hz, 3H).  
13C NMR (100 Hz, DMSO-d6) ppm: 168.49 (COO, C1), 164.88 (COO, C14), 148.32 (ArC, 
C5/C6), 147.36 (ArC, C5/C6), 137.51 (ArCH, C16), 125.71 (ArC, C3), 124.10 (ArCH, 
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C17/C18), 123.36 (ArCH, C8), 121.89 (ArCH, C17/C18), 109.59 (ArCH, C7), 108.00 (ArCH, 
C4), 101.56 (OCH2O, C9), 76.77 (OCH, C2), 66.48 (OCH2, C10), 65.45 (OCH2, C23), 50.39 
(NCH2, C19), 50.51 (NCH2, C15), 31.80 (CH2), 31.09 (CH2) 30.31 (CH2), 29.59 (CH2), 29.33 
(CH2), 28.47 (CH2), 25.71 (CH2), 22.98 (CH2), 19.32 (CH2), 18.81 (CH2), 14.13 (CH3), 13.33 
(CH3), 13.24 (CH3). 
IR (neat, cm-1): 3150, 2957, 1724, 1563, 1488, 1427, 1249, 1169, 1053, 1017, 975, 815.  
MS (m/z): 417.20 [M-OctOSO3¯ ]+ 
1-{2-[1-(2H-1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl}pyridin-1-ium octyl 
sulfate (130c) 
 
The title compound (130c) was prepared using bromide salt (130a) (1.58 g, 3.5 mmol), 
sodium octyl sulphate (810 mg, 3.49 mmol) and distilled water (10 mL) according to the 
general procedure T to obtain a pale yellow gel in 91 % yield (1.86 g, 3.2 mmol). 
Molecular formula: C28H39NO10S 
Molecular weight: 581.67 g/mol 
1H NMR (400 Hz, CDCl3) ppm: 8.95 (d, J = 6.2 Hz, 2H, H16, H20), 8.40 (t, J = 7.8 Hz, 1H, 
H18), 7.96 (dd, J = 7.8, 6.2 Hz, 2H, H17, H19), 6.85 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.82 (d, J 
= 2.0 Hz, 1H, H4), 6.73 (d, J = 8.0 Hz, 1H, H7), 5.92 (dd, J = 3.4, 3.4, 2H, H9), 5.90 (s, 1H, 
H2), 5.86 (d part A of an AB system, J = 17.6 Hz, 1H, H15), 5.71 (d part B of an AB system, 
J = 17.6 Hz, 1H, H15), 4.07-4.02 (m, 2H, H10), 3.87 (t, J = 7.2 Hz, 2H, H21), 1.52-1.44 (m, 
4H, H11, H22), 1.23-1.14 (m, 12H), 0.81 (t, J = 7.2 Hz, 3H), 0.78 (t, J = 7.6 Hz, 3H).  
13C NMR (100 Hz, CDCl3) ppm: 168.45 (COO, C1), 165.33 (COO, C14), 149.28 (ArC, 
C5/C6), 148.37 (ArC, C5/C6), 146.67 (ArCH, C18), 146.13 (2ArCH, C16, C20), 129.08 
(2ArCH, C17, C19), 124.91 (ArC, C3), 122.76 (ArCH, C8), 108.78 (ArCH, C7), 107.23 
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(ArCH, C4), 101.61 (OCH2O, C9), 76.29 (OCH, C2), 65.89 (OCH2, C21), 65.17 (OCH2, 
C10), 62.00 (CH2, C15), 31.32 (CH2), 30.33 (CH2), 29.24 (CH2), 28.66 (CH2), 25.53 (CH2), 
22.48 (CH2), 18.82 (CH2), 18.51 (CH2), 14.38 (CH3), 13.16 (CH3). 
IR (neat, cm-1): 3055, 2968, 1742, 1638, 1481, 1457, 1345, 1180, 1112, 1050, 1031, 922, 790.  
MS (m/z): 372.10 [M-OctOSO3¯ ]+ 
1-{2-[2-Methoxy-1-(4-methoxyphenyl)-2-oxoethoxy]-2-oxoethyl}-3-methyl-1H-imidazol-
3-ium octyl sulfate (132c) 
 
The title compound (132c) was prepared using bromide salt (132a) (1.00 g, 2.5 mmol), 
sodium octyl sulphate (580 mg, 2.50 mmol) and distilled water (10 mL) according to the 
general procedure T to obtain a pale brown oil in 88 % yield (1.17 g, 2.2 mmol). 
Molecular formula: C24H36N2O9S 
Molecular weight : 528.62 g/mol 
1H NMR (400 Hz, CDCl3) ppm: 9.32 (s, 1H, H13), 7.40 (t, J = 1.6 Hz, 1H, H14/H15), 7.31 (t, 
J = 1.6 Hz, 1H, H14/H15), 7.27 (d, J = 8.4 Hz, 2H, H4, H8), 6.83 (d, J = 8.4 Hz, 2H, H5, 
H7), 5.88 (s, 1H, H2), 5.31 (d part A of an AB system, J = 18.0  Hz, 1H, H12), 5.20 (d part B 
of an AB system, J = 18.0 Hz, 1H, H12), 3.90 (t, J = 6.8 Hz, 2H, H17), 3.88 (s, 3H, H9), 3.74 
(s, 3H, H16), 3.64 (s, 3H, H10), 1.56-1.52 (m , 2H, H18), 1.26-1.14 (m, 10H, H19-H23), 0.80 
(t, J = 7.2 Hz, 3H, H24). 
13C NMR (100 MHz, CDCl3) ppm: 167.81 (COO, C1), 166.04 (COO, C11), 159.80 (ArC, 
C6), 138.06 (ArCH, C13), 130.53 (ArC, C3), 127.91 (2ArCH, C4, C8), 123.98 (ArCH, 
C14/C15), 123.11 (ArCH, C14/C15), 114.25 (2ArCH, C5, C7), 76.13 (OCH, C2), 68.36 
(OCH2, C17), 55.34 (OCH3, C9), 52.89 (OCH3, C10), 49.88 (CH2, C12), 36.37 (CH3, C16), 
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31.80 (CH2, C18), 29.38 (CH2, C19), 29.29 (CH2, C20), 29.08 (CH2, C21), 25.78 (CH2, C22), 
22.63 (CH2, C23), 14.07 (CH3, C24). 
IR (neat, cm-1): 2928, 1746, 1611, 1514, 1439, 1211, 1171, 1026, 974. 
MS (m/z): 319.10 [M-OctOSO3¯ ]+ 
1-(2-{2-Methoxy-2-oxo-1-[4-(trifluoromethyl)phenyl]ethoxy}-2-oxoethyl)-3-methyl-1H-
imidazol-3-ium octyl sulfate (133c) 
 
The title compound (133c) was prepared using bromide salt (133a) (1.04 g, 2.38 mmol), 
sodium octyl sulphate (540 mg, 2.33 mmol) and distilled water (10 mL) according to the 
general procedure T to obtain a white solid in 87 % yield (1.14 g, 2.03 mmol). 
Molecular formula: C24H33F3N2O8S 
Molecular weight: 566.59 g/mol 
Melting Point: 60-61°C 
1H NMR (400 Hz, CDCl3) ppm: 9.31 (s, 1H, H13), 7.63 (d, J = 8.4 Hz, 2H, H4, H8), 7.57 (d, 
J = 8.4 Hz, 2H, H5, H7), 7.50 (t, J = 1.6 Hz, 1H, H14/H15), 7.36 (t, J = 1.6 Hz, 1H, 
H14/H15), 6.08 (s, 1H, H2), 5.47 (d part A of an AB system, J = 18.0  Hz, 1H, H12), 5.32 (d 
part B of an AB system, J = 18.0 Hz, 1H, H12), 3.93 (t, J = 6.8 Hz, 2H, H17), 3.92 (s, 3H, 
H16), 3.76 (s, 3H, H10), 1.60-1.53 (m , 2H, H18), 1.36-1.17 (m, 10H, H19-H23), 0.85 (t, J = 
6.8 Hz, 3H, H24). 
13C NMR (100 Hz, CDCl3) ppm: 169.27 (COO, C1), 165.97 (COO, C11), 137.70 (ArC, C13), 
136.34 (ArC, C3), 128.83 (q, J = 32.0 Hz, ArCH, C6), 127.56 (2ArCH, C4, C8), 125.67 (q, J 
= 270.5 Hz, CF3, C9), 123.51 (q, J = 3.8 Hz, 2ArCH, C5, C7), 120.66 (ArCH, C14/C15), 
116.43 (ArCH, C14/C15), 74.55 (OCH, C2), 67.78 (OCH2, C17), 53.76 (OCH3, C10), 49.89 
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(CH2, C12), 35.46 (CH3, C16), 31.71 (CH2), 29.65 (CH2), 29.19 (CH2), 29.68 (CH2), 25.88 
(CH2), 22.13 (CH2), 14.50 (CH3). 
19F NMR (376 MHz, CDCl3) ppm: -62.09 (3F) 
IR (neat, cm-1): 3119, 2929, 1736, 1620, 1579, 1416, 1325, 1165, 1124, 1066, 1017, 832. 
MS (m/z): 357.10 [M-OctOSO3¯ ]+ 
 
6.5 Miscellaneous: 
6.5.1 Fluorinated compounds: 
Ethyl 2-fluoro-2-phenylacetate (134)16 
 
To a stirred solution of alcohol (510 mg, 2.83 mmol) in CH2Cl2 (10 mL) was added DAST 
(0.70 mL, 5.1 mmol) at 0 °C, and the resulting mixture was slowly warmed to rt and stirred 
for 14 h. The reaction was carefully quenched with saturated NaHCO3 solution and extracted 
with CH2Cl2 (2 X 10 mL). The combined extracts were washed with 0.5 N HCl solution and 
dried over MgSO4. After evaporation of the solvent under reduced pressure, the resulting 
residue was chromatographed using silica gel (10:90 EtOAc/hexane) to obtain the title 
compound (134) as light yellow oil in 51 % yield (260 mg, 1.43 mmol). 
Molecular formula: C10H11FO2 
Molecular weight: 182.19 g/mol 
1H NMR (600 MHz, CDCl3) ppm: 7.48-7.46 (m, 2H, H5, H7) 7.42-7.39 (m, 3H, H4, H6, H8), 
5.78 (d, J = 48.0 Hz, 1H), 4.26-4.13 (m, 2H, H9), 1.25 (t, J = 7.2 Hz, 3H, H10). 
13C NMR (150 MHz, CDCl3) ppm: 168.60 (d, 2JC-F = 27.5 Hz, C1), 134.35 (ArC, d, 2JC-F = 
20.6 Hz, C3), 129.63 (ArCH, C6), 128.81 (2ArCH, C5, C7), 126.70 (2ArCH, d, 3JC-F = 6.5 
Hz, C4, C8), 89.4 (FCH, d, 1JC-F = 184.5 Hz, C2), 61.8 (OCH2, C9), 14.0 (CCH3, C10). 
19F NMR (376 MHz, CDCl3) ppm: -179.68 (d, J = 48 MHz, 1F, HCF) 
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1H and 13C-NMR spectra are in agreement with literature data.16 
Ethyl 2-bromo-2-fluoro-2-phenylacetate (135) 
7
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Fluoro ethyl ester (250 mg, 1.37 mmol) and NBS (240 mg, 1.37 mmol) were refluxed in CCl4 
(10 mL) under illumination from a 300-W mercury lamp. After 1 h an orange coloration 
appeared in the mixture which disappeared with additional 5 h. Filtration, evaporation of the 
solvent followed by column chromatography (SiO2, EtOAc:Hexane; 10:90) afforded title 
compound (135) in  75 % yield (270 mg, 1.03 mmol).17 
Molecular formula: C10H10BrFO2 
Molecular weight: 261.09 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.74-7.69 (m, 2H, H5, H7) 7.44-7.41 (m, 3H, H4, H6, H8), 
4.33 (dt, J = 10.8, 7.2 Hz, 2H, H9), 1.33 (t, J = 7.2 Hz, 3H, H10). 
13C NMR (100 MHz, CDCl3) ppm: 165.77 (d, 2JC-F = 28.3 Hz, C1), 136.94 (ArC, d, 2JC-F = 
21.7 Hz, C3), 130.40 (ArCH, C6), 128.55 (2ArCH, C5, C7), 126.16 (2ArCH, d, 3JC-F = 8.0 
Hz, C4, C8), 96.80 (FCBr, d, 1JC-F = 262.3 Hz, C2), 63.76 (OCH2, C9), 13.94 (CCH3, C10). 
19F NMR (376 MHz, CDCl3) ppm: -114.36 (FCBr). 
IR (neat, cm-1): 2920, 2850, 1729, 1463, 1256, 727.  
6.5.2 Commercial Ionic Liquids: 
1-Methyl-3-propyl-1H-imidazol-3-ium iodide (138)18 
 
To a stirred solution of iodopropane (21.93 g, 129.0 mmol) in diethyl ether (100 mL) at RT 
was added 1-methylimidazole (10.6 mL, 129 mmol) dropwise and the reaction mixture was 
stirred for 12 h. The viscous liquid which had settled at bottom, was washed with diethyl ether 
(5 x 50 mL) and dried under high vacuum to give the title compound as a pale yellow liquid in 
81 % yield (26.41 g, 104.8 mmol). 
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Molecular formula: C7H13IN2 
Molecular weight: 252.09 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 9.58 (s, 1H, H2), 7.45 (t, J = 1.6 Hz, 1H, H3/H4), 7.42 (t, J 
= 1.6 Hz, 1H, H3/H4), 4.06 (t, J = 7.2 Hz, 2H, H5), 1.72 (qt, J = 7.6, 7.2 Hz, 2H, H6), 3.86 (s, 
3H, H1), 0.72 (t, J = 7.6 Hz, 3H, H7). 
13C NMR (100 MHz, CDCl3) ppm: 135.58 (ArCH, C2), 123.18 (ArCH, C3/C4), 121.92 
(ArCH, C3/C4), 50.76 (NCH2, C5), 36.43 (NCH3, C1), 23.02 (CCH2, C6), 10.12 (CCH3, C7). 
1H and 13C-NMR spectra are in agreement with the literature data.18 
 
1-Methyl-3-(prop-2-en-1-yl)-1H-imidazol-3-ium iodide (139)18 
 
To a stirred solution of allyl iodide (15.28 g, 91.0 mmol) in diethyl ether (100 mL) at RT was 
added 1-methylimidazole (7.5 mL, 91 mmol) dropwise and the reaction mixture was stirred 
for 12 h. Solid generated was washed with diethyl ether (5 x 50 mL) and dried under high 
vacuum to give the title compound as a pale yellow solid in 76 % yield (17.25 g, 67.0 mmol). 
Molecular formula: C7H11IN2 
Molecular weight: 250.08 g/mol 
Melting point: 65-67 °C 
1H NMR (600 MHz, CDCl3) ppm: 9.76 (s, 1H, H2), 7.61 (t, J = 1.8 Hz, 1H, H3/H4), 7.48 (t, J 
= 1.8 Hz, 1H, H3/H4), 5.99 (m, 1H, H6), 5.47 (d, J = 16.8 Hz, 1H, H7), 5.40 (d, J = 10.2 Hz, 
1H, H7), 4.95 (d, J = 6.6 Hz, 2H, H5), 4.05 (s, 3H, H1). 
13C NMR (150 MHz, CDCl3) ppm: 136.39 (ArCH, C2), 129.54 (ArCH, C3/C4), 123.91 
(ArCH, C3/C4), 122.96 (CCH2, C7), 122.17 (CCH, C6), 52.05 (CCH2, C5), 37.19 (CCH3, 
C1). 
1H and 13C-NMR spectra are in agreement with the literature data.18 
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3-(Carboxymethyl)-1-methyl-imidazolium chloride (140)19 
 
Chloroacetic acid (18.2 g, 192.6 mmol) was added to 1-methylimidazole (15.5 mL, 193 
mmol) over a period of an hour, and then the mixture was heated at 70 °C for 3.5 h. The solid 
thus obtained was cooled to RT, washed with acetonitrile (100 mL) and dried under high 
vacuum to obtain a white solid in 45 % yield (15.39 g, 87.2 mmol). 
Molecular formula: C6H9ClN2O2 
Molecular weight: 176.6 g/mol 
Melting point: 140-142 °C 
1H NMR (400 MHz, D2O) ppm: 8.73 (s, 1H, H3), 7.44-7.43 (m, 2H, H4, H5), 4.99 (s, 2H, 
H2), 3.89 (s, 3H, H6). 
13C NMR (100 MHz, D2O) ppm: 170.63 (COO, C1), 137.15 (ArCH, C3), 123.37 (ArCH, 
C4/C5), 123.31 (ArCH, C4/C5), 50.37 (NCH2, C2), 35.78 (NCH3, C6). 
IR (neat, cm-1): 3359, 3155, 3113, 3028, 1720, 1664, 1569, 1474, 1440, 1391, 1199, 1164, 
979, 777. 
MS (m/z): 141.10 [M-Cl -]+ 
 
1H and 13C-NMR spectra are in agreement with literature data.19 
 
6.5.3 Tsuji-Trost Reaction Products: 
 (2E)-1,3-Diphenylprop-2-en-1-yl acetate (161)20 
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To a solution of (E)-1,3-diphenyl allyl alcohol (5.87 g, 27.9 mmol) triethylamine (7.80 mL, 
56 mmol) and DMAP (3.41 g, 27.9 mmol) in diethyl ether (100 mL) acetic anhydride (3.96 
mL, 41.88 mmol) was slowly added at 0-5 °C. The reaction was allowed to stir overnight at 
room temperature. The organic layer was extracted with saturated NaHCO3 (1 x100 mL), 
water (1 x 100 mL), brine (1 x 100 mL), dried (Na2SO4) and concentrated to yield a dark 
yellow oil that was purified by column chromatography (SiO2, 9:1 hexanes/EtOAc) to afford 
a colourless liquid in 93 % yield (6.54 g, 25.9 mmol). 
Molecular formula: C17H16O2 
Molecular weight: 252.31 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.32-7.12 (m, 10H, H5-H9, H13-17), 6.53 (d, J = 15.6 Hz, 
1H, H11), 6.34 (d, J = 7.0 Hz, 1H, H3), 6.24 (dd, J = 15.6, 7.0 Hz, 1H, H10), 2.02 (s, 3H, 
H1). 
13C NMR (100 MHz, CDCl3) ppm: 170.10 (COO, C2), 139.28 (ArC), 136.17 (ArC), 132.63 
(ArCH), 128.70 (2ArCH), 128.65 (2ArCH), 128.25 (ArCH), 128.14 (ArCH), 127.52 (ArCH), 
127.11 (2ArCH), 126.76 (2ArCH), 76.21 (CH, C3), 21.43 (CH3, C1). 
1H and 13C-NMR spectra are in agreement with the literature data.20 
1,3-Dimethyl 2-[(2E)-1,3-diphenylprop-2-en-1-yl]propanedioate (162)21 
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To a mixture of 1,3-diphenyl allyl acetate (96 mg, 0.38 mmol), Pd(PPh3)4 (22 mg, 0.02 mmol) 
and potassium carbonate (105 mg, 0.76 mmol) in dry THF (2 mL) dimethylmalonate (75 mg, 
0.06 mmol) was added at rt under nitorgen and reaction was stirred at rt for 6 h. The volatiles 
were removed under reduced pressure, and residual crude product was purified by column 
chromatography (EtOAc:Hexane, 10:90) to afford colourless liquid in 55 % yield (67 mg, 
0.21 mmol). 
Molecular formula: C20H20O4 
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Molecular weight: 324.37 g/mol 
1H NMR (400 MHz, CDCl3) ppm: 7.18-7.14 (m, 10H, H8-H12, H16-20), 6.44 (d, J = 15.6 
Hz, 1H, H14), 6.28 (dd, J = 15.6, 8.8 Hz, 1H, H13),4.22 (dd, J = 10.8, 8.8 Hz, 1H, H6), 3.91 
(d, J = 10.8 Hz, 1H, H3), 3.66 (s, 3H, H1/H5), 3.48 (s, 3H, H1/H5). 
13C NMR (100 MHz, CDCl3) ppm: 168.35 (COO, C2/C4), 167.93 (COO, C2/C4), 140.27 
(ArC), 136.92 (ArC), 131.96 (2ArCH), 129.21 (ArCH), 128.88 (2ArCH), 128.62 (2ArCH), 
128.00 (2ArCH), 127.72 (ArCH), 127.32 (ArCH), 126.53 (ArCH), 57.77 (CH, C3), 52.81 
(OCH3, C1/C5), 52.63 (OCH3, C1/C5), 49.34 (CH, C6). 
1H and 13C-NMR spectra are in agreement with the literature data.21 
6.6 Procedures for Toxicity and Biodegradation Tests and Applications: 
6.6.1 Antibacterial Toxicity Screening at Charles University (Czech Republic) 
 
In vitro antibacterial activities of the compounds were evaluated on a panel of three CCM 
strains (Staphylococcus aureus CCM 4516, Escherichia coli CCM 4517, Pseudomonas 
aeruginosa CCM 1961) and five clinical isolates (Staphylococcus aureus MRSA H 5996/08, 
Staphylococcus epidermidis H 6966/08, Enterococcus sp. H 14365/08, Klebsiella pneumoniae 
D 11750/08, Klebsiella pneumoniae ESBL H 14368/08) from the collection of fungal strains 
deposited at the Department of Biological and Medical Sciences, Faculty of Pharmacy, 
Charles University, Hradec Králové, Czech Republic. The abovementioned ATCC strains also 
served as the quality control strains. All the isolates were maintained on Mueller-Hinton 
dextrose agar prior to being tested.  
Dimethyl sulfoxide (100 %) served as a diluent for all compounds; the final concentration did 
not exceed 2 %. Mueller-Hinton agar (MH, HiMedia, adersky-Envitek, Czech Republic) 
buffered to pH 7.4 (±0.2) was used as the test medium. The wells of the microdilution tray 
contained 200 µL of the Mueller-Hinton medium with 2-fold serial dilutions of the 
compounds (2000 or 1000 to 0.48 µmol/l) and 10 µL of inoculum suspension. Inoculum in 
MH medium was prepared to give a final concentration of 0.5 McFarland scale (1.5 × 108 
cfu.mL-1). The trays were incubated at 36°C and MICs were read visually after 24 h and 48 h. 
The MICs were defined as 95 % inhibition of the growth of control. MICs were determined 
twice and in duplicate. The deviations from the usually obtained values were no higher than 
the nearest concentration value up and down the dilution scale.  
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6.6.2 Antifungal Toxicity Screening at Charles University (Czech Republic) 
 
In vitro antifungal activities of the compounds were evaluated on a panel of four ATCC 
strains (Candida albicans ATCC 44859,  Candida albicans ATCC 90028,  Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258) and eight clinical isolates of yeasts 
(Candida krusei E28,  Candida tropicalis 156,  Candida glabrata 20/I, Candida lusitaniae 
2446/I, Trichosporon asahii 1188) and filamentous fungi (Aspergillus fumigatus 231, Absidia 
corymbifera 272, Trichophyton mentagrophytes 445) from the collection of fungal strains 
deposited at the Department of Biological and Medical Sciences, Faculty of Pharmacy, 
Charles University, Hradec Králové, Czech Republic. Three of the above ATCC strains 
(Candida albicans ATCC 90028, Candida parapsilosis ATCC 22019, Candida krusei ATCC 
6258) also served as the quality control strains. All the isolates were maintained on Sabouraud 
dextrose agar prior to being tested. Minimum inhibitory concentrations (MICs) were 
determined by the microdilution format of the NCCLS M27-A guidelines.22 
Dimethyl sulfoxide (100 %) served as a diluent for all compounds; the final concentration did 
not exceed 2 %. RPMI 1640 (Sevapharma, Prague) medium supplemented with L-glutamine 
and buffered with 0.165 M morpholinepropanesulfonic acid (Serva) to pH 7.0 by 10 N NaOH 
was used  as the test medium. The wells of the microdilution tray contained 100 µL of the 
RPMI 1640 medium with 2-fold serial dilutions of the compounds (2000 or 1000 to 0.48 
µmol/L) and 100 µL of inoculum suspension. Fungal inoculum in RPMI 1640 was prepared 
to give a final concentration of 5 × 103 ± 0.2 cfu.mL-1. The trays were incubated at 35°C and 
MICs were read visually for filamentous fungi and photometrically for yeasts as an 
absorbance at 540 nm after 24 h and 48 h. The MIC/IC50 values for the dermatophytic strain 
(T. mentagrophytes) were determined after 72 h and 120 h and for A. fumigatus, A. 
corymbifera after 24 and 48 h. For all other strains MIC/IC80 values were evaluated. The 
MICs were defined as 50 % or 80 % inhibition of the growth of control. MICs were 
determined twice and in duplicate. The deviations from the usually obtained values were no 
higher than the nearest concentration value up and down the dilution scale. 
 
6.6.3 Antibacterial Toxicity Screening at Higher Concentration (Dept. of Biotechnology, 
DCU) 
Mueller-Hinton broth was purchased from Oxoid. Five bacteria strains were used in this 
study: the Gram-positive bacterium Bacillus subtilis DSMZ 10 (B. subtilis) and the Gram-
negative bacteria Escherichia coli DSMZ 498 (E. coli), Pseudomonas fluorescens   DSMZ 
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50090 (P. fluorescence), Pseudomonas putida CP1 (P. putida CP1) and Pseudomonas putida 
KT2440 (P. putida KT2440). All strains were purchased at DSMZ (German Collection of 
Microorganisms and Cell Cultures). 
IC50 values for the compounds were determined using a modification of the  broth 
microdilution method described by Amsterdam.23 Strains were grown in nutrient broth 
overnight, washed with 0.01M sodium phosphate buffer (pH 7) and the cell number adjusted 
to give an optical density reading of 0.07 at 660 nm. The antimicrobial activity of the ILs was 
tested in 96 well round bottom microplates. 180 µL of Mueller-Hinton broth was pipetted into 
column 1 of the wells and 100 µL into the other wells. 20 µL of the chemical solution was 
transferred into column 1 giving a concentration of 200 mM. 100 µL of the solution from 
column 1 was then transferred to the next column and mixed. The procedure was repeated to 
give a series of two-fold dilutions. Each well was inoculated with 5 µL of bacterial culture. 
Wells containing medium only were used as blanks and wells containing medium and culture 
only were used as positive controls. All the toxicity tests were carried out in triplicate. The 
microplates were incubated overnight at 30°C. The presence or absence of growth was 
determined by measuring the optical density of the wells at a wavelength of 405nm using a 
plate reader. The IC50 values were determined as the concentration or range of concentrations 
that caused a 50% reduction in growth. 
6.6.4 Toxicity Study using Fresh water Green Algae (Aveiro, Portugal) 
  
The growth inhibition of the ILs towards the green microalgae P. subcapitata and C. vulgaris 
was assessed using a static bioassay conducted according to adequate growth inhibition 
testing procedures24 guidelines, with adaptation to 24-well microplate.25 The algae were 
exposed during 72 h under continuous illumination to serial dilutions of the IL in MBL 
medium: 0 (control), 6.25, 12.5, 25, 50, 75 and 100 %. Peripheral wells of the microplates 
were excluded from the assay given that as an “edge-effect” the evaporation is greater in these 
wells, which would introduce unnecessary variability among replicates. Each microplate held 
two test treatments with three 3 replicates plus 2 replicates of a blank control. Each well was 
filled with 990 µL test solution plus 10 µL microalgae inoculum; this was prepared based on 
microscopic cell counting in a Neubauer haemocytometer by dilution of the exponential-
growing batch culture to achieve a cell density of 106 cells.mL-1 so that the final nominal cell 
density at the beginning of the test could be set at 104 cells.mL-1. The test microplates were 
incubated as described above for algal cultures and the contents of each well were thoroughly 
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mixed twice daily by repetitive pipetting to promote active gas exchange and prevent cell 
clumping. At the end of the bioassay, cell density was determined by microscopic cell 
counting in a Neubauer haemocytometer of a well-mixed aliquot collected from each 
replicate. Yield and the daily growth rate were calculated from the cell density measurements. 
EC50 parameters and their 95% confidence limits were estimated on the basis of non-linear 
regression with former fitting of the data to the logistic equation through the least squares 
statistical method. 
 
6.6.5. CO2 Headspace test (Spain): 
To evaluate the biodegradability of the test ionic liquids, the “CO2 Headspace” test (ISO 
14593) was applied.23 There are several biodegradation study methods (Chapter 1) but the 
CO2 Headspace test was chosen as it is particularly suited for charged, volatile and water 
soluble compounds. Also, this method allows for the evaluation of the ultimate aerobic 
biodegradability of an organic compound in an aqueous medium at a given concentration of 
microorganism, by analysis of the inorganic carbon produced. The test ionic liquid, as the 
only source of carbon and energy, was added to a buffer/mineral salts medium which had 
been inoculated with a mixed population of microorganisms derived from activated sludge 
collected from a sewage treatment plant located in Manresa (Barcelona), to give a final 
organic carbon concentration of 20 mg/L. These solutions were incubated in sealed vessels 
with a “headspace” of air, which provided a reservoir of oxygen for aerobic biodegradation. 
The volume of activated sludge used for inoculation was that which gave a concentration of 4 
mg/L suspended solids in the final mixture. Based on experience, the use of this inoculum 
concentration in this test is suitable to give a population (102-105 colony-forming units in the 
final mixture) which offers adequate biodegradative activity and degrades the reference 
substance by the stipulated percentage. 
Biodegradation (mineralization to carbon dioxide) was determined by measuring the net 
increase in total inorganic carbon (TIC) levels over time compared to unamended blanks. 
Sodium n-dodecyl sulfate (SDS) was used as a reference substance. The test ran for 28 days. 
The extent of biodegradation was expressed as a percentage of the theoretical amount of 
inorganic carbon (ThID) based on the amount of IL added initially. Assuming 100% 
mineralization of the test ionic liquid, the theoretical amount of inorganic carbon (ThID), in 
excess of that produced in the blank controls, equals the amount of total organic carbon 
(TOC) added as the test compound to each vessel at the start of the test, that is: (ThIC=TOC) 
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Percentage biodegradation Dt in each case is given by: 
    =
(	
)

x100 
where: 
TICt is the TIC, in milligrams, in test vessel at time t, 
TICb is the mean TIC, in milligrams, in blank control vessels at time t 
TOCi is the TOC, in milligrams, initially added to the test vessel 
The measured data of the last day of the test (28 days) were used to calculate the mean 
biodegradation value and the precision with which the percentage of biodegradation was 
determined. To know the precision with which percentage of biodegradation was determined, 
four replicate test vessels and the same number of blanks control vessels on the 28th day were 
analysed:  
• the mean total inorganic carbon in the blank vessels and the percentage of 
biodegradation for each individual vessel was calculated 
• the mean of the separate degradation values and their standard deviation was 
calculated 
• and finally the confidence limits for the mean value of biodegradation was evaluated 
as   
±
.
√
  
where t is the Student’s t value for (n-1) degrees of freedom at the 95% probability 
level, s is the standard deviation and n is the number of individual values used to 
determine the biodegradation percentage. 
6.6.6 Procedure for Tsuji-Trost Reactions:26 
Pd2(dba)3·CHCl3 (4.58 mg, 0.005 mmol) and ferrocenylphosphine ligand (19.25 mg, 0.02 
mmol) were added to pre-dried IL (0.50 mmol) and the resulting mixture was stirred at 80°C 
under Ar-atmosphere for 20 min. Substrate (126 mg, 0.50 mmol), dimethyl malonate (132 
mg, 1.0 mmol) and K2CO3 (276 mg, 1.0 mmol) were added to the cooled reaction mixture. 
The reaction mixture was stirred at room temperature under Ar-atmosphere for 15 h. Toluene 
(2 mL) was added and mixture was vigorously stirred for 5 min, the separated toluene layer 
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was collected and this procedure was repeated until no product was detected in the toluene 
layer (ca.10 times). The combined toluene extracts were washed with water (5 mL), dried and 
solvent was evaporated. The residue was purified by chromatography on a SiO2-column (30 g, 
12.5% EtOAc–hexane). The product was obtained after evaporation of solvent as clear 
colourless oil.  
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